GeneSet	gene_ID	N	M	n	m	p_value	FDR_q_value
Alzheimer disease	100132406	155	19	8	4	0.0084151	0.19581
RNA degradation	100132406	155	19	2	2	0.014328	0.19581
Protein digestion and absorption	100132406	155	19	2	2	0.014328	0.19581
Pathways of neurodegeneration - multiple diseases	100132406	155	19	7	3	0.040114	0.27921
Mucin type O-glycan biosynthesis	100132406	155	19	1	1	0.12258	0.27921
Glycerolipid metabolism	100132406	155	19	1	1	0.12258	0.27921
Glycerophospholipid metabolism	100132406	155	19	1	1	0.12258	0.27921
Arachidonic acid metabolism	100132406	155	19	1	1	0.12258	0.27921
Sphingolipid metabolism	100132406	155	19	1	1	0.12258	0.27921
ABC transporters	100132406	155	19	1	1	0.12258	0.27921
mTOR signaling pathway	100132406	155	19	1	1	0.12258	0.27921
Signaling pathways regulating pluripotency of stem cells	100132406	155	19	1	1	0.12258	0.27921
Glutamatergic synapse	100132406	155	19	1	1	0.12258	0.27921
Serotonergic synapse	100132406	155	19	1	1	0.12258	0.27921
GABAergic synapse	100132406	155	19	1	1	0.12258	0.27921
Fat digestion and absorption	100132406	155	19	1	1	0.12258	0.27921
Epithelial cell signaling in Helicobacter pylori infection	100132406	155	19	1	1	0.12258	0.27921
Pathogenic Escherichia coli infection	100132406	155	19	1	1	0.12258	0.27921
Parkinson disease	100132406	155	19	6	2	0.15838	0.34178
Notch signaling pathway	100132406	155	19	2	1	0.23083	0.37857
Complement and coagulation cascades	100132406	155	19	2	1	0.23083	0.37857
Renin-angiotensin system	100132406	155	19	2	1	0.23083	0.37857
Alcoholic liver disease	100132406	155	19	2	1	0.23083	0.37857
Cholesterol metabolism	100132406	155	19	2	1	0.23083	0.37857
Salmonella infection	100132406	155	19	2	1	0.23083	0.37857
Gap junction	100132406	155	19	3	1	0.32635	0.47787
Thyroid hormone signaling pathway	100132406	155	19	3	1	0.32635	0.47787
Lipid and atherosclerosis	100132406	155	19	3	1	0.32635	0.47787
Coronavirus disease - COVID-19	100132406	155	19	11	2	0.40114	0.51009
Ubiquitin mediated proteolysis	100132406	155	19	4	1	0.41056	0.51009
Amyotrophic lateral sclerosis	100132406	155	19	4	1	0.41056	0.51009
Huntington disease	100132406	155	19	4	1	0.41056	0.51009
Prion disease	100132406	155	19	4	1	0.41056	0.51009
Phagosome	100132406	155	19	5	1	0.48473	0.56782
Hematopoietic cell lineage	100132406	155	19	5	1	0.48473	0.56782
Protein processing in endoplasmic reticulum	100132406	155	19	6	1	0.54999	0.62638
Metabolic pathways	100132406	155	19	24	3	0.59474	0.63852
Oocyte meiosis	100132406	155	19	7	1	0.60738	0.63852
Progesterone-mediated oocyte maturation	100132406	155	19	7	1	0.60738	0.63852
NOD-like receptor signaling pathway	100132406	155	19	15	1	0.87293	0.89475
Ribosome biogenesis in eukaryotes	100132406	155	19	18	1	0.91824	0.91824
Transcriptional misregulation in cancer	100133941	155	12	8	4	0.0012586	0.025171
Amoebiasis	100133941	155	12	2	2	0.00553	0.04204
Staphylococcus aureus infection	100133941	155	12	6	3	0.006306	0.04204
Phagosome	100133941	155	12	5	2	0.048387	0.24194
Carbohydrate digestion and absorption	100133941	155	12	1	1	0.077419	0.24885
Asthma	100133941	155	12	1	1	0.077419	0.24885
NOD-like receptor signaling pathway	100133941	155	12	15	3	0.094794	0.24885
Amino sugar and nucleotide sugar metabolism	100133941	155	12	2	1	0.14931	0.24885
PPAR signaling pathway	100133941	155	12	2	1	0.14931	0.24885
Lysosome	100133941	155	12	2	1	0.14931	0.24885
Renin-angiotensin system	100133941	155	12	2	1	0.14931	0.24885
IL-17 signaling pathway	100133941	155	12	2	1	0.14931	0.24885
Drug metabolism - other enzymes	100133941	155	12	3	1	0.21603	0.27004
Neuroactive ligand-receptor interaction	100133941	155	12	3	1	0.21603	0.27004
Acute myeloid leukemia	100133941	155	12	3	1	0.21603	0.27004
Lipid and atherosclerosis	100133941	155	12	3	1	0.21603	0.27004
Neutrophil extracellular trap formation	100133941	155	12	13	2	0.2651	0.31188
Hematopoietic cell lineage	100133941	155	12	5	1	0.33531	0.37256
Systemic lupus erythematosus	100133941	155	12	10	1	0.5645	0.59421
Metabolic pathways	100133941	155	12	24	1	0.87769	0.87769
Ribosome	100169751	155	16	17	16	7.1416e-21	1.4283e-20
Ribosome biogenesis in eukaryotes	100169751	155	16	18	16	6.4274e-20	6.4274e-20
Ribosome	100169753	155	16	17	16	7.1416e-21	1.4283e-20
Ribosome biogenesis in eukaryotes	100169753	155	16	18	16	6.4274e-20	6.4274e-20
Ribosome	100169754	155	16	17	16	7.1416e-21	1.4283e-20
Ribosome biogenesis in eukaryotes	100169754	155	16	18	16	6.4274e-20	6.4274e-20
Ribosome	100169755	155	16	17	16	7.1416e-21	1.4283e-20
Ribosome biogenesis in eukaryotes	100169755	155	16	18	16	6.4274e-20	6.4274e-20
Ribosome	100169756	155	16	17	16	7.1416e-21	1.4283e-20
Ribosome biogenesis in eukaryotes	100169756	155	16	18	16	6.4274e-20	6.4274e-20
Ribosome	100169757	155	16	17	16	7.1416e-21	1.4283e-20
Ribosome biogenesis in eukaryotes	100169757	155	16	18	16	6.4274e-20	6.4274e-20
Ribosome	100169758	155	16	17	16	7.1416e-21	1.4283e-20
Ribosome biogenesis in eukaryotes	100169758	155	16	18	16	6.4274e-20	6.4274e-20
Ribosome	100169759	155	16	17	16	7.1416e-21	1.4283e-20
Ribosome biogenesis in eukaryotes	100169759	155	16	18	16	6.4274e-20	6.4274e-20
Ribosome	100169760	155	1	17	1	0.10968	0.11613
Ribosome biogenesis in eukaryotes	100169760	155	1	18	1	0.11613	0.11613
Ribosome	100169761	155	16	17	16	7.1416e-21	1.4283e-20
Ribosome biogenesis in eukaryotes	100169761	155	16	18	16	6.4274e-20	6.4274e-20
Ribosome	100169762	155	16	17	16	7.1416e-21	1.4283e-20
Ribosome biogenesis in eukaryotes	100169762	155	16	18	16	6.4274e-20	6.4274e-20
Ribosome	100169763	155	16	17	16	7.1416e-21	1.4283e-20
Ribosome biogenesis in eukaryotes	100169763	155	16	18	16	6.4274e-20	6.4274e-20
Ribosome	100169764	155	16	17	16	7.1416e-21	1.4283e-20
Ribosome biogenesis in eukaryotes	100169764	155	16	18	16	6.4274e-20	6.4274e-20
Ribosome	100169765	155	16	17	16	7.1416e-21	1.4283e-20
Ribosome biogenesis in eukaryotes	100169765	155	16	18	16	6.4274e-20	6.4274e-20
Ribosome	100169766	155	16	17	16	7.1416e-21	1.4283e-20
Ribosome biogenesis in eukaryotes	100169766	155	16	18	16	6.4274e-20	6.4274e-20
Ribosome	100169767	155	16	17	16	7.1416e-21	1.4283e-20
Ribosome biogenesis in eukaryotes	100169767	155	16	18	16	6.4274e-20	6.4274e-20
Ribosome	100169768	155	16	17	16	7.1416e-21	1.4283e-20
Ribosome biogenesis in eukaryotes	100169768	155	16	18	16	6.4274e-20	6.4274e-20
Cell cycle	10024	155	19	14	8	2.1716e-05	0.00084694
p53 signaling pathway	10024	155	19	4	4	0.00016757	0.002898
Oocyte meiosis	10024	155	19	7	5	0.00029723	0.002898
Cellular senescence	10024	155	19	7	5	0.00029723	0.002898
Progesterone-mediated oocyte maturation	10024	155	19	7	4	0.0045728	0.028592
Human T-cell leukemia virus 1 infection	10024	155	19	7	4	0.0045728	0.028592
Pyrimidine metabolism	10024	155	19	4	3	0.0058651	0.028592
Nucleotide metabolism	10024	155	19	4	3	0.0058651	0.028592
Drug metabolism - other enzymes	10024	155	19	3	2	0.039799	0.15644
Human immunodeficiency virus 1 infection	10024	155	19	7	3	0.040114	0.15644
DNA replication	10024	155	19	4	2	0.073733	0.2054
FoxO signaling pathway	10024	155	19	4	2	0.073733	0.2054
Ubiquitin mediated proteolysis	10024	155	19	4	2	0.073733	0.2054
MicroRNAs in cancer	10024	155	19	4	2	0.073733	0.2054
Purine metabolism	10024	155	19	1	1	0.12258	0.25161
Base excision repair	10024	155	19	1	1	0.12258	0.25161
Non-homologous end-joining	10024	155	19	1	1	0.12258	0.25161
Fanconi anemia pathway	10024	155	19	1	1	0.12258	0.25161
Hippo signaling pathway	10024	155	19	1	1	0.12258	0.25161
Viral carcinogenesis	10024	155	19	13	3	0.20094	0.32152
Glutathione metabolism	10024	155	19	2	1	0.23083	0.32152
One carbon pool by folate	10024	155	19	2	1	0.23083	0.32152
Platinum drug resistance	10024	155	19	2	1	0.23083	0.32152
MAPK signaling pathway	10024	155	19	2	1	0.23083	0.32152
Apoptosis	10024	155	19	2	1	0.23083	0.32152
Apoptosis - multiple species	10024	155	19	2	1	0.23083	0.32152
ECM-receptor interaction	10024	155	19	2	1	0.23083	0.32152
Colorectal cancer	10024	155	19	2	1	0.23083	0.32152
Hepatitis B	10024	155	19	8	2	0.25455	0.34232
Pathways in cancer	10024	155	19	9	2	0.30392	0.37434
Antifolate resistance	10024	155	19	3	1	0.32635	0.37434
AMPK signaling pathway	10024	155	19	3	1	0.32635	0.37434
Gap junction	10024	155	19	3	1	0.32635	0.37434
Acute myeloid leukemia	10024	155	19	3	1	0.32635	0.37434
Chemical carcinogenesis - receptor activation	10024	155	19	5	1	0.48473	0.54012
Metabolic pathways	10024	155	19	24	3	0.59474	0.6443
Transcriptional misregulation in cancer	10024	155	19	8	1	0.65778	0.69334
Human papillomavirus infection	10024	155	19	10	1	0.74079	0.76029
Epstein-Barr virus infection	10024	155	19	11	1	0.77476	0.77476
Intestinal immune network for IgA production	100423062	155	8	2	2	0.002346	0.028152
Cytokine-cytokine receptor interaction	100423062	155	8	3	2	0.0068541	0.041125
Protein processing in endoplasmic reticulum	100423062	155	8	6	2	0.031645	0.077419
Glycine, serine and threonine metabolism	100423062	155	8	1	1	0.051613	0.077419
Glyoxylate and dicarboxylate metabolism	100423062	155	8	1	1	0.051613	0.077419
Carbon metabolism	100423062	155	8	1	1	0.051613	0.077419
Protein export	100423062	155	8	1	1	0.051613	0.077419
Primary immunodeficiency	100423062	155	8	1	1	0.051613	0.077419
Parkinson disease	100423062	155	8	6	1	0.27628	0.34379
Cellular senescence	100423062	155	8	7	1	0.31514	0.34379
Pathways of neurodegeneration - multiple diseases	100423062	155	8	7	1	0.31514	0.34379
Metabolic pathways	100423062	155	8	24	1	0.74845	0.74845
RNA degradation	100913187	155	8	2	2	0.002346	0.032845
ABC transporters	100913187	155	8	1	1	0.051613	0.24086
Fat digestion and absorption	100913187	155	8	1	1	0.051613	0.24086
Cholesterol metabolism	100913187	155	8	2	1	0.10088	0.35308
Lipid and atherosclerosis	100913187	155	8	3	1	0.14789	0.36766
Ubiquitin mediated proteolysis	100913187	155	8	4	1	0.19274	0.36766
Viral life cycle - HIV-1	100913187	155	8	5	1	0.23551	0.36766
Parkinson disease	100913187	155	8	6	1	0.27628	0.36766
Oocyte meiosis	100913187	155	8	7	1	0.31514	0.36766
Progesterone-mediated oocyte maturation	100913187	155	8	7	1	0.31514	0.36766
Pathways of neurodegeneration - multiple diseases	100913187	155	8	7	1	0.31514	0.36766
Human immunodeficiency virus 1 infection	100913187	155	8	7	1	0.31514	0.36766
NOD-like receptor signaling pathway	100913187	155	8	15	1	0.56582	0.60935
Ribosome biogenesis in eukaryotes	100913187	155	8	18	1	0.63656	0.63656
RNA degradation	101060226	155	15	2	2	0.0087977	0.24194
Pathways of neurodegeneration - multiple diseases	101060226	155	15	7	3	0.020488	0.24194
Alzheimer disease	101060226	155	15	8	3	0.030834	0.24194
Glycerolipid metabolism	101060226	155	15	1	1	0.096774	0.24194
Glycerophospholipid metabolism	101060226	155	15	1	1	0.096774	0.24194
ABC transporters	101060226	155	15	1	1	0.096774	0.24194
mTOR signaling pathway	101060226	155	15	1	1	0.096774	0.24194
Signaling pathways regulating pluripotency of stem cells	101060226	155	15	1	1	0.096774	0.24194
Glutamatergic synapse	101060226	155	15	1	1	0.096774	0.24194
Serotonergic synapse	101060226	155	15	1	1	0.096774	0.24194
GABAergic synapse	101060226	155	15	1	1	0.096774	0.24194
Fat digestion and absorption	101060226	155	15	1	1	0.096774	0.24194
Epithelial cell signaling in Helicobacter pylori infection	101060226	155	15	1	1	0.096774	0.24194
Pathogenic Escherichia coli infection	101060226	155	15	1	1	0.096774	0.24194
Parkinson disease	101060226	155	15	6	2	0.10462	0.24411
Notch signaling pathway	101060226	155	15	2	1	0.18475	0.32331
Alcoholic liver disease	101060226	155	15	2	1	0.18475	0.32331
Protein digestion and absorption	101060226	155	15	2	1	0.18475	0.32331
Cholesterol metabolism	101060226	155	15	2	1	0.18475	0.32331
Salmonella infection	101060226	155	15	2	1	0.18475	0.32331
Gap junction	101060226	155	15	3	1	0.26468	0.40277
Thyroid hormone signaling pathway	101060226	155	15	3	1	0.26468	0.40277
Lipid and atherosclerosis	101060226	155	15	3	1	0.26468	0.40277
Ubiquitin mediated proteolysis	101060226	155	15	4	1	0.33724	0.43717
Amyotrophic lateral sclerosis	101060226	155	15	4	1	0.33724	0.43717
Huntington disease	101060226	155	15	4	1	0.33724	0.43717
Prion disease	101060226	155	15	4	1	0.33724	0.43717
Phagosome	101060226	155	15	5	1	0.40308	0.50385
Protein processing in endoplasmic reticulum	101060226	155	15	6	1	0.46277	0.55852
Oocyte meiosis	101060226	155	15	7	1	0.51685	0.58355
Progesterone-mediated oocyte maturation	101060226	155	15	7	1	0.51685	0.58355
Coronavirus disease - COVID-19	101060226	155	15	11	1	0.68637	0.75072
NOD-like receptor signaling pathway	101060226	155	15	15	1	0.799	0.84743
Ribosome biogenesis in eukaryotes	101060226	155	15	18	1	0.85731	0.88252
Metabolic pathways	101060226	155	15	24	1	0.92982	0.92982
Staphylococcus aureus infection	10321	155	12	6	4	0.00029433	0.0061809
Transcriptional misregulation in cancer	10321	155	12	8	4	0.0012586	0.013215
Amoebiasis	10321	155	12	2	2	0.00553	0.03871
NOD-like receptor signaling pathway	10321	155	12	15	4	0.017982	0.094407
Phagosome	10321	155	12	5	2	0.048387	0.20323
Neutrophil extracellular trap formation	10321	155	12	13	3	0.065366	0.22878
Carbohydrate digestion and absorption	10321	155	12	1	1	0.077419	0.23226
Amino sugar and nucleotide sugar metabolism	10321	155	12	2	1	0.14931	0.24119
PPAR signaling pathway	10321	155	12	2	1	0.14931	0.24119
Lysosome	10321	155	12	2	1	0.14931	0.24119
Renin-angiotensin system	10321	155	12	2	1	0.14931	0.24119
IL-17 signaling pathway	10321	155	12	2	1	0.14931	0.24119
Salivary secretion	10321	155	12	2	1	0.14931	0.24119
Drug metabolism - other enzymes	10321	155	12	3	1	0.21603	0.26686
Neuroactive ligand-receptor interaction	10321	155	12	3	1	0.21603	0.26686
Acute myeloid leukemia	10321	155	12	3	1	0.21603	0.26686
Lipid and atherosclerosis	10321	155	12	3	1	0.21603	0.26686
Tuberculosis	10321	155	12	4	1	0.27792	0.32424
Hematopoietic cell lineage	10321	155	12	5	1	0.33531	0.3706
Systemic lupus erythematosus	10321	155	12	10	1	0.5645	0.59272
Metabolic pathways	10321	155	12	24	1	0.87769	0.87769
Cell cycle	1033	155	24	14	11	3.2386e-08	1.3278e-06
Oocyte meiosis	1033	155	24	7	6	4.8365e-05	0.00099149
p53 signaling pathway	1033	155	24	4	4	0.0004594	0.0062785
Cellular senescence	1033	155	24	7	5	0.001022	0.0083805
Progesterone-mediated oocyte maturation	1033	155	24	7	5	0.001022	0.0083805
Human T-cell leukemia virus 1 infection	1033	155	24	7	4	0.011489	0.054314
Pyrimidine metabolism	1033	155	24	4	3	0.011923	0.054314
Nucleotide metabolism	1033	155	24	4	3	0.011923	0.054314
DNA replication	1033	155	24	4	3	0.011923	0.054314
Platinum drug resistance	1033	155	24	2	2	0.023125	0.094814
Drug metabolism - other enzymes	1033	155	24	3	2	0.062725	0.21431
Antifolate resistance	1033	155	24	3	2	0.062725	0.21431
Human immunodeficiency virus 1 infection	1033	155	24	7	3	0.075286	0.23744
FoxO signaling pathway	1033	155	24	4	2	0.11353	0.29092
Ubiquitin mediated proteolysis	1033	155	24	4	2	0.11353	0.29092
MicroRNAs in cancer	1033	155	24	4	2	0.11353	0.29092
Purine metabolism	1033	155	24	1	1	0.15484	0.3023
Base excision repair	1033	155	24	1	1	0.15484	0.3023
Non-homologous end-joining	1033	155	24	1	1	0.15484	0.3023
Fanconi anemia pathway	1033	155	24	1	1	0.15484	0.3023
Hippo signaling pathway	1033	155	24	1	1	0.15484	0.3023
Chemical carcinogenesis - receptor activation	1033	155	24	5	2	0.1714	0.31942
Glutathione metabolism	1033	155	24	2	1	0.28655	0.39162
One carbon pool by folate	1033	155	24	2	1	0.28655	0.39162
Folate biosynthesis	1033	155	24	2	1	0.28655	0.39162
MAPK signaling pathway	1033	155	24	2	1	0.28655	0.39162
Apoptosis	1033	155	24	2	1	0.28655	0.39162
Apoptosis - multiple species	1033	155	24	2	1	0.28655	0.39162
ECM-receptor interaction	1033	155	24	2	1	0.28655	0.39162
Colorectal cancer	1033	155	24	2	1	0.28655	0.39162
Viral carcinogenesis	1033	155	24	13	3	0.32449	0.42917
Hepatitis B	1033	155	24	8	2	0.35896	0.45992
AMPK signaling pathway	1033	155	24	3	1	0.39847	0.46677
Gap junction	1033	155	24	3	1	0.39847	0.46677
Acute myeloid leukemia	1033	155	24	3	1	0.39847	0.46677
Pathways in cancer	1033	155	24	9	2	0.41991	0.47823
Biosynthesis of cofactors	1033	155	24	4	1	0.49344	0.54679
Transcriptional misregulation in cancer	1033	155	24	8	1	0.74845	0.8037
Metabolic pathways	1033	155	24	24	3	0.7645	0.8037
Human papillomavirus infection	1033	155	24	10	1	0.82412	0.84473
Epstein-Barr virus infection	1033	155	24	11	1	0.85323	0.85323
Coronavirus disease - COVID-19	10346	155	31	11	8	0.00012055	0.0041233
Measles	10346	155	31	9	7	0.00018742	0.0041233
Herpes simplex virus 1 infection	10346	155	31	9	7	0.00018742	0.0041233
Influenza A	10346	155	31	10	7	0.00053553	0.0088362
NOD-like receptor signaling pathway	10346	155	31	15	8	0.0025535	0.028525
Hepatitis C	10346	155	31	12	7	0.0025931	0.028525
Epstein-Barr virus infection	10346	155	31	11	6	0.0089306	0.084203
Necroptosis	10346	155	31	4	3	0.025458	0.18367
Kaposi sarcoma-associated herpesvirus infection	10346	155	31	4	3	0.025458	0.18367
RNA degradation	10346	155	31	2	2	0.038961	0.18367
Chemokine signaling pathway	10346	155	31	2	2	0.038961	0.18367
Notch signaling pathway	10346	155	31	2	2	0.038961	0.18367
RIG-I-like receptor signaling pathway	10346	155	31	2	2	0.038961	0.18367
C-type lectin receptor signaling pathway	10346	155	31	2	2	0.038961	0.18367
Hepatitis B	10346	155	31	8	4	0.051452	0.22639
JAK-STAT signaling pathway	10346	155	31	3	2	0.10211	0.4
Osteoclast differentiation	10346	155	31	4	2	0.17877	0.4
PD-L1 expression and PD-1 checkpoint pathway in cancer	10346	155	31	4	2	0.17877	0.4
Mucin type O-glycan biosynthesis	10346	155	31	1	1	0.2	0.4
Sphingolipid metabolism	10346	155	31	1	1	0.2	0.4
ABC transporters	10346	155	31	1	1	0.2	0.4
NF-kappa B signaling pathway	10346	155	31	1	1	0.2	0.4
Signaling pathways regulating pluripotency of stem cells	10346	155	31	1	1	0.2	0.4
Toll-like receptor signaling pathway	10346	155	31	1	1	0.2	0.4
Th1 and Th2 cell differentiation	10346	155	31	1	1	0.2	0.4
Glutamatergic synapse	10346	155	31	1	1	0.2	0.4
GABAergic synapse	10346	155	31	1	1	0.2	0.4
Prolactin signaling pathway	10346	155	31	1	1	0.2	0.4
AGE-RAGE signaling pathway in diabetic complications	10346	155	31	1	1	0.2	0.4
Growth hormone synthesis, secretion and action	10346	155	31	1	1	0.2	0.4
Fat digestion and absorption	10346	155	31	1	1	0.2	0.4
Epithelial cell signaling in Helicobacter pylori infection	10346	155	31	1	1	0.2	0.4
Toxoplasmosis	10346	155	31	1	1	0.2	0.4
Viral life cycle - HIV-1	10346	155	31	5	2	0.26135	0.50732
Human papillomavirus infection	10346	155	31	10	3	0.32009	0.52952
Protein processing in endoplasmic reticulum	10346	155	31	6	2	0.34461	0.52952
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	10346	155	31	2	1	0.36104	0.52952
Lysosome	10346	155	31	2	1	0.36104	0.52952
Cell adhesion molecules	10346	155	31	2	1	0.36104	0.52952
Cytosolic DNA-sensing pathway	10346	155	31	2	1	0.36104	0.52952
Th17 cell differentiation	10346	155	31	2	1	0.36104	0.52952
Protein digestion and absorption	10346	155	31	2	1	0.36104	0.52952
Cholesterol metabolism	10346	155	31	2	1	0.36104	0.52952
Leishmaniasis	10346	155	31	2	1	0.36104	0.52952
Inflammatory bowel disease	10346	155	31	2	1	0.36104	0.52952
Human immunodeficiency virus 1 infection	10346	155	31	7	2	0.42509	0.60991
Thyroid hormone signaling pathway	10346	155	31	3	1	0.4905	0.66068
Pancreatic cancer	10346	155	31	3	1	0.4905	0.66068
Lipid and atherosclerosis	10346	155	31	3	1	0.4905	0.66068
Alzheimer disease	10346	155	31	8	2	0.50057	0.66076
Pathways in cancer	10346	155	31	9	2	0.56983	0.70056
Pyrimidine metabolism	10346	155	31	4	1	0.59441	0.70056
Nucleotide metabolism	10346	155	31	4	1	0.59441	0.70056
Biosynthesis of cofactors	10346	155	31	4	1	0.59441	0.70056
Ubiquitin mediated proteolysis	10346	155	31	4	1	0.59441	0.70056
Tuberculosis	10346	155	31	4	1	0.59441	0.70056
Parkinson disease	10346	155	31	6	1	0.74429	0.86181
Viral carcinogenesis	10346	155	31	13	2	0.77891	0.86286
Oocyte meiosis	10346	155	31	7	1	0.79749	0.86286
Progesterone-mediated oocyte maturation	10346	155	31	7	1	0.79749	0.86286
Pathways of neurodegeneration - multiple diseases	10346	155	31	7	1	0.79749	0.86286
Alcoholism	10346	155	31	8	1	0.83991	0.8941
Systemic lupus erythematosus	10346	155	31	10	1	0.90049	0.93327
Metabolic pathways	10346	155	31	24	3	0.90499	0.93327
Neutrophil extracellular trap formation	10346	155	31	13	1	0.95192	0.96656
Ribosome biogenesis in eukaryotes	10346	155	31	18	1	0.98625	0.98625
NOD-like receptor signaling pathway	10384	155	16	15	9	3.8968e-07	1.2908e-05
Measles	10384	155	16	9	7	9.9289e-07	1.2908e-05
Herpes simplex virus 1 infection	10384	155	16	9	7	9.9289e-07	1.2908e-05
Influenza A	10384	155	16	10	7	3.1317e-06	3.0534e-05
Coronavirus disease - COVID-19	10384	155	16	11	7	8.1469e-06	6.3546e-05
Epstein-Barr virus infection	10384	155	16	11	6	0.0001571	0.0010211
Hepatitis C	10384	155	16	12	6	0.00029571	0.0016475
Necroptosis	10384	155	16	4	3	0.003444	0.01679
Hepatitis B	10384	155	16	8	4	0.0042308	0.018334
Chemokine signaling pathway	10384	155	16	2	2	0.010054	0.030163
RIG-I-like receptor signaling pathway	10384	155	16	2	2	0.010054	0.030163
Cytosolic DNA-sensing pathway	10384	155	16	2	2	0.010054	0.030163
C-type lectin receptor signaling pathway	10384	155	16	2	2	0.010054	0.030163
JAK-STAT signaling pathway	10384	155	16	3	2	0.028323	0.078901
Osteoclast differentiation	10384	155	16	4	2	0.053203	0.12968
Kaposi sarcoma-associated herpesvirus infection	10384	155	16	4	2	0.053203	0.12968
Glycolysis / Gluconeogenesis	10384	155	16	1	1	0.10323	0.15484
Galactose metabolism	10384	155	16	1	1	0.10323	0.15484
NF-kappa B signaling pathway	10384	155	16	1	1	0.10323	0.15484
Signaling pathways regulating pluripotency of stem cells	10384	155	16	1	1	0.10323	0.15484
Toll-like receptor signaling pathway	10384	155	16	1	1	0.10323	0.15484
Th1 and Th2 cell differentiation	10384	155	16	1	1	0.10323	0.15484
Prolactin signaling pathway	10384	155	16	1	1	0.10323	0.15484
AGE-RAGE signaling pathway in diabetic complications	10384	155	16	1	1	0.10323	0.15484
Growth hormone synthesis, secretion and action	10384	155	16	1	1	0.10323	0.15484
Toxoplasmosis	10384	155	16	1	1	0.10323	0.15484
Notch signaling pathway	10384	155	16	2	1	0.1964	0.25532
Th17 cell differentiation	10384	155	16	2	1	0.1964	0.25532
Leishmaniasis	10384	155	16	2	1	0.1964	0.25532
Inflammatory bowel disease	10384	155	16	2	1	0.1964	0.25532
Pathways in cancer	10384	155	16	9	2	0.23418	0.29461
Human papillomavirus infection	10384	155	16	10	2	0.27538	0.32167
Thyroid hormone signaling pathway	10384	155	16	3	1	0.28043	0.32167
Pancreatic cancer	10384	155	16	3	1	0.28043	0.32167
Tuberculosis	10384	155	16	4	1	0.35618	0.38586
PD-L1 expression and PD-1 checkpoint pathway in cancer	10384	155	16	4	1	0.35618	0.38586
Viral life cycle - HIV-1	10384	155	16	5	1	0.4244	0.44734
Human immunodeficiency virus 1 infection	10384	155	16	7	1	0.54101	0.55525
Metabolic pathways	10384	155	16	24	1	0.94185	0.94185
DNA replication	10403	155	4	4	2	0.0029639	0.029639
Oxytocin signaling pathway	10403	155	4	1	1	0.025806	0.073015
Pancreatic secretion	10403	155	4	1	1	0.025806	0.073015
Cell cycle	10403	155	4	14	2	0.041094	0.073015
Nicotinate and nicotinamide metabolism	10403	155	4	2	1	0.05111	0.073015
Calcium signaling pathway	10403	155	4	2	1	0.05111	0.073015
Salivary secretion	10403	155	4	2	1	0.05111	0.073015
Hematopoietic cell lineage	10403	155	4	5	1	0.12407	0.15509
Protein processing in endoplasmic reticulum	10403	155	4	6	1	0.14743	0.16381
Metabolic pathways	10403	155	4	24	1	0.49344	0.49344
Influenza A	10561	155	27	10	10	5.1445e-09	2.6237e-07
Measles	10561	155	27	9	9	4.1727e-08	1.064e-06
Hepatitis C	10561	155	27	12	10	2.7084e-07	4.6043e-06
Coronavirus disease - COVID-19	10561	155	27	11	9	1.8128e-06	2.3114e-05
Herpes simplex virus 1 infection	10561	155	27	9	8	2.5717e-06	2.6232e-05
NOD-like receptor signaling pathway	10561	155	27	15	9	0.00010217	0.00086849
Epstein-Barr virus infection	10561	155	27	11	7	0.00047513	0.0034616
Necroptosis	10561	155	27	4	4	0.00075875	0.0048371
Human papillomavirus infection	10561	155	27	10	5	0.015146	0.085829
Kaposi sarcoma-associated herpesvirus infection	10561	155	27	4	3	0.016946	0.086422
Chemokine signaling pathway	10561	155	27	2	2	0.029409	0.10713
RIG-I-like receptor signaling pathway	10561	155	27	2	2	0.029409	0.10713
Cytosolic DNA-sensing pathway	10561	155	27	2	2	0.029409	0.10713
C-type lectin receptor signaling pathway	10561	155	27	2	2	0.029409	0.10713
Hepatitis B	10561	155	27	8	4	0.0316	0.10744
JAK-STAT signaling pathway	10561	155	27	3	2	0.078617	0.25059
Osteoclast differentiation	10561	155	27	4	2	0.14029	0.31728
PD-L1 expression and PD-1 checkpoint pathway in cancer	10561	155	27	4	2	0.14029	0.31728
Glycolysis / Gluconeogenesis	10561	155	27	1	1	0.17419	0.31728
Galactose metabolism	10561	155	27	1	1	0.17419	0.31728
NF-kappa B signaling pathway	10561	155	27	1	1	0.17419	0.31728
Toll-like receptor signaling pathway	10561	155	27	1	1	0.17419	0.31728
Th1 and Th2 cell differentiation	10561	155	27	1	1	0.17419	0.31728
Prolactin signaling pathway	10561	155	27	1	1	0.17419	0.31728
AGE-RAGE signaling pathway in diabetic complications	10561	155	27	1	1	0.17419	0.31728
Growth hormone synthesis, secretion and action	10561	155	27	1	1	0.17419	0.31728
Pertussis	10561	155	27	1	1	0.17419	0.31728
Toxoplasmosis	10561	155	27	1	1	0.17419	0.31728
Viral life cycle - HIV-1	10561	155	27	5	2	0.2089	0.36738
Lysosome	10561	155	27	2	1	0.31898	0.4281
Apoptosis	10561	155	27	2	1	0.31898	0.4281
Apoptosis - multiple species	10561	155	27	2	1	0.31898	0.4281
Notch signaling pathway	10561	155	27	2	1	0.31898	0.4281
Cell adhesion molecules	10561	155	27	2	1	0.31898	0.4281
Complement and coagulation cascades	10561	155	27	2	1	0.31898	0.4281
Th17 cell differentiation	10561	155	27	2	1	0.31898	0.4281
Leishmaniasis	10561	155	27	2	1	0.31898	0.4281
Inflammatory bowel disease	10561	155	27	2	1	0.31898	0.4281
Thyroid hormone signaling pathway	10561	155	27	3	1	0.43916	0.55993
Pancreatic cancer	10561	155	27	3	1	0.43916	0.55993
Pathways in cancer	10561	155	27	9	2	0.4866	0.60529
Pyrimidine metabolism	10561	155	27	4	1	0.53878	0.61062
Nucleotide metabolism	10561	155	27	4	1	0.53878	0.61062
Biosynthesis of cofactors	10561	155	27	4	1	0.53878	0.61062
Tuberculosis	10561	155	27	4	1	0.53878	0.61062
Protein processing in endoplasmic reticulum	10561	155	27	6	1	0.68943	0.76436
Human immunodeficiency virus 1 infection	10561	155	27	7	1	0.7457	0.80917
Alzheimer disease	10561	155	27	8	1	0.7921	0.82443
Transcriptional misregulation in cancer	10561	155	27	8	1	0.7921	0.82443
Viral carcinogenesis	10561	155	27	13	1	0.9258	0.94432
Metabolic pathways	10561	155	27	24	2	0.9525	0.9525
Transcriptional misregulation in cancer	10562	155	9	8	4	0.00034225	0.0047915
Staphylococcus aureus infection	10562	155	9	6	3	0.0025214	0.01765
Phagosome	10562	155	9	5	2	0.027484	0.12826
NOD-like receptor signaling pathway	10562	155	9	15	3	0.043502	0.15226
Amino sugar and nucleotide sugar metabolism	10562	155	9	2	1	0.11311	0.19795
PPAR signaling pathway	10562	155	9	2	1	0.11311	0.19795
IL-17 signaling pathway	10562	155	9	2	1	0.11311	0.19795
Amoebiasis	10562	155	9	2	1	0.11311	0.19795
Drug metabolism - other enzymes	10562	155	9	3	1	0.16528	0.21036
Acute myeloid leukemia	10562	155	9	3	1	0.16528	0.21036
Lipid and atherosclerosis	10562	155	9	3	1	0.16528	0.21036
Hematopoietic cell lineage	10562	155	9	5	1	0.26151	0.3051
Neutrophil extracellular trap formation	10562	155	9	13	1	0.55536	0.59808
Metabolic pathways	10562	155	9	24	1	0.78952	0.78952
Cell cycle	10615	155	36	14	12	3.1328e-07	2.1616e-05
Oocyte meiosis	10615	155	36	7	6	0.00064602	0.022288
DNA replication	10615	155	36	4	4	0.0025467	0.04393
p53 signaling pathway	10615	155	36	4	4	0.0025467	0.04393
Cellular senescence	10615	155	36	7	5	0.0077667	0.089317
Progesterone-mediated oocyte maturation	10615	155	36	7	5	0.0077667	0.089317
Antifolate resistance	10615	155	36	3	3	0.01173	0.11563
Human T-cell leukemia virus 1 infection	10615	155	36	7	4	0.051158	0.30352
Glutathione metabolism	10615	155	36	2	2	0.052786	0.30352
One carbon pool by folate	10615	155	36	2	2	0.052786	0.30352
Folate biosynthesis	10615	155	36	2	2	0.052786	0.30352
Platinum drug resistance	10615	155	36	2	2	0.052786	0.30352
Chemical carcinogenesis - receptor activation	10615	155	36	5	3	0.08234	0.41092
AMPK signaling pathway	10615	155	36	3	2	0.1349	0.41092
Protein processing in endoplasmic reticulum	10615	155	36	6	3	0.13832	0.41092
Metabolic pathways	10615	155	36	24	8	0.15539	0.41092
Human immunodeficiency virus 1 infection	10615	155	36	7	3	0.20369	0.41092
Pyrimidine metabolism	10615	155	36	4	2	0.23051	0.41092
Nucleotide metabolism	10615	155	36	4	2	0.23051	0.41092
Biosynthesis of cofactors	10615	155	36	4	2	0.23051	0.41092
FoxO signaling pathway	10615	155	36	4	2	0.23051	0.41092
Ubiquitin mediated proteolysis	10615	155	36	4	2	0.23051	0.41092
MicroRNAs in cancer	10615	155	36	4	2	0.23051	0.41092
Purine metabolism	10615	155	36	1	1	0.23226	0.41092
Glycine, serine and threonine metabolism	10615	155	36	1	1	0.23226	0.41092
Glyoxylate and dicarboxylate metabolism	10615	155	36	1	1	0.23226	0.41092
Biosynthesis of unsaturated fatty acids	10615	155	36	1	1	0.23226	0.41092
Carbon metabolism	10615	155	36	1	1	0.23226	0.41092
Fatty acid metabolism	10615	155	36	1	1	0.23226	0.41092
Biosynthesis of nucleotide sugars	10615	155	36	1	1	0.23226	0.41092
Protein export	10615	155	36	1	1	0.23226	0.41092
Base excision repair	10615	155	36	1	1	0.23226	0.41092
Non-homologous end-joining	10615	155	36	1	1	0.23226	0.41092
Fanconi anemia pathway	10615	155	36	1	1	0.23226	0.41092
Hippo signaling pathway	10615	155	36	1	1	0.23226	0.41092
Estrogen signaling pathway	10615	155	36	1	1	0.23226	0.41092
Thyroid hormone synthesis	10615	155	36	1	1	0.23226	0.41092
Oxytocin signaling pathway	10615	155	36	1	1	0.23226	0.41092
Pancreatic secretion	10615	155	36	1	1	0.23226	0.41092
Pathways in cancer	10615	155	36	9	3	0.34833	0.51653
Amino sugar and nucleotide sugar metabolism	10615	155	36	2	1	0.41173	0.51653
Nicotinate and nicotinamide metabolism	10615	155	36	2	1	0.41173	0.51653
PPAR signaling pathway	10615	155	36	2	1	0.41173	0.51653
MAPK signaling pathway	10615	155	36	2	1	0.41173	0.51653
Calcium signaling pathway	10615	155	36	2	1	0.41173	0.51653
Apoptosis	10615	155	36	2	1	0.41173	0.51653
Apoptosis - multiple species	10615	155	36	2	1	0.41173	0.51653
ECM-receptor interaction	10615	155	36	2	1	0.41173	0.51653
IL-17 signaling pathway	10615	155	36	2	1	0.41173	0.51653
Th17 cell differentiation	10615	155	36	2	1	0.41173	0.51653
Alcoholic liver disease	10615	155	36	2	1	0.41173	0.51653
Salivary secretion	10615	155	36	2	1	0.41173	0.51653
Salmonella infection	10615	155	36	2	1	0.41173	0.51653
Colorectal cancer	10615	155	36	2	1	0.41173	0.51653
Fluid shear stress and atherosclerosis	10615	155	36	2	1	0.41173	0.51653
Drug metabolism - other enzymes	10615	155	36	3	1	0.55015	0.6223
PI3K-Akt signaling pathway	10615	155	36	3	1	0.55015	0.6223
Gap junction	10615	155	36	3	1	0.55015	0.6223
Prostate cancer	10615	155	36	3	1	0.55015	0.6223
Acute myeloid leukemia	10615	155	36	3	1	0.55015	0.6223
Lipid and atherosclerosis	10615	155	36	3	1	0.55015	0.6223
Hepatitis B	10615	155	36	8	2	0.5927	0.65962
Viral carcinogenesis	10615	155	36	13	3	0.62014	0.6792
Hematopoietic cell lineage	10615	155	36	5	1	0.73854	0.79624
Parkinson disease	10615	155	36	6	1	0.80129	0.8506
Pathways of neurodegeneration - multiple diseases	10615	155	36	7	1	0.8493	0.8879
Transcriptional misregulation in cancer	10615	155	36	8	1	0.88596	0.9124
Human papillomavirus infection	10615	155	36	10	1	0.93512	0.94887
Epstein-Barr virus infection	10615	155	36	11	1	0.95123	0.95123
Staphylococcus aureus infection	1088	155	13	6	4	0.00042045	0.0092498
Transcriptional misregulation in cancer	1088	155	13	8	4	0.0017779	0.019557
Amoebiasis	1088	155	13	2	2	0.0065354	0.047926
NOD-like receptor signaling pathway	1088	155	13	15	4	0.024428	0.13435
Phagosome	1088	155	13	5	2	0.056413	0.23065
Neutrophil extracellular trap formation	1088	155	13	13	3	0.08073	0.23065
Carbohydrate digestion and absorption	1088	155	13	1	1	0.083871	0.23065
Asthma	1088	155	13	1	1	0.083871	0.23065
Amino sugar and nucleotide sugar metabolism	1088	155	13	2	1	0.16121	0.25332
PPAR signaling pathway	1088	155	13	2	1	0.16121	0.25332
Lysosome	1088	155	13	2	1	0.16121	0.25332
Renin-angiotensin system	1088	155	13	2	1	0.16121	0.25332
IL-17 signaling pathway	1088	155	13	2	1	0.16121	0.25332
Salivary secretion	1088	155	13	2	1	0.16121	0.25332
Drug metabolism - other enzymes	1088	155	13	3	1	0.23248	0.28414
Neuroactive ligand-receptor interaction	1088	155	13	3	1	0.23248	0.28414
Acute myeloid leukemia	1088	155	13	3	1	0.23248	0.28414
Lipid and atherosclerosis	1088	155	13	3	1	0.23248	0.28414
Tuberculosis	1088	155	13	4	1	0.29812	0.34519
Hematopoietic cell lineage	1088	155	13	5	1	0.35855	0.3944
Systemic lupus erythematosus	1088	155	13	10	1	0.59495	0.62328
Metabolic pathways	1088	155	13	24	1	0.89822	0.89822
Influenza A	10964	155	27	10	10	5.1445e-09	2.6237e-07
Measles	10964	155	27	9	9	4.1727e-08	1.064e-06
Hepatitis C	10964	155	27	12	10	2.7084e-07	4.6043e-06
Coronavirus disease - COVID-19	10964	155	27	11	9	1.8128e-06	2.3114e-05
Herpes simplex virus 1 infection	10964	155	27	9	8	2.5717e-06	2.6232e-05
NOD-like receptor signaling pathway	10964	155	27	15	9	0.00010217	0.00086849
Epstein-Barr virus infection	10964	155	27	11	7	0.00047513	0.0034616
Necroptosis	10964	155	27	4	4	0.00075875	0.0048371
Human papillomavirus infection	10964	155	27	10	5	0.015146	0.085829
Kaposi sarcoma-associated herpesvirus infection	10964	155	27	4	3	0.016946	0.086422
Chemokine signaling pathway	10964	155	27	2	2	0.029409	0.10713
RIG-I-like receptor signaling pathway	10964	155	27	2	2	0.029409	0.10713
Cytosolic DNA-sensing pathway	10964	155	27	2	2	0.029409	0.10713
C-type lectin receptor signaling pathway	10964	155	27	2	2	0.029409	0.10713
Hepatitis B	10964	155	27	8	4	0.0316	0.10744
JAK-STAT signaling pathway	10964	155	27	3	2	0.078617	0.25059
Osteoclast differentiation	10964	155	27	4	2	0.14029	0.31728
PD-L1 expression and PD-1 checkpoint pathway in cancer	10964	155	27	4	2	0.14029	0.31728
Glycolysis / Gluconeogenesis	10964	155	27	1	1	0.17419	0.31728
Galactose metabolism	10964	155	27	1	1	0.17419	0.31728
NF-kappa B signaling pathway	10964	155	27	1	1	0.17419	0.31728
Toll-like receptor signaling pathway	10964	155	27	1	1	0.17419	0.31728
Th1 and Th2 cell differentiation	10964	155	27	1	1	0.17419	0.31728
Prolactin signaling pathway	10964	155	27	1	1	0.17419	0.31728
AGE-RAGE signaling pathway in diabetic complications	10964	155	27	1	1	0.17419	0.31728
Growth hormone synthesis, secretion and action	10964	155	27	1	1	0.17419	0.31728
Pertussis	10964	155	27	1	1	0.17419	0.31728
Toxoplasmosis	10964	155	27	1	1	0.17419	0.31728
Viral life cycle - HIV-1	10964	155	27	5	2	0.2089	0.36738
Lysosome	10964	155	27	2	1	0.31898	0.4281
Apoptosis	10964	155	27	2	1	0.31898	0.4281
Apoptosis - multiple species	10964	155	27	2	1	0.31898	0.4281
Notch signaling pathway	10964	155	27	2	1	0.31898	0.4281
Cell adhesion molecules	10964	155	27	2	1	0.31898	0.4281
Complement and coagulation cascades	10964	155	27	2	1	0.31898	0.4281
Th17 cell differentiation	10964	155	27	2	1	0.31898	0.4281
Leishmaniasis	10964	155	27	2	1	0.31898	0.4281
Inflammatory bowel disease	10964	155	27	2	1	0.31898	0.4281
Thyroid hormone signaling pathway	10964	155	27	3	1	0.43916	0.55993
Pancreatic cancer	10964	155	27	3	1	0.43916	0.55993
Pathways in cancer	10964	155	27	9	2	0.4866	0.60529
Pyrimidine metabolism	10964	155	27	4	1	0.53878	0.61062
Nucleotide metabolism	10964	155	27	4	1	0.53878	0.61062
Biosynthesis of cofactors	10964	155	27	4	1	0.53878	0.61062
Tuberculosis	10964	155	27	4	1	0.53878	0.61062
Protein processing in endoplasmic reticulum	10964	155	27	6	1	0.68943	0.76436
Human immunodeficiency virus 1 infection	10964	155	27	7	1	0.7457	0.80917
Alzheimer disease	10964	155	27	8	1	0.7921	0.82443
Transcriptional misregulation in cancer	10964	155	27	8	1	0.7921	0.82443
Viral carcinogenesis	10964	155	27	13	1	0.9258	0.94432
Metabolic pathways	10964	155	27	24	2	0.9525	0.9525
Cell cycle	11004	155	25	14	12	1.5302e-09	6.1206e-08
Oocyte meiosis	11004	155	25	7	6	6.323e-05	0.0012646
DNA replication	11004	155	25	4	4	0.00054691	0.0054691
p53 signaling pathway	11004	155	25	4	4	0.00054691	0.0054691
Cellular senescence	11004	155	25	7	5	0.0012617	0.0084114
Progesterone-mediated oocyte maturation	11004	155	25	7	5	0.0012617	0.0084114
Human T-cell leukemia virus 1 infection	11004	155	25	7	4	0.013437	0.059884
Pyrimidine metabolism	11004	155	25	4	3	0.013474	0.059884
Nucleotide metabolism	11004	155	25	4	3	0.013474	0.059884
Platinum drug resistance	11004	155	25	2	2	0.025136	0.10054
Drug metabolism - other enzymes	11004	155	25	3	2	0.067851	0.24673
Human immunodeficiency virus 1 infection	11004	155	25	7	3	0.08372	0.27907
FoxO signaling pathway	11004	155	25	4	2	0.12223	0.30722
Ubiquitin mediated proteolysis	11004	155	25	4	2	0.12223	0.30722
MicroRNAs in cancer	11004	155	25	4	2	0.12223	0.30722
Purine metabolism	11004	155	25	1	1	0.16129	0.30722
Base excision repair	11004	155	25	1	1	0.16129	0.30722
Non-homologous end-joining	11004	155	25	1	1	0.16129	0.30722
Fanconi anemia pathway	11004	155	25	1	1	0.16129	0.30722
Hippo signaling pathway	11004	155	25	1	1	0.16129	0.30722
Carbohydrate digestion and absorption	11004	155	25	1	1	0.16129	0.30722
Chemical carcinogenesis - receptor activation	11004	155	25	5	2	0.18369	0.33398
Glutathione metabolism	11004	155	25	2	1	0.29744	0.41027
One carbon pool by folate	11004	155	25	2	1	0.29744	0.41027
MAPK signaling pathway	11004	155	25	2	1	0.29744	0.41027
Apoptosis	11004	155	25	2	1	0.29744	0.41027
Apoptosis - multiple species	11004	155	25	2	1	0.29744	0.41027
ECM-receptor interaction	11004	155	25	2	1	0.29744	0.41027
Colorectal cancer	11004	155	25	2	1	0.29744	0.41027
Viral carcinogenesis	11004	155	25	13	3	0.35026	0.46702
Hepatitis B	11004	155	25	8	2	0.37978	0.47113
Antifolate resistance	11004	155	25	3	1	0.41224	0.47113
AMPK signaling pathway	11004	155	25	3	1	0.41224	0.47113
Gap junction	11004	155	25	3	1	0.41224	0.47113
Acute myeloid leukemia	11004	155	25	3	1	0.41224	0.47113
Pathways in cancer	11004	155	25	9	2	0.44248	0.49164
Transcriptional misregulation in cancer	11004	155	25	8	1	0.76382	0.82575
Metabolic pathways	11004	155	25	24	3	0.79105	0.83269
Human papillomavirus infection	11004	155	25	10	1	0.83755	0.85902
Epstein-Barr virus infection	11004	155	25	11	1	0.86556	0.86556
Cell cycle	11065	155	22	14	11	9.5413e-09	3.8165e-07
Oocyte meiosis	11065	155	22	7	6	2.7155e-05	0.00054311
p53 signaling pathway	11065	155	22	4	4	0.00031626	0.0042167
Cellular senescence	11065	155	22	7	5	0.00064903	0.0051922
Progesterone-mediated oocyte maturation	11065	155	22	7	5	0.00064903	0.0051922
Human T-cell leukemia virus 1 infection	11065	155	22	7	4	0.0081921	0.054614
Platinum drug resistance	11065	155	22	2	2	0.019355	0.1106
Antifolate resistance	11065	155	22	3	2	0.053004	0.26502
Human immunodeficiency virus 1 infection	11065	155	22	7	3	0.059803	0.26579
Pyrimidine metabolism	11065	155	22	4	2	0.096837	0.27668
Nucleotide metabolism	11065	155	22	4	2	0.096837	0.27668
DNA replication	11065	155	22	4	2	0.096837	0.27668
FoxO signaling pathway	11065	155	22	4	2	0.096837	0.27668
Ubiquitin mediated proteolysis	11065	155	22	4	2	0.096837	0.27668
Purine metabolism	11065	155	22	1	1	0.14194	0.32787
Fanconi anemia pathway	11065	155	22	1	1	0.14194	0.32787
Hippo signaling pathway	11065	155	22	1	1	0.14194	0.32787
Chemical carcinogenesis - receptor activation	11065	155	22	5	2	0.14754	0.32787
Glutathione metabolism	11065	155	22	2	1	0.26452	0.42101
One carbon pool by folate	11065	155	22	2	1	0.26452	0.42101
Folate biosynthesis	11065	155	22	2	1	0.26452	0.42101
Apoptosis	11065	155	22	2	1	0.26452	0.42101
Apoptosis - multiple species	11065	155	22	2	1	0.26452	0.42101
ECM-receptor interaction	11065	155	22	2	1	0.26452	0.42101
Colorectal cancer	11065	155	22	2	1	0.26452	0.42101
Viral carcinogenesis	11065	155	22	13	3	0.27366	0.42101
Hepatitis B	11065	155	22	8	2	0.31712	0.46746
Drug metabolism - other enzymes	11065	155	22	3	1	0.37027	0.46746
AMPK signaling pathway	11065	155	22	3	1	0.37027	0.46746
Gap junction	11065	155	22	3	1	0.37027	0.46746
Acute myeloid leukemia	11065	155	22	3	1	0.37027	0.46746
Pathways in cancer	11065	155	22	9	2	0.37397	0.46746
Biosynthesis of cofactors	11065	155	22	4	1	0.46142	0.54284
MicroRNAs in cancer	11065	155	22	4	1	0.46142	0.54284
Parkinson disease	11065	155	22	6	1	0.60737	0.69414
Pathways of neurodegeneration - multiple diseases	11065	155	22	7	1	0.66534	0.73927
Transcriptional misregulation in cancer	11065	155	22	8	1	0.71509	0.77307
Human papillomavirus infection	11065	155	22	10	1	0.79423	0.83604
Epstein-Barr virus infection	11065	155	22	11	1	0.82545	0.84662
Metabolic pathways	11065	155	22	24	2	0.89432	0.89432
Measles	11119	155	25	9	8	1.27e-06	3.175e-05
Herpes simplex virus 1 infection	11119	155	25	9	8	1.27e-06	3.175e-05
Influenza A	11119	155	25	10	8	5.6943e-06	9.4904e-05
Coronavirus disease - COVID-19	11119	155	25	11	8	1.8713e-05	0.00023391
NOD-like receptor signaling pathway	11119	155	25	15	9	4.8415e-05	0.00041906
Hepatitis C	11119	155	25	12	8	5.0287e-05	0.00041906
Epstein-Barr virus infection	11119	155	25	11	7	0.00027131	0.0019379
Necroptosis	11119	155	25	4	4	0.00054691	0.0034182
Kaposi sarcoma-associated herpesvirus infection	11119	155	25	4	3	0.013474	0.074855
Alcoholism	11119	155	25	8	4	0.023884	0.07855
Hepatitis B	11119	155	25	8	4	0.023884	0.07855
RNA degradation	11119	155	25	2	2	0.025136	0.07855
Chemokine signaling pathway	11119	155	25	2	2	0.025136	0.07855
RIG-I-like receptor signaling pathway	11119	155	25	2	2	0.025136	0.07855
Cytosolic DNA-sensing pathway	11119	155	25	2	2	0.025136	0.07855
C-type lectin receptor signaling pathway	11119	155	25	2	2	0.025136	0.07855
Viral carcinogenesis	11119	155	25	13	5	0.03792	0.11153
Systemic lupus erythematosus	11119	155	25	10	4	0.056613	0.15726
JAK-STAT signaling pathway	11119	155	25	3	2	0.067851	0.17856
Osteoclast differentiation	11119	155	25	4	2	0.12223	0.26015
Neutrophil extracellular trap formation	11119	155	25	13	4	0.13553	0.26015
Glycolysis / Gluconeogenesis	11119	155	25	1	1	0.16129	0.26015
Galactose metabolism	11119	155	25	1	1	0.16129	0.26015
NF-kappa B signaling pathway	11119	155	25	1	1	0.16129	0.26015
Signaling pathways regulating pluripotency of stem cells	11119	155	25	1	1	0.16129	0.26015
Toll-like receptor signaling pathway	11119	155	25	1	1	0.16129	0.26015
Th1 and Th2 cell differentiation	11119	155	25	1	1	0.16129	0.26015
Prolactin signaling pathway	11119	155	25	1	1	0.16129	0.26015
AGE-RAGE signaling pathway in diabetic complications	11119	155	25	1	1	0.16129	0.26015
Growth hormone synthesis, secretion and action	11119	155	25	1	1	0.16129	0.26015
Toxoplasmosis	11119	155	25	1	1	0.16129	0.26015
Human papillomavirus infection	11119	155	25	10	3	0.20477	0.31996
Notch signaling pathway	11119	155	25	2	1	0.29744	0.41312
Th17 cell differentiation	11119	155	25	2	1	0.29744	0.41312
Leishmaniasis	11119	155	25	2	1	0.29744	0.41312
Inflammatory bowel disease	11119	155	25	2	1	0.29744	0.41312
Thyroid hormone signaling pathway	11119	155	25	3	1	0.41224	0.54242
Pancreatic cancer	11119	155	25	3	1	0.41224	0.54242
Pathways in cancer	11119	155	25	9	2	0.44248	0.56728
Pyrimidine metabolism	11119	155	25	4	1	0.50891	0.57831
Nucleotide metabolism	11119	155	25	4	1	0.50891	0.57831
Biosynthesis of cofactors	11119	155	25	4	1	0.50891	0.57831
Tuberculosis	11119	155	25	4	1	0.50891	0.57831
PD-L1 expression and PD-1 checkpoint pathway in cancer	11119	155	25	4	1	0.50891	0.57831
Viral life cycle - HIV-1	11119	155	25	5	1	0.59022	0.6558
Protein processing in endoplasmic reticulum	11119	155	25	6	1	0.65851	0.71578
Human immunodeficiency virus 1 infection	11119	155	25	7	1	0.71581	0.7615
Alzheimer disease	11119	155	25	8	1	0.76382	0.79564
Metabolic pathways	11119	155	25	24	2	0.93406	0.95312
Ribosome biogenesis in eukaryotes	11119	155	25	18	1	0.96572	0.96572
Cell cycle	11130	155	37	14	12	4.5658e-07	3.0591e-05
Oocyte meiosis	11130	155	37	7	6	0.00076569	0.025651
DNA replication	11130	155	37	4	4	0.0028554	0.047828
p53 signaling pathway	11130	155	37	4	4	0.0028554	0.047828
Cellular senescence	11130	155	37	7	5	0.0088606	0.098943
Progesterone-mediated oocyte maturation	11130	155	37	7	5	0.0088606	0.098943
Protein processing in endoplasmic reticulum	11130	155	37	6	4	0.029185	0.27935
Pyrimidine metabolism	11130	155	37	4	3	0.042495	0.31426
Nucleotide metabolism	11130	155	37	4	3	0.042495	0.31426
Glutathione metabolism	11130	155	37	2	2	0.055802	0.31426
Platinum drug resistance	11130	155	37	2	2	0.055802	0.31426
Human T-cell leukemia virus 1 infection	11130	155	37	7	4	0.056285	0.31426
Chemical carcinogenesis - receptor activation	11130	155	37	5	3	0.088566	0.45645
Drug metabolism - other enzymes	11130	155	37	3	2	0.14188	0.48983
Antifolate resistance	11130	155	37	3	2	0.14188	0.48983
Human immunodeficiency virus 1 infection	11130	155	37	7	3	0.21669	0.48983
Purine metabolism	11130	155	37	1	1	0.23871	0.48983
Glycine, serine and threonine metabolism	11130	155	37	1	1	0.23871	0.48983
Glyoxylate and dicarboxylate metabolism	11130	155	37	1	1	0.23871	0.48983
Carbon metabolism	11130	155	37	1	1	0.23871	0.48983
Biosynthesis of nucleotide sugars	11130	155	37	1	1	0.23871	0.48983
Protein export	11130	155	37	1	1	0.23871	0.48983
Base excision repair	11130	155	37	1	1	0.23871	0.48983
Non-homologous end-joining	11130	155	37	1	1	0.23871	0.48983
Fanconi anemia pathway	11130	155	37	1	1	0.23871	0.48983
Hippo signaling pathway	11130	155	37	1	1	0.23871	0.48983
Estrogen signaling pathway	11130	155	37	1	1	0.23871	0.48983
Thyroid hormone synthesis	11130	155	37	1	1	0.23871	0.48983
Oxytocin signaling pathway	11130	155	37	1	1	0.23871	0.48983
Pancreatic secretion	11130	155	37	1	1	0.23871	0.48983
FoxO signaling pathway	11130	155	37	4	2	0.24126	0.48983
Ubiquitin mediated proteolysis	11130	155	37	4	2	0.24126	0.48983
MicroRNAs in cancer	11130	155	37	4	2	0.24126	0.48983
Metabolic pathways	11130	155	37	24	7	0.33461	0.55389
Pathways in cancer	11130	155	37	9	3	0.36681	0.55389
Amino sugar and nucleotide sugar metabolism	11130	155	37	2	1	0.42162	0.55389
One carbon pool by folate	11130	155	37	2	1	0.42162	0.55389
Nicotinate and nicotinamide metabolism	11130	155	37	2	1	0.42162	0.55389
Folate biosynthesis	11130	155	37	2	1	0.42162	0.55389
MAPK signaling pathway	11130	155	37	2	1	0.42162	0.55389
Calcium signaling pathway	11130	155	37	2	1	0.42162	0.55389
Apoptosis	11130	155	37	2	1	0.42162	0.55389
Apoptosis - multiple species	11130	155	37	2	1	0.42162	0.55389
ECM-receptor interaction	11130	155	37	2	1	0.42162	0.55389
IL-17 signaling pathway	11130	155	37	2	1	0.42162	0.55389
Th17 cell differentiation	11130	155	37	2	1	0.42162	0.55389
Intestinal immune network for IgA production	11130	155	37	2	1	0.42162	0.55389
Salivary secretion	11130	155	37	2	1	0.42162	0.55389
Salmonella infection	11130	155	37	2	1	0.42162	0.55389
Colorectal cancer	11130	155	37	2	1	0.42162	0.55389
Fluid shear stress and atherosclerosis	11130	155	37	2	1	0.42162	0.55389
Cytokine-cytokine receptor interaction	11130	155	37	3	1	0.56149	0.64861
PI3K-Akt signaling pathway	11130	155	37	3	1	0.56149	0.64861
AMPK signaling pathway	11130	155	37	3	1	0.56149	0.64861
Gap junction	11130	155	37	3	1	0.56149	0.64861
Prostate cancer	11130	155	37	3	1	0.56149	0.64861
Acute myeloid leukemia	11130	155	37	3	1	0.56149	0.64861
Lipid and atherosclerosis	11130	155	37	3	1	0.56149	0.64861
Hepatitis B	11130	155	37	8	2	0.60995	0.69266
Viral carcinogenesis	11130	155	37	13	3	0.64166	0.71652
Biosynthesis of cofactors	11130	155	37	4	1	0.66823	0.73396
Hematopoietic cell lineage	11130	155	37	5	1	0.74953	0.80997
Parkinson disease	11130	155	37	6	1	0.81131	0.86282
Pathways of neurodegeneration - multiple diseases	11130	155	37	7	1	0.85817	0.89839
Transcriptional misregulation in cancer	11130	155	37	8	1	0.89362	0.92112
Human papillomavirus infection	11130	155	37	10	1	0.94057	0.95482
Epstein-Barr virus infection	11130	155	37	11	1	0.95574	0.95574
Transcriptional misregulation in cancer	1118	155	8	8	4	0.00019433	0.0031093
Staphylococcus aureus infection	1118	155	8	6	3	0.0017067	0.013654
NOD-like receptor signaling pathway	1118	155	8	15	3	0.030834	0.16445
Amino sugar and nucleotide sugar metabolism	1118	155	8	2	1	0.10088	0.19719
Lysosome	1118	155	8	2	1	0.10088	0.19719
Renin-angiotensin system	1118	155	8	2	1	0.10088	0.19719
IL-17 signaling pathway	1118	155	8	2	1	0.10088	0.19719
Amoebiasis	1118	155	8	2	1	0.10088	0.19719
Neutrophil extracellular trap formation	1118	155	8	13	2	0.13646	0.19719
Drug metabolism - other enzymes	1118	155	8	3	1	0.14789	0.19719
Neuroactive ligand-receptor interaction	1118	155	8	3	1	0.14789	0.19719
Acute myeloid leukemia	1118	155	8	3	1	0.14789	0.19719
Phagosome	1118	155	8	5	1	0.23551	0.26915
Hematopoietic cell lineage	1118	155	8	5	1	0.23551	0.26915
Systemic lupus erythematosus	1118	155	8	10	1	0.42098	0.44905
Metabolic pathways	1118	155	8	24	1	0.74845	0.74845
Influenza A	11274	155	24	10	10	1.196e-09	5.8603e-08
Measles	11274	155	24	9	9	1.1641e-08	2.852e-07
Hepatitis C	11274	155	24	12	10	6.5651e-08	1.0723e-06
Coronavirus disease - COVID-19	11274	155	24	11	9	5.2704e-07	6.4563e-06
Herpes simplex virus 1 infection	11274	155	24	9	8	8.6943e-07	8.5204e-06
Epstein-Barr virus infection	11274	155	24	11	7	0.00020058	0.0016381
Necroptosis	11274	155	24	4	4	0.0004594	0.0032158
NOD-like receptor signaling pathway	11274	155	24	15	7	0.0025347	0.015525
Human papillomavirus infection	11274	155	24	10	5	0.0087564	0.047674
Kaposi sarcoma-associated herpesvirus infection	11274	155	24	4	3	0.011923	0.058421
Hepatitis B	11274	155	24	8	4	0.020541	0.075543
Chemokine signaling pathway	11274	155	24	2	2	0.023125	0.075543
RIG-I-like receptor signaling pathway	11274	155	24	2	2	0.023125	0.075543
Cytosolic DNA-sensing pathway	11274	155	24	2	2	0.023125	0.075543
C-type lectin receptor signaling pathway	11274	155	24	2	2	0.023125	0.075543
JAK-STAT signaling pathway	11274	155	24	3	2	0.062725	0.1921
Osteoclast differentiation	11274	155	24	4	2	0.11353	0.27097
PD-L1 expression and PD-1 checkpoint pathway in cancer	11274	155	24	4	2	0.11353	0.27097
Glycolysis / Gluconeogenesis	11274	155	24	1	1	0.15484	0.27097
Galactose metabolism	11274	155	24	1	1	0.15484	0.27097
NF-kappa B signaling pathway	11274	155	24	1	1	0.15484	0.27097
Toll-like receptor signaling pathway	11274	155	24	1	1	0.15484	0.27097
Th1 and Th2 cell differentiation	11274	155	24	1	1	0.15484	0.27097
Prolactin signaling pathway	11274	155	24	1	1	0.15484	0.27097
AGE-RAGE signaling pathway in diabetic complications	11274	155	24	1	1	0.15484	0.27097
Growth hormone synthesis, secretion and action	11274	155	24	1	1	0.15484	0.27097
Pertussis	11274	155	24	1	1	0.15484	0.27097
Toxoplasmosis	11274	155	24	1	1	0.15484	0.27097
Viral life cycle - HIV-1	11274	155	24	5	2	0.1714	0.2896
Lysosome	11274	155	24	2	1	0.28655	0.39003
Notch signaling pathway	11274	155	24	2	1	0.28655	0.39003
Cell adhesion molecules	11274	155	24	2	1	0.28655	0.39003
Complement and coagulation cascades	11274	155	24	2	1	0.28655	0.39003
Th17 cell differentiation	11274	155	24	2	1	0.28655	0.39003
Leishmaniasis	11274	155	24	2	1	0.28655	0.39003
Inflammatory bowel disease	11274	155	24	2	1	0.28655	0.39003
Thyroid hormone signaling pathway	11274	155	24	3	1	0.39847	0.51381
Pancreatic cancer	11274	155	24	3	1	0.39847	0.51381
Pathways in cancer	11274	155	24	9	2	0.41991	0.52757
Pyrimidine metabolism	11274	155	24	4	1	0.49344	0.5623
Nucleotide metabolism	11274	155	24	4	1	0.49344	0.5623
Biosynthesis of cofactors	11274	155	24	4	1	0.49344	0.5623
Tuberculosis	11274	155	24	4	1	0.49344	0.5623
Protein processing in endoplasmic reticulum	11274	155	24	6	1	0.64212	0.71509
Human immunodeficiency virus 1 infection	11274	155	24	7	1	0.69977	0.76197
Alzheimer disease	11274	155	24	8	1	0.74845	0.7803
Transcriptional misregulation in cancer	11274	155	24	8	1	0.74845	0.7803
Viral carcinogenesis	11274	155	24	13	1	0.89822	0.91693
Metabolic pathways	11274	155	24	24	2	0.92262	0.92262
Cell cycle	113130	155	25	14	12	1.5302e-09	6.1206e-08
Oocyte meiosis	113130	155	25	7	6	6.323e-05	0.0012646
DNA replication	113130	155	25	4	4	0.00054691	0.0054691
p53 signaling pathway	113130	155	25	4	4	0.00054691	0.0054691
Cellular senescence	113130	155	25	7	5	0.0012617	0.0084114
Progesterone-mediated oocyte maturation	113130	155	25	7	5	0.0012617	0.0084114
Human T-cell leukemia virus 1 infection	113130	155	25	7	4	0.013437	0.059884
Pyrimidine metabolism	113130	155	25	4	3	0.013474	0.059884
Nucleotide metabolism	113130	155	25	4	3	0.013474	0.059884
Platinum drug resistance	113130	155	25	2	2	0.025136	0.10054
Drug metabolism - other enzymes	113130	155	25	3	2	0.067851	0.24673
Human immunodeficiency virus 1 infection	113130	155	25	7	3	0.08372	0.27907
FoxO signaling pathway	113130	155	25	4	2	0.12223	0.30722
Ubiquitin mediated proteolysis	113130	155	25	4	2	0.12223	0.30722
MicroRNAs in cancer	113130	155	25	4	2	0.12223	0.30722
Purine metabolism	113130	155	25	1	1	0.16129	0.30722
Base excision repair	113130	155	25	1	1	0.16129	0.30722
Non-homologous end-joining	113130	155	25	1	1	0.16129	0.30722
Fanconi anemia pathway	113130	155	25	1	1	0.16129	0.30722
Hippo signaling pathway	113130	155	25	1	1	0.16129	0.30722
Carbohydrate digestion and absorption	113130	155	25	1	1	0.16129	0.30722
Chemical carcinogenesis - receptor activation	113130	155	25	5	2	0.18369	0.33398
Glutathione metabolism	113130	155	25	2	1	0.29744	0.41027
One carbon pool by folate	113130	155	25	2	1	0.29744	0.41027
MAPK signaling pathway	113130	155	25	2	1	0.29744	0.41027
Apoptosis	113130	155	25	2	1	0.29744	0.41027
Apoptosis - multiple species	113130	155	25	2	1	0.29744	0.41027
ECM-receptor interaction	113130	155	25	2	1	0.29744	0.41027
Colorectal cancer	113130	155	25	2	1	0.29744	0.41027
Viral carcinogenesis	113130	155	25	13	3	0.35026	0.46702
Hepatitis B	113130	155	25	8	2	0.37978	0.47113
Antifolate resistance	113130	155	25	3	1	0.41224	0.47113
AMPK signaling pathway	113130	155	25	3	1	0.41224	0.47113
Gap junction	113130	155	25	3	1	0.41224	0.47113
Acute myeloid leukemia	113130	155	25	3	1	0.41224	0.47113
Pathways in cancer	113130	155	25	9	2	0.44248	0.49164
Transcriptional misregulation in cancer	113130	155	25	8	1	0.76382	0.82575
Metabolic pathways	113130	155	25	24	3	0.79105	0.83269
Human papillomavirus infection	113130	155	25	10	1	0.83755	0.85902
Epstein-Barr virus infection	113130	155	25	11	1	0.86556	0.86556
Influenza A	114908	155	23	10	10	6.9765e-10	3.2092e-08
Measles	114908	155	23	9	9	7.2755e-09	1.6734e-07
Hepatitis C	114908	155	23	12	10	3.8826e-08	5.9533e-07
Coronavirus disease - COVID-19	114908	155	23	11	9	3.339e-07	3.8399e-06
Herpes simplex virus 1 infection	114908	155	23	9	8	5.835e-07	5.3682e-06
NOD-like receptor signaling pathway	114908	155	23	15	9	2.103e-05	0.00016123
Epstein-Barr virus infection	114908	155	23	11	7	0.00014587	0.00095854
Necroptosis	114908	155	23	4	4	0.00038284	0.0022013
Kaposi sarcoma-associated herpesvirus infection	114908	155	23	4	3	0.01049	0.053614
Hepatitis B	114908	155	23	8	4	0.017524	0.065008
RNA degradation	114908	155	23	2	2	0.021198	0.065008
Chemokine signaling pathway	114908	155	23	2	2	0.021198	0.065008
RIG-I-like receptor signaling pathway	114908	155	23	2	2	0.021198	0.065008
Cytosolic DNA-sensing pathway	114908	155	23	2	2	0.021198	0.065008
C-type lectin receptor signaling pathway	114908	155	23	2	2	0.021198	0.065008
Human papillomavirus infection	114908	155	23	10	4	0.042503	0.1222
JAK-STAT signaling pathway	114908	155	23	3	2	0.057775	0.15633
Osteoclast differentiation	114908	155	23	4	2	0.10506	0.26253
NF-kappa B signaling pathway	114908	155	23	1	1	0.14839	0.26253
Signaling pathways regulating pluripotency of stem cells	114908	155	23	1	1	0.14839	0.26253
Toll-like receptor signaling pathway	114908	155	23	1	1	0.14839	0.26253
Th1 and Th2 cell differentiation	114908	155	23	1	1	0.14839	0.26253
Prolactin signaling pathway	114908	155	23	1	1	0.14839	0.26253
AGE-RAGE signaling pathway in diabetic complications	114908	155	23	1	1	0.14839	0.26253
Growth hormone synthesis, secretion and action	114908	155	23	1	1	0.14839	0.26253
Toxoplasmosis	114908	155	23	1	1	0.14839	0.26253
Viral life cycle - HIV-1	114908	155	23	5	2	0.15934	0.27147
Lysosome	114908	155	23	2	1	0.27558	0.39614
Notch signaling pathway	114908	155	23	2	1	0.27558	0.39614
Th17 cell differentiation	114908	155	23	2	1	0.27558	0.39614
Leishmaniasis	114908	155	23	2	1	0.27558	0.39614
Inflammatory bowel disease	114908	155	23	2	1	0.27558	0.39614
Thyroid hormone signaling pathway	114908	155	23	3	1	0.38448	0.52017
Pancreatic cancer	114908	155	23	3	1	0.38448	0.52017
Pathways in cancer	114908	155	23	9	2	0.39705	0.52184
Pyrimidine metabolism	114908	155	23	4	1	0.47761	0.54926
Nucleotide metabolism	114908	155	23	4	1	0.47761	0.54926
Biosynthesis of cofactors	114908	155	23	4	1	0.47761	0.54926
Tuberculosis	114908	155	23	4	1	0.47761	0.54926
PD-L1 expression and PD-1 checkpoint pathway in cancer	114908	155	23	4	1	0.47761	0.54926
Protein processing in endoplasmic reticulum	114908	155	23	6	1	0.62508	0.70131
Human immunodeficiency virus 1 infection	114908	155	23	7	1	0.68296	0.748
Alzheimer disease	114908	155	23	8	1	0.73223	0.78331
Viral carcinogenesis	114908	155	23	13	1	0.8871	0.92743
Ribosome biogenesis in eukaryotes	114908	155	23	18	1	0.95398	0.97518
Metabolic pathways	114908	155	23	24	1	0.98507	0.98507
Influenza A	115361	155	22	10	8	1.7524e-06	8.0611e-05
NOD-like receptor signaling pathway	115361	155	22	15	9	1.3334e-05	0.00014825
Measles	115361	155	22	9	7	1.3711e-05	0.00014825
Herpes simplex virus 1 infection	115361	155	22	9	7	1.3711e-05	0.00014825
Hepatitis C	115361	155	22	12	8	1.6114e-05	0.00014825
Coronavirus disease - COVID-19	115361	155	22	11	7	0.00010416	0.00079856
Epstein-Barr virus infection	115361	155	22	11	6	0.0012135	0.0079746
Necroptosis	115361	155	22	4	3	0.0091714	0.052736
Hepatitis B	115361	155	22	8	4	0.014818	0.068486
Chemokine signaling pathway	115361	155	22	2	2	0.019355	0.068486
RIG-I-like receptor signaling pathway	115361	155	22	2	2	0.019355	0.068486
Cytosolic DNA-sensing pathway	115361	155	22	2	2	0.019355	0.068486
C-type lectin receptor signaling pathway	115361	155	22	2	2	0.019355	0.068486
JAK-STAT signaling pathway	115361	155	22	3	2	0.053004	0.17416
Osteoclast differentiation	115361	155	22	4	2	0.096837	0.24182
Kaposi sarcoma-associated herpesvirus infection	115361	155	22	4	2	0.096837	0.24182
Glycolysis / Gluconeogenesis	115361	155	22	1	1	0.14194	0.24182
Galactose metabolism	115361	155	22	1	1	0.14194	0.24182
NF-kappa B signaling pathway	115361	155	22	1	1	0.14194	0.24182
Signaling pathways regulating pluripotency of stem cells	115361	155	22	1	1	0.14194	0.24182
Toll-like receptor signaling pathway	115361	155	22	1	1	0.14194	0.24182
Th1 and Th2 cell differentiation	115361	155	22	1	1	0.14194	0.24182
Prolactin signaling pathway	115361	155	22	1	1	0.14194	0.24182
AGE-RAGE signaling pathway in diabetic complications	115361	155	22	1	1	0.14194	0.24182
Growth hormone synthesis, secretion and action	115361	155	22	1	1	0.14194	0.24182
Pertussis	115361	155	22	1	1	0.14194	0.24182
Toxoplasmosis	115361	155	22	1	1	0.14194	0.24182
Lysosome	115361	155	22	2	1	0.26452	0.36872
Notch signaling pathway	115361	155	22	2	1	0.26452	0.36872
Complement and coagulation cascades	115361	155	22	2	1	0.26452	0.36872
Th17 cell differentiation	115361	155	22	2	1	0.26452	0.36872
Leishmaniasis	115361	155	22	2	1	0.26452	0.36872
Inflammatory bowel disease	115361	155	22	2	1	0.26452	0.36872
Thyroid hormone signaling pathway	115361	155	22	3	1	0.37027	0.47785
Pancreatic cancer	115361	155	22	3	1	0.37027	0.47785
Pathways in cancer	115361	155	22	9	2	0.37397	0.47785
Human papillomavirus infection	115361	155	22	10	2	0.42917	0.50536
Pyrimidine metabolism	115361	155	22	4	1	0.46142	0.50536
Nucleotide metabolism	115361	155	22	4	1	0.46142	0.50536
Biosynthesis of cofactors	115361	155	22	4	1	0.46142	0.50536
Tuberculosis	115361	155	22	4	1	0.46142	0.50536
PD-L1 expression and PD-1 checkpoint pathway in cancer	115361	155	22	4	1	0.46142	0.50536
Viral life cycle - HIV-1	115361	155	22	5	1	0.53989	0.57755
Human immunodeficiency virus 1 infection	115361	155	22	7	1	0.66534	0.69558
Transcriptional misregulation in cancer	115361	155	22	8	1	0.71509	0.73098
Metabolic pathways	115361	155	22	24	2	0.89432	0.89432
Influenza A	115362	155	21	10	8	1.13e-06	4.9719e-05
NOD-like receptor signaling pathway	115362	155	21	15	9	8.2052e-06	9.2662e-05
Measles	115362	155	21	9	7	9.4705e-06	9.2662e-05
Herpes simplex virus 1 infection	115362	155	21	9	7	9.4705e-06	9.2662e-05
Hepatitis C	115362	155	21	12	8	1.053e-05	9.2662e-05
Coronavirus disease - COVID-19	115362	155	21	11	7	7.2887e-05	0.00053451
Epstein-Barr virus infection	115362	155	21	11	6	0.00091098	0.0057261
Necroptosis	115362	155	21	4	3	0.0079639	0.043801
Hepatitis B	115362	155	21	8	4	0.012408	0.059553
Chemokine signaling pathway	115362	155	21	2	2	0.017595	0.059553
RIG-I-like receptor signaling pathway	115362	155	21	2	2	0.017595	0.059553
Cytosolic DNA-sensing pathway	115362	155	21	2	2	0.017595	0.059553
C-type lectin receptor signaling pathway	115362	155	21	2	2	0.017595	0.059553
JAK-STAT signaling pathway	115362	155	21	3	2	0.048416	0.15216
Osteoclast differentiation	115362	155	21	4	2	0.088868	0.22928
Kaposi sarcoma-associated herpesvirus infection	115362	155	21	4	2	0.088868	0.22928
PD-L1 expression and PD-1 checkpoint pathway in cancer	115362	155	21	4	2	0.088868	0.22928
NF-kappa B signaling pathway	115362	155	21	1	1	0.13548	0.22928
Signaling pathways regulating pluripotency of stem cells	115362	155	21	1	1	0.13548	0.22928
Toll-like receptor signaling pathway	115362	155	21	1	1	0.13548	0.22928
Th1 and Th2 cell differentiation	115362	155	21	1	1	0.13548	0.22928
Prolactin signaling pathway	115362	155	21	1	1	0.13548	0.22928
AGE-RAGE signaling pathway in diabetic complications	115362	155	21	1	1	0.13548	0.22928
Growth hormone synthesis, secretion and action	115362	155	21	1	1	0.13548	0.22928
Pertussis	115362	155	21	1	1	0.13548	0.22928
Toxoplasmosis	115362	155	21	1	1	0.13548	0.22928
RNA degradation	115362	155	21	2	1	0.25337	0.34839
Notch signaling pathway	115362	155	21	2	1	0.25337	0.34839
Complement and coagulation cascades	115362	155	21	2	1	0.25337	0.34839
Th17 cell differentiation	115362	155	21	2	1	0.25337	0.34839
Leishmaniasis	115362	155	21	2	1	0.25337	0.34839
Inflammatory bowel disease	115362	155	21	2	1	0.25337	0.34839
Pathways in cancer	115362	155	21	9	2	0.35071	0.44736
Thyroid hormone signaling pathway	115362	155	21	3	1	0.35585	0.44736
Pancreatic cancer	115362	155	21	3	1	0.35585	0.44736
Human papillomavirus infection	115362	155	21	10	2	0.40408	0.48933
Pyrimidine metabolism	115362	155	21	4	1	0.44485	0.48933
Nucleotide metabolism	115362	155	21	4	1	0.44485	0.48933
Biosynthesis of cofactors	115362	155	21	4	1	0.44485	0.48933
Tuberculosis	115362	155	21	4	1	0.44485	0.48933
Viral life cycle - HIV-1	115362	155	21	5	1	0.52205	0.56025
Human immunodeficiency virus 1 infection	115362	155	21	7	1	0.6469	0.6777
Ribosome biogenesis in eukaryotes	115362	155	21	18	1	0.93852	0.96035
Metabolic pathways	115362	155	21	24	1	0.9778	0.9778
Influenza A	116071	155	22	10	9	4.0737e-08	1.8332e-06
Measles	116071	155	22	9	8	3.8307e-07	8.6191e-06
Hepatitis C	116071	155	22	12	9	7.5727e-07	1.1359e-05
Coronavirus disease - COVID-19	116071	155	22	11	8	5.8762e-06	6.6107e-05
Herpes simplex virus 1 infection	116071	155	22	9	7	1.3711e-05	0.0001234
NOD-like receptor signaling pathway	116071	155	22	15	8	0.00015955	0.0011966
Epstein-Barr virus infection	116071	155	22	11	6	0.0012135	0.0078013
Necroptosis	116071	155	22	4	3	0.0091714	0.051589
Hepatitis B	116071	155	22	8	4	0.014818	0.066998
Chemokine signaling pathway	116071	155	22	2	2	0.019355	0.066998
RIG-I-like receptor signaling pathway	116071	155	22	2	2	0.019355	0.066998
Cytosolic DNA-sensing pathway	116071	155	22	2	2	0.019355	0.066998
C-type lectin receptor signaling pathway	116071	155	22	2	2	0.019355	0.066998
Human papillomavirus infection	116071	155	22	10	4	0.036355	0.11685
JAK-STAT signaling pathway	116071	155	22	3	2	0.053004	0.15901
Osteoclast differentiation	116071	155	22	4	2	0.096837	0.22811
Kaposi sarcoma-associated herpesvirus infection	116071	155	22	4	2	0.096837	0.22811
PD-L1 expression and PD-1 checkpoint pathway in cancer	116071	155	22	4	2	0.096837	0.22811
Glycolysis / Gluconeogenesis	116071	155	22	1	1	0.14194	0.22811
Galactose metabolism	116071	155	22	1	1	0.14194	0.22811
NF-kappa B signaling pathway	116071	155	22	1	1	0.14194	0.22811
Toll-like receptor signaling pathway	116071	155	22	1	1	0.14194	0.22811
Th1 and Th2 cell differentiation	116071	155	22	1	1	0.14194	0.22811
Prolactin signaling pathway	116071	155	22	1	1	0.14194	0.22811
AGE-RAGE signaling pathway in diabetic complications	116071	155	22	1	1	0.14194	0.22811
Growth hormone synthesis, secretion and action	116071	155	22	1	1	0.14194	0.22811
Pertussis	116071	155	22	1	1	0.14194	0.22811
Toxoplasmosis	116071	155	22	1	1	0.14194	0.22811
Apoptosis	116071	155	22	2	1	0.26452	0.34009
Apoptosis - multiple species	116071	155	22	2	1	0.26452	0.34009
Notch signaling pathway	116071	155	22	2	1	0.26452	0.34009
Complement and coagulation cascades	116071	155	22	2	1	0.26452	0.34009
Th17 cell differentiation	116071	155	22	2	1	0.26452	0.34009
Leishmaniasis	116071	155	22	2	1	0.26452	0.34009
Inflammatory bowel disease	116071	155	22	2	1	0.26452	0.34009
Thyroid hormone signaling pathway	116071	155	22	3	1	0.37027	0.44286
Pancreatic cancer	116071	155	22	3	1	0.37027	0.44286
Pathways in cancer	116071	155	22	9	2	0.37397	0.44286
Pyrimidine metabolism	116071	155	22	4	1	0.46142	0.49438
Nucleotide metabolism	116071	155	22	4	1	0.46142	0.49438
Biosynthesis of cofactors	116071	155	22	4	1	0.46142	0.49438
Tuberculosis	116071	155	22	4	1	0.46142	0.49438
Viral life cycle - HIV-1	116071	155	22	5	1	0.53989	0.565
Transcriptional misregulation in cancer	116071	155	22	8	1	0.71509	0.73134
Metabolic pathways	116071	155	22	24	2	0.89432	0.89432
Alzheimer disease	120892	155	22	8	4	0.014818	0.30968
RNA degradation	120892	155	22	2	2	0.019355	0.30968
Protein digestion and absorption	120892	155	22	2	2	0.019355	0.30968
Pathways of neurodegeneration - multiple diseases	120892	155	22	7	3	0.059803	0.35857
Mucin type O-glycan biosynthesis	120892	155	22	1	1	0.14194	0.35857
Glycerolipid metabolism	120892	155	22	1	1	0.14194	0.35857
Glycerophospholipid metabolism	120892	155	22	1	1	0.14194	0.35857
Arachidonic acid metabolism	120892	155	22	1	1	0.14194	0.35857
Sphingolipid metabolism	120892	155	22	1	1	0.14194	0.35857
ABC transporters	120892	155	22	1	1	0.14194	0.35857
mTOR signaling pathway	120892	155	22	1	1	0.14194	0.35857
Signaling pathways regulating pluripotency of stem cells	120892	155	22	1	1	0.14194	0.35857
Glutamatergic synapse	120892	155	22	1	1	0.14194	0.35857
Serotonergic synapse	120892	155	22	1	1	0.14194	0.35857
GABAergic synapse	120892	155	22	1	1	0.14194	0.35857
Insulin signaling pathway	120892	155	22	1	1	0.14194	0.35857
Fat digestion and absorption	120892	155	22	1	1	0.14194	0.35857
Epithelial cell signaling in Helicobacter pylori infection	120892	155	22	1	1	0.14194	0.35857
Pathogenic Escherichia coli infection	120892	155	22	1	1	0.14194	0.35857
Parkinson disease	120892	155	22	6	2	0.20247	0.48593
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	120892	155	22	2	1	0.26452	0.48834
Notch signaling pathway	120892	155	22	2	1	0.26452	0.48834
Renin-angiotensin system	120892	155	22	2	1	0.26452	0.48834
Alcoholic liver disease	120892	155	22	2	1	0.26452	0.48834
Cholesterol metabolism	120892	155	22	2	1	0.26452	0.48834
Salmonella infection	120892	155	22	2	1	0.26452	0.48834
Gap junction	120892	155	22	3	1	0.37027	0.61286
Thyroid hormone signaling pathway	120892	155	22	3	1	0.37027	0.61286
Lipid and atherosclerosis	120892	155	22	3	1	0.37027	0.61286
Metabolic pathways	120892	155	22	24	4	0.45485	0.65141
Ubiquitin mediated proteolysis	120892	155	22	4	1	0.46142	0.65141
Amyotrophic lateral sclerosis	120892	155	22	4	1	0.46142	0.65141
Huntington disease	120892	155	22	4	1	0.46142	0.65141
Prion disease	120892	155	22	4	1	0.46142	0.65141
Viral life cycle - HIV-1	120892	155	22	5	1	0.53989	0.70039
Phagosome	120892	155	22	5	1	0.53989	0.70039
Hematopoietic cell lineage	120892	155	22	5	1	0.53989	0.70039
Protein processing in endoplasmic reticulum	120892	155	22	6	1	0.60737	0.7672
Oocyte meiosis	120892	155	22	7	1	0.66534	0.77894
Progesterone-mediated oocyte maturation	120892	155	22	7	1	0.66534	0.77894
Human immunodeficiency virus 1 infection	120892	155	22	7	1	0.66534	0.77894
Alcoholism	120892	155	22	8	1	0.71509	0.81724
Systemic lupus erythematosus	120892	155	22	10	1	0.79423	0.88659
Coronavirus disease - COVID-19	120892	155	22	11	1	0.82545	0.9005
Neutrophil extracellular trap formation	120892	155	22	13	1	0.87487	0.91291
Viral carcinogenesis	120892	155	22	13	1	0.87487	0.91291
NOD-like receptor signaling pathway	120892	155	22	15	1	0.91076	0.93013
Ribosome biogenesis in eukaryotes	120892	155	22	18	1	0.94678	0.94678
Cell cycle	122509	155	11	14	4	0.009721	0.2333
DNA replication	122509	155	11	4	2	0.025524	0.23773
Protein export	122509	155	11	1	1	0.070968	0.23773
Base excision repair	122509	155	11	1	1	0.070968	0.23773
Non-homologous end-joining	122509	155	11	1	1	0.070968	0.23773
Hippo signaling pathway	122509	155	11	1	1	0.070968	0.23773
Oocyte meiosis	122509	155	11	7	2	0.079242	0.23773
Human T-cell leukemia virus 1 infection	122509	155	11	7	2	0.079242	0.23773
Platinum drug resistance	122509	155	11	2	1	0.13733	0.27465
Apoptosis	122509	155	11	2	1	0.13733	0.27465
Apoptosis - multiple species	122509	155	11	2	1	0.13733	0.27465
Colorectal cancer	122509	155	11	2	1	0.13733	0.27465
Drug metabolism - other enzymes	122509	155	11	3	1	0.19935	0.36323
Pyrimidine metabolism	122509	155	11	4	1	0.25729	0.36323
Nucleotide metabolism	122509	155	11	4	1	0.25729	0.36323
Ubiquitin mediated proteolysis	122509	155	11	4	1	0.25729	0.36323
MicroRNAs in cancer	122509	155	11	4	1	0.25729	0.36323
Chemical carcinogenesis - receptor activation	122509	155	11	5	1	0.3114	0.41519
Protein processing in endoplasmic reticulum	122509	155	11	6	1	0.36189	0.45713
Cellular senescence	122509	155	11	7	1	0.409	0.4908
Hepatitis B	122509	155	11	8	1	0.45293	0.51763
Pathways in cancer	122509	155	11	9	1	0.49386	0.53876
Viral carcinogenesis	122509	155	11	13	1	0.63127	0.65871
Metabolic pathways	122509	155	11	24	1	0.85323	0.85323
Influenza A	129607	155	27	10	10	5.1445e-09	2.6237e-07
Measles	129607	155	27	9	9	4.1727e-08	1.064e-06
Hepatitis C	129607	155	27	12	10	2.7084e-07	4.6043e-06
Coronavirus disease - COVID-19	129607	155	27	11	9	1.8128e-06	2.3114e-05
Herpes simplex virus 1 infection	129607	155	27	9	8	2.5717e-06	2.6232e-05
NOD-like receptor signaling pathway	129607	155	27	15	9	0.00010217	0.00086849
Epstein-Barr virus infection	129607	155	27	11	7	0.00047513	0.0034616
Necroptosis	129607	155	27	4	4	0.00075875	0.0048371
Human papillomavirus infection	129607	155	27	10	5	0.015146	0.085829
Kaposi sarcoma-associated herpesvirus infection	129607	155	27	4	3	0.016946	0.086422
Chemokine signaling pathway	129607	155	27	2	2	0.029409	0.10713
RIG-I-like receptor signaling pathway	129607	155	27	2	2	0.029409	0.10713
Cytosolic DNA-sensing pathway	129607	155	27	2	2	0.029409	0.10713
C-type lectin receptor signaling pathway	129607	155	27	2	2	0.029409	0.10713
Hepatitis B	129607	155	27	8	4	0.0316	0.10744
JAK-STAT signaling pathway	129607	155	27	3	2	0.078617	0.25059
Osteoclast differentiation	129607	155	27	4	2	0.14029	0.31728
PD-L1 expression and PD-1 checkpoint pathway in cancer	129607	155	27	4	2	0.14029	0.31728
Glycolysis / Gluconeogenesis	129607	155	27	1	1	0.17419	0.31728
Galactose metabolism	129607	155	27	1	1	0.17419	0.31728
NF-kappa B signaling pathway	129607	155	27	1	1	0.17419	0.31728
Toll-like receptor signaling pathway	129607	155	27	1	1	0.17419	0.31728
Th1 and Th2 cell differentiation	129607	155	27	1	1	0.17419	0.31728
Prolactin signaling pathway	129607	155	27	1	1	0.17419	0.31728
AGE-RAGE signaling pathway in diabetic complications	129607	155	27	1	1	0.17419	0.31728
Growth hormone synthesis, secretion and action	129607	155	27	1	1	0.17419	0.31728
Pertussis	129607	155	27	1	1	0.17419	0.31728
Toxoplasmosis	129607	155	27	1	1	0.17419	0.31728
Viral life cycle - HIV-1	129607	155	27	5	2	0.2089	0.36738
Lysosome	129607	155	27	2	1	0.31898	0.4281
Apoptosis	129607	155	27	2	1	0.31898	0.4281
Apoptosis - multiple species	129607	155	27	2	1	0.31898	0.4281
Notch signaling pathway	129607	155	27	2	1	0.31898	0.4281
Cell adhesion molecules	129607	155	27	2	1	0.31898	0.4281
Complement and coagulation cascades	129607	155	27	2	1	0.31898	0.4281
Th17 cell differentiation	129607	155	27	2	1	0.31898	0.4281
Leishmaniasis	129607	155	27	2	1	0.31898	0.4281
Inflammatory bowel disease	129607	155	27	2	1	0.31898	0.4281
Thyroid hormone signaling pathway	129607	155	27	3	1	0.43916	0.55993
Pancreatic cancer	129607	155	27	3	1	0.43916	0.55993
Pathways in cancer	129607	155	27	9	2	0.4866	0.60529
Pyrimidine metabolism	129607	155	27	4	1	0.53878	0.61062
Nucleotide metabolism	129607	155	27	4	1	0.53878	0.61062
Biosynthesis of cofactors	129607	155	27	4	1	0.53878	0.61062
Tuberculosis	129607	155	27	4	1	0.53878	0.61062
Protein processing in endoplasmic reticulum	129607	155	27	6	1	0.68943	0.76436
Human immunodeficiency virus 1 infection	129607	155	27	7	1	0.7457	0.80917
Alzheimer disease	129607	155	27	8	1	0.7921	0.82443
Transcriptional misregulation in cancer	129607	155	27	8	1	0.7921	0.82443
Viral carcinogenesis	129607	155	27	13	1	0.9258	0.94432
Metabolic pathways	129607	155	27	24	2	0.9525	0.9525
Influenza A	130589	155	25	10	10	1.9933e-09	9.9665e-08
Measles	130589	155	25	9	9	1.8189e-08	4.5472e-07
Hepatitis C	130589	155	25	12	10	1.0792e-07	1.7986e-06
Coronavirus disease - COVID-19	130589	155	25	11	9	8.1233e-07	1.0154e-05
Herpes simplex virus 1 infection	130589	155	25	9	8	1.27e-06	1.27e-05
Epstein-Barr virus infection	130589	155	25	11	7	0.00027131	0.0022609
NOD-like receptor signaling pathway	130589	155	25	15	8	0.00046839	0.0033457
Necroptosis	130589	155	25	4	4	0.00054691	0.0034182
Human papillomavirus infection	130589	155	25	10	5	0.010611	0.058951
Kaposi sarcoma-associated herpesvirus infection	130589	155	25	4	3	0.013474	0.067369
Hepatitis B	130589	155	25	8	4	0.023884	0.083787
Chemokine signaling pathway	130589	155	25	2	2	0.025136	0.083787
RIG-I-like receptor signaling pathway	130589	155	25	2	2	0.025136	0.083787
Cytosolic DNA-sensing pathway	130589	155	25	2	2	0.025136	0.083787
C-type lectin receptor signaling pathway	130589	155	25	2	2	0.025136	0.083787
JAK-STAT signaling pathway	130589	155	25	3	2	0.067851	0.21203
Osteoclast differentiation	130589	155	25	4	2	0.12223	0.28802
PD-L1 expression and PD-1 checkpoint pathway in cancer	130589	155	25	4	2	0.12223	0.28802
Glycolysis / Gluconeogenesis	130589	155	25	1	1	0.16129	0.28802
Galactose metabolism	130589	155	25	1	1	0.16129	0.28802
NF-kappa B signaling pathway	130589	155	25	1	1	0.16129	0.28802
Toll-like receptor signaling pathway	130589	155	25	1	1	0.16129	0.28802
Th1 and Th2 cell differentiation	130589	155	25	1	1	0.16129	0.28802
Prolactin signaling pathway	130589	155	25	1	1	0.16129	0.28802
AGE-RAGE signaling pathway in diabetic complications	130589	155	25	1	1	0.16129	0.28802
Growth hormone synthesis, secretion and action	130589	155	25	1	1	0.16129	0.28802
Pertussis	130589	155	25	1	1	0.16129	0.28802
Toxoplasmosis	130589	155	25	1	1	0.16129	0.28802
Viral life cycle - HIV-1	130589	155	25	5	2	0.18369	0.3167
Apoptosis	130589	155	25	2	1	0.29744	0.40195
Apoptosis - multiple species	130589	155	25	2	1	0.29744	0.40195
Notch signaling pathway	130589	155	25	2	1	0.29744	0.40195
Cell adhesion molecules	130589	155	25	2	1	0.29744	0.40195
Complement and coagulation cascades	130589	155	25	2	1	0.29744	0.40195
Th17 cell differentiation	130589	155	25	2	1	0.29744	0.40195
Leishmaniasis	130589	155	25	2	1	0.29744	0.40195
Inflammatory bowel disease	130589	155	25	2	1	0.29744	0.40195
Thyroid hormone signaling pathway	130589	155	25	3	1	0.41224	0.52851
Pancreatic cancer	130589	155	25	3	1	0.41224	0.52851
Pathways in cancer	130589	155	25	9	2	0.44248	0.5531
Pyrimidine metabolism	130589	155	25	4	1	0.50891	0.57831
Nucleotide metabolism	130589	155	25	4	1	0.50891	0.57831
Biosynthesis of cofactors	130589	155	25	4	1	0.50891	0.57831
Tuberculosis	130589	155	25	4	1	0.50891	0.57831
Protein processing in endoplasmic reticulum	130589	155	25	6	1	0.65851	0.73168
Human immunodeficiency virus 1 infection	130589	155	25	7	1	0.71581	0.77806
Alzheimer disease	130589	155	25	8	1	0.76382	0.79564
Transcriptional misregulation in cancer	130589	155	25	8	1	0.76382	0.79564
Viral carcinogenesis	130589	155	25	13	1	0.90832	0.92686
Metabolic pathways	130589	155	25	24	2	0.93406	0.93406
Influenza A	135112	155	23	10	10	6.9765e-10	3.279e-08
Measles	135112	155	23	9	9	7.2755e-09	1.7098e-07
Hepatitis C	135112	155	23	12	10	3.8826e-08	6.0828e-07
Coronavirus disease - COVID-19	135112	155	23	11	9	3.339e-07	3.9233e-06
Herpes simplex virus 1 infection	135112	155	23	9	8	5.835e-07	5.4849e-06
Epstein-Barr virus infection	135112	155	23	11	7	0.00014587	0.0011426
NOD-like receptor signaling pathway	135112	155	23	15	8	0.00023343	0.0015673
Necroptosis	135112	155	23	4	4	0.00038284	0.0022492
Kaposi sarcoma-associated herpesvirus infection	135112	155	23	4	3	0.01049	0.05478
Hepatitis B	135112	155	23	8	4	0.017524	0.066421
RNA degradation	135112	155	23	2	2	0.021198	0.066421
Chemokine signaling pathway	135112	155	23	2	2	0.021198	0.066421
RIG-I-like receptor signaling pathway	135112	155	23	2	2	0.021198	0.066421
Cytosolic DNA-sensing pathway	135112	155	23	2	2	0.021198	0.066421
C-type lectin receptor signaling pathway	135112	155	23	2	2	0.021198	0.066421
Human papillomavirus infection	135112	155	23	10	4	0.042503	0.12485
JAK-STAT signaling pathway	135112	155	23	3	2	0.057775	0.15973
Osteoclast differentiation	135112	155	23	4	2	0.10506	0.26824
NF-kappa B signaling pathway	135112	155	23	1	1	0.14839	0.26824
Signaling pathways regulating pluripotency of stem cells	135112	155	23	1	1	0.14839	0.26824
Toll-like receptor signaling pathway	135112	155	23	1	1	0.14839	0.26824
Th1 and Th2 cell differentiation	135112	155	23	1	1	0.14839	0.26824
Prolactin signaling pathway	135112	155	23	1	1	0.14839	0.26824
AGE-RAGE signaling pathway in diabetic complications	135112	155	23	1	1	0.14839	0.26824
Growth hormone synthesis, secretion and action	135112	155	23	1	1	0.14839	0.26824
Toxoplasmosis	135112	155	23	1	1	0.14839	0.26824
Viral life cycle - HIV-1	135112	155	23	5	2	0.15934	0.27737
Lysosome	135112	155	23	2	1	0.27558	0.39249
Notch signaling pathway	135112	155	23	2	1	0.27558	0.39249
Cell adhesion molecules	135112	155	23	2	1	0.27558	0.39249
Th17 cell differentiation	135112	155	23	2	1	0.27558	0.39249
Leishmaniasis	135112	155	23	2	1	0.27558	0.39249
Inflammatory bowel disease	135112	155	23	2	1	0.27558	0.39249
Thyroid hormone signaling pathway	135112	155	23	3	1	0.38448	0.5163
Pancreatic cancer	135112	155	23	3	1	0.38448	0.5163
Pathways in cancer	135112	155	23	9	2	0.39705	0.51837
Pyrimidine metabolism	135112	155	23	4	1	0.47761	0.54751
Nucleotide metabolism	135112	155	23	4	1	0.47761	0.54751
Biosynthesis of cofactors	135112	155	23	4	1	0.47761	0.54751
Tuberculosis	135112	155	23	4	1	0.47761	0.54751
PD-L1 expression and PD-1 checkpoint pathway in cancer	135112	155	23	4	1	0.47761	0.54751
Protein processing in endoplasmic reticulum	135112	155	23	6	1	0.62508	0.6995
Human immunodeficiency virus 1 infection	135112	155	23	7	1	0.68296	0.74649
Alzheimer disease	135112	155	23	8	1	0.73223	0.78215
Viral carcinogenesis	135112	155	23	13	1	0.8871	0.92653
Ribosome biogenesis in eukaryotes	135112	155	23	18	1	0.95398	0.97472
Metabolic pathways	135112	155	23	24	1	0.98507	0.98507
Pantothenate and CoA biosynthesis	1397	155	2	1	1	0.012903	0.03871
Hematopoietic cell lineage	1397	155	2	5	1	0.063678	0.095517
Metabolic pathways	1397	155	2	24	1	0.28655	0.28655
Alzheimer disease	140609	155	23	8	6	0.0001317	0.0039815
Parkinson disease	140609	155	23	6	5	0.00026013	0.0039815
Amyotrophic lateral sclerosis	140609	155	23	4	4	0.00038284	0.0039815
Huntington disease	140609	155	23	4	4	0.00038284	0.0039815
Prion disease	140609	155	23	4	4	0.00038284	0.0039815
Pathways of neurodegeneration - multiple diseases	140609	155	23	7	5	0.00081917	0.0070995
Oxidative phosphorylation	140609	155	23	3	3	0.0029096	0.016811
Thermogenesis	140609	155	23	3	3	0.0029096	0.016811
Diabetic cardiomyopathy	140609	155	23	3	3	0.0029096	0.016811
Chemical carcinogenesis - reactive oxygen species	140609	155	23	4	3	0.01049	0.054546
RNA degradation	140609	155	23	2	2	0.021198	0.078736
Retrograde endocannabinoid signaling	140609	155	23	2	2	0.021198	0.078736
Non-alcoholic fatty liver disease	140609	155	23	2	2	0.021198	0.078736
Protein digestion and absorption	140609	155	23	2	2	0.021198	0.078736
Metabolic pathways	140609	155	23	24	7	0.039725	0.13771
Ubiquitin mediated proteolysis	140609	155	23	4	2	0.10506	0.26607
Mucin type O-glycan biosynthesis	140609	155	23	1	1	0.14839	0.26607
Glycerolipid metabolism	140609	155	23	1	1	0.14839	0.26607
Glycerophospholipid metabolism	140609	155	23	1	1	0.14839	0.26607
Sphingolipid metabolism	140609	155	23	1	1	0.14839	0.26607
ABC transporters	140609	155	23	1	1	0.14839	0.26607
mTOR signaling pathway	140609	155	23	1	1	0.14839	0.26607
Glutamatergic synapse	140609	155	23	1	1	0.14839	0.26607
GABAergic synapse	140609	155	23	1	1	0.14839	0.26607
Insulin signaling pathway	140609	155	23	1	1	0.14839	0.26607
Fat digestion and absorption	140609	155	23	1	1	0.14839	0.26607
Epithelial cell signaling in Helicobacter pylori infection	140609	155	23	1	1	0.14839	0.26607
Pathogenic Escherichia coli infection	140609	155	23	1	1	0.14839	0.26607
Renal cell carcinoma	140609	155	23	1	1	0.14839	0.26607
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	140609	155	23	2	1	0.27558	0.38021
Nicotinate and nicotinamide metabolism	140609	155	23	2	1	0.27558	0.38021
HIF-1 signaling pathway	140609	155	23	2	1	0.27558	0.38021
Notch signaling pathway	140609	155	23	2	1	0.27558	0.38021
Renin-angiotensin system	140609	155	23	2	1	0.27558	0.38021
Alcoholic liver disease	140609	155	23	2	1	0.27558	0.38021
Cholesterol metabolism	140609	155	23	2	1	0.27558	0.38021
Salmonella infection	140609	155	23	2	1	0.27558	0.38021
Human immunodeficiency virus 1 infection	140609	155	23	7	2	0.27784	0.38021
Gap junction	140609	155	23	3	1	0.38448	0.48763
Thyroid hormone signaling pathway	140609	155	23	3	1	0.38448	0.48763
Lipid and atherosclerosis	140609	155	23	3	1	0.38448	0.48763
Biosynthesis of cofactors	140609	155	23	4	1	0.47761	0.59133
Viral life cycle - HIV-1	140609	155	23	5	1	0.55718	0.64386
Phagosome	140609	155	23	5	1	0.55718	0.64386
Hematopoietic cell lineage	140609	155	23	5	1	0.55718	0.64386
Protein processing in endoplasmic reticulum	140609	155	23	6	1	0.62508	0.70661
Oocyte meiosis	140609	155	23	7	1	0.68296	0.73987
Progesterone-mediated oocyte maturation	140609	155	23	7	1	0.68296	0.73987
Pathways in cancer	140609	155	23	9	1	0.77412	0.82152
Coronavirus disease - COVID-19	140609	155	23	11	1	0.83989	0.87349
NOD-like receptor signaling pathway	140609	155	23	15	1	0.92082	0.93888
Ribosome biogenesis in eukaryotes	140609	155	23	18	1	0.95398	0.95398
RNA degradation	147339	155	16	2	2	0.010054	0.39212
Mucin type O-glycan biosynthesis	147339	155	16	1	1	0.10323	0.50323
Sphingolipid metabolism	147339	155	16	1	1	0.10323	0.50323
ABC transporters	147339	155	16	1	1	0.10323	0.50323
Glutamatergic synapse	147339	155	16	1	1	0.10323	0.50323
GABAergic synapse	147339	155	16	1	1	0.10323	0.50323
Fat digestion and absorption	147339	155	16	1	1	0.10323	0.50323
Epithelial cell signaling in Helicobacter pylori infection	147339	155	16	1	1	0.10323	0.50323
Protein processing in endoplasmic reticulum	147339	155	16	6	2	0.11741	0.50877
Alzheimer disease	147339	155	16	8	2	0.19367	0.54711
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	147339	155	16	2	1	0.1964	0.54711
Notch signaling pathway	147339	155	16	2	1	0.1964	0.54711
Protein digestion and absorption	147339	155	16	2	1	0.1964	0.54711
Cholesterol metabolism	147339	155	16	2	1	0.1964	0.54711
Thyroid hormone signaling pathway	147339	155	16	3	1	0.28043	0.68356
Lipid and atherosclerosis	147339	155	16	3	1	0.28043	0.68356
Coronavirus disease - COVID-19	147339	155	16	11	2	0.31673	0.69455
Ubiquitin mediated proteolysis	147339	155	16	4	1	0.35618	0.69455
Necroptosis	147339	155	16	4	1	0.35618	0.69455
Kaposi sarcoma-associated herpesvirus infection	147339	155	16	4	1	0.35618	0.69455
Viral carcinogenesis	147339	155	16	13	2	0.39822	0.73956
Viral life cycle - HIV-1	147339	155	16	5	1	0.4244	0.75234
Parkinson disease	147339	155	16	6	1	0.4858	0.78146
Oocyte meiosis	147339	155	16	7	1	0.54101	0.78146
Progesterone-mediated oocyte maturation	147339	155	16	7	1	0.54101	0.78146
Pathways of neurodegeneration - multiple diseases	147339	155	16	7	1	0.54101	0.78146
Human immunodeficiency virus 1 infection	147339	155	16	7	1	0.54101	0.78146
Alcoholism	147339	155	16	8	1	0.59063	0.79793
Measles	147339	155	16	9	1	0.63519	0.79793
Herpes simplex virus 1 infection	147339	155	16	9	1	0.63519	0.79793
Influenza A	147339	155	16	10	1	0.67517	0.79793
Human papillomavirus infection	147339	155	16	10	1	0.67517	0.79793
Systemic lupus erythematosus	147339	155	16	10	1	0.67517	0.79793
Epstein-Barr virus infection	147339	155	16	11	1	0.71101	0.8118
Hepatitis C	147339	155	16	12	1	0.74312	0.8118
Metabolic pathways	147339	155	16	24	2	0.74935	0.8118
Neutrophil extracellular trap formation	147339	155	16	13	1	0.77186	0.81359
NOD-like receptor signaling pathway	147339	155	16	15	1	0.82054	0.84213
Ribosome biogenesis in eukaryotes	147339	155	16	18	1	0.87565	0.87565
Oxidative phosphorylation	147807	155	10	3	3	0.00019715	0.0019057
Thermogenesis	147807	155	10	3	3	0.00019715	0.0019057
Diabetic cardiomyopathy	147807	155	10	3	3	0.00019715	0.0019057
Amyotrophic lateral sclerosis	147807	155	10	4	3	0.00076135	0.0031542
Huntington disease	147807	155	10	4	3	0.00076135	0.0031542
Prion disease	147807	155	10	4	3	0.00076135	0.0031542
Chemical carcinogenesis - reactive oxygen species	147807	155	10	4	3	0.00076135	0.0031542
Parkinson disease	147807	155	10	6	3	0.0035472	0.010934
Retrograde endocannabinoid signaling	147807	155	10	2	2	0.0037704	0.010934
Non-alcoholic fatty liver disease	147807	155	10	2	2	0.0037704	0.010934
Pathways of neurodegeneration - multiple diseases	147807	155	10	7	3	0.0059914	0.015796
Alzheimer disease	147807	155	10	8	3	0.0092515	0.022358
Neuroactive ligand-receptor interaction	147807	155	10	3	2	0.010917	0.024353
Metabolic pathways	147807	155	10	24	4	0.049253	0.10202
Sphingolipid signaling pathway	147807	155	10	1	1	0.064516	0.11694
Renal cell carcinoma	147807	155	10	1	1	0.064516	0.11694
Nicotinate and nicotinamide metabolism	147807	155	10	2	1	0.12526	0.19119
HIF-1 signaling pathway	147807	155	10	2	1	0.12526	0.19119
Cholesterol metabolism	147807	155	10	2	1	0.12526	0.19119
Biosynthesis of cofactors	147807	155	10	4	1	0.23622	0.31138
FoxO signaling pathway	147807	155	10	4	1	0.23622	0.31138
Ubiquitin mediated proteolysis	147807	155	10	4	1	0.23622	0.31138
Hematopoietic cell lineage	147807	155	10	5	1	0.2868	0.36162
Oocyte meiosis	147807	155	10	7	1	0.37902	0.4071
Progesterone-mediated oocyte maturation	147807	155	10	7	1	0.37902	0.4071
Human T-cell leukemia virus 1 infection	147807	155	10	7	1	0.37902	0.4071
Human immunodeficiency virus 1 infection	147807	155	10	7	1	0.37902	0.4071
Pathways in cancer	147807	155	10	9	1	0.46037	0.47681
NOD-like receptor signaling pathway	147807	155	10	15	1	0.65018	0.65018
Staphylococcus aureus infection	1511	155	13	6	5	1.0563e-05	0.00023239
Transcriptional misregulation in cancer	1511	155	13	8	5	8.9968e-05	0.00098964
NOD-like receptor signaling pathway	1511	155	13	15	5	0.0034794	0.025516
Phagosome	1511	155	13	5	2	0.056413	0.25332
Neutrophil extracellular trap formation	1511	155	13	13	3	0.08073	0.25332
Carbohydrate digestion and absorption	1511	155	13	1	1	0.083871	0.25332
Asthma	1511	155	13	1	1	0.083871	0.25332
Amino sugar and nucleotide sugar metabolism	1511	155	13	2	1	0.16121	0.25332
PPAR signaling pathway	1511	155	13	2	1	0.16121	0.25332
Lysosome	1511	155	13	2	1	0.16121	0.25332
Renin-angiotensin system	1511	155	13	2	1	0.16121	0.25332
IL-17 signaling pathway	1511	155	13	2	1	0.16121	0.25332
Salivary secretion	1511	155	13	2	1	0.16121	0.25332
Amoebiasis	1511	155	13	2	1	0.16121	0.25332
Drug metabolism - other enzymes	1511	155	13	3	1	0.23248	0.28414
Neuroactive ligand-receptor interaction	1511	155	13	3	1	0.23248	0.28414
Acute myeloid leukemia	1511	155	13	3	1	0.23248	0.28414
Lipid and atherosclerosis	1511	155	13	3	1	0.23248	0.28414
Tuberculosis	1511	155	13	4	1	0.29812	0.34519
Hematopoietic cell lineage	1511	155	13	5	1	0.35855	0.3944
Systemic lupus erythematosus	1511	155	13	10	1	0.59495	0.62328
Metabolic pathways	1511	155	13	24	1	0.89822	0.89822
Influenza A	151636	155	30	10	10	1.8322e-08	1.0626e-06
Measles	151636	155	30	9	9	1.2738e-07	3.694e-06
Hepatitis C	151636	155	30	12	10	9.2431e-07	1.787e-05
Coronavirus disease - COVID-19	151636	155	30	11	9	5.3057e-06	7.6933e-05
Herpes simplex virus 1 infection	151636	155	30	9	8	6.641e-06	7.7036e-05
NOD-like receptor signaling pathway	151636	155	30	15	9	0.00027463	0.0026548
Epstein-Barr virus infection	151636	155	30	11	7	0.0010041	0.0083193
Necroptosis	151636	155	30	4	4	0.0011848	0.00859
Kaposi sarcoma-associated herpesvirus infection	151636	155	30	4	3	0.023126	0.1282
PD-L1 expression and PD-1 checkpoint pathway in cancer	151636	155	30	4	3	0.023126	0.1282
Human papillomavirus infection	151636	155	30	10	5	0.024313	0.1282
RNA degradation	151636	155	30	2	2	0.036447	0.13212
Chemokine signaling pathway	151636	155	30	2	2	0.036447	0.13212
RIG-I-like receptor signaling pathway	151636	155	30	2	2	0.036447	0.13212
Cytosolic DNA-sensing pathway	151636	155	30	2	2	0.036447	0.13212
C-type lectin receptor signaling pathway	151636	155	30	2	2	0.036447	0.13212
Hepatitis B	151636	155	30	8	4	0.045913	0.15665
JAK-STAT signaling pathway	151636	155	30	3	2	0.096002	0.30934
Osteoclast differentiation	151636	155	30	4	2	0.16888	0.35081
Glycolysis / Gluconeogenesis	151636	155	30	1	1	0.19355	0.35081
Galactose metabolism	151636	155	30	1	1	0.19355	0.35081
ABC transporters	151636	155	30	1	1	0.19355	0.35081
NF-kappa B signaling pathway	151636	155	30	1	1	0.19355	0.35081
Signaling pathways regulating pluripotency of stem cells	151636	155	30	1	1	0.19355	0.35081
Toll-like receptor signaling pathway	151636	155	30	1	1	0.19355	0.35081
Th1 and Th2 cell differentiation	151636	155	30	1	1	0.19355	0.35081
Prolactin signaling pathway	151636	155	30	1	1	0.19355	0.35081
AGE-RAGE signaling pathway in diabetic complications	151636	155	30	1	1	0.19355	0.35081
Growth hormone synthesis, secretion and action	151636	155	30	1	1	0.19355	0.35081
Fat digestion and absorption	151636	155	30	1	1	0.19355	0.35081
Pertussis	151636	155	30	1	1	0.19355	0.35081
Toxoplasmosis	151636	155	30	1	1	0.19355	0.35081
Viral life cycle - HIV-1	151636	155	30	5	2	0.24803	0.43593
Lysosome	151636	155	30	2	1	0.35065	0.49604
Notch signaling pathway	151636	155	30	2	1	0.35065	0.49604
Cell adhesion molecules	151636	155	30	2	1	0.35065	0.49604
Complement and coagulation cascades	151636	155	30	2	1	0.35065	0.49604
Th17 cell differentiation	151636	155	30	2	1	0.35065	0.49604
Cholesterol metabolism	151636	155	30	2	1	0.35065	0.49604
Leishmaniasis	151636	155	30	2	1	0.35065	0.49604
Inflammatory bowel disease	151636	155	30	2	1	0.35065	0.49604
Thyroid hormone signaling pathway	151636	155	30	3	1	0.47797	0.63006
Pancreatic cancer	151636	155	30	3	1	0.47797	0.63006
Lipid and atherosclerosis	151636	155	30	3	1	0.47797	0.63006
Pathways in cancer	151636	155	30	9	2	0.54972	0.68772
Pyrimidine metabolism	151636	155	30	4	1	0.581	0.68772
Nucleotide metabolism	151636	155	30	4	1	0.581	0.68772
Biosynthesis of cofactors	151636	155	30	4	1	0.581	0.68772
Tuberculosis	151636	155	30	4	1	0.581	0.68772
Protein processing in endoplasmic reticulum	151636	155	30	6	1	0.7314	0.84842
Viral carcinogenesis	151636	155	30	13	2	0.76113	0.8656
Human immunodeficiency virus 1 infection	151636	155	30	7	1	0.78548	0.87611
Alzheimer disease	151636	155	30	8	1	0.82896	0.89037
Alcoholism	151636	155	30	8	1	0.82896	0.89037
Systemic lupus erythematosus	151636	155	30	10	1	0.89184	0.94049
Neutrophil extracellular trap formation	151636	155	30	13	1	0.94634	0.98013
Metabolic pathways	151636	155	30	24	2	0.97153	0.98393
Ribosome biogenesis in eukaryotes	151636	155	30	18	1	0.98393	0.98393
RNA degradation	153222	155	17	2	2	0.011395	0.20511
Protein digestion and absorption	153222	155	17	2	2	0.011395	0.20511
Mucin type O-glycan biosynthesis	153222	155	17	1	1	0.10968	0.30372
Glycerolipid metabolism	153222	155	17	1	1	0.10968	0.30372
Glycerophospholipid metabolism	153222	155	17	1	1	0.10968	0.30372
Sphingolipid metabolism	153222	155	17	1	1	0.10968	0.30372
ABC transporters	153222	155	17	1	1	0.10968	0.30372
mTOR signaling pathway	153222	155	17	1	1	0.10968	0.30372
Glutamatergic synapse	153222	155	17	1	1	0.10968	0.30372
GABAergic synapse	153222	155	17	1	1	0.10968	0.30372
Insulin signaling pathway	153222	155	17	1	1	0.10968	0.30372
Fat digestion and absorption	153222	155	17	1	1	0.10968	0.30372
Epithelial cell signaling in Helicobacter pylori infection	153222	155	17	1	1	0.10968	0.30372
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	153222	155	17	2	1	0.20796	0.40483
Notch signaling pathway	153222	155	17	2	1	0.20796	0.40483
Renin-angiotensin system	153222	155	17	2	1	0.20796	0.40483
Alcoholic liver disease	153222	155	17	2	1	0.20796	0.40483
Cholesterol metabolism	153222	155	17	2	1	0.20796	0.40483
Alzheimer disease	153222	155	17	8	2	0.21366	0.40483
Thyroid hormone signaling pathway	153222	155	17	3	1	0.29596	0.50737
Lipid and atherosclerosis	153222	155	17	3	1	0.29596	0.50737
Ubiquitin mediated proteolysis	153222	155	17	4	1	0.37471	0.61315
Hematopoietic cell lineage	153222	155	17	5	1	0.4451	0.69668
Protein processing in endoplasmic reticulum	153222	155	17	6	1	0.50799	0.70029
Parkinson disease	153222	155	17	6	1	0.50799	0.70029
Metabolic pathways	153222	155	17	24	3	0.51046	0.70029
Oocyte meiosis	153222	155	17	7	1	0.56413	0.70029
Progesterone-mediated oocyte maturation	153222	155	17	7	1	0.56413	0.70029
Pathways of neurodegeneration - multiple diseases	153222	155	17	7	1	0.56413	0.70029
Alcoholism	153222	155	17	8	1	0.61419	0.73703
Systemic lupus erythematosus	153222	155	17	10	1	0.69854	0.8112
Coronavirus disease - COVID-19	153222	155	17	11	1	0.73388	0.82562
Neutrophil extracellular trap formation	153222	155	17	13	1	0.7932	0.83986
Viral carcinogenesis	153222	155	17	13	1	0.7932	0.83986
NOD-like receptor signaling pathway	153222	155	17	15	1	0.83991	0.8639
Ribosome biogenesis in eukaryotes	153222	155	17	18	1	0.89176	0.89176
Measles	162394	155	14	9	7	3.0537e-07	5.6494e-06
Herpes simplex virus 1 infection	162394	155	14	9	7	3.0537e-07	5.6494e-06
Influenza A	162394	155	14	10	7	9.7532e-07	1.2029e-05
Coronavirus disease - COVID-19	162394	155	14	11	7	2.5694e-06	2.3767e-05
NOD-like receptor signaling pathway	162394	155	14	15	7	4.2091e-05	0.00031148
Epstein-Barr virus infection	162394	155	14	11	6	6.2624e-05	0.00038618
Hepatitis C	162394	155	14	12	6	0.00011934	0.00063081
Necroptosis	162394	155	14	4	3	0.0022622	0.010007
Hepatitis B	162394	155	14	8	4	0.0024341	0.010007
Chemokine signaling pathway	162394	155	14	2	2	0.0076246	0.021701
RIG-I-like receptor signaling pathway	162394	155	14	2	2	0.0076246	0.021701
Cytosolic DNA-sensing pathway	162394	155	14	2	2	0.0076246	0.021701
C-type lectin receptor signaling pathway	162394	155	14	2	2	0.0076246	0.021701
JAK-STAT signaling pathway	162394	155	14	3	2	0.021678	0.057292
Osteoclast differentiation	162394	155	14	4	2	0.041094	0.095029
Kaposi sarcoma-associated herpesvirus infection	162394	155	14	4	2	0.041094	0.095029
NF-kappa B signaling pathway	162394	155	14	1	1	0.090323	0.13925
Signaling pathways regulating pluripotency of stem cells	162394	155	14	1	1	0.090323	0.13925
Toll-like receptor signaling pathway	162394	155	14	1	1	0.090323	0.13925
Th1 and Th2 cell differentiation	162394	155	14	1	1	0.090323	0.13925
Prolactin signaling pathway	162394	155	14	1	1	0.090323	0.13925
AGE-RAGE signaling pathway in diabetic complications	162394	155	14	1	1	0.090323	0.13925
Growth hormone synthesis, secretion and action	162394	155	14	1	1	0.090323	0.13925
Toxoplasmosis	162394	155	14	1	1	0.090323	0.13925
Lysosome	162394	155	14	2	1	0.17302	0.22075
Notch signaling pathway	162394	155	14	2	1	0.17302	0.22075
Th17 cell differentiation	162394	155	14	2	1	0.17302	0.22075
Leishmaniasis	162394	155	14	2	1	0.17302	0.22075
Inflammatory bowel disease	162394	155	14	2	1	0.17302	0.22075
Pathways in cancer	162394	155	14	9	2	0.18901	0.23311
Human papillomavirus infection	162394	155	14	10	2	0.22414	0.26752
Thyroid hormone signaling pathway	162394	155	14	3	1	0.24869	0.27884
Pancreatic cancer	162394	155	14	3	1	0.24869	0.27884
Tuberculosis	162394	155	14	4	1	0.31789	0.33606
PD-L1 expression and PD-1 checkpoint pathway in cancer	162394	155	14	4	1	0.31789	0.33606
Viral life cycle - HIV-1	162394	155	14	5	1	0.38113	0.39172
Human immunodeficiency virus 1 infection	162394	155	14	7	1	0.49162	0.49162
Staphylococcus aureus infection	1667	155	13	6	5	1.0563e-05	0.00022183
Transcriptional misregulation in cancer	1667	155	13	8	5	8.9968e-05	0.00094466
NOD-like receptor signaling pathway	1667	155	13	15	5	0.0034794	0.024356
Amoebiasis	1667	155	13	2	2	0.0065354	0.034311
Phagosome	1667	155	13	5	2	0.056413	0.23693
Neutrophil extracellular trap formation	1667	155	13	13	3	0.08073	0.25161
Asthma	1667	155	13	1	1	0.083871	0.25161
Amino sugar and nucleotide sugar metabolism	1667	155	13	2	1	0.16121	0.26041
PPAR signaling pathway	1667	155	13	2	1	0.16121	0.26041
Lysosome	1667	155	13	2	1	0.16121	0.26041
Renin-angiotensin system	1667	155	13	2	1	0.16121	0.26041
IL-17 signaling pathway	1667	155	13	2	1	0.16121	0.26041
Salivary secretion	1667	155	13	2	1	0.16121	0.26041
Drug metabolism - other enzymes	1667	155	13	3	1	0.23248	0.28718
Neuroactive ligand-receptor interaction	1667	155	13	3	1	0.23248	0.28718
Acute myeloid leukemia	1667	155	13	3	1	0.23248	0.28718
Lipid and atherosclerosis	1667	155	13	3	1	0.23248	0.28718
Tuberculosis	1667	155	13	4	1	0.29812	0.34781
Hematopoietic cell lineage	1667	155	13	5	1	0.35855	0.39629
Systemic lupus erythematosus	1667	155	13	10	1	0.59495	0.6247
Metabolic pathways	1667	155	13	24	1	0.89822	0.89822
Staphylococcus aureus infection	1668	155	5	6	4	3.2082e-06	2.8874e-05
Transcriptional misregulation in cancer	1668	155	5	8	4	1.4811e-05	6.665e-05
NOD-like receptor signaling pathway	1668	155	5	15	4	0.00027787	0.00083362
Lysosome	1668	155	5	2	1	0.063678	0.095517
Renin-angiotensin system	1668	155	5	2	1	0.063678	0.095517
Amoebiasis	1668	155	5	2	1	0.063678	0.095517
Neuroactive ligand-receptor interaction	1668	155	5	3	1	0.094277	0.12121
Systemic lupus erythematosus	1668	155	5	10	1	0.2868	0.32265
Neutrophil extracellular trap formation	1668	155	5	13	1	0.35855	0.35855
Staphylococcus aureus infection	1669	155	14	6	5	1.6336e-05	0.0003594
Transcriptional misregulation in cancer	1669	155	14	8	5	0.00013752	0.0015127
NOD-like receptor signaling pathway	1669	155	14	15	5	0.0051022	0.037416
Amoebiasis	1669	155	14	2	2	0.0076246	0.041935
Phagosome	1669	155	14	5	2	0.064924	0.26842
Carbohydrate digestion and absorption	1669	155	14	1	1	0.090323	0.26842
Asthma	1669	155	14	1	1	0.090323	0.26842
Neutrophil extracellular trap formation	1669	155	14	13	3	0.097609	0.26842
Amino sugar and nucleotide sugar metabolism	1669	155	14	2	1	0.17302	0.27189
PPAR signaling pathway	1669	155	14	2	1	0.17302	0.27189
Lysosome	1669	155	14	2	1	0.17302	0.27189
Renin-angiotensin system	1669	155	14	2	1	0.17302	0.27189
IL-17 signaling pathway	1669	155	14	2	1	0.17302	0.27189
Salivary secretion	1669	155	14	2	1	0.17302	0.27189
Drug metabolism - other enzymes	1669	155	14	3	1	0.24869	0.30396
Neuroactive ligand-receptor interaction	1669	155	14	3	1	0.24869	0.30396
Acute myeloid leukemia	1669	155	14	3	1	0.24869	0.30396
Lipid and atherosclerosis	1669	155	14	3	1	0.24869	0.30396
Tuberculosis	1669	155	14	4	1	0.31789	0.36808
Hematopoietic cell lineage	1669	155	14	5	1	0.38113	0.41925
Systemic lupus erythematosus	1669	155	14	10	1	0.62348	0.65317
Metabolic pathways	1669	155	14	24	1	0.91542	0.91542
Steroid biosynthesis	1718	155	1	1	1	0.0064516	0.012903
Metabolic pathways	1718	155	1	24	1	0.15484	0.15484
Cell cycle	1719	155	11	14	5	0.00097012	0.034924
Progesterone-mediated oocyte maturation	1719	155	11	7	3	0.0080711	0.14528
AMPK signaling pathway	1719	155	11	3	2	0.013283	0.15939
DNA replication	1719	155	11	4	2	0.025524	0.18377
p53 signaling pathway	1719	155	11	4	2	0.025524	0.18377
Purine metabolism	1719	155	11	1	1	0.070968	0.25934
Biosynthesis of unsaturated fatty acids	1719	155	11	1	1	0.070968	0.25934
Fatty acid metabolism	1719	155	11	1	1	0.070968	0.25934
Serotonergic synapse	1719	155	11	1	1	0.070968	0.25934
Oocyte meiosis	1719	155	11	7	2	0.079242	0.25934
Cellular senescence	1719	155	11	7	2	0.079242	0.25934
Glutathione metabolism	1719	155	11	2	1	0.13733	0.27465
One carbon pool by folate	1719	155	11	2	1	0.13733	0.27465
Folate biosynthesis	1719	155	11	2	1	0.13733	0.27465
Platinum drug resistance	1719	155	11	2	1	0.13733	0.27465
PPAR signaling pathway	1719	155	11	2	1	0.13733	0.27465
ECM-receptor interaction	1719	155	11	2	1	0.13733	0.27465
Alcoholic liver disease	1719	155	11	2	1	0.13733	0.27465
Drug metabolism - other enzymes	1719	155	11	3	1	0.19935	0.32621
Antifolate resistance	1719	155	11	3	1	0.19935	0.32621
Gap junction	1719	155	11	3	1	0.19935	0.32621
Acute myeloid leukemia	1719	155	11	3	1	0.19935	0.32621
Metabolic pathways	1719	155	11	24	3	0.23117	0.34305
Viral carcinogenesis	1719	155	11	13	2	0.23181	0.34305
Pyrimidine metabolism	1719	155	11	4	1	0.25729	0.34305
Nucleotide metabolism	1719	155	11	4	1	0.25729	0.34305
Biosynthesis of cofactors	1719	155	11	4	1	0.25729	0.34305
Pathways of neurodegeneration - multiple diseases	1719	155	11	7	1	0.409	0.4908
Human T-cell leukemia virus 1 infection	1719	155	11	7	1	0.409	0.4908
Human immunodeficiency virus 1 infection	1719	155	11	7	1	0.409	0.4908
Alzheimer disease	1719	155	11	8	1	0.45293	0.4941
Hepatitis B	1719	155	11	8	1	0.45293	0.4941
Transcriptional misregulation in cancer	1719	155	11	8	1	0.45293	0.4941
Pathways in cancer	1719	155	11	9	1	0.49386	0.52292
Human papillomavirus infection	1719	155	11	10	1	0.532	0.5472
Epstein-Barr virus infection	1719	155	11	11	1	0.5675	0.5675
Endocrine resistance	1869	155	1	1	1	0.0064516	0.025806
Mitophagy - animal	1869	155	1	1	1	0.0064516	0.025806
Cushing syndrome	1869	155	1	1	1	0.0064516	0.025806
Chronic myeloid leukemia	1869	155	1	1	1	0.0064516	0.025806
Small cell lung cancer	1869	155	1	1	1	0.0064516	0.025806
Hepatocellular carcinoma	1869	155	1	1	1	0.0064516	0.025806
Human cytomegalovirus infection	1869	155	1	2	1	0.012903	0.025806
Glioma	1869	155	1	2	1	0.012903	0.025806
Melanoma	1869	155	1	2	1	0.012903	0.025806
Bladder cancer	1869	155	1	2	1	0.012903	0.025806
Non-small cell lung cancer	1869	155	1	2	1	0.012903	0.025806
Breast cancer	1869	155	1	2	1	0.012903	0.025806
Gastric cancer	1869	155	1	2	1	0.012903	0.025806
Pancreatic cancer	1869	155	1	3	1	0.019355	0.033548
Prostate cancer	1869	155	1	3	1	0.019355	0.033548
Kaposi sarcoma-associated herpesvirus infection	1869	155	1	4	1	0.025806	0.039469
MicroRNAs in cancer	1869	155	1	4	1	0.025806	0.039469
Chemical carcinogenesis - receptor activation	1869	155	1	5	1	0.032258	0.046595
Cellular senescence	1869	155	1	7	1	0.045161	0.05871
Human T-cell leukemia virus 1 infection	1869	155	1	7	1	0.045161	0.05871
Hepatitis B	1869	155	1	8	1	0.051613	0.063902
Pathways in cancer	1869	155	1	9	1	0.058065	0.068622
Human papillomavirus infection	1869	155	1	10	1	0.064516	0.072931
Epstein-Barr virus infection	1869	155	1	11	1	0.070968	0.076882
Hepatitis C	1869	155	1	12	1	0.077419	0.080516
Cell cycle	1869	155	1	14	1	0.090323	0.090323
RNA degradation	19	155	22	2	2	0.019355	0.3718
Notch signaling pathway	19	155	22	2	2	0.019355	0.3718
Protein digestion and absorption	19	155	22	2	2	0.019355	0.3718
Thyroid hormone signaling pathway	19	155	22	3	2	0.053004	0.3718
Alzheimer disease	19	155	22	8	3	0.086794	0.3718
Necroptosis	19	155	22	4	2	0.096837	0.3718
Kaposi sarcoma-associated herpesvirus infection	19	155	22	4	2	0.096837	0.3718
Mucin type O-glycan biosynthesis	19	155	22	1	1	0.14194	0.3718
Glycerolipid metabolism	19	155	22	1	1	0.14194	0.3718
Glycerophospholipid metabolism	19	155	22	1	1	0.14194	0.3718
Sphingolipid metabolism	19	155	22	1	1	0.14194	0.3718
ABC transporters	19	155	22	1	1	0.14194	0.3718
mTOR signaling pathway	19	155	22	1	1	0.14194	0.3718
Signaling pathways regulating pluripotency of stem cells	19	155	22	1	1	0.14194	0.3718
Toll-like receptor signaling pathway	19	155	22	1	1	0.14194	0.3718
Th1 and Th2 cell differentiation	19	155	22	1	1	0.14194	0.3718
Glutamatergic synapse	19	155	22	1	1	0.14194	0.3718
GABAergic synapse	19	155	22	1	1	0.14194	0.3718
Prolactin signaling pathway	19	155	22	1	1	0.14194	0.3718
AGE-RAGE signaling pathway in diabetic complications	19	155	22	1	1	0.14194	0.3718
Growth hormone synthesis, secretion and action	19	155	22	1	1	0.14194	0.3718
Fat digestion and absorption	19	155	22	1	1	0.14194	0.3718
Epithelial cell signaling in Helicobacter pylori infection	19	155	22	1	1	0.14194	0.3718
Toxoplasmosis	19	155	22	1	1	0.14194	0.3718
Viral life cycle - HIV-1	19	155	22	5	2	0.14754	0.3718
Coronavirus disease - COVID-19	19	155	22	11	3	0.19124	0.4629
Protein processing in endoplasmic reticulum	19	155	22	6	2	0.20247	0.4629
Human immunodeficiency virus 1 infection	19	155	22	7	2	0.25954	0.4629
Chemokine signaling pathway	19	155	22	2	1	0.26452	0.4629
Renin-angiotensin system	19	155	22	2	1	0.26452	0.4629
C-type lectin receptor signaling pathway	19	155	22	2	1	0.26452	0.4629
Th17 cell differentiation	19	155	22	2	1	0.26452	0.4629
Alcoholic liver disease	19	155	22	2	1	0.26452	0.4629
Cholesterol metabolism	19	155	22	2	1	0.26452	0.4629
Leishmaniasis	19	155	22	2	1	0.26452	0.4629
Inflammatory bowel disease	19	155	22	2	1	0.26452	0.4629
Viral carcinogenesis	19	155	22	13	3	0.27366	0.46596
Alcoholism	19	155	22	8	2	0.31712	0.52574
JAK-STAT signaling pathway	19	155	22	3	1	0.37027	0.54791
Pancreatic cancer	19	155	22	3	1	0.37027	0.54791
Lipid and atherosclerosis	19	155	22	3	1	0.37027	0.54791
Measles	19	155	22	9	2	0.37397	0.54791
Herpes simplex virus 1 infection	19	155	22	9	2	0.37397	0.54791
Influenza A	19	155	22	10	2	0.42917	0.58139
Human papillomavirus infection	19	155	22	10	2	0.42917	0.58139
Systemic lupus erythematosus	19	155	22	10	2	0.42917	0.58139
Ubiquitin mediated proteolysis	19	155	22	4	1	0.46142	0.58139
Osteoclast differentiation	19	155	22	4	1	0.46142	0.58139
Tuberculosis	19	155	22	4	1	0.46142	0.58139
PD-L1 expression and PD-1 checkpoint pathway in cancer	19	155	22	4	1	0.46142	0.58139
Epstein-Barr virus infection	19	155	22	11	2	0.48204	0.59546
Hepatitis C	19	155	22	12	2	0.53212	0.64175
Hematopoietic cell lineage	19	155	22	5	1	0.53989	0.64175
Neutrophil extracellular trap formation	19	155	22	13	2	0.57911	0.67563
Parkinson disease	19	155	22	6	1	0.60737	0.69571
NOD-like receptor signaling pathway	19	155	22	15	2	0.66327	0.71045
Oocyte meiosis	19	155	22	7	1	0.66534	0.71045
Progesterone-mediated oocyte maturation	19	155	22	7	1	0.66534	0.71045
Pathways of neurodegeneration - multiple diseases	19	155	22	7	1	0.66534	0.71045
Hepatitis B	19	155	22	8	1	0.71509	0.75084
Pathways in cancer	19	155	22	9	1	0.75773	0.78257
Metabolic pathways	19	155	22	24	2	0.89432	0.90874
Ribosome biogenesis in eukaryotes	19	155	22	18	1	0.94678	0.94678
Rap1 signaling pathway	1950	155	8	2	2	0.002346	0.048485
Focal adhesion	1950	155	8	2	2	0.002346	0.048485
Regulation of actin cytoskeleton	1950	155	8	2	2	0.002346	0.048485
PI3K-Akt signaling pathway	1950	155	8	3	2	0.0068541	0.084991
Gap junction	1950	155	8	3	2	0.0068541	0.084991
Phagosome	1950	155	8	5	2	0.021665	0.14545
Pathways of neurodegeneration - multiple diseases	1950	155	8	7	2	0.043138	0.14545
EGFR tyrosine kinase inhibitor resistance	1950	155	8	1	1	0.051613	0.14545
ErbB signaling pathway	1950	155	8	1	1	0.051613	0.14545
Ras signaling pathway	1950	155	8	1	1	0.051613	0.14545
Phospholipase D signaling pathway	1950	155	8	1	1	0.051613	0.14545
Axon guidance	1950	155	8	1	1	0.051613	0.14545
Platelet activation	1950	155	8	1	1	0.051613	0.14545
Serotonergic synapse	1950	155	8	1	1	0.051613	0.14545
Insulin signaling pathway	1950	155	8	1	1	0.051613	0.14545
Pathogenic Escherichia coli infection	1950	155	8	1	1	0.051613	0.14545
Proteoglycans in cancer	1950	155	8	1	1	0.051613	0.14545
Endometrial cancer	1950	155	8	1	1	0.051613	0.14545
Choline metabolism in cancer	1950	155	8	1	1	0.051613	0.14545
Hypertrophic cardiomyopathy	1950	155	8	1	1	0.051613	0.14545
Arrhythmogenic right ventricular cardiomyopathy	1950	155	8	1	1	0.051613	0.14545
Dilated cardiomyopathy	1950	155	8	1	1	0.051613	0.14545
Alzheimer disease	1950	155	8	8	2	0.056003	0.15096
Human papillomavirus infection	1950	155	8	10	2	0.085319	0.16037
MAPK signaling pathway	1950	155	8	2	1	0.10088	0.16037
Calcium signaling pathway	1950	155	8	2	1	0.10088	0.16037
HIF-1 signaling pathway	1950	155	8	2	1	0.10088	0.16037
ECM-receptor interaction	1950	155	8	2	1	0.10088	0.16037
Complement and coagulation cascades	1950	155	8	2	1	0.10088	0.16037
Salmonella infection	1950	155	8	2	1	0.10088	0.16037
Human cytomegalovirus infection	1950	155	8	2	1	0.10088	0.16037
Colorectal cancer	1950	155	8	2	1	0.10088	0.16037
Glioma	1950	155	8	2	1	0.10088	0.16037
Melanoma	1950	155	8	2	1	0.10088	0.16037
Bladder cancer	1950	155	8	2	1	0.10088	0.16037
Non-small cell lung cancer	1950	155	8	2	1	0.10088	0.16037
Breast cancer	1950	155	8	2	1	0.10088	0.16037
Gastric cancer	1950	155	8	2	1	0.10088	0.16037
Fluid shear stress and atherosclerosis	1950	155	8	2	1	0.10088	0.16037
Neutrophil extracellular trap formation	1950	155	8	13	2	0.13646	0.20839
JAK-STAT signaling pathway	1950	155	8	3	1	0.14789	0.20839
Thyroid hormone signaling pathway	1950	155	8	3	1	0.14789	0.20839
Pancreatic cancer	1950	155	8	3	1	0.14789	0.20839
Prostate cancer	1950	155	8	3	1	0.14789	0.20839
FoxO signaling pathway	1950	155	8	4	1	0.19274	0.22981
Osteoclast differentiation	1950	155	8	4	1	0.19274	0.22981
Amyotrophic lateral sclerosis	1950	155	8	4	1	0.19274	0.22981
Huntington disease	1950	155	8	4	1	0.19274	0.22981
Prion disease	1950	155	8	4	1	0.19274	0.22981
MicroRNAs in cancer	1950	155	8	4	1	0.19274	0.22981
Chemical carcinogenesis - reactive oxygen species	1950	155	8	4	1	0.19274	0.22981
PD-L1 expression and PD-1 checkpoint pathway in cancer	1950	155	8	4	1	0.19274	0.22981
Hematopoietic cell lineage	1950	155	8	5	1	0.23551	0.2704
Chemical carcinogenesis - receptor activation	1950	155	8	5	1	0.23551	0.2704
Parkinson disease	1950	155	8	6	1	0.27628	0.31145
Alcoholism	1950	155	8	8	1	0.35216	0.38989
Herpes simplex virus 1 infection	1950	155	8	9	1	0.38742	0.41413
Pathways in cancer	1950	155	8	9	1	0.38742	0.41413
Systemic lupus erythematosus	1950	155	8	10	1	0.42098	0.44239
Coronavirus disease - COVID-19	1950	155	8	11	1	0.45293	0.46803
Hepatitis C	1950	155	8	12	1	0.48332	0.49124
Viral carcinogenesis	1950	155	8	13	1	0.51223	0.51223
Alzheimer disease	1955	155	21	8	5	0.0012328	0.057943
Pathways of neurodegeneration - multiple diseases	1955	155	21	7	4	0.0068206	0.16028
RNA degradation	1955	155	21	2	2	0.017595	0.20674
Protein digestion and absorption	1955	155	21	2	2	0.017595	0.20674
Parkinson disease	1955	155	21	6	3	0.033074	0.28944
Amyotrophic lateral sclerosis	1955	155	21	4	2	0.088868	0.28944
Huntington disease	1955	155	21	4	2	0.088868	0.28944
Prion disease	1955	155	21	4	2	0.088868	0.28944
Mucin type O-glycan biosynthesis	1955	155	21	1	1	0.13548	0.28944
Glycerolipid metabolism	1955	155	21	1	1	0.13548	0.28944
Glycerophospholipid metabolism	1955	155	21	1	1	0.13548	0.28944
Arachidonic acid metabolism	1955	155	21	1	1	0.13548	0.28944
Sphingolipid metabolism	1955	155	21	1	1	0.13548	0.28944
ABC transporters	1955	155	21	1	1	0.13548	0.28944
mTOR signaling pathway	1955	155	21	1	1	0.13548	0.28944
Glutamatergic synapse	1955	155	21	1	1	0.13548	0.28944
Serotonergic synapse	1955	155	21	1	1	0.13548	0.28944
GABAergic synapse	1955	155	21	1	1	0.13548	0.28944
Insulin signaling pathway	1955	155	21	1	1	0.13548	0.28944
Fat digestion and absorption	1955	155	21	1	1	0.13548	0.28944
Epithelial cell signaling in Helicobacter pylori infection	1955	155	21	1	1	0.13548	0.28944
Pathogenic Escherichia coli infection	1955	155	21	1	1	0.13548	0.28944
Metabolic pathways	1955	155	21	24	5	0.20331	0.41064
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	1955	155	21	2	1	0.25337	0.41064
Notch signaling pathway	1955	155	21	2	1	0.25337	0.41064
Renin-angiotensin system	1955	155	21	2	1	0.25337	0.41064
Alcoholic liver disease	1955	155	21	2	1	0.25337	0.41064
Cholesterol metabolism	1955	155	21	2	1	0.25337	0.41064
Salmonella infection	1955	155	21	2	1	0.25337	0.41064
Oxidative phosphorylation	1955	155	21	3	1	0.35585	0.47786
Gap junction	1955	155	21	3	1	0.35585	0.47786
Thermogenesis	1955	155	21	3	1	0.35585	0.47786
Thyroid hormone signaling pathway	1955	155	21	3	1	0.35585	0.47786
Diabetic cardiomyopathy	1955	155	21	3	1	0.35585	0.47786
Lipid and atherosclerosis	1955	155	21	3	1	0.35585	0.47786
Ubiquitin mediated proteolysis	1955	155	21	4	1	0.44485	0.56507
Chemical carcinogenesis - reactive oxygen species	1955	155	21	4	1	0.44485	0.56507
Viral life cycle - HIV-1	1955	155	21	5	1	0.52205	0.61341
Phagosome	1955	155	21	5	1	0.52205	0.61341
Hematopoietic cell lineage	1955	155	21	5	1	0.52205	0.61341
Protein processing in endoplasmic reticulum	1955	155	21	6	1	0.58896	0.67515
Oocyte meiosis	1955	155	21	7	1	0.6469	0.691
Progesterone-mediated oocyte maturation	1955	155	21	7	1	0.6469	0.691
Human immunodeficiency virus 1 infection	1955	155	21	7	1	0.6469	0.691
Coronavirus disease - COVID-19	1955	155	21	11	1	0.80984	0.84584
NOD-like receptor signaling pathway	1955	155	21	15	1	0.89951	0.91906
Ribosome biogenesis in eukaryotes	1955	155	21	18	1	0.93852	0.93852
RNA degradation	1997	155	27	2	2	0.029409	0.42387
Notch signaling pathway	1997	155	27	2	2	0.029409	0.42387
Alzheimer disease	1997	155	27	8	4	0.0316	0.42387
Thyroid hormone signaling pathway	1997	155	27	3	2	0.078617	0.42387
Coronavirus disease - COVID-19	1997	155	27	11	4	0.1011	0.42387
Pathways of neurodegeneration - multiple diseases	1997	155	27	7	3	0.10193	0.42387
Necroptosis	1997	155	27	4	2	0.14029	0.42387
Tuberculosis	1997	155	27	4	2	0.14029	0.42387
Kaposi sarcoma-associated herpesvirus infection	1997	155	27	4	2	0.14029	0.42387
Mucin type O-glycan biosynthesis	1997	155	27	1	1	0.17419	0.42387
Glycerolipid metabolism	1997	155	27	1	1	0.17419	0.42387
Glycerophospholipid metabolism	1997	155	27	1	1	0.17419	0.42387
Sphingolipid metabolism	1997	155	27	1	1	0.17419	0.42387
ABC transporters	1997	155	27	1	1	0.17419	0.42387
mTOR signaling pathway	1997	155	27	1	1	0.17419	0.42387
Signaling pathways regulating pluripotency of stem cells	1997	155	27	1	1	0.17419	0.42387
Toll-like receptor signaling pathway	1997	155	27	1	1	0.17419	0.42387
Th1 and Th2 cell differentiation	1997	155	27	1	1	0.17419	0.42387
Neurotrophin signaling pathway	1997	155	27	1	1	0.17419	0.42387
Glutamatergic synapse	1997	155	27	1	1	0.17419	0.42387
Serotonergic synapse	1997	155	27	1	1	0.17419	0.42387
GABAergic synapse	1997	155	27	1	1	0.17419	0.42387
Insulin signaling pathway	1997	155	27	1	1	0.17419	0.42387
Prolactin signaling pathway	1997	155	27	1	1	0.17419	0.42387
AGE-RAGE signaling pathway in diabetic complications	1997	155	27	1	1	0.17419	0.42387
Growth hormone synthesis, secretion and action	1997	155	27	1	1	0.17419	0.42387
Fat digestion and absorption	1997	155	27	1	1	0.17419	0.42387
Epithelial cell signaling in Helicobacter pylori infection	1997	155	27	1	1	0.17419	0.42387
Pathogenic Escherichia coli infection	1997	155	27	1	1	0.17419	0.42387
Toxoplasmosis	1997	155	27	1	1	0.17419	0.42387
Viral life cycle - HIV-1	1997	155	27	5	2	0.2089	0.49193
Protein processing in endoplasmic reticulum	1997	155	27	6	2	0.28038	0.52921
Parkinson disease	1997	155	27	6	2	0.28038	0.52921
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	1997	155	27	2	1	0.31898	0.52921
Chemokine signaling pathway	1997	155	27	2	1	0.31898	0.52921
Complement and coagulation cascades	1997	155	27	2	1	0.31898	0.52921
C-type lectin receptor signaling pathway	1997	155	27	2	1	0.31898	0.52921
Th17 cell differentiation	1997	155	27	2	1	0.31898	0.52921
Alcoholic liver disease	1997	155	27	2	1	0.31898	0.52921
Protein digestion and absorption	1997	155	27	2	1	0.31898	0.52921
Cholesterol metabolism	1997	155	27	2	1	0.31898	0.52921
Salmonella infection	1997	155	27	2	1	0.31898	0.52921
Leishmaniasis	1997	155	27	2	1	0.31898	0.52921
Inflammatory bowel disease	1997	155	27	2	1	0.31898	0.52921
Human immunodeficiency virus 1 infection	1997	155	27	7	2	0.35175	0.57062
Viral carcinogenesis	1997	155	27	13	3	0.40196	0.6286
Alcoholism	1997	155	27	8	2	0.42096	0.6286
Gap junction	1997	155	27	3	1	0.43916	0.6286
JAK-STAT signaling pathway	1997	155	27	3	1	0.43916	0.6286
Pancreatic cancer	1997	155	27	3	1	0.43916	0.6286
Lipid and atherosclerosis	1997	155	27	3	1	0.43916	0.6286
Measles	1997	155	27	9	2	0.4866	0.645
Herpes simplex virus 1 infection	1997	155	27	9	2	0.4866	0.645
Ubiquitin mediated proteolysis	1997	155	27	4	1	0.53878	0.645
Osteoclast differentiation	1997	155	27	4	1	0.53878	0.645
Amyotrophic lateral sclerosis	1997	155	27	4	1	0.53878	0.645
Huntington disease	1997	155	27	4	1	0.53878	0.645
Prion disease	1997	155	27	4	1	0.53878	0.645
PD-L1 expression and PD-1 checkpoint pathway in cancer	1997	155	27	4	1	0.53878	0.645
Influenza A	1997	155	27	10	2	0.54781	0.645
Human papillomavirus infection	1997	155	27	10	2	0.54781	0.645
Systemic lupus erythematosus	1997	155	27	10	2	0.54781	0.645
Epstein-Barr virus infection	1997	155	27	11	2	0.60409	0.69997
Phagosome	1997	155	27	5	1	0.62125	0.70861
Hepatitis C	1997	155	27	12	2	0.65524	0.73589
Neutrophil extracellular trap formation	1997	155	27	13	2	0.7013	0.77568
Oocyte meiosis	1997	155	27	7	1	0.7457	0.80054
Progesterone-mediated oocyte maturation	1997	155	27	7	1	0.7457	0.80054
NOD-like receptor signaling pathway	1997	155	27	15	2	0.77882	0.82397
Hepatitis B	1997	155	27	8	1	0.7921	0.82604
Pathways in cancer	1997	155	27	9	1	0.83028	0.84883
Metabolic pathways	1997	155	27	24	3	0.8372	0.84883
Ribosome biogenesis in eukaryotes	1997	155	27	18	1	0.97459	0.97459
Rap1 signaling pathway	2162	155	10	2	2	0.0037704	0.076665
Focal adhesion	2162	155	10	2	2	0.0037704	0.076665
Regulation of actin cytoskeleton	2162	155	10	2	2	0.0037704	0.076665
PI3K-Akt signaling pathway	2162	155	10	3	2	0.010917	0.11099
Gap junction	2162	155	10	3	2	0.010917	0.11099
Thyroid hormone signaling pathway	2162	155	10	3	2	0.010917	0.11099
Phagosome	2162	155	10	5	2	0.033896	0.17584
EGFR tyrosine kinase inhibitor resistance	2162	155	10	1	1	0.064516	0.17584
ErbB signaling pathway	2162	155	10	1	1	0.064516	0.17584
Ras signaling pathway	2162	155	10	1	1	0.064516	0.17584
Phospholipase D signaling pathway	2162	155	10	1	1	0.064516	0.17584
Axon guidance	2162	155	10	1	1	0.064516	0.17584
Platelet activation	2162	155	10	1	1	0.064516	0.17584
Serotonergic synapse	2162	155	10	1	1	0.064516	0.17584
Insulin signaling pathway	2162	155	10	1	1	0.064516	0.17584
Pathogenic Escherichia coli infection	2162	155	10	1	1	0.064516	0.17584
Proteoglycans in cancer	2162	155	10	1	1	0.064516	0.17584
Endometrial cancer	2162	155	10	1	1	0.064516	0.17584
Choline metabolism in cancer	2162	155	10	1	1	0.064516	0.17584
Hypertrophic cardiomyopathy	2162	155	10	1	1	0.064516	0.17584
Arrhythmogenic right ventricular cardiomyopathy	2162	155	10	1	1	0.064516	0.17584
Dilated cardiomyopathy	2162	155	10	1	1	0.064516	0.17584
Pathways of neurodegeneration - multiple diseases	2162	155	10	7	2	0.066302	0.17584
Alzheimer disease	2162	155	10	8	2	0.085319	0.19478
MAPK signaling pathway	2162	155	10	2	1	0.12526	0.19478
Calcium signaling pathway	2162	155	10	2	1	0.12526	0.19478
HIF-1 signaling pathway	2162	155	10	2	1	0.12526	0.19478
ECM-receptor interaction	2162	155	10	2	1	0.12526	0.19478
Complement and coagulation cascades	2162	155	10	2	1	0.12526	0.19478
Salmonella infection	2162	155	10	2	1	0.12526	0.19478
Human cytomegalovirus infection	2162	155	10	2	1	0.12526	0.19478
Colorectal cancer	2162	155	10	2	1	0.12526	0.19478
Glioma	2162	155	10	2	1	0.12526	0.19478
Melanoma	2162	155	10	2	1	0.12526	0.19478
Bladder cancer	2162	155	10	2	1	0.12526	0.19478
Non-small cell lung cancer	2162	155	10	2	1	0.12526	0.19478
Breast cancer	2162	155	10	2	1	0.12526	0.19478
Gastric cancer	2162	155	10	2	1	0.12526	0.19478
Fluid shear stress and atherosclerosis	2162	155	10	2	1	0.12526	0.19478
Human papillomavirus infection	2162	155	10	10	2	0.12772	0.19478
JAK-STAT signaling pathway	2162	155	10	3	1	0.18243	0.2588
Pancreatic cancer	2162	155	10	3	1	0.18243	0.2588
Prostate cancer	2162	155	10	3	1	0.18243	0.2588
FoxO signaling pathway	2162	155	10	4	1	0.23622	0.27711
Ubiquitin mediated proteolysis	2162	155	10	4	1	0.23622	0.27711
Osteoclast differentiation	2162	155	10	4	1	0.23622	0.27711
Amyotrophic lateral sclerosis	2162	155	10	4	1	0.23622	0.27711
Huntington disease	2162	155	10	4	1	0.23622	0.27711
Prion disease	2162	155	10	4	1	0.23622	0.27711
MicroRNAs in cancer	2162	155	10	4	1	0.23622	0.27711
Chemical carcinogenesis - reactive oxygen species	2162	155	10	4	1	0.23622	0.27711
PD-L1 expression and PD-1 checkpoint pathway in cancer	2162	155	10	4	1	0.23622	0.27711
Hematopoietic cell lineage	2162	155	10	5	1	0.2868	0.32398
Chemical carcinogenesis - receptor activation	2162	155	10	5	1	0.2868	0.32398
Protein processing in endoplasmic reticulum	2162	155	10	6	1	0.33435	0.3642
Parkinson disease	2162	155	10	6	1	0.33435	0.3642
Herpes simplex virus 1 infection	2162	155	10	9	1	0.46037	0.48418
Pathways in cancer	2162	155	10	9	1	0.46037	0.48418
Coronavirus disease - COVID-19	2162	155	10	11	1	0.532	0.55003
Hepatitis C	2162	155	10	12	1	0.5645	0.57391
Neutrophil extracellular trap formation	2162	155	10	13	1	0.59495	0.59495
Influenza A	219285	155	29	10	10	1.2214e-08	6.7179e-07
Measles	219285	155	29	9	9	8.9165e-08	2.452e-06
Hepatitis C	219285	155	29	12	10	6.2509e-07	1.146e-05
Coronavirus disease - COVID-19	219285	155	29	11	9	3.7669e-06	5.1794e-05
Herpes simplex virus 1 infection	219285	155	29	9	8	4.9041e-06	5.3945e-05
NOD-like receptor signaling pathway	219285	155	29	15	9	0.00020063	0.0018391
Epstein-Barr virus infection	219285	155	29	11	7	0.00079109	0.0062157
Necroptosis	219285	155	29	4	4	0.0010268	0.0070596
Human papillomavirus infection	219285	155	29	10	5	0.020916	0.10466
Kaposi sarcoma-associated herpesvirus infection	219285	155	29	4	3	0.020932	0.10466
PD-L1 expression and PD-1 checkpoint pathway in cancer	219285	155	29	4	3	0.020932	0.10466
RNA degradation	219285	155	29	2	2	0.034018	0.11694
Chemokine signaling pathway	219285	155	29	2	2	0.034018	0.11694
RIG-I-like receptor signaling pathway	219285	155	29	2	2	0.034018	0.11694
Cytosolic DNA-sensing pathway	219285	155	29	2	2	0.034018	0.11694
C-type lectin receptor signaling pathway	219285	155	29	2	2	0.034018	0.11694
Hepatitis B	219285	155	29	8	4	0.040764	0.13188
JAK-STAT signaling pathway	219285	155	29	3	2	0.090047	0.27514
Osteoclast differentiation	219285	155	29	4	2	0.15916	0.32157
Glycolysis / Gluconeogenesis	219285	155	29	1	1	0.1871	0.32157
Galactose metabolism	219285	155	29	1	1	0.1871	0.32157
ABC transporters	219285	155	29	1	1	0.1871	0.32157
NF-kappa B signaling pathway	219285	155	29	1	1	0.1871	0.32157
Signaling pathways regulating pluripotency of stem cells	219285	155	29	1	1	0.1871	0.32157
Toll-like receptor signaling pathway	219285	155	29	1	1	0.1871	0.32157
Th1 and Th2 cell differentiation	219285	155	29	1	1	0.1871	0.32157
Prolactin signaling pathway	219285	155	29	1	1	0.1871	0.32157
AGE-RAGE signaling pathway in diabetic complications	219285	155	29	1	1	0.1871	0.32157
Growth hormone synthesis, secretion and action	219285	155	29	1	1	0.1871	0.32157
Fat digestion and absorption	219285	155	29	1	1	0.1871	0.32157
Pertussis	219285	155	29	1	1	0.1871	0.32157
Toxoplasmosis	219285	155	29	1	1	0.1871	0.32157
Viral life cycle - HIV-1	219285	155	29	5	2	0.23484	0.39139
Lysosome	219285	155	29	2	1	0.34018	0.45633
Notch signaling pathway	219285	155	29	2	1	0.34018	0.45633
Cell adhesion molecules	219285	155	29	2	1	0.34018	0.45633
Complement and coagulation cascades	219285	155	29	2	1	0.34018	0.45633
Th17 cell differentiation	219285	155	29	2	1	0.34018	0.45633
Cholesterol metabolism	219285	155	29	2	1	0.34018	0.45633
Leishmaniasis	219285	155	29	2	1	0.34018	0.45633
Inflammatory bowel disease	219285	155	29	2	1	0.34018	0.45633
Thyroid hormone signaling pathway	219285	155	29	3	1	0.46524	0.58155
Pancreatic cancer	219285	155	29	3	1	0.46524	0.58155
Lipid and atherosclerosis	219285	155	29	3	1	0.46524	0.58155
Pathways in cancer	219285	155	29	9	2	0.52913	0.63673
Pyrimidine metabolism	219285	155	29	4	1	0.56727	0.63673
Nucleotide metabolism	219285	155	29	4	1	0.56727	0.63673
Biosynthesis of cofactors	219285	155	29	4	1	0.56727	0.63673
Tuberculosis	219285	155	29	4	1	0.56727	0.63673
Protein processing in endoplasmic reticulum	219285	155	29	6	1	0.71797	0.78977
Human immunodeficiency virus 1 infection	219285	155	29	7	1	0.77286	0.83348
Alzheimer disease	219285	155	29	8	1	0.81737	0.86452
Viral carcinogenesis	219285	155	29	13	1	0.94016	0.97564
Metabolic pathways	219285	155	29	24	2	0.96614	0.98126
Ribosome biogenesis in eukaryotes	219285	155	29	18	1	0.98126	0.98126
Influenza A	219537	155	27	10	10	5.1445e-09	2.6237e-07
Measles	219537	155	27	9	9	4.1727e-08	1.064e-06
Hepatitis C	219537	155	27	12	10	2.7084e-07	4.6043e-06
Coronavirus disease - COVID-19	219537	155	27	11	9	1.8128e-06	2.3114e-05
Herpes simplex virus 1 infection	219537	155	27	9	8	2.5717e-06	2.6232e-05
NOD-like receptor signaling pathway	219537	155	27	15	9	0.00010217	0.00086849
Epstein-Barr virus infection	219537	155	27	11	7	0.00047513	0.0034616
Necroptosis	219537	155	27	4	4	0.00075875	0.0048371
Human papillomavirus infection	219537	155	27	10	5	0.015146	0.085829
Kaposi sarcoma-associated herpesvirus infection	219537	155	27	4	3	0.016946	0.086422
Chemokine signaling pathway	219537	155	27	2	2	0.029409	0.10713
RIG-I-like receptor signaling pathway	219537	155	27	2	2	0.029409	0.10713
Cytosolic DNA-sensing pathway	219537	155	27	2	2	0.029409	0.10713
C-type lectin receptor signaling pathway	219537	155	27	2	2	0.029409	0.10713
Hepatitis B	219537	155	27	8	4	0.0316	0.10744
JAK-STAT signaling pathway	219537	155	27	3	2	0.078617	0.25059
Osteoclast differentiation	219537	155	27	4	2	0.14029	0.31728
PD-L1 expression and PD-1 checkpoint pathway in cancer	219537	155	27	4	2	0.14029	0.31728
Glycolysis / Gluconeogenesis	219537	155	27	1	1	0.17419	0.31728
Galactose metabolism	219537	155	27	1	1	0.17419	0.31728
NF-kappa B signaling pathway	219537	155	27	1	1	0.17419	0.31728
Toll-like receptor signaling pathway	219537	155	27	1	1	0.17419	0.31728
Th1 and Th2 cell differentiation	219537	155	27	1	1	0.17419	0.31728
Prolactin signaling pathway	219537	155	27	1	1	0.17419	0.31728
AGE-RAGE signaling pathway in diabetic complications	219537	155	27	1	1	0.17419	0.31728
Growth hormone synthesis, secretion and action	219537	155	27	1	1	0.17419	0.31728
Pertussis	219537	155	27	1	1	0.17419	0.31728
Toxoplasmosis	219537	155	27	1	1	0.17419	0.31728
Viral life cycle - HIV-1	219537	155	27	5	2	0.2089	0.36738
Lysosome	219537	155	27	2	1	0.31898	0.4281
Apoptosis	219537	155	27	2	1	0.31898	0.4281
Apoptosis - multiple species	219537	155	27	2	1	0.31898	0.4281
Notch signaling pathway	219537	155	27	2	1	0.31898	0.4281
Cell adhesion molecules	219537	155	27	2	1	0.31898	0.4281
Complement and coagulation cascades	219537	155	27	2	1	0.31898	0.4281
Th17 cell differentiation	219537	155	27	2	1	0.31898	0.4281
Leishmaniasis	219537	155	27	2	1	0.31898	0.4281
Inflammatory bowel disease	219537	155	27	2	1	0.31898	0.4281
Thyroid hormone signaling pathway	219537	155	27	3	1	0.43916	0.55993
Pancreatic cancer	219537	155	27	3	1	0.43916	0.55993
Pathways in cancer	219537	155	27	9	2	0.4866	0.60529
Pyrimidine metabolism	219537	155	27	4	1	0.53878	0.61062
Nucleotide metabolism	219537	155	27	4	1	0.53878	0.61062
Biosynthesis of cofactors	219537	155	27	4	1	0.53878	0.61062
Tuberculosis	219537	155	27	4	1	0.53878	0.61062
Protein processing in endoplasmic reticulum	219537	155	27	6	1	0.68943	0.76436
Human immunodeficiency virus 1 infection	219537	155	27	7	1	0.7457	0.80917
Alzheimer disease	219537	155	27	8	1	0.7921	0.82443
Transcriptional misregulation in cancer	219537	155	27	8	1	0.7921	0.82443
Viral carcinogenesis	219537	155	27	13	1	0.9258	0.94432
Metabolic pathways	219537	155	27	24	2	0.9525	0.9525
Coronavirus disease - COVID-19	219988	155	30	11	7	0.0010041	0.045063
Measles	219988	155	30	9	6	0.0018269	0.045063
Herpes simplex virus 1 infection	219988	155	30	9	6	0.0018269	0.045063
Influenza A	219988	155	30	10	6	0.0039323	0.072748
Necroptosis	219988	155	30	4	3	0.023126	0.23661
Kaposi sarcoma-associated herpesvirus infection	219988	155	30	4	3	0.023126	0.23661
RNA degradation	219988	155	30	2	2	0.036447	0.23661
Chemokine signaling pathway	219988	155	30	2	2	0.036447	0.23661
Notch signaling pathway	219988	155	30	2	2	0.036447	0.23661
RIG-I-like receptor signaling pathway	219988	155	30	2	2	0.036447	0.23661
C-type lectin receptor signaling pathway	219988	155	30	2	2	0.036447	0.23661
Epstein-Barr virus infection	219988	155	30	11	5	0.038369	0.23661
Alzheimer disease	219988	155	30	8	4	0.045913	0.24269
Hepatitis B	219988	155	30	8	4	0.045913	0.24269
Hepatitis C	219988	155	30	12	5	0.056622	0.27934
JAK-STAT signaling pathway	219988	155	30	3	2	0.096002	0.34101
Thyroid hormone signaling pathway	219988	155	30	3	2	0.096002	0.34101
Pathways of neurodegeneration - multiple diseases	219988	155	30	7	3	0.13245	0.34101
NOD-like receptor signaling pathway	219988	155	30	15	5	0.13707	0.34101
Osteoclast differentiation	219988	155	30	4	2	0.16888	0.34101
Tuberculosis	219988	155	30	4	2	0.16888	0.34101
Mucin type O-glycan biosynthesis	219988	155	30	1	1	0.19355	0.34101
Glycerolipid metabolism	219988	155	30	1	1	0.19355	0.34101
Glycerophospholipid metabolism	219988	155	30	1	1	0.19355	0.34101
Sphingolipid metabolism	219988	155	30	1	1	0.19355	0.34101
ABC transporters	219988	155	30	1	1	0.19355	0.34101
NF-kappa B signaling pathway	219988	155	30	1	1	0.19355	0.34101
mTOR signaling pathway	219988	155	30	1	1	0.19355	0.34101
Signaling pathways regulating pluripotency of stem cells	219988	155	30	1	1	0.19355	0.34101
Toll-like receptor signaling pathway	219988	155	30	1	1	0.19355	0.34101
Th1 and Th2 cell differentiation	219988	155	30	1	1	0.19355	0.34101
Neurotrophin signaling pathway	219988	155	30	1	1	0.19355	0.34101
Glutamatergic synapse	219988	155	30	1	1	0.19355	0.34101
Serotonergic synapse	219988	155	30	1	1	0.19355	0.34101
GABAergic synapse	219988	155	30	1	1	0.19355	0.34101
Prolactin signaling pathway	219988	155	30	1	1	0.19355	0.34101
AGE-RAGE signaling pathway in diabetic complications	219988	155	30	1	1	0.19355	0.34101
Growth hormone synthesis, secretion and action	219988	155	30	1	1	0.19355	0.34101
Fat digestion and absorption	219988	155	30	1	1	0.19355	0.34101
Epithelial cell signaling in Helicobacter pylori infection	219988	155	30	1	1	0.19355	0.34101
Pathogenic Escherichia coli infection	219988	155	30	1	1	0.19355	0.34101
Toxoplasmosis	219988	155	30	1	1	0.19355	0.34101
Viral life cycle - HIV-1	219988	155	30	5	2	0.24803	0.42684
Human papillomavirus infection	219988	155	30	10	3	0.30012	0.47178
Protein processing in endoplasmic reticulum	219988	155	30	6	2	0.3285	0.47178
Parkinson disease	219988	155	30	6	2	0.3285	0.47178
Lysosome	219988	155	30	2	1	0.35065	0.47178
Cytosolic DNA-sensing pathway	219988	155	30	2	1	0.35065	0.47178
Th17 cell differentiation	219988	155	30	2	1	0.35065	0.47178
Alcoholic liver disease	219988	155	30	2	1	0.35065	0.47178
Protein digestion and absorption	219988	155	30	2	1	0.35065	0.47178
Cholesterol metabolism	219988	155	30	2	1	0.35065	0.47178
Salmonella infection	219988	155	30	2	1	0.35065	0.47178
Leishmaniasis	219988	155	30	2	1	0.35065	0.47178
Inflammatory bowel disease	219988	155	30	2	1	0.35065	0.47178
Human immunodeficiency virus 1 infection	219988	155	30	7	2	0.40691	0.53771
Gap junction	219988	155	30	3	1	0.47797	0.58362
Pancreatic cancer	219988	155	30	3	1	0.47797	0.58362
Lipid and atherosclerosis	219988	155	30	3	1	0.47797	0.58362
Viral carcinogenesis	219988	155	30	13	3	0.47844	0.58362
Alcoholism	219988	155	30	8	2	0.48109	0.58362
Pathways in cancer	219988	155	30	9	2	0.54972	0.64171
Ubiquitin mediated proteolysis	219988	155	30	4	1	0.581	0.64171
Amyotrophic lateral sclerosis	219988	155	30	4	1	0.581	0.64171
Huntington disease	219988	155	30	4	1	0.581	0.64171
Prion disease	219988	155	30	4	1	0.581	0.64171
PD-L1 expression and PD-1 checkpoint pathway in cancer	219988	155	30	4	1	0.581	0.64171
Systemic lupus erythematosus	219988	155	30	10	2	0.61212	0.66613
Phagosome	219988	155	30	5	1	0.66425	0.71238
Neutrophil extracellular trap formation	219988	155	30	13	2	0.76113	0.80462
Oocyte meiosis	219988	155	30	7	1	0.78548	0.8073
Progesterone-mediated oocyte maturation	219988	155	30	7	1	0.78548	0.8073
Metabolic pathways	219988	155	30	24	2	0.97153	0.98393
Ribosome biogenesis in eukaryotes	219988	155	30	18	1	0.98393	0.98393
Natural killer cell mediated cytotoxicity	2215	155	1	1	1	0.0064516	0.029032
Fc gamma R-mediated phagocytosis	2215	155	1	1	1	0.0064516	0.029032
Leishmaniasis	2215	155	1	2	1	0.012903	0.03871
Osteoclast differentiation	2215	155	1	4	1	0.025806	0.046452
Tuberculosis	2215	155	1	4	1	0.025806	0.046452
Phagosome	2215	155	1	5	1	0.032258	0.048387
Staphylococcus aureus infection	2215	155	1	6	1	0.03871	0.04977
Systemic lupus erythematosus	2215	155	1	10	1	0.064516	0.072581
Neutrophil extracellular trap formation	2215	155	1	13	1	0.083871	0.083871
Cell cycle	2237	155	32	14	12	6.0029e-08	3.6618e-06
Oocyte meiosis	2237	155	32	7	6	0.00030891	0.0094218
DNA replication	2237	155	32	4	4	0.0015547	0.023709
p53 signaling pathway	2237	155	32	4	4	0.0015547	0.023709
Cellular senescence	2237	155	32	7	5	0.0043736	0.044465
Progesterone-mediated oocyte maturation	2237	155	32	7	5	0.0043736	0.044465
Pyrimidine metabolism	2237	155	32	4	3	0.027931	0.21297
Nucleotide metabolism	2237	155	32	4	3	0.027931	0.21297
Human T-cell leukemia virus 1 infection	2237	155	32	7	4	0.033649	0.22807
Glutathione metabolism	2237	155	32	2	2	0.041558	0.23046
Platinum drug resistance	2237	155	32	2	2	0.041558	0.23046
Chemical carcinogenesis - receptor activation	2237	155	32	5	3	0.059897	0.30447
Protein processing in endoplasmic reticulum	2237	155	32	6	3	0.10287	0.39355
Drug metabolism - other enzymes	2237	155	32	3	2	0.10838	0.39355
Human immunodeficiency virus 1 infection	2237	155	32	7	3	0.15479	0.39355
FoxO signaling pathway	2237	155	32	4	2	0.18883	0.39355
MicroRNAs in cancer	2237	155	32	4	2	0.18883	0.39355
Metabolic pathways	2237	155	32	24	7	0.19527	0.39355
Purine metabolism	2237	155	32	1	1	0.20645	0.39355
Glycine, serine and threonine metabolism	2237	155	32	1	1	0.20645	0.39355
Glyoxylate and dicarboxylate metabolism	2237	155	32	1	1	0.20645	0.39355
Carbon metabolism	2237	155	32	1	1	0.20645	0.39355
Biosynthesis of nucleotide sugars	2237	155	32	1	1	0.20645	0.39355
Protein export	2237	155	32	1	1	0.20645	0.39355
Base excision repair	2237	155	32	1	1	0.20645	0.39355
Non-homologous end-joining	2237	155	32	1	1	0.20645	0.39355
Fanconi anemia pathway	2237	155	32	1	1	0.20645	0.39355
Hippo signaling pathway	2237	155	32	1	1	0.20645	0.39355
Estrogen signaling pathway	2237	155	32	1	1	0.20645	0.39355
Thyroid hormone synthesis	2237	155	32	1	1	0.20645	0.39355
Oxytocin signaling pathway	2237	155	32	1	1	0.20645	0.39355
Pancreatic secretion	2237	155	32	1	1	0.20645	0.39355
Pathways in cancer	2237	155	32	9	3	0.27578	0.48196
Amino sugar and nucleotide sugar metabolism	2237	155	32	2	1	0.37134	0.48196
One carbon pool by folate	2237	155	32	2	1	0.37134	0.48196
Nicotinate and nicotinamide metabolism	2237	155	32	2	1	0.37134	0.48196
MAPK signaling pathway	2237	155	32	2	1	0.37134	0.48196
Calcium signaling pathway	2237	155	32	2	1	0.37134	0.48196
Apoptosis	2237	155	32	2	1	0.37134	0.48196
Apoptosis - multiple species	2237	155	32	2	1	0.37134	0.48196
ECM-receptor interaction	2237	155	32	2	1	0.37134	0.48196
IL-17 signaling pathway	2237	155	32	2	1	0.37134	0.48196
Th17 cell differentiation	2237	155	32	2	1	0.37134	0.48196
Salivary secretion	2237	155	32	2	1	0.37134	0.48196
Salmonella infection	2237	155	32	2	1	0.37134	0.48196
Colorectal cancer	2237	155	32	2	1	0.37134	0.48196
Fluid shear stress and atherosclerosis	2237	155	32	2	1	0.37134	0.48196
Antifolate resistance	2237	155	32	3	1	0.50283	0.56801
PI3K-Akt signaling pathway	2237	155	32	3	1	0.50283	0.56801
AMPK signaling pathway	2237	155	32	3	1	0.50283	0.56801
Gap junction	2237	155	32	3	1	0.50283	0.56801
Prostate cancer	2237	155	32	3	1	0.50283	0.56801
Acute myeloid leukemia	2237	155	32	3	1	0.50283	0.56801
Lipid and atherosclerosis	2237	155	32	3	1	0.50283	0.56801
Hepatitis B	2237	155	32	8	2	0.51973	0.57489
Viral carcinogenesis	2237	155	32	13	3	0.52776	0.57489
Ubiquitin mediated proteolysis	2237	155	32	4	1	0.6075	0.65013
Hematopoietic cell lineage	2237	155	32	5	1	0.69068	0.7264
Transcriptional misregulation in cancer	2237	155	32	8	1	0.85024	0.87906
Human papillomavirus infection	2237	155	32	10	1	0.90852	0.92366
Epstein-Barr virus infection	2237	155	32	11	1	0.92871	0.92871
Rap1 signaling pathway	22885	155	6	2	2	0.0012568	0.024298
Focal adhesion	22885	155	6	2	2	0.0012568	0.024298
Regulation of actin cytoskeleton	22885	155	6	2	2	0.0012568	0.024298
PI3K-Akt signaling pathway	22885	155	6	3	2	0.0037047	0.042975
Gap junction	22885	155	6	3	2	0.0037047	0.042975
Phagosome	22885	155	6	5	2	0.011921	0.11226
EGFR tyrosine kinase inhibitor resistance	22885	155	6	1	1	0.03871	0.11226
ErbB signaling pathway	22885	155	6	1	1	0.03871	0.11226
Ras signaling pathway	22885	155	6	1	1	0.03871	0.11226
Phospholipase D signaling pathway	22885	155	6	1	1	0.03871	0.11226
Axon guidance	22885	155	6	1	1	0.03871	0.11226
Platelet activation	22885	155	6	1	1	0.03871	0.11226
Insulin signaling pathway	22885	155	6	1	1	0.03871	0.11226
Pathogenic Escherichia coli infection	22885	155	6	1	1	0.03871	0.11226
Proteoglycans in cancer	22885	155	6	1	1	0.03871	0.11226
Endometrial cancer	22885	155	6	1	1	0.03871	0.11226
Choline metabolism in cancer	22885	155	6	1	1	0.03871	0.11226
Hypertrophic cardiomyopathy	22885	155	6	1	1	0.03871	0.11226
Arrhythmogenic right ventricular cardiomyopathy	22885	155	6	1	1	0.03871	0.11226
Dilated cardiomyopathy	22885	155	6	1	1	0.03871	0.11226
Human papillomavirus infection	22885	155	6	10	2	0.04907	0.12271
MAPK signaling pathway	22885	155	6	2	1	0.076163	0.12271
Calcium signaling pathway	22885	155	6	2	1	0.076163	0.12271
HIF-1 signaling pathway	22885	155	6	2	1	0.076163	0.12271
ECM-receptor interaction	22885	155	6	2	1	0.076163	0.12271
Complement and coagulation cascades	22885	155	6	2	1	0.076163	0.12271
Salmonella infection	22885	155	6	2	1	0.076163	0.12271
Human cytomegalovirus infection	22885	155	6	2	1	0.076163	0.12271
Colorectal cancer	22885	155	6	2	1	0.076163	0.12271
Glioma	22885	155	6	2	1	0.076163	0.12271
Melanoma	22885	155	6	2	1	0.076163	0.12271
Bladder cancer	22885	155	6	2	1	0.076163	0.12271
Non-small cell lung cancer	22885	155	6	2	1	0.076163	0.12271
Breast cancer	22885	155	6	2	1	0.076163	0.12271
Gastric cancer	22885	155	6	2	1	0.076163	0.12271
Fluid shear stress and atherosclerosis	22885	155	6	2	1	0.076163	0.12271
JAK-STAT signaling pathway	22885	155	6	3	1	0.11239	0.16297
Thyroid hormone signaling pathway	22885	155	6	3	1	0.11239	0.16297
Pancreatic cancer	22885	155	6	3	1	0.11239	0.16297
Prostate cancer	22885	155	6	3	1	0.11239	0.16297
FoxO signaling pathway	22885	155	6	4	1	0.14743	0.17814
Osteoclast differentiation	22885	155	6	4	1	0.14743	0.17814
Amyotrophic lateral sclerosis	22885	155	6	4	1	0.14743	0.17814
Huntington disease	22885	155	6	4	1	0.14743	0.17814
Prion disease	22885	155	6	4	1	0.14743	0.17814
MicroRNAs in cancer	22885	155	6	4	1	0.14743	0.17814
Chemical carcinogenesis - reactive oxygen species	22885	155	6	4	1	0.14743	0.17814
PD-L1 expression and PD-1 checkpoint pathway in cancer	22885	155	6	4	1	0.14743	0.17814
Hematopoietic cell lineage	22885	155	6	5	1	0.18131	0.21031
Chemical carcinogenesis - receptor activation	22885	155	6	5	1	0.18131	0.21031
Parkinson disease	22885	155	6	6	1	0.21405	0.24343
Pathways of neurodegeneration - multiple diseases	22885	155	6	7	1	0.2457	0.27405
Alzheimer disease	22885	155	6	8	1	0.27628	0.30235
Herpes simplex virus 1 infection	22885	155	6	9	1	0.30582	0.3225
Pathways in cancer	22885	155	6	9	1	0.30582	0.3225
Coronavirus disease - COVID-19	22885	155	6	11	1	0.36189	0.37482
Hepatitis C	22885	155	6	12	1	0.38848	0.3953
Neutrophil extracellular trap formation	22885	155	6	13	1	0.41414	0.41414
Protein processing in endoplasmic reticulum	22936	155	11	6	3	0.004803	0.12488
Chemical carcinogenesis - receptor activation	22936	155	11	5	2	0.040873	0.23065
Glycine, serine and threonine metabolism	22936	155	11	1	1	0.070968	0.23065
Glyoxylate and dicarboxylate metabolism	22936	155	11	1	1	0.070968	0.23065
Carbon metabolism	22936	155	11	1	1	0.070968	0.23065
Biosynthesis of nucleotide sugars	22936	155	11	1	1	0.070968	0.23065
Estrogen signaling pathway	22936	155	11	1	1	0.070968	0.23065
Thyroid hormone synthesis	22936	155	11	1	1	0.070968	0.23065
Glutathione metabolism	22936	155	11	2	1	0.13733	0.23803
Amino sugar and nucleotide sugar metabolism	22936	155	11	2	1	0.13733	0.23803
Folate biosynthesis	22936	155	11	2	1	0.13733	0.23803
IL-17 signaling pathway	22936	155	11	2	1	0.13733	0.23803
Th17 cell differentiation	22936	155	11	2	1	0.13733	0.23803
Salmonella infection	22936	155	11	2	1	0.13733	0.23803
Fluid shear stress and atherosclerosis	22936	155	11	2	1	0.13733	0.23803
Antifolate resistance	22936	155	11	3	1	0.19935	0.27279
PI3K-Akt signaling pathway	22936	155	11	3	1	0.19935	0.27279
Prostate cancer	22936	155	11	3	1	0.19935	0.27279
Lipid and atherosclerosis	22936	155	11	3	1	0.19935	0.27279
Metabolic pathways	22936	155	11	24	3	0.23117	0.30052
Biosynthesis of cofactors	22936	155	11	4	1	0.25729	0.3072
Cell cycle	22936	155	11	14	2	0.25994	0.3072
Viral life cycle - HIV-1	22936	155	11	5	1	0.3114	0.35201
Oocyte meiosis	22936	155	11	7	1	0.409	0.42536
Progesterone-mediated oocyte maturation	22936	155	11	7	1	0.409	0.42536
Pathways in cancer	22936	155	11	9	1	0.49386	0.49386
Cell cycle	22974	155	26	14	12	2.8017e-09	1.1767e-07
Oocyte meiosis	22974	155	26	7	6	8.1668e-05	0.001715
DNA replication	22974	155	26	4	4	0.00064635	0.0067866
p53 signaling pathway	22974	155	26	4	4	0.00064635	0.0067866
Cellular senescence	22974	155	26	7	5	0.0015427	0.010799
Progesterone-mediated oocyte maturation	22974	155	26	7	5	0.0015427	0.010799
Pyrimidine metabolism	22974	155	26	4	3	0.015147	0.072797
Nucleotide metabolism	22974	155	26	4	3	0.015147	0.072797
Human T-cell leukemia virus 1 infection	22974	155	26	7	4	0.015599	0.072797
One carbon pool by folate	22974	155	26	2	2	0.027231	0.10397
Platinum drug resistance	22974	155	26	2	2	0.027231	0.10397
Drug metabolism - other enzymes	22974	155	26	3	2	0.073149	0.23633
Antifolate resistance	22974	155	26	3	2	0.073149	0.23633
Human immunodeficiency virus 1 infection	22974	155	26	7	3	0.092605	0.27782
FoxO signaling pathway	22974	155	26	4	2	0.13115	0.30631
Ubiquitin mediated proteolysis	22974	155	26	4	2	0.13115	0.30631
MicroRNAs in cancer	22974	155	26	4	2	0.13115	0.30631
Purine metabolism	22974	155	26	1	1	0.16774	0.30631
Base excision repair	22974	155	26	1	1	0.16774	0.30631
Non-homologous end-joining	22974	155	26	1	1	0.16774	0.30631
Fanconi anemia pathway	22974	155	26	1	1	0.16774	0.30631
Hippo signaling pathway	22974	155	26	1	1	0.16774	0.30631
Carbohydrate digestion and absorption	22974	155	26	1	1	0.16774	0.30631
Chemical carcinogenesis - receptor activation	22974	155	26	5	2	0.1962	0.34334
Glutathione metabolism	22974	155	26	2	1	0.30825	0.41763
Folate biosynthesis	22974	155	26	2	1	0.30825	0.41763
MAPK signaling pathway	22974	155	26	2	1	0.30825	0.41763
Apoptosis	22974	155	26	2	1	0.30825	0.41763
Apoptosis - multiple species	22974	155	26	2	1	0.30825	0.41763
ECM-receptor interaction	22974	155	26	2	1	0.30825	0.41763
Colorectal cancer	22974	155	26	2	1	0.30825	0.41763
Viral carcinogenesis	22974	155	26	13	3	0.37612	0.49365
Hepatitis B	22974	155	26	8	2	0.40046	0.49677
AMPK signaling pathway	22974	155	26	3	1	0.4258	0.49677
Gap junction	22974	155	26	3	1	0.4258	0.49677
Acute myeloid leukemia	22974	155	26	3	1	0.4258	0.49677
Pathways in cancer	22974	155	26	9	2	0.46472	0.52752
Biosynthesis of cofactors	22974	155	26	4	1	0.52402	0.57918
Metabolic pathways	22974	155	26	24	4	0.60551	0.65209
Transcriptional misregulation in cancer	22974	155	26	8	1	0.77835	0.81727
Human papillomavirus infection	22974	155	26	10	1	0.85004	0.87078
Epstein-Barr virus infection	22974	155	26	11	1	0.87693	0.87693
Protein processing in endoplasmic reticulum	23231	155	10	6	3	0.0035472	0.10287
Metabolic pathways	23231	155	10	24	4	0.049253	0.1871
Glycine, serine and threonine metabolism	23231	155	10	1	1	0.064516	0.1871
Glyoxylate and dicarboxylate metabolism	23231	155	10	1	1	0.064516	0.1871
Carbon metabolism	23231	155	10	1	1	0.064516	0.1871
Biosynthesis of nucleotide sugars	23231	155	10	1	1	0.064516	0.1871
Estrogen signaling pathway	23231	155	10	1	1	0.064516	0.1871
Thyroid hormone synthesis	23231	155	10	1	1	0.064516	0.1871
Oxytocin signaling pathway	23231	155	10	1	1	0.064516	0.1871
Pancreatic secretion	23231	155	10	1	1	0.064516	0.1871
Glutathione metabolism	23231	155	10	2	1	0.12526	0.19119
Amino sugar and nucleotide sugar metabolism	23231	155	10	2	1	0.12526	0.19119
Nicotinate and nicotinamide metabolism	23231	155	10	2	1	0.12526	0.19119
Calcium signaling pathway	23231	155	10	2	1	0.12526	0.19119
IL-17 signaling pathway	23231	155	10	2	1	0.12526	0.19119
Th17 cell differentiation	23231	155	10	2	1	0.12526	0.19119
Salivary secretion	23231	155	10	2	1	0.12526	0.19119
Salmonella infection	23231	155	10	2	1	0.12526	0.19119
Fluid shear stress and atherosclerosis	23231	155	10	2	1	0.12526	0.19119
PI3K-Akt signaling pathway	23231	155	10	3	1	0.18243	0.24048
Prostate cancer	23231	155	10	3	1	0.18243	0.24048
Lipid and atherosclerosis	23231	155	10	3	1	0.18243	0.24048
Viral life cycle - HIV-1	23231	155	10	5	1	0.2868	0.33269
Hematopoietic cell lineage	23231	155	10	5	1	0.2868	0.33269
Chemical carcinogenesis - receptor activation	23231	155	10	5	1	0.2868	0.33269
Oocyte meiosis	23231	155	10	7	1	0.37902	0.4071
Progesterone-mediated oocyte maturation	23231	155	10	7	1	0.37902	0.4071
Pathways in cancer	23231	155	10	9	1	0.46037	0.47681
Cell cycle	23231	155	10	14	1	0.62348	0.62348
Alzheimer disease	23347	155	28	8	5	0.0052251	0.40233
RNA degradation	23347	155	28	2	2	0.031672	0.4487
Notch signaling pathway	23347	155	28	2	2	0.031672	0.4487
Protein digestion and absorption	23347	155	28	2	2	0.031672	0.4487
Thyroid hormone signaling pathway	23347	155	28	3	2	0.08425	0.4487
Pathways of neurodegeneration - multiple diseases	23347	155	28	7	3	0.11169	0.4487
Coronavirus disease - COVID-19	23347	155	28	11	4	0.11319	0.4487
Necroptosis	23347	155	28	4	2	0.14963	0.4487
Kaposi sarcoma-associated herpesvirus infection	23347	155	28	4	2	0.14963	0.4487
Mucin type O-glycan biosynthesis	23347	155	28	1	1	0.18065	0.4487
Glycerolipid metabolism	23347	155	28	1	1	0.18065	0.4487
Glycerophospholipid metabolism	23347	155	28	1	1	0.18065	0.4487
Arachidonic acid metabolism	23347	155	28	1	1	0.18065	0.4487
Sphingolipid metabolism	23347	155	28	1	1	0.18065	0.4487
ABC transporters	23347	155	28	1	1	0.18065	0.4487
NF-kappa B signaling pathway	23347	155	28	1	1	0.18065	0.4487
mTOR signaling pathway	23347	155	28	1	1	0.18065	0.4487
Signaling pathways regulating pluripotency of stem cells	23347	155	28	1	1	0.18065	0.4487
Toll-like receptor signaling pathway	23347	155	28	1	1	0.18065	0.4487
Th1 and Th2 cell differentiation	23347	155	28	1	1	0.18065	0.4487
Glutamatergic synapse	23347	155	28	1	1	0.18065	0.4487
Serotonergic synapse	23347	155	28	1	1	0.18065	0.4487
GABAergic synapse	23347	155	28	1	1	0.18065	0.4487
Insulin signaling pathway	23347	155	28	1	1	0.18065	0.4487
Prolactin signaling pathway	23347	155	28	1	1	0.18065	0.4487
AGE-RAGE signaling pathway in diabetic complications	23347	155	28	1	1	0.18065	0.4487
Growth hormone synthesis, secretion and action	23347	155	28	1	1	0.18065	0.4487
Fat digestion and absorption	23347	155	28	1	1	0.18065	0.4487
Epithelial cell signaling in Helicobacter pylori infection	23347	155	28	1	1	0.18065	0.4487
Pathogenic Escherichia coli infection	23347	155	28	1	1	0.18065	0.4487
Toxoplasmosis	23347	155	28	1	1	0.18065	0.4487
Measles	23347	155	28	9	3	0.20737	0.48385
Herpes simplex virus 1 infection	23347	155	28	9	3	0.20737	0.48385
Viral life cycle - HIV-1	23347	155	28	5	2	0.22179	0.50229
Influenza A	23347	155	28	10	3	0.26092	0.50761
Protein processing in endoplasmic reticulum	23347	155	28	6	2	0.29636	0.50761
Parkinson disease	23347	155	28	6	2	0.29636	0.50761
Epstein-Barr virus infection	23347	155	28	11	3	0.31632	0.50761
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	23347	155	28	2	1	0.32962	0.50761
Chemokine signaling pathway	23347	155	28	2	1	0.32962	0.50761
Renin-angiotensin system	23347	155	28	2	1	0.32962	0.50761
RIG-I-like receptor signaling pathway	23347	155	28	2	1	0.32962	0.50761
Cytosolic DNA-sensing pathway	23347	155	28	2	1	0.32962	0.50761
C-type lectin receptor signaling pathway	23347	155	28	2	1	0.32962	0.50761
Th17 cell differentiation	23347	155	28	2	1	0.32962	0.50761
Alcoholic liver disease	23347	155	28	2	1	0.32962	0.50761
Cholesterol metabolism	23347	155	28	2	1	0.32962	0.50761
Salmonella infection	23347	155	28	2	1	0.32962	0.50761
Leishmaniasis	23347	155	28	2	1	0.32962	0.50761
Inflammatory bowel disease	23347	155	28	2	1	0.32962	0.50761
Human immunodeficiency virus 1 infection	23347	155	28	7	2	0.37022	0.55125
Hepatitis C	23347	155	28	12	3	0.37227	0.55125
Viral carcinogenesis	23347	155	28	13	3	0.42768	0.59029
Alcoholism	23347	155	28	8	2	0.44126	0.59029
Hepatitis B	23347	155	28	8	2	0.44126	0.59029
Gap junction	23347	155	28	3	1	0.4523	0.59029
JAK-STAT signaling pathway	23347	155	28	3	1	0.4523	0.59029
Pancreatic cancer	23347	155	28	3	1	0.4523	0.59029
Lipid and atherosclerosis	23347	155	28	3	1	0.4523	0.59029
Ubiquitin mediated proteolysis	23347	155	28	4	1	0.55319	0.6453
Osteoclast differentiation	23347	155	28	4	1	0.55319	0.6453
Amyotrophic lateral sclerosis	23347	155	28	4	1	0.55319	0.6453
Huntington disease	23347	155	28	4	1	0.55319	0.6453
Prion disease	23347	155	28	4	1	0.55319	0.6453
Tuberculosis	23347	155	28	4	1	0.55319	0.6453
PD-L1 expression and PD-1 checkpoint pathway in cancer	23347	155	28	4	1	0.55319	0.6453
Human papillomavirus infection	23347	155	28	10	2	0.56988	0.6453
Systemic lupus erythematosus	23347	155	28	10	2	0.56988	0.6453
Phagosome	23347	155	28	5	1	0.63605	0.69965
Hematopoietic cell lineage	23347	155	28	5	1	0.63605	0.69965
Metabolic pathways	23347	155	28	24	4	0.67206	0.72886
Neutrophil extracellular trap formation	23347	155	28	13	2	0.72234	0.77251
Oocyte meiosis	23347	155	28	7	1	0.75961	0.79041
Progesterone-mediated oocyte maturation	23347	155	28	7	1	0.75961	0.79041
NOD-like receptor signaling pathway	23347	155	28	15	2	0.7977	0.81897
Pathways in cancer	23347	155	28	9	1	0.84222	0.8533
Ribosome biogenesis in eukaryotes	23347	155	28	18	1	0.97816	0.97816
Alzheimer disease	23389	155	21	8	4	0.012408	0.2522
RNA degradation	23389	155	21	2	2	0.017595	0.2522
Protein digestion and absorption	23389	155	21	2	2	0.017595	0.2522
Pathways of neurodegeneration - multiple diseases	23389	155	21	7	3	0.052765	0.30662
Mucin type O-glycan biosynthesis	23389	155	21	1	1	0.13548	0.30662
Glycerolipid metabolism	23389	155	21	1	1	0.13548	0.30662
Glycerophospholipid metabolism	23389	155	21	1	1	0.13548	0.30662
Arachidonic acid metabolism	23389	155	21	1	1	0.13548	0.30662
Sphingolipid metabolism	23389	155	21	1	1	0.13548	0.30662
ABC transporters	23389	155	21	1	1	0.13548	0.30662
mTOR signaling pathway	23389	155	21	1	1	0.13548	0.30662
Signaling pathways regulating pluripotency of stem cells	23389	155	21	1	1	0.13548	0.30662
Glutamatergic synapse	23389	155	21	1	1	0.13548	0.30662
Serotonergic synapse	23389	155	21	1	1	0.13548	0.30662
GABAergic synapse	23389	155	21	1	1	0.13548	0.30662
Insulin signaling pathway	23389	155	21	1	1	0.13548	0.30662
Fat digestion and absorption	23389	155	21	1	1	0.13548	0.30662
Epithelial cell signaling in Helicobacter pylori infection	23389	155	21	1	1	0.13548	0.30662
Pathogenic Escherichia coli infection	23389	155	21	1	1	0.13548	0.30662
Parkinson disease	23389	155	21	6	2	0.18749	0.4031
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	23389	155	21	2	1	0.25337	0.40352
Notch signaling pathway	23389	155	21	2	1	0.25337	0.40352
Complement and coagulation cascades	23389	155	21	2	1	0.25337	0.40352
Renin-angiotensin system	23389	155	21	2	1	0.25337	0.40352
Alcoholic liver disease	23389	155	21	2	1	0.25337	0.40352
Cholesterol metabolism	23389	155	21	2	1	0.25337	0.40352
Salmonella infection	23389	155	21	2	1	0.25337	0.40352
Gap junction	23389	155	21	3	1	0.35585	0.51005
Thyroid hormone signaling pathway	23389	155	21	3	1	0.35585	0.51005
Lipid and atherosclerosis	23389	155	21	3	1	0.35585	0.51005
Metabolic pathways	23389	155	21	24	4	0.41485	0.54419
Ubiquitin mediated proteolysis	23389	155	21	4	1	0.44485	0.54419
Amyotrophic lateral sclerosis	23389	155	21	4	1	0.44485	0.54419
Huntington disease	23389	155	21	4	1	0.44485	0.54419
Prion disease	23389	155	21	4	1	0.44485	0.54419
Coronavirus disease - COVID-19	23389	155	21	11	2	0.4556	0.54419
Phagosome	23389	155	21	5	1	0.52205	0.59074
Hematopoietic cell lineage	23389	155	21	5	1	0.52205	0.59074
Protein processing in endoplasmic reticulum	23389	155	21	6	1	0.58896	0.64937
Oocyte meiosis	23389	155	21	7	1	0.6469	0.67845
Progesterone-mediated oocyte maturation	23389	155	21	7	1	0.6469	0.67845
NOD-like receptor signaling pathway	23389	155	21	15	1	0.89951	0.92092
Ribosome biogenesis in eukaryotes	23389	155	21	18	1	0.93852	0.93852
Intestinal immune network for IgA production	23495	155	13	2	2	0.0065354	0.10897
Protein processing in endoplasmic reticulum	23495	155	13	6	3	0.0080716	0.10897
Cytokine-cytokine receptor interaction	23495	155	13	3	2	0.018666	0.168
Chemical carcinogenesis - receptor activation	23495	155	13	5	2	0.056413	0.18871
Glycine, serine and threonine metabolism	23495	155	13	1	1	0.083871	0.18871
Glyoxylate and dicarboxylate metabolism	23495	155	13	1	1	0.083871	0.18871
Carbon metabolism	23495	155	13	1	1	0.083871	0.18871
Biosynthesis of nucleotide sugars	23495	155	13	1	1	0.083871	0.18871
Protein export	23495	155	13	1	1	0.083871	0.18871
Estrogen signaling pathway	23495	155	13	1	1	0.083871	0.18871
Thyroid hormone synthesis	23495	155	13	1	1	0.083871	0.18871
Primary immunodeficiency	23495	155	13	1	1	0.083871	0.18871
Glutathione metabolism	23495	155	13	2	1	0.16121	0.24181
Amino sugar and nucleotide sugar metabolism	23495	155	13	2	1	0.16121	0.24181
IL-17 signaling pathway	23495	155	13	2	1	0.16121	0.24181
Th17 cell differentiation	23495	155	13	2	1	0.16121	0.24181
Salmonella infection	23495	155	13	2	1	0.16121	0.24181
Fluid shear stress and atherosclerosis	23495	155	13	2	1	0.16121	0.24181
PI3K-Akt signaling pathway	23495	155	13	3	1	0.23248	0.2989
Prostate cancer	23495	155	13	3	1	0.23248	0.2989
Lipid and atherosclerosis	23495	155	13	3	1	0.23248	0.2989
Metabolic pathways	23495	155	13	24	3	0.32449	0.39824
Parkinson disease	23495	155	13	6	1	0.41414	0.48616
Cellular senescence	23495	155	13	7	1	0.46525	0.50248
Pathways of neurodegeneration - multiple diseases	23495	155	13	7	1	0.46525	0.50248
Pathways in cancer	23495	155	13	9	1	0.55536	0.57672
Cell cycle	23495	155	13	14	1	0.72297	0.72297
Rap1 signaling pathway	23531	155	8	2	2	0.002346	0.046921
Focal adhesion	23531	155	8	2	2	0.002346	0.046921
Regulation of actin cytoskeleton	23531	155	8	2	2	0.002346	0.046921
PI3K-Akt signaling pathway	23531	155	8	3	2	0.0068541	0.082249
Gap junction	23531	155	8	3	2	0.0068541	0.082249
Phagosome	23531	155	8	5	2	0.021665	0.13464
Pathways of neurodegeneration - multiple diseases	23531	155	8	7	2	0.043138	0.13464
EGFR tyrosine kinase inhibitor resistance	23531	155	8	1	1	0.051613	0.13464
ErbB signaling pathway	23531	155	8	1	1	0.051613	0.13464
Ras signaling pathway	23531	155	8	1	1	0.051613	0.13464
Phospholipase D signaling pathway	23531	155	8	1	1	0.051613	0.13464
Axon guidance	23531	155	8	1	1	0.051613	0.13464
Signaling pathways regulating pluripotency of stem cells	23531	155	8	1	1	0.051613	0.13464
Platelet activation	23531	155	8	1	1	0.051613	0.13464
Serotonergic synapse	23531	155	8	1	1	0.051613	0.13464
Insulin signaling pathway	23531	155	8	1	1	0.051613	0.13464
Pathogenic Escherichia coli infection	23531	155	8	1	1	0.051613	0.13464
Proteoglycans in cancer	23531	155	8	1	1	0.051613	0.13464
Endometrial cancer	23531	155	8	1	1	0.051613	0.13464
Choline metabolism in cancer	23531	155	8	1	1	0.051613	0.13464
Hypertrophic cardiomyopathy	23531	155	8	1	1	0.051613	0.13464
Arrhythmogenic right ventricular cardiomyopathy	23531	155	8	1	1	0.051613	0.13464
Dilated cardiomyopathy	23531	155	8	1	1	0.051613	0.13464
Alzheimer disease	23531	155	8	8	2	0.056003	0.14001
Human papillomavirus infection	23531	155	8	10	2	0.085319	0.15132
MAPK signaling pathway	23531	155	8	2	1	0.10088	0.15132
Calcium signaling pathway	23531	155	8	2	1	0.10088	0.15132
HIF-1 signaling pathway	23531	155	8	2	1	0.10088	0.15132
ECM-receptor interaction	23531	155	8	2	1	0.10088	0.15132
Complement and coagulation cascades	23531	155	8	2	1	0.10088	0.15132
Salmonella infection	23531	155	8	2	1	0.10088	0.15132
Human cytomegalovirus infection	23531	155	8	2	1	0.10088	0.15132
Colorectal cancer	23531	155	8	2	1	0.10088	0.15132
Glioma	23531	155	8	2	1	0.10088	0.15132
Melanoma	23531	155	8	2	1	0.10088	0.15132
Bladder cancer	23531	155	8	2	1	0.10088	0.15132
Non-small cell lung cancer	23531	155	8	2	1	0.10088	0.15132
Breast cancer	23531	155	8	2	1	0.10088	0.15132
Gastric cancer	23531	155	8	2	1	0.10088	0.15132
Fluid shear stress and atherosclerosis	23531	155	8	2	1	0.10088	0.15132
JAK-STAT signaling pathway	23531	155	8	3	1	0.14789	0.20167
Thyroid hormone signaling pathway	23531	155	8	3	1	0.14789	0.20167
Pancreatic cancer	23531	155	8	3	1	0.14789	0.20167
Prostate cancer	23531	155	8	3	1	0.14789	0.20167
FoxO signaling pathway	23531	155	8	4	1	0.19274	0.22239
Osteoclast differentiation	23531	155	8	4	1	0.19274	0.22239
Amyotrophic lateral sclerosis	23531	155	8	4	1	0.19274	0.22239
Huntington disease	23531	155	8	4	1	0.19274	0.22239
Prion disease	23531	155	8	4	1	0.19274	0.22239
MicroRNAs in cancer	23531	155	8	4	1	0.19274	0.22239
Chemical carcinogenesis - reactive oxygen species	23531	155	8	4	1	0.19274	0.22239
PD-L1 expression and PD-1 checkpoint pathway in cancer	23531	155	8	4	1	0.19274	0.22239
Hematopoietic cell lineage	23531	155	8	5	1	0.23551	0.26168
Chemical carcinogenesis - receptor activation	23531	155	8	5	1	0.23551	0.26168
Parkinson disease	23531	155	8	6	1	0.27628	0.3014
Herpes simplex virus 1 infection	23531	155	8	9	1	0.38742	0.40781
Pathways in cancer	23531	155	8	9	1	0.38742	0.40781
Coronavirus disease - COVID-19	23531	155	8	11	1	0.45293	0.46855
Hepatitis C	23531	155	8	12	1	0.48332	0.49151
Neutrophil extracellular trap formation	23531	155	8	13	1	0.51223	0.51223
Influenza A	23586	155	30	10	10	1.8322e-08	9.5272e-07
Measles	23586	155	30	9	9	1.2738e-07	3.3118e-06
Hepatitis C	23586	155	30	12	10	9.2431e-07	1.6021e-05
Coronavirus disease - COVID-19	23586	155	30	11	9	5.3057e-06	6.8974e-05
Herpes simplex virus 1 infection	23586	155	30	9	8	6.641e-06	6.9067e-05
NOD-like receptor signaling pathway	23586	155	30	15	9	0.00027463	0.0023802
Epstein-Barr virus infection	23586	155	30	11	7	0.0010041	0.0074587
Necroptosis	23586	155	30	4	4	0.0011848	0.0077014
Kaposi sarcoma-associated herpesvirus infection	23586	155	30	4	3	0.023126	0.11149
PD-L1 expression and PD-1 checkpoint pathway in cancer	23586	155	30	4	3	0.023126	0.11149
Human papillomavirus infection	23586	155	30	10	5	0.024313	0.11149
RNA degradation	23586	155	30	2	2	0.036447	0.11149
Chemokine signaling pathway	23586	155	30	2	2	0.036447	0.11149
Cell adhesion molecules	23586	155	30	2	2	0.036447	0.11149
RIG-I-like receptor signaling pathway	23586	155	30	2	2	0.036447	0.11149
Cytosolic DNA-sensing pathway	23586	155	30	2	2	0.036447	0.11149
C-type lectin receptor signaling pathway	23586	155	30	2	2	0.036447	0.11149
Hepatitis B	23586	155	30	8	4	0.045913	0.13264
JAK-STAT signaling pathway	23586	155	30	3	2	0.096002	0.26274
Osteoclast differentiation	23586	155	30	4	2	0.16888	0.32466
Glycolysis / Gluconeogenesis	23586	155	30	1	1	0.19355	0.32466
Galactose metabolism	23586	155	30	1	1	0.19355	0.32466
NF-kappa B signaling pathway	23586	155	30	1	1	0.19355	0.32466
Signaling pathways regulating pluripotency of stem cells	23586	155	30	1	1	0.19355	0.32466
Toll-like receptor signaling pathway	23586	155	30	1	1	0.19355	0.32466
Th1 and Th2 cell differentiation	23586	155	30	1	1	0.19355	0.32466
Prolactin signaling pathway	23586	155	30	1	1	0.19355	0.32466
AGE-RAGE signaling pathway in diabetic complications	23586	155	30	1	1	0.19355	0.32466
Growth hormone synthesis, secretion and action	23586	155	30	1	1	0.19355	0.32466
Pertussis	23586	155	30	1	1	0.19355	0.32466
Toxoplasmosis	23586	155	30	1	1	0.19355	0.32466
Viral life cycle - HIV-1	23586	155	30	5	2	0.24803	0.40305
Lysosome	23586	155	30	2	1	0.35065	0.47984
Notch signaling pathway	23586	155	30	2	1	0.35065	0.47984
Complement and coagulation cascades	23586	155	30	2	1	0.35065	0.47984
Th17 cell differentiation	23586	155	30	2	1	0.35065	0.47984
Leishmaniasis	23586	155	30	2	1	0.35065	0.47984
Inflammatory bowel disease	23586	155	30	2	1	0.35065	0.47984
Thyroid hormone signaling pathway	23586	155	30	3	1	0.47797	0.62136
Pancreatic cancer	23586	155	30	3	1	0.47797	0.62136
Pathways in cancer	23586	155	30	9	2	0.54972	0.67138
Pyrimidine metabolism	23586	155	30	4	1	0.581	0.67138
Nucleotide metabolism	23586	155	30	4	1	0.581	0.67138
Biosynthesis of cofactors	23586	155	30	4	1	0.581	0.67138
Tuberculosis	23586	155	30	4	1	0.581	0.67138
Protein processing in endoplasmic reticulum	23586	155	30	6	1	0.7314	0.8268
Human immunodeficiency virus 1 infection	23586	155	30	7	1	0.78548	0.86904
Alzheimer disease	23586	155	30	8	1	0.82896	0.87972
Transcriptional misregulation in cancer	23586	155	30	8	1	0.82896	0.87972
Viral carcinogenesis	23586	155	30	13	1	0.94634	0.98393
Metabolic pathways	23586	155	30	24	2	0.97153	0.98393
Ribosome biogenesis in eukaryotes	23586	155	30	18	1	0.98393	0.98393
Influenza A	24138	155	29	10	10	1.2214e-08	6.3515e-07
Measles	24138	155	29	9	9	8.9165e-08	2.3183e-06
Hepatitis C	24138	155	29	12	10	6.2509e-07	1.0835e-05
Coronavirus disease - COVID-19	24138	155	29	11	9	3.7669e-06	4.8969e-05
Herpes simplex virus 1 infection	24138	155	29	9	8	4.9041e-06	5.1002e-05
NOD-like receptor signaling pathway	24138	155	29	15	9	0.00020063	0.0017388
Epstein-Barr virus infection	24138	155	29	11	7	0.00079109	0.0058766
Necroptosis	24138	155	29	4	4	0.0010268	0.0066745
Human papillomavirus infection	24138	155	29	10	5	0.020916	0.10885
Kaposi sarcoma-associated herpesvirus infection	24138	155	29	4	3	0.020932	0.10885
RNA degradation	24138	155	29	2	2	0.034018	0.11793
Chemokine signaling pathway	24138	155	29	2	2	0.034018	0.11793
RIG-I-like receptor signaling pathway	24138	155	29	2	2	0.034018	0.11793
Cytosolic DNA-sensing pathway	24138	155	29	2	2	0.034018	0.11793
C-type lectin receptor signaling pathway	24138	155	29	2	2	0.034018	0.11793
Hepatitis B	24138	155	29	8	4	0.040764	0.13248
JAK-STAT signaling pathway	24138	155	29	3	2	0.090047	0.27544
Osteoclast differentiation	24138	155	29	4	2	0.15916	0.3243
PD-L1 expression and PD-1 checkpoint pathway in cancer	24138	155	29	4	2	0.15916	0.3243
Glycolysis / Gluconeogenesis	24138	155	29	1	1	0.1871	0.3243
Galactose metabolism	24138	155	29	1	1	0.1871	0.3243
NF-kappa B signaling pathway	24138	155	29	1	1	0.1871	0.3243
Signaling pathways regulating pluripotency of stem cells	24138	155	29	1	1	0.1871	0.3243
Toll-like receptor signaling pathway	24138	155	29	1	1	0.1871	0.3243
Th1 and Th2 cell differentiation	24138	155	29	1	1	0.1871	0.3243
Prolactin signaling pathway	24138	155	29	1	1	0.1871	0.3243
AGE-RAGE signaling pathway in diabetic complications	24138	155	29	1	1	0.1871	0.3243
Growth hormone synthesis, secretion and action	24138	155	29	1	1	0.1871	0.3243
Pertussis	24138	155	29	1	1	0.1871	0.3243
Toxoplasmosis	24138	155	29	1	1	0.1871	0.3243
Viral life cycle - HIV-1	24138	155	29	5	2	0.23484	0.39392
Lysosome	24138	155	29	2	1	0.34018	0.4655
Notch signaling pathway	24138	155	29	2	1	0.34018	0.4655
Cell adhesion molecules	24138	155	29	2	1	0.34018	0.4655
Complement and coagulation cascades	24138	155	29	2	1	0.34018	0.4655
Th17 cell differentiation	24138	155	29	2	1	0.34018	0.4655
Leishmaniasis	24138	155	29	2	1	0.34018	0.4655
Inflammatory bowel disease	24138	155	29	2	1	0.34018	0.4655
Thyroid hormone signaling pathway	24138	155	29	3	1	0.46524	0.60481
Pancreatic cancer	24138	155	29	3	1	0.46524	0.60481
Pathways in cancer	24138	155	29	9	2	0.52913	0.65551
Pyrimidine metabolism	24138	155	29	4	1	0.56727	0.65551
Nucleotide metabolism	24138	155	29	4	1	0.56727	0.65551
Biosynthesis of cofactors	24138	155	29	4	1	0.56727	0.65551
Tuberculosis	24138	155	29	4	1	0.56727	0.65551
Protein processing in endoplasmic reticulum	24138	155	29	6	1	0.71797	0.81162
Human immunodeficiency virus 1 infection	24138	155	29	7	1	0.77286	0.85508
Alzheimer disease	24138	155	29	8	1	0.81737	0.86741
Transcriptional misregulation in cancer	24138	155	29	8	1	0.81737	0.86741
Viral carcinogenesis	24138	155	29	13	1	0.94016	0.97777
Metabolic pathways	24138	155	29	24	2	0.96614	0.98126
Ribosome biogenesis in eukaryotes	24138	155	29	18	1	0.98126	0.98126
Glycosphingolipid biosynthesis - lacto and neolacto series	2529	155	2	1	1	0.012903	0.032258
Sphingolipid signaling pathway	2529	155	2	1	1	0.012903	0.032258
Neuroactive ligand-receptor interaction	2529	155	2	3	1	0.038458	0.063888
FoxO signaling pathway	2529	155	2	4	1	0.05111	0.063888
Metabolic pathways	2529	155	2	24	1	0.28655	0.28655
Influenza A	2537	155	19	10	8	4.3082e-07	1.4217e-05
Hepatitis C	2537	155	19	12	8	4.1219e-06	4.6316e-05
Measles	2537	155	19	9	7	4.2106e-06	4.6316e-05
Coronavirus disease - COVID-19	2537	155	19	11	7	3.3254e-05	0.00027434
Herpes simplex virus 1 infection	2537	155	19	9	6	0.00010326	0.00068151
Epstein-Barr virus infection	2537	155	19	11	5	0.0047123	0.025918
RIG-I-like receptor signaling pathway	2537	155	19	2	2	0.014328	0.059101
Cytosolic DNA-sensing pathway	2537	155	19	2	2	0.014328	0.059101
NOD-like receptor signaling pathway	2537	155	19	15	5	0.021986	0.080614
Hepatitis B	2537	155	19	8	3	0.059133	0.19514
Necroptosis	2537	155	19	4	2	0.073733	0.2212
Human papillomavirus infection	2537	155	19	10	3	0.1076	0.25282
Glycolysis / Gluconeogenesis	2537	155	19	1	1	0.12258	0.25282
Galactose metabolism	2537	155	19	1	1	0.12258	0.25282
NF-kappa B signaling pathway	2537	155	19	1	1	0.12258	0.25282
Pertussis	2537	155	19	1	1	0.12258	0.25282
Chemokine signaling pathway	2537	155	19	2	1	0.23083	0.34625
Apoptosis	2537	155	19	2	1	0.23083	0.34625
Apoptosis - multiple species	2537	155	19	2	1	0.23083	0.34625
Cell adhesion molecules	2537	155	19	2	1	0.23083	0.34625
Complement and coagulation cascades	2537	155	19	2	1	0.23083	0.34625
C-type lectin receptor signaling pathway	2537	155	19	2	1	0.23083	0.34625
JAK-STAT signaling pathway	2537	155	19	3	1	0.32635	0.46719
Pyrimidine metabolism	2537	155	19	4	1	0.41056	0.46719
Nucleotide metabolism	2537	155	19	4	1	0.41056	0.46719
Biosynthesis of cofactors	2537	155	19	4	1	0.41056	0.46719
Osteoclast differentiation	2537	155	19	4	1	0.41056	0.46719
Kaposi sarcoma-associated herpesvirus infection	2537	155	19	4	1	0.41056	0.46719
PD-L1 expression and PD-1 checkpoint pathway in cancer	2537	155	19	4	1	0.41056	0.46719
Viral life cycle - HIV-1	2537	155	19	5	1	0.48473	0.5332
Transcriptional misregulation in cancer	2537	155	19	8	1	0.65778	0.70022
Pathways in cancer	2537	155	19	9	1	0.70201	0.72395
Metabolic pathways	2537	155	19	24	2	0.83494	0.83494
Alzheimer disease	254225	155	24	8	4	0.020541	0.41625
RNA degradation	254225	155	24	2	2	0.023125	0.41625
Notch signaling pathway	254225	155	24	2	2	0.023125	0.41625
Pathways of neurodegeneration - multiple diseases	254225	155	24	7	3	0.075286	0.46452
Mucin type O-glycan biosynthesis	254225	155	24	1	1	0.15484	0.46452
Glycerolipid metabolism	254225	155	24	1	1	0.15484	0.46452
Glycerophospholipid metabolism	254225	155	24	1	1	0.15484	0.46452
Sphingolipid metabolism	254225	155	24	1	1	0.15484	0.46452
ABC transporters	254225	155	24	1	1	0.15484	0.46452
mTOR signaling pathway	254225	155	24	1	1	0.15484	0.46452
Signaling pathways regulating pluripotency of stem cells	254225	155	24	1	1	0.15484	0.46452
Glutamatergic synapse	254225	155	24	1	1	0.15484	0.46452
Serotonergic synapse	254225	155	24	1	1	0.15484	0.46452
GABAergic synapse	254225	155	24	1	1	0.15484	0.46452
Insulin signaling pathway	254225	155	24	1	1	0.15484	0.46452
Fat digestion and absorption	254225	155	24	1	1	0.15484	0.46452
Epithelial cell signaling in Helicobacter pylori infection	254225	155	24	1	1	0.15484	0.46452
Pathogenic Escherichia coli infection	254225	155	24	1	1	0.15484	0.46452
Viral life cycle - HIV-1	254225	155	24	5	2	0.1714	0.48713
Coronavirus disease - COVID-19	254225	155	24	11	3	0.23117	0.55165
Protein processing in endoplasmic reticulum	254225	155	24	6	2	0.23312	0.55165
Parkinson disease	254225	155	24	6	2	0.23312	0.55165
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	254225	155	24	2	1	0.28655	0.55165
Complement and coagulation cascades	254225	155	24	2	1	0.28655	0.55165
Alcoholic liver disease	254225	155	24	2	1	0.28655	0.55165
Protein digestion and absorption	254225	155	24	2	1	0.28655	0.55165
Cholesterol metabolism	254225	155	24	2	1	0.28655	0.55165
Salmonella infection	254225	155	24	2	1	0.28655	0.55165
Human immunodeficiency virus 1 infection	254225	155	24	7	2	0.29626	0.55165
Gap junction	254225	155	24	3	1	0.39847	0.67241
Thyroid hormone signaling pathway	254225	155	24	3	1	0.39847	0.67241
Lipid and atherosclerosis	254225	155	24	3	1	0.39847	0.67241
Ubiquitin mediated proteolysis	254225	155	24	4	1	0.49344	0.70121
Necroptosis	254225	155	24	4	1	0.49344	0.70121
Amyotrophic lateral sclerosis	254225	155	24	4	1	0.49344	0.70121
Huntington disease	254225	155	24	4	1	0.49344	0.70121
Prion disease	254225	155	24	4	1	0.49344	0.70121
Kaposi sarcoma-associated herpesvirus infection	254225	155	24	4	1	0.49344	0.70121
Phagosome	254225	155	24	5	1	0.57396	0.79471
Viral carcinogenesis	254225	155	24	13	2	0.63137	0.85235
Oocyte meiosis	254225	155	24	7	1	0.69977	0.8997
Progesterone-mediated oocyte maturation	254225	155	24	7	1	0.69977	0.8997
Alcoholism	254225	155	24	8	1	0.74845	0.90822
Metabolic pathways	254225	155	24	24	3	0.7645	0.90822
Measles	254225	155	24	9	1	0.78952	0.90822
Herpes simplex virus 1 infection	254225	155	24	9	1	0.78952	0.90822
Influenza A	254225	155	24	10	1	0.82412	0.90822
Human papillomavirus infection	254225	155	24	10	1	0.82412	0.90822
Systemic lupus erythematosus	254225	155	24	10	1	0.82412	0.90822
Epstein-Barr virus infection	254225	155	24	11	1	0.85323	0.92149
Hepatitis C	254225	155	24	12	1	0.87769	0.92932
Neutrophil extracellular trap formation	254225	155	24	13	1	0.89822	0.93277
NOD-like receptor signaling pathway	254225	155	24	15	1	0.92982	0.94736
Ribosome biogenesis in eukaryotes	254225	155	24	18	1	0.96026	0.96026
EGFR tyrosine kinase inhibitor resistance	257019	155	3	1	1	0.019355	0.069225
ErbB signaling pathway	257019	155	3	1	1	0.019355	0.069225
Ras signaling pathway	257019	155	3	1	1	0.019355	0.069225
Phospholipase D signaling pathway	257019	155	3	1	1	0.019355	0.069225
Axon guidance	257019	155	3	1	1	0.019355	0.069225
Endometrial cancer	257019	155	3	1	1	0.019355	0.069225
Choline metabolism in cancer	257019	155	3	1	1	0.019355	0.069225
MAPK signaling pathway	257019	155	3	2	1	0.038458	0.069225
Rap1 signaling pathway	257019	155	3	2	1	0.038458	0.069225
Calcium signaling pathway	257019	155	3	2	1	0.038458	0.069225
HIF-1 signaling pathway	257019	155	3	2	1	0.038458	0.069225
Focal adhesion	257019	155	3	2	1	0.038458	0.069225
Regulation of actin cytoskeleton	257019	155	3	2	1	0.038458	0.069225
Colorectal cancer	257019	155	3	2	1	0.038458	0.069225
Glioma	257019	155	3	2	1	0.038458	0.069225
Melanoma	257019	155	3	2	1	0.038458	0.069225
Bladder cancer	257019	155	3	2	1	0.038458	0.069225
Non-small cell lung cancer	257019	155	3	2	1	0.038458	0.069225
Breast cancer	257019	155	3	2	1	0.038458	0.069225
Gastric cancer	257019	155	3	2	1	0.038458	0.069225
PI3K-Akt signaling pathway	257019	155	3	3	1	0.057312	0.082529
Gap junction	257019	155	3	3	1	0.057312	0.082529
JAK-STAT signaling pathway	257019	155	3	3	1	0.057312	0.082529
Pancreatic cancer	257019	155	3	3	1	0.057312	0.082529
Prostate cancer	257019	155	3	3	1	0.057312	0.082529
FoxO signaling pathway	257019	155	3	4	1	0.075918	0.097609
Chemical carcinogenesis - reactive oxygen species	257019	155	3	4	1	0.075918	0.097609
PD-L1 expression and PD-1 checkpoint pathway in cancer	257019	155	3	4	1	0.075918	0.097609
Chemical carcinogenesis - receptor activation	257019	155	3	5	1	0.094277	0.11703
Alcoholism	257019	155	3	8	1	0.14789	0.17747
Pathways in cancer	257019	155	3	9	1	0.16528	0.19194
Human papillomavirus infection	257019	155	3	10	1	0.18243	0.19902
Systemic lupus erythematosus	257019	155	3	10	1	0.18243	0.19902
Hepatitis C	257019	155	3	12	1	0.21603	0.22874
Neutrophil extracellular trap formation	257019	155	3	13	1	0.23248	0.23248
Viral carcinogenesis	257019	155	3	13	1	0.23248	0.23248
Alzheimer disease	25832	155	18	8	4	0.0067973	0.17093
RNA degradation	25832	155	18	2	2	0.012819	0.17093
Protein digestion and absorption	25832	155	18	2	2	0.012819	0.17093
Pathways of neurodegeneration - multiple diseases	25832	155	18	7	3	0.034502	0.30968
Glycerolipid metabolism	25832	155	18	1	1	0.11613	0.30968
Glycerophospholipid metabolism	25832	155	18	1	1	0.11613	0.30968
ABC transporters	25832	155	18	1	1	0.11613	0.30968
mTOR signaling pathway	25832	155	18	1	1	0.11613	0.30968
Signaling pathways regulating pluripotency of stem cells	25832	155	18	1	1	0.11613	0.30968
Glutamatergic synapse	25832	155	18	1	1	0.11613	0.30968
Serotonergic synapse	25832	155	18	1	1	0.11613	0.30968
GABAergic synapse	25832	155	18	1	1	0.11613	0.30968
Fat digestion and absorption	25832	155	18	1	1	0.11613	0.30968
Epithelial cell signaling in Helicobacter pylori infection	25832	155	18	1	1	0.11613	0.30968
Pathogenic Escherichia coli infection	25832	155	18	1	1	0.11613	0.30968
Parkinson disease	25832	155	18	6	2	0.14433	0.36083
Notch signaling pathway	25832	155	18	2	1	0.21944	0.39898
Complement and coagulation cascades	25832	155	18	2	1	0.21944	0.39898
Renin-angiotensin system	25832	155	18	2	1	0.21944	0.39898
Alcoholic liver disease	25832	155	18	2	1	0.21944	0.39898
Cholesterol metabolism	25832	155	18	2	1	0.21944	0.39898
Salmonella infection	25832	155	18	2	1	0.21944	0.39898
Gap junction	25832	155	18	3	1	0.31127	0.49803
Thyroid hormone signaling pathway	25832	155	18	3	1	0.31127	0.49803
Lipid and atherosclerosis	25832	155	18	3	1	0.31127	0.49803
Coronavirus disease - COVID-19	25832	155	18	11	2	0.37327	0.52377
Ubiquitin mediated proteolysis	25832	155	18	4	1	0.39283	0.52377
Amyotrophic lateral sclerosis	25832	155	18	4	1	0.39283	0.52377
Huntington disease	25832	155	18	4	1	0.39283	0.52377
Prion disease	25832	155	18	4	1	0.39283	0.52377
Viral life cycle - HIV-1	25832	155	18	5	1	0.46521	0.56389
Phagosome	25832	155	18	5	1	0.46521	0.56389
Hematopoietic cell lineage	25832	155	18	5	1	0.46521	0.56389
Protein processing in endoplasmic reticulum	25832	155	18	6	1	0.52938	0.6228
Oocyte meiosis	25832	155	18	7	1	0.58624	0.63377
Progesterone-mediated oocyte maturation	25832	155	18	7	1	0.58624	0.63377
Human immunodeficiency virus 1 infection	25832	155	18	7	1	0.58624	0.63377
NOD-like receptor signaling pathway	25832	155	18	15	1	0.85731	0.90243
Ribosome biogenesis in eukaryotes	25832	155	18	18	1	0.90587	0.9291
Metabolic pathways	25832	155	18	24	1	0.96026	0.96026
Influenza A	2633	155	29	10	10	1.2214e-08	6.5957e-07
Measles	2633	155	29	9	9	8.9165e-08	2.4074e-06
Hepatitis C	2633	155	29	12	10	6.2509e-07	1.1252e-05
Coronavirus disease - COVID-19	2633	155	29	11	9	3.7669e-06	5.0853e-05
Herpes simplex virus 1 infection	2633	155	29	9	8	4.9041e-06	5.2964e-05
NOD-like receptor signaling pathway	2633	155	29	15	9	0.00020063	0.0018057
Epstein-Barr virus infection	2633	155	29	11	7	0.00079109	0.0061027
Necroptosis	2633	155	29	4	4	0.0010268	0.0069312
Human papillomavirus infection	2633	155	29	10	5	0.020916	0.10276
Kaposi sarcoma-associated herpesvirus infection	2633	155	29	4	3	0.020932	0.10276
PD-L1 expression and PD-1 checkpoint pathway in cancer	2633	155	29	4	3	0.020932	0.10276
Chemokine signaling pathway	2633	155	29	2	2	0.034018	0.12246
RIG-I-like receptor signaling pathway	2633	155	29	2	2	0.034018	0.12246
Cytosolic DNA-sensing pathway	2633	155	29	2	2	0.034018	0.12246
C-type lectin receptor signaling pathway	2633	155	29	2	2	0.034018	0.12246
Hepatitis B	2633	155	29	8	4	0.040764	0.13758
JAK-STAT signaling pathway	2633	155	29	3	2	0.090047	0.28603
Osteoclast differentiation	2633	155	29	4	2	0.15916	0.34839
Glycolysis / Gluconeogenesis	2633	155	29	1	1	0.1871	0.34839
Galactose metabolism	2633	155	29	1	1	0.1871	0.34839
NF-kappa B signaling pathway	2633	155	29	1	1	0.1871	0.34839
Signaling pathways regulating pluripotency of stem cells	2633	155	29	1	1	0.1871	0.34839
Toll-like receptor signaling pathway	2633	155	29	1	1	0.1871	0.34839
Th1 and Th2 cell differentiation	2633	155	29	1	1	0.1871	0.34839
Prolactin signaling pathway	2633	155	29	1	1	0.1871	0.34839
AGE-RAGE signaling pathway in diabetic complications	2633	155	29	1	1	0.1871	0.34839
Growth hormone synthesis, secretion and action	2633	155	29	1	1	0.1871	0.34839
Pertussis	2633	155	29	1	1	0.1871	0.34839
Toxoplasmosis	2633	155	29	1	1	0.1871	0.34839
Viral life cycle - HIV-1	2633	155	29	5	2	0.23484	0.42271
RNA degradation	2633	155	29	2	1	0.34018	0.45924
Lysosome	2633	155	29	2	1	0.34018	0.45924
Apoptosis	2633	155	29	2	1	0.34018	0.45924
Apoptosis - multiple species	2633	155	29	2	1	0.34018	0.45924
Notch signaling pathway	2633	155	29	2	1	0.34018	0.45924
Cell adhesion molecules	2633	155	29	2	1	0.34018	0.45924
Complement and coagulation cascades	2633	155	29	2	1	0.34018	0.45924
Th17 cell differentiation	2633	155	29	2	1	0.34018	0.45924
Leishmaniasis	2633	155	29	2	1	0.34018	0.45924
Inflammatory bowel disease	2633	155	29	2	1	0.34018	0.45924
Thyroid hormone signaling pathway	2633	155	29	3	1	0.46524	0.59817
Pancreatic cancer	2633	155	29	3	1	0.46524	0.59817
Pathways in cancer	2633	155	29	9	2	0.52913	0.65175
Pyrimidine metabolism	2633	155	29	4	1	0.56727	0.65175
Nucleotide metabolism	2633	155	29	4	1	0.56727	0.65175
Biosynthesis of cofactors	2633	155	29	4	1	0.56727	0.65175
Tuberculosis	2633	155	29	4	1	0.56727	0.65175
Protein processing in endoplasmic reticulum	2633	155	29	6	1	0.71797	0.80772
Human immunodeficiency virus 1 infection	2633	155	29	7	1	0.77286	0.85172
Alzheimer disease	2633	155	29	8	1	0.81737	0.86545
Transcriptional misregulation in cancer	2633	155	29	8	1	0.81737	0.86545
Viral carcinogenesis	2633	155	29	13	1	0.94016	0.97632
Metabolic pathways	2633	155	29	24	2	0.96614	0.98126
Ribosome biogenesis in eukaryotes	2633	155	29	18	1	0.98126	0.98126
Influenza A	2635	155	30	10	10	1.8322e-08	9.8936e-07
Measles	2635	155	30	9	9	1.2738e-07	3.4392e-06
Hepatitis C	2635	155	30	12	10	9.2431e-07	1.6638e-05
Coronavirus disease - COVID-19	2635	155	30	11	9	5.3057e-06	7.1627e-05
Herpes simplex virus 1 infection	2635	155	30	9	8	6.641e-06	7.1723e-05
NOD-like receptor signaling pathway	2635	155	30	15	9	0.00027463	0.0024717
Epstein-Barr virus infection	2635	155	30	11	7	0.0010041	0.0077456
Necroptosis	2635	155	30	4	4	0.0011848	0.0079976
Kaposi sarcoma-associated herpesvirus infection	2635	155	30	4	3	0.023126	0.13121
Human papillomavirus infection	2635	155	30	10	5	0.024313	0.13121
RNA degradation	2635	155	30	2	2	0.036447	0.13121
Chemokine signaling pathway	2635	155	30	2	2	0.036447	0.13121
RIG-I-like receptor signaling pathway	2635	155	30	2	2	0.036447	0.13121
Cytosolic DNA-sensing pathway	2635	155	30	2	2	0.036447	0.13121
C-type lectin receptor signaling pathway	2635	155	30	2	2	0.036447	0.13121
Hepatitis B	2635	155	30	8	4	0.045913	0.15496
JAK-STAT signaling pathway	2635	155	30	3	2	0.096002	0.30495
Osteoclast differentiation	2635	155	30	4	2	0.16888	0.34839
PD-L1 expression and PD-1 checkpoint pathway in cancer	2635	155	30	4	2	0.16888	0.34839
Glycolysis / Gluconeogenesis	2635	155	30	1	1	0.19355	0.34839
Galactose metabolism	2635	155	30	1	1	0.19355	0.34839
NF-kappa B signaling pathway	2635	155	30	1	1	0.19355	0.34839
Signaling pathways regulating pluripotency of stem cells	2635	155	30	1	1	0.19355	0.34839
Toll-like receptor signaling pathway	2635	155	30	1	1	0.19355	0.34839
Th1 and Th2 cell differentiation	2635	155	30	1	1	0.19355	0.34839
Prolactin signaling pathway	2635	155	30	1	1	0.19355	0.34839
AGE-RAGE signaling pathway in diabetic complications	2635	155	30	1	1	0.19355	0.34839
Growth hormone synthesis, secretion and action	2635	155	30	1	1	0.19355	0.34839
Pertussis	2635	155	30	1	1	0.19355	0.34839
Toxoplasmosis	2635	155	30	1	1	0.19355	0.34839
Viral life cycle - HIV-1	2635	155	30	5	2	0.24803	0.43205
Lysosome	2635	155	30	2	1	0.35065	0.47338
Apoptosis	2635	155	30	2	1	0.35065	0.47338
Apoptosis - multiple species	2635	155	30	2	1	0.35065	0.47338
Notch signaling pathway	2635	155	30	2	1	0.35065	0.47338
Cell adhesion molecules	2635	155	30	2	1	0.35065	0.47338
Complement and coagulation cascades	2635	155	30	2	1	0.35065	0.47338
Th17 cell differentiation	2635	155	30	2	1	0.35065	0.47338
Leishmaniasis	2635	155	30	2	1	0.35065	0.47338
Inflammatory bowel disease	2635	155	30	2	1	0.35065	0.47338
Thyroid hormone signaling pathway	2635	155	30	3	1	0.47797	0.61454
Pancreatic cancer	2635	155	30	3	1	0.47797	0.61454
Pathways in cancer	2635	155	30	9	2	0.54972	0.66754
Pyrimidine metabolism	2635	155	30	4	1	0.581	0.66754
Nucleotide metabolism	2635	155	30	4	1	0.581	0.66754
Biosynthesis of cofactors	2635	155	30	4	1	0.581	0.66754
Tuberculosis	2635	155	30	4	1	0.581	0.66754
Protein processing in endoplasmic reticulum	2635	155	30	6	1	0.7314	0.82282
Human immunodeficiency virus 1 infection	2635	155	30	7	1	0.78548	0.86563
Alzheimer disease	2635	155	30	8	1	0.82896	0.87773
Transcriptional misregulation in cancer	2635	155	30	8	1	0.82896	0.87773
Viral carcinogenesis	2635	155	30	13	1	0.94634	0.98273
Metabolic pathways	2635	155	30	24	2	0.97153	0.98393
Ribosome biogenesis in eukaryotes	2635	155	30	18	1	0.98393	0.98393
Protein processing in endoplasmic reticulum	2731	155	21	6	4	0.0032132	0.15745
Glutathione metabolism	2731	155	21	2	2	0.017595	0.28739
Intestinal immune network for IgA production	2731	155	21	2	2	0.017595	0.28739
Cytokine-cytokine receptor interaction	2731	155	21	3	2	0.048416	0.35078
p53 signaling pathway	2731	155	21	4	2	0.088868	0.35078
Purine metabolism	2731	155	21	1	1	0.13548	0.35078
Glycine, serine and threonine metabolism	2731	155	21	1	1	0.13548	0.35078
Glyoxylate and dicarboxylate metabolism	2731	155	21	1	1	0.13548	0.35078
Carbon metabolism	2731	155	21	1	1	0.13548	0.35078
Biosynthesis of nucleotide sugars	2731	155	21	1	1	0.13548	0.35078
Protein export	2731	155	21	1	1	0.13548	0.35078
Base excision repair	2731	155	21	1	1	0.13548	0.35078
Non-homologous end-joining	2731	155	21	1	1	0.13548	0.35078
Estrogen signaling pathway	2731	155	21	1	1	0.13548	0.35078
Thyroid hormone synthesis	2731	155	21	1	1	0.13548	0.35078
Oxytocin signaling pathway	2731	155	21	1	1	0.13548	0.35078
Pancreatic secretion	2731	155	21	1	1	0.13548	0.35078
Primary immunodeficiency	2731	155	21	1	1	0.13548	0.35078
Chemical carcinogenesis - receptor activation	2731	155	21	5	2	0.13602	0.35078
Metabolic pathways	2731	155	21	24	5	0.20331	0.38798
Oocyte meiosis	2731	155	21	7	2	0.24138	0.38798
Cellular senescence	2731	155	21	7	2	0.24138	0.38798
Progesterone-mediated oocyte maturation	2731	155	21	7	2	0.24138	0.38798
Amino sugar and nucleotide sugar metabolism	2731	155	21	2	1	0.25337	0.38798
Nicotinate and nicotinamide metabolism	2731	155	21	2	1	0.25337	0.38798
Folate biosynthesis	2731	155	21	2	1	0.25337	0.38798
Calcium signaling pathway	2731	155	21	2	1	0.25337	0.38798
IL-17 signaling pathway	2731	155	21	2	1	0.25337	0.38798
Th17 cell differentiation	2731	155	21	2	1	0.25337	0.38798
Salivary secretion	2731	155	21	2	1	0.25337	0.38798
Salmonella infection	2731	155	21	2	1	0.25337	0.38798
Fluid shear stress and atherosclerosis	2731	155	21	2	1	0.25337	0.38798
Cell cycle	2731	155	21	14	3	0.2893	0.42957
Drug metabolism - other enzymes	2731	155	21	3	1	0.35585	0.45886
Antifolate resistance	2731	155	21	3	1	0.35585	0.45886
PI3K-Akt signaling pathway	2731	155	21	3	1	0.35585	0.45886
Prostate cancer	2731	155	21	3	1	0.35585	0.45886
Lipid and atherosclerosis	2731	155	21	3	1	0.35585	0.45886
Pyrimidine metabolism	2731	155	21	4	1	0.44485	0.50692
Nucleotide metabolism	2731	155	21	4	1	0.44485	0.50692
Biosynthesis of cofactors	2731	155	21	4	1	0.44485	0.50692
DNA replication	2731	155	21	4	1	0.44485	0.50692
FoxO signaling pathway	2731	155	21	4	1	0.44485	0.50692
Viral life cycle - HIV-1	2731	155	21	5	1	0.52205	0.56846
Hematopoietic cell lineage	2731	155	21	5	1	0.52205	0.56846
Parkinson disease	2731	155	21	6	1	0.58896	0.62738
Pathways of neurodegeneration - multiple diseases	2731	155	21	7	1	0.6469	0.66037
Human immunodeficiency virus 1 infection	2731	155	21	7	1	0.6469	0.66037
Pathways in cancer	2731	155	21	9	1	0.74028	0.74028
Primary immunodeficiency	28834	155	2	1	1	0.012903	0.051278
Intestinal immune network for IgA production	28834	155	2	2	1	0.025723	0.051278
Cytokine-cytokine receptor interaction	28834	155	2	3	1	0.038458	0.051278
Protein processing in endoplasmic reticulum	28834	155	2	6	1	0.076163	0.076163
AMPK signaling pathway	29028	155	13	3	2	0.018666	0.33938
Cell cycle	29028	155	13	14	4	0.018842	0.33938
DNA replication	29028	155	13	4	2	0.035546	0.33938
Biosynthesis of unsaturated fatty acids	29028	155	13	1	1	0.083871	0.33938
Fatty acid metabolism	29028	155	13	1	1	0.083871	0.33938
Biosynthesis of nucleotide sugars	29028	155	13	1	1	0.083871	0.33938
Serotonergic synapse	29028	155	13	1	1	0.083871	0.33938
Pathogenic Escherichia coli infection	29028	155	13	1	1	0.083871	0.33938
Progesterone-mediated oocyte maturation	29028	155	13	7	2	0.10745	0.33938
Pathways of neurodegeneration - multiple diseases	29028	155	13	7	2	0.10745	0.33938
Alzheimer disease	29028	155	13	8	2	0.13646	0.33938
Amino sugar and nucleotide sugar metabolism	29028	155	13	2	1	0.16121	0.33938
One carbon pool by folate	29028	155	13	2	1	0.16121	0.33938
Folate biosynthesis	29028	155	13	2	1	0.16121	0.33938
Platinum drug resistance	29028	155	13	2	1	0.16121	0.33938
PPAR signaling pathway	29028	155	13	2	1	0.16121	0.33938
ECM-receptor interaction	29028	155	13	2	1	0.16121	0.33938
Alcoholic liver disease	29028	155	13	2	1	0.16121	0.33938
Salmonella infection	29028	155	13	2	1	0.16121	0.33938
Antifolate resistance	29028	155	13	3	1	0.23248	0.42268
Gap junction	29028	155	13	3	1	0.23248	0.42268
Acute myeloid leukemia	29028	155	13	3	1	0.23248	0.42268
Biosynthesis of cofactors	29028	155	13	4	1	0.29812	0.45865
Amyotrophic lateral sclerosis	29028	155	13	4	1	0.29812	0.45865
Huntington disease	29028	155	13	4	1	0.29812	0.45865
Prion disease	29028	155	13	4	1	0.29812	0.45865
Metabolic pathways	29028	155	13	24	3	0.32449	0.48073
Viral life cycle - HIV-1	29028	155	13	5	1	0.35855	0.49455
Phagosome	29028	155	13	5	1	0.35855	0.49455
Protein processing in endoplasmic reticulum	29028	155	13	6	1	0.41414	0.53437
Parkinson disease	29028	155	13	6	1	0.41414	0.53437
Oocyte meiosis	29028	155	13	7	1	0.46525	0.54736
Cellular senescence	29028	155	13	7	1	0.46525	0.54736
Human T-cell leukemia virus 1 infection	29028	155	13	7	1	0.46525	0.54736
Hepatitis B	29028	155	13	8	1	0.51223	0.56914
Transcriptional misregulation in cancer	29028	155	13	8	1	0.51223	0.56914
Pathways in cancer	29028	155	13	9	1	0.55536	0.60039
Human papillomavirus infection	29028	155	13	10	1	0.59495	0.62627
Epstein-Barr virus infection	29028	155	13	11	1	0.63127	0.64745
Viral carcinogenesis	29028	155	13	13	1	0.69505	0.69505
Cell cycle	29089	155	24	14	11	3.2386e-08	1.2955e-06
Oocyte meiosis	29089	155	24	7	6	4.8365e-05	0.00096731
p53 signaling pathway	29089	155	24	4	4	0.0004594	0.0061254
Cellular senescence	29089	155	24	7	5	0.001022	0.0081761
Progesterone-mediated oocyte maturation	29089	155	24	7	5	0.001022	0.0081761
Human T-cell leukemia virus 1 infection	29089	155	24	7	4	0.011489	0.052989
Pyrimidine metabolism	29089	155	24	4	3	0.011923	0.052989
Nucleotide metabolism	29089	155	24	4	3	0.011923	0.052989
DNA replication	29089	155	24	4	3	0.011923	0.052989
Platinum drug resistance	29089	155	24	2	2	0.023125	0.092501
Drug metabolism - other enzymes	29089	155	24	3	2	0.062725	0.22809
Human immunodeficiency virus 1 infection	29089	155	24	7	3	0.075286	0.25095
FoxO signaling pathway	29089	155	24	4	2	0.11353	0.29493
Ubiquitin mediated proteolysis	29089	155	24	4	2	0.11353	0.29493
MicroRNAs in cancer	29089	155	24	4	2	0.11353	0.29493
Purine metabolism	29089	155	24	1	1	0.15484	0.29493
Protein export	29089	155	24	1	1	0.15484	0.29493
Base excision repair	29089	155	24	1	1	0.15484	0.29493
Non-homologous end-joining	29089	155	24	1	1	0.15484	0.29493
Fanconi anemia pathway	29089	155	24	1	1	0.15484	0.29493
Hippo signaling pathway	29089	155	24	1	1	0.15484	0.29493
Chemical carcinogenesis - receptor activation	29089	155	24	5	2	0.1714	0.31163
Glutathione metabolism	29089	155	24	2	1	0.28655	0.39524
One carbon pool by folate	29089	155	24	2	1	0.28655	0.39524
MAPK signaling pathway	29089	155	24	2	1	0.28655	0.39524
Apoptosis	29089	155	24	2	1	0.28655	0.39524
Apoptosis - multiple species	29089	155	24	2	1	0.28655	0.39524
ECM-receptor interaction	29089	155	24	2	1	0.28655	0.39524
Colorectal cancer	29089	155	24	2	1	0.28655	0.39524
Viral carcinogenesis	29089	155	24	13	3	0.32449	0.43266
Hepatitis B	29089	155	24	8	2	0.35896	0.45539
Antifolate resistance	29089	155	24	3	1	0.39847	0.45539
AMPK signaling pathway	29089	155	24	3	1	0.39847	0.45539
Gap junction	29089	155	24	3	1	0.39847	0.45539
Acute myeloid leukemia	29089	155	24	3	1	0.39847	0.45539
Pathways in cancer	29089	155	24	9	2	0.41991	0.46656
Transcriptional misregulation in cancer	29089	155	24	8	1	0.74845	0.80473
Metabolic pathways	29089	155	24	24	3	0.7645	0.80473
Human papillomavirus infection	29089	155	24	10	1	0.82412	0.84525
Epstein-Barr virus infection	29089	155	24	11	1	0.85323	0.85323
Tuberculosis	29126	155	6	4	2	0.0072799	0.10253
PD-L1 expression and PD-1 checkpoint pathway in cancer	29126	155	6	4	2	0.0072799	0.10253
Hepatitis B	29126	155	6	8	2	0.031645	0.10253
NF-kappa B signaling pathway	29126	155	6	1	1	0.03871	0.10253
Toll-like receptor signaling pathway	29126	155	6	1	1	0.03871	0.10253
Th1 and Th2 cell differentiation	29126	155	6	1	1	0.03871	0.10253
Neurotrophin signaling pathway	29126	155	6	1	1	0.03871	0.10253
Prolactin signaling pathway	29126	155	6	1	1	0.03871	0.10253
AGE-RAGE signaling pathway in diabetic complications	29126	155	6	1	1	0.03871	0.10253
Growth hormone synthesis, secretion and action	29126	155	6	1	1	0.03871	0.10253
Toxoplasmosis	29126	155	6	1	1	0.03871	0.10253
Measles	29126	155	6	9	2	0.039966	0.10253
Herpes simplex virus 1 infection	29126	155	6	9	2	0.039966	0.10253
Influenza A	29126	155	6	10	2	0.04907	0.10253
Epstein-Barr virus infection	29126	155	6	11	2	0.058908	0.10253
Coronavirus disease - COVID-19	29126	155	6	11	2	0.058908	0.10253
Hepatitis C	29126	155	6	12	2	0.069428	0.10253
Chemokine signaling pathway	29126	155	6	2	1	0.076163	0.10253
Notch signaling pathway	29126	155	6	2	1	0.076163	0.10253
Cell adhesion molecules	29126	155	6	2	1	0.076163	0.10253
RIG-I-like receptor signaling pathway	29126	155	6	2	1	0.076163	0.10253
Cytosolic DNA-sensing pathway	29126	155	6	2	1	0.076163	0.10253
C-type lectin receptor signaling pathway	29126	155	6	2	1	0.076163	0.10253
Th17 cell differentiation	29126	155	6	2	1	0.076163	0.10253
Leishmaniasis	29126	155	6	2	1	0.076163	0.10253
Inflammatory bowel disease	29126	155	6	2	1	0.076163	0.10253
NOD-like receptor signaling pathway	29126	155	6	15	2	0.10462	0.13112
JAK-STAT signaling pathway	29126	155	6	3	1	0.11239	0.13112
Thyroid hormone signaling pathway	29126	155	6	3	1	0.11239	0.13112
Pancreatic cancer	29126	155	6	3	1	0.11239	0.13112
Necroptosis	29126	155	6	4	1	0.14743	0.15636
Osteoclast differentiation	29126	155	6	4	1	0.14743	0.15636
Kaposi sarcoma-associated herpesvirus infection	29126	155	6	4	1	0.14743	0.15636
Pathways in cancer	29126	155	6	9	1	0.30582	0.31482
Human papillomavirus infection	29126	155	6	10	1	0.33435	0.33435
Oxidative phosphorylation	29952	155	8	3	3	9.2002e-05	0.00073601
Thermogenesis	29952	155	8	3	3	9.2002e-05	0.00073601
Diabetic cardiomyopathy	29952	155	8	3	3	9.2002e-05	0.00073601
Metabolic pathways	29952	155	8	24	6	0.00017336	0.0010402
Amyotrophic lateral sclerosis	29952	155	8	4	3	0.00035893	0.0010768
Huntington disease	29952	155	8	4	3	0.00035893	0.0010768
Prion disease	29952	155	8	4	3	0.00035893	0.0010768
Chemical carcinogenesis - reactive oxygen species	29952	155	8	4	3	0.00035893	0.0010768
Parkinson disease	29952	155	8	6	3	0.0017067	0.0045512
Retrograde endocannabinoid signaling	29952	155	8	2	2	0.002346	0.0051186
Non-alcoholic fatty liver disease	29952	155	8	2	2	0.002346	0.0051186
Pathways of neurodegeneration - multiple diseases	29952	155	8	7	3	0.0029123	0.0058246
Alzheimer disease	29952	155	8	8	3	0.004543	0.0083872
Mucin type O-glycan biosynthesis	29952	155	8	1	1	0.051613	0.072865
Sphingolipid metabolism	29952	155	8	1	1	0.051613	0.072865
Pantothenate and CoA biosynthesis	29952	155	8	1	1	0.051613	0.072865
Renal cell carcinoma	29952	155	8	1	1	0.051613	0.072865
Nicotinate and nicotinamide metabolism	29952	155	8	2	1	0.10088	0.12743
HIF-1 signaling pathway	29952	155	8	2	1	0.10088	0.12743
Biosynthesis of cofactors	29952	155	8	4	1	0.19274	0.22027
Ubiquitin mediated proteolysis	29952	155	8	4	1	0.19274	0.22027
Hematopoietic cell lineage	29952	155	8	5	1	0.23551	0.25692
Human immunodeficiency virus 1 infection	29952	155	8	7	1	0.31514	0.32884
Pathways in cancer	29952	155	8	9	1	0.38742	0.38742
Viral carcinogenesis	3017	155	9	13	6	7.292e-06	8.4955e-05
Alcoholism	3017	155	9	8	5	9.4394e-06	8.4955e-05
Systemic lupus erythematosus	3017	155	9	10	5	4.0577e-05	0.00024346
Neutrophil extracellular trap formation	3017	155	9	13	5	0.00019331	0.0008699
Necroptosis	3017	155	9	4	2	0.01701	0.061237
Human papillomavirus infection	3017	155	9	10	2	0.10587	0.29086
Cytosolic DNA-sensing pathway	3017	155	9	2	1	0.11311	0.29086
Kaposi sarcoma-associated herpesvirus infection	3017	155	9	4	1	0.21471	0.48309
Viral life cycle - HIV-1	3017	155	9	5	1	0.26151	0.52292
Protein processing in endoplasmic reticulum	3017	155	9	6	1	0.30582	0.52292
Human immunodeficiency virus 1 infection	3017	155	9	7	1	0.34775	0.52292
Alzheimer disease	3017	155	9	8	1	0.38742	0.52292
Measles	3017	155	9	9	1	0.42492	0.52292
Herpes simplex virus 1 infection	3017	155	9	9	1	0.42492	0.52292
Influenza A	3017	155	9	10	1	0.46037	0.52292
Epstein-Barr virus infection	3017	155	9	11	1	0.49386	0.52292
Coronavirus disease - COVID-19	3017	155	9	11	1	0.49386	0.52292
Hepatitis C	3017	155	9	12	1	0.5255	0.5255
African trypanosomiasis	3039	155	3	3	3	1.6429e-06	1.6429e-06
Malaria	3039	155	3	3	3	1.6429e-06	1.6429e-06
African trypanosomiasis	3040	155	3	3	3	1.6429e-06	1.6429e-06
Malaria	3040	155	3	3	3	1.6429e-06	1.6429e-06
African trypanosomiasis	3043	155	3	3	3	1.6429e-06	1.6429e-06
Malaria	3043	155	3	3	3	1.6429e-06	1.6429e-06
Cell cycle	3161	155	24	14	11	3.2386e-08	1.3278e-06
Oocyte meiosis	3161	155	24	7	6	4.8365e-05	0.00099149
p53 signaling pathway	3161	155	24	4	4	0.0004594	0.0062785
Progesterone-mediated oocyte maturation	3161	155	24	7	5	0.001022	0.010476
Antifolate resistance	3161	155	24	3	3	0.0033252	0.027267
Cellular senescence	3161	155	24	7	4	0.011489	0.061103
Human T-cell leukemia virus 1 infection	3161	155	24	7	4	0.011489	0.061103
DNA replication	3161	155	24	4	3	0.011923	0.061103
Glutathione metabolism	3161	155	24	2	2	0.023125	0.079011
One carbon pool by folate	3161	155	24	2	2	0.023125	0.079011
Folate biosynthesis	3161	155	24	2	2	0.023125	0.079011
Platinum drug resistance	3161	155	24	2	2	0.023125	0.079011
Human immunodeficiency virus 1 infection	3161	155	24	7	3	0.075286	0.23744
Pyrimidine metabolism	3161	155	24	4	2	0.11353	0.24498
Nucleotide metabolism	3161	155	24	4	2	0.11353	0.24498
Biosynthesis of cofactors	3161	155	24	4	2	0.11353	0.24498
FoxO signaling pathway	3161	155	24	4	2	0.11353	0.24498
Ubiquitin mediated proteolysis	3161	155	24	4	2	0.11353	0.24498
MicroRNAs in cancer	3161	155	24	4	2	0.11353	0.24498
Purine metabolism	3161	155	24	1	1	0.15484	0.26452
Base excision repair	3161	155	24	1	1	0.15484	0.26452
Non-homologous end-joining	3161	155	24	1	1	0.15484	0.26452
Fanconi anemia pathway	3161	155	24	1	1	0.15484	0.26452
Hippo signaling pathway	3161	155	24	1	1	0.15484	0.26452
Chemical carcinogenesis - receptor activation	3161	155	24	5	2	0.1714	0.28109
MAPK signaling pathway	3161	155	24	2	1	0.28655	0.39162
Apoptosis	3161	155	24	2	1	0.28655	0.39162
Apoptosis - multiple species	3161	155	24	2	1	0.28655	0.39162
ECM-receptor interaction	3161	155	24	2	1	0.28655	0.39162
Colorectal cancer	3161	155	24	2	1	0.28655	0.39162
Viral carcinogenesis	3161	155	24	13	3	0.32449	0.42917
Hepatitis B	3161	155	24	8	2	0.35896	0.45381
Drug metabolism - other enzymes	3161	155	24	3	1	0.39847	0.45381
AMPK signaling pathway	3161	155	24	3	1	0.39847	0.45381
Gap junction	3161	155	24	3	1	0.39847	0.45381
Acute myeloid leukemia	3161	155	24	3	1	0.39847	0.45381
Pathways in cancer	3161	155	24	9	2	0.41991	0.4653
Metabolic pathways	3161	155	24	24	4	0.53258	0.57463
Transcriptional misregulation in cancer	3161	155	24	8	1	0.74845	0.78684
Human papillomavirus infection	3161	155	24	10	1	0.82412	0.84473
Epstein-Barr virus infection	3161	155	24	11	1	0.85323	0.85323
Cell cycle	332	155	23	14	11	1.7912e-08	7.165e-07
Oocyte meiosis	332	155	23	7	6	3.6507e-05	0.00073014
p53 signaling pathway	332	155	23	4	4	0.00038284	0.0051045
Cellular senescence	332	155	23	7	5	0.00081917	0.0065534
Progesterone-mediated oocyte maturation	332	155	23	7	5	0.00081917	0.0065534
Human T-cell leukemia virus 1 infection	332	155	23	7	4	0.0097443	0.046621
Pyrimidine metabolism	332	155	23	4	3	0.01049	0.046621
Nucleotide metabolism	332	155	23	4	3	0.01049	0.046621
DNA replication	332	155	23	4	3	0.01049	0.046621
Drug metabolism - other enzymes	332	155	23	3	2	0.057775	0.2311
Human immunodeficiency virus 1 infection	332	155	23	7	3	0.067311	0.24477
FoxO signaling pathway	332	155	23	4	2	0.10506	0.29677
Ubiquitin mediated proteolysis	332	155	23	4	2	0.10506	0.29677
MicroRNAs in cancer	332	155	23	4	2	0.10506	0.29677
Purine metabolism	332	155	23	1	1	0.14839	0.29677
Base excision repair	332	155	23	1	1	0.14839	0.29677
Non-homologous end-joining	332	155	23	1	1	0.14839	0.29677
Fanconi anemia pathway	332	155	23	1	1	0.14839	0.29677
Hippo signaling pathway	332	155	23	1	1	0.14839	0.29677
Carbohydrate digestion and absorption	332	155	23	1	1	0.14839	0.29677
Chemical carcinogenesis - receptor activation	332	155	23	5	2	0.15934	0.30351
Glutathione metabolism	332	155	23	2	1	0.27558	0.3801
One carbon pool by folate	332	155	23	2	1	0.27558	0.3801
Platinum drug resistance	332	155	23	2	1	0.27558	0.3801
MAPK signaling pathway	332	155	23	2	1	0.27558	0.3801
Apoptosis	332	155	23	2	1	0.27558	0.3801
Apoptosis - multiple species	332	155	23	2	1	0.27558	0.3801
ECM-receptor interaction	332	155	23	2	1	0.27558	0.3801
Colorectal cancer	332	155	23	2	1	0.27558	0.3801
Viral carcinogenesis	332	155	23	13	3	0.29892	0.39856
Hepatitis B	332	155	23	8	2	0.33806	0.43621
Antifolate resistance	332	155	23	3	1	0.38448	0.4394
AMPK signaling pathway	332	155	23	3	1	0.38448	0.4394
Gap junction	332	155	23	3	1	0.38448	0.4394
Acute myeloid leukemia	332	155	23	3	1	0.38448	0.4394
Pathways in cancer	332	155	23	9	2	0.39705	0.44117
Transcriptional misregulation in cancer	332	155	23	8	1	0.73223	0.77422
Metabolic pathways	332	155	23	24	3	0.73551	0.77422
Human papillomavirus infection	332	155	23	10	1	0.80971	0.83047
Epstein-Barr virus infection	332	155	23	11	1	0.83989	0.83989
Hepatitis C	3429	155	11	12	6	2.047e-05	0.00036846
Influenza A	3429	155	11	10	5	0.00014045	0.0012641
Measles	3429	155	11	9	4	0.0014859	0.0089155
Coronavirus disease - COVID-19	3429	155	11	11	4	0.0036024	0.016211
Herpes simplex virus 1 infection	3429	155	11	9	3	0.017856	0.06428
Epstein-Barr virus infection	3429	155	11	11	3	0.032319	0.096956
Pertussis	3429	155	11	1	1	0.070968	0.17008
NOD-like receptor signaling pathway	3429	155	11	15	3	0.075591	0.17008
Cell adhesion molecules	3429	155	11	2	1	0.13733	0.22472
Complement and coagulation cascades	3429	155	11	2	1	0.13733	0.22472
Cytosolic DNA-sensing pathway	3429	155	11	2	1	0.13733	0.22472
Human papillomavirus infection	3429	155	11	10	2	0.15066	0.226
Pyrimidine metabolism	3429	155	11	4	1	0.25729	0.28945
Nucleotide metabolism	3429	155	11	4	1	0.25729	0.28945
Biosynthesis of cofactors	3429	155	11	4	1	0.25729	0.28945
Necroptosis	3429	155	11	4	1	0.25729	0.28945
Viral life cycle - HIV-1	3429	155	11	5	1	0.3114	0.32971
Metabolic pathways	3429	155	11	24	1	0.85323	0.85323
Influenza A	3433	155	29	10	10	1.2214e-08	6.5957e-07
Measles	3433	155	29	9	9	8.9165e-08	2.4074e-06
Hepatitis C	3433	155	29	12	10	6.2509e-07	1.1252e-05
Coronavirus disease - COVID-19	3433	155	29	11	9	3.7669e-06	5.0853e-05
Herpes simplex virus 1 infection	3433	155	29	9	8	4.9041e-06	5.2964e-05
NOD-like receptor signaling pathway	3433	155	29	15	9	0.00020063	0.0018057
Epstein-Barr virus infection	3433	155	29	11	7	0.00079109	0.0061027
Necroptosis	3433	155	29	4	4	0.0010268	0.0069312
Human papillomavirus infection	3433	155	29	10	5	0.020916	0.11303
Kaposi sarcoma-associated herpesvirus infection	3433	155	29	4	3	0.020932	0.11303
RNA degradation	3433	155	29	2	2	0.034018	0.12246
Chemokine signaling pathway	3433	155	29	2	2	0.034018	0.12246
RIG-I-like receptor signaling pathway	3433	155	29	2	2	0.034018	0.12246
Cytosolic DNA-sensing pathway	3433	155	29	2	2	0.034018	0.12246
C-type lectin receptor signaling pathway	3433	155	29	2	2	0.034018	0.12246
Hepatitis B	3433	155	29	8	4	0.040764	0.13758
JAK-STAT signaling pathway	3433	155	29	3	2	0.090047	0.28603
Osteoclast differentiation	3433	155	29	4	2	0.15916	0.33677
PD-L1 expression and PD-1 checkpoint pathway in cancer	3433	155	29	4	2	0.15916	0.33677
Glycolysis / Gluconeogenesis	3433	155	29	1	1	0.1871	0.33677
Galactose metabolism	3433	155	29	1	1	0.1871	0.33677
NF-kappa B signaling pathway	3433	155	29	1	1	0.1871	0.33677
Signaling pathways regulating pluripotency of stem cells	3433	155	29	1	1	0.1871	0.33677
Toll-like receptor signaling pathway	3433	155	29	1	1	0.1871	0.33677
Th1 and Th2 cell differentiation	3433	155	29	1	1	0.1871	0.33677
Prolactin signaling pathway	3433	155	29	1	1	0.1871	0.33677
AGE-RAGE signaling pathway in diabetic complications	3433	155	29	1	1	0.1871	0.33677
Growth hormone synthesis, secretion and action	3433	155	29	1	1	0.1871	0.33677
Pertussis	3433	155	29	1	1	0.1871	0.33677
Toxoplasmosis	3433	155	29	1	1	0.1871	0.33677
Viral life cycle - HIV-1	3433	155	29	5	2	0.23484	0.40907
Lysosome	3433	155	29	2	1	0.34018	0.49647
Notch signaling pathway	3433	155	29	2	1	0.34018	0.49647
Complement and coagulation cascades	3433	155	29	2	1	0.34018	0.49647
Th17 cell differentiation	3433	155	29	2	1	0.34018	0.49647
Leishmaniasis	3433	155	29	2	1	0.34018	0.49647
Inflammatory bowel disease	3433	155	29	2	1	0.34018	0.49647
Thyroid hormone signaling pathway	3433	155	29	3	1	0.46524	0.64418
Pancreatic cancer	3433	155	29	3	1	0.46524	0.64418
Pathways in cancer	3433	155	29	9	2	0.52913	0.69619
Pyrimidine metabolism	3433	155	29	4	1	0.56727	0.69619
Nucleotide metabolism	3433	155	29	4	1	0.56727	0.69619
Biosynthesis of cofactors	3433	155	29	4	1	0.56727	0.69619
Tuberculosis	3433	155	29	4	1	0.56727	0.69619
Protein processing in endoplasmic reticulum	3433	155	29	6	1	0.71797	0.86156
Viral carcinogenesis	3433	155	29	13	2	0.74228	0.87137
Human immunodeficiency virus 1 infection	3433	155	29	7	1	0.77286	0.88276
Alzheimer disease	3433	155	29	8	1	0.81737	0.88276
Alcoholism	3433	155	29	8	1	0.81737	0.88276
Transcriptional misregulation in cancer	3433	155	29	8	1	0.81737	0.88276
Systemic lupus erythematosus	3433	155	29	10	1	0.88252	0.93443
Neutrophil extracellular trap formation	3433	155	29	13	1	0.94016	0.97632
Metabolic pathways	3433	155	29	24	2	0.96614	0.98126
Ribosome biogenesis in eukaryotes	3433	155	29	18	1	0.98126	0.98126
Influenza A	3434	155	27	10	10	5.1445e-09	2.6237e-07
Measles	3434	155	27	9	9	4.1727e-08	1.064e-06
Hepatitis C	3434	155	27	12	10	2.7084e-07	4.6043e-06
Coronavirus disease - COVID-19	3434	155	27	11	9	1.8128e-06	2.3114e-05
Herpes simplex virus 1 infection	3434	155	27	9	8	2.5717e-06	2.6232e-05
NOD-like receptor signaling pathway	3434	155	27	15	9	0.00010217	0.00086849
Epstein-Barr virus infection	3434	155	27	11	7	0.00047513	0.0034616
Necroptosis	3434	155	27	4	4	0.00075875	0.0048371
Human papillomavirus infection	3434	155	27	10	5	0.015146	0.085829
Kaposi sarcoma-associated herpesvirus infection	3434	155	27	4	3	0.016946	0.086422
Chemokine signaling pathway	3434	155	27	2	2	0.029409	0.10713
RIG-I-like receptor signaling pathway	3434	155	27	2	2	0.029409	0.10713
Cytosolic DNA-sensing pathway	3434	155	27	2	2	0.029409	0.10713
C-type lectin receptor signaling pathway	3434	155	27	2	2	0.029409	0.10713
Hepatitis B	3434	155	27	8	4	0.0316	0.10744
JAK-STAT signaling pathway	3434	155	27	3	2	0.078617	0.25059
Osteoclast differentiation	3434	155	27	4	2	0.14029	0.31728
PD-L1 expression and PD-1 checkpoint pathway in cancer	3434	155	27	4	2	0.14029	0.31728
Glycolysis / Gluconeogenesis	3434	155	27	1	1	0.17419	0.31728
Galactose metabolism	3434	155	27	1	1	0.17419	0.31728
NF-kappa B signaling pathway	3434	155	27	1	1	0.17419	0.31728
Toll-like receptor signaling pathway	3434	155	27	1	1	0.17419	0.31728
Th1 and Th2 cell differentiation	3434	155	27	1	1	0.17419	0.31728
Prolactin signaling pathway	3434	155	27	1	1	0.17419	0.31728
AGE-RAGE signaling pathway in diabetic complications	3434	155	27	1	1	0.17419	0.31728
Growth hormone synthesis, secretion and action	3434	155	27	1	1	0.17419	0.31728
Pertussis	3434	155	27	1	1	0.17419	0.31728
Toxoplasmosis	3434	155	27	1	1	0.17419	0.31728
Viral life cycle - HIV-1	3434	155	27	5	2	0.2089	0.36738
Lysosome	3434	155	27	2	1	0.31898	0.4281
Apoptosis	3434	155	27	2	1	0.31898	0.4281
Apoptosis - multiple species	3434	155	27	2	1	0.31898	0.4281
Notch signaling pathway	3434	155	27	2	1	0.31898	0.4281
Cell adhesion molecules	3434	155	27	2	1	0.31898	0.4281
Complement and coagulation cascades	3434	155	27	2	1	0.31898	0.4281
Th17 cell differentiation	3434	155	27	2	1	0.31898	0.4281
Leishmaniasis	3434	155	27	2	1	0.31898	0.4281
Inflammatory bowel disease	3434	155	27	2	1	0.31898	0.4281
Thyroid hormone signaling pathway	3434	155	27	3	1	0.43916	0.55993
Pancreatic cancer	3434	155	27	3	1	0.43916	0.55993
Pathways in cancer	3434	155	27	9	2	0.4866	0.60529
Pyrimidine metabolism	3434	155	27	4	1	0.53878	0.61062
Nucleotide metabolism	3434	155	27	4	1	0.53878	0.61062
Biosynthesis of cofactors	3434	155	27	4	1	0.53878	0.61062
Tuberculosis	3434	155	27	4	1	0.53878	0.61062
Protein processing in endoplasmic reticulum	3434	155	27	6	1	0.68943	0.76436
Human immunodeficiency virus 1 infection	3434	155	27	7	1	0.7457	0.80917
Alzheimer disease	3434	155	27	8	1	0.7921	0.82443
Transcriptional misregulation in cancer	3434	155	27	8	1	0.7921	0.82443
Viral carcinogenesis	3434	155	27	13	1	0.9258	0.94432
Metabolic pathways	3434	155	27	24	2	0.9525	0.9525
Influenza A	3437	155	27	10	10	5.1445e-09	2.6237e-07
Measles	3437	155	27	9	9	4.1727e-08	1.064e-06
Hepatitis C	3437	155	27	12	10	2.7084e-07	4.6043e-06
Coronavirus disease - COVID-19	3437	155	27	11	9	1.8128e-06	2.3114e-05
Herpes simplex virus 1 infection	3437	155	27	9	8	2.5717e-06	2.6232e-05
NOD-like receptor signaling pathway	3437	155	27	15	9	0.00010217	0.00086849
Epstein-Barr virus infection	3437	155	27	11	7	0.00047513	0.0034616
Necroptosis	3437	155	27	4	4	0.00075875	0.0048371
Human papillomavirus infection	3437	155	27	10	5	0.015146	0.085829
Kaposi sarcoma-associated herpesvirus infection	3437	155	27	4	3	0.016946	0.086422
Chemokine signaling pathway	3437	155	27	2	2	0.029409	0.10713
RIG-I-like receptor signaling pathway	3437	155	27	2	2	0.029409	0.10713
Cytosolic DNA-sensing pathway	3437	155	27	2	2	0.029409	0.10713
C-type lectin receptor signaling pathway	3437	155	27	2	2	0.029409	0.10713
Hepatitis B	3437	155	27	8	4	0.0316	0.10744
JAK-STAT signaling pathway	3437	155	27	3	2	0.078617	0.25059
Osteoclast differentiation	3437	155	27	4	2	0.14029	0.31728
PD-L1 expression and PD-1 checkpoint pathway in cancer	3437	155	27	4	2	0.14029	0.31728
Glycolysis / Gluconeogenesis	3437	155	27	1	1	0.17419	0.31728
Galactose metabolism	3437	155	27	1	1	0.17419	0.31728
NF-kappa B signaling pathway	3437	155	27	1	1	0.17419	0.31728
Toll-like receptor signaling pathway	3437	155	27	1	1	0.17419	0.31728
Th1 and Th2 cell differentiation	3437	155	27	1	1	0.17419	0.31728
Prolactin signaling pathway	3437	155	27	1	1	0.17419	0.31728
AGE-RAGE signaling pathway in diabetic complications	3437	155	27	1	1	0.17419	0.31728
Growth hormone synthesis, secretion and action	3437	155	27	1	1	0.17419	0.31728
Pertussis	3437	155	27	1	1	0.17419	0.31728
Toxoplasmosis	3437	155	27	1	1	0.17419	0.31728
Viral life cycle - HIV-1	3437	155	27	5	2	0.2089	0.36738
Lysosome	3437	155	27	2	1	0.31898	0.4281
Apoptosis	3437	155	27	2	1	0.31898	0.4281
Apoptosis - multiple species	3437	155	27	2	1	0.31898	0.4281
Notch signaling pathway	3437	155	27	2	1	0.31898	0.4281
Cell adhesion molecules	3437	155	27	2	1	0.31898	0.4281
Complement and coagulation cascades	3437	155	27	2	1	0.31898	0.4281
Th17 cell differentiation	3437	155	27	2	1	0.31898	0.4281
Leishmaniasis	3437	155	27	2	1	0.31898	0.4281
Inflammatory bowel disease	3437	155	27	2	1	0.31898	0.4281
Thyroid hormone signaling pathway	3437	155	27	3	1	0.43916	0.55993
Pancreatic cancer	3437	155	27	3	1	0.43916	0.55993
Pathways in cancer	3437	155	27	9	2	0.4866	0.60529
Pyrimidine metabolism	3437	155	27	4	1	0.53878	0.61062
Nucleotide metabolism	3437	155	27	4	1	0.53878	0.61062
Biosynthesis of cofactors	3437	155	27	4	1	0.53878	0.61062
Tuberculosis	3437	155	27	4	1	0.53878	0.61062
Protein processing in endoplasmic reticulum	3437	155	27	6	1	0.68943	0.76436
Human immunodeficiency virus 1 infection	3437	155	27	7	1	0.7457	0.80917
Alzheimer disease	3437	155	27	8	1	0.7921	0.82443
Transcriptional misregulation in cancer	3437	155	27	8	1	0.7921	0.82443
Viral carcinogenesis	3437	155	27	13	1	0.9258	0.94432
Metabolic pathways	3437	155	27	24	2	0.9525	0.9525
Oxidative phosphorylation	348262	155	16	3	3	0.00092002	0.0098305
Thermogenesis	348262	155	16	3	3	0.00092002	0.0098305
Diabetic cardiomyopathy	348262	155	16	3	3	0.00092002	0.0098305
Parkinson disease	348262	155	16	6	4	0.0010348	0.0098305
Pathways of neurodegeneration - multiple diseases	348262	155	16	7	4	0.0022602	0.014541
Amyotrophic lateral sclerosis	348262	155	16	4	3	0.003444	0.014541
Huntington disease	348262	155	16	4	3	0.003444	0.014541
Prion disease	348262	155	16	4	3	0.003444	0.014541
Chemical carcinogenesis - reactive oxygen species	348262	155	16	4	3	0.003444	0.014541
Alzheimer disease	348262	155	16	8	4	0.0042308	0.016077
Retrograde endocannabinoid signaling	348262	155	16	2	2	0.010054	0.031839
Non-alcoholic fatty liver disease	348262	155	16	2	2	0.010054	0.031839
Neuroactive ligand-receptor interaction	348262	155	16	3	2	0.028323	0.082791
Ubiquitin mediated proteolysis	348262	155	16	4	2	0.053203	0.14441
Metabolic pathways	348262	155	16	24	5	0.076995	0.1783
Mucin type O-glycan biosynthesis	348262	155	16	1	1	0.10323	0.1783
Sphingolipid metabolism	348262	155	16	1	1	0.10323	0.1783
Sphingolipid signaling pathway	348262	155	16	1	1	0.10323	0.1783
Glutamatergic synapse	348262	155	16	1	1	0.10323	0.1783
GABAergic synapse	348262	155	16	1	1	0.10323	0.1783
Epithelial cell signaling in Helicobacter pylori infection	348262	155	16	1	1	0.10323	0.1783
Renal cell carcinoma	348262	155	16	1	1	0.10323	0.1783
Nicotinate and nicotinamide metabolism	348262	155	16	2	1	0.1964	0.27641
HIF-1 signaling pathway	348262	155	16	2	1	0.1964	0.27641
Notch signaling pathway	348262	155	16	2	1	0.1964	0.27641
Protein digestion and absorption	348262	155	16	2	1	0.1964	0.27641
Cholesterol metabolism	348262	155	16	2	1	0.1964	0.27641
Thyroid hormone signaling pathway	348262	155	16	3	1	0.28043	0.38059
Biosynthesis of cofactors	348262	155	16	4	1	0.35618	0.45116
FoxO signaling pathway	348262	155	16	4	1	0.35618	0.45116
Hematopoietic cell lineage	348262	155	16	5	1	0.4244	0.52023
Oocyte meiosis	348262	155	16	7	1	0.54101	0.58738
Progesterone-mediated oocyte maturation	348262	155	16	7	1	0.54101	0.58738
Human T-cell leukemia virus 1 infection	348262	155	16	7	1	0.54101	0.58738
Human immunodeficiency virus 1 infection	348262	155	16	7	1	0.54101	0.58738
Pathways in cancer	348262	155	16	9	1	0.63519	0.67048
Coronavirus disease - COVID-19	348262	155	16	11	1	0.71101	0.73023
NOD-like receptor signaling pathway	348262	155	16	15	1	0.82054	0.82054
Intestinal immune network for IgA production	3493	155	6	2	2	0.0012568	0.0075408
Cytokine-cytokine receptor interaction	3493	155	6	3	2	0.0037047	0.011114
Protein processing in endoplasmic reticulum	3493	155	6	6	2	0.017567	0.035134
Protein export	3493	155	6	1	1	0.03871	0.046452
Primary immunodeficiency	3493	155	6	1	1	0.03871	0.046452
Cellular senescence	3493	155	6	7	1	0.2457	0.2457
Intestinal immune network for IgA production	3494	155	3	2	2	0.00025136	0.0010054
Cytokine-cytokine receptor interaction	3494	155	3	3	2	0.0007508	0.0015016
Primary immunodeficiency	3494	155	3	1	1	0.019355	0.025806
Protein processing in endoplasmic reticulum	3494	155	3	6	1	0.11239	0.11239
Intestinal immune network for IgA production	3500	155	8	2	2	0.002346	0.028152
Cytokine-cytokine receptor interaction	3500	155	8	3	2	0.0068541	0.041125
Protein processing in endoplasmic reticulum	3500	155	8	6	2	0.031645	0.077419
Glycine, serine and threonine metabolism	3500	155	8	1	1	0.051613	0.077419
Glyoxylate and dicarboxylate metabolism	3500	155	8	1	1	0.051613	0.077419
Carbon metabolism	3500	155	8	1	1	0.051613	0.077419
Protein export	3500	155	8	1	1	0.051613	0.077419
Primary immunodeficiency	3500	155	8	1	1	0.051613	0.077419
Parkinson disease	3500	155	8	6	1	0.27628	0.34379
Cellular senescence	3500	155	8	7	1	0.31514	0.34379
Pathways of neurodegeneration - multiple diseases	3500	155	8	7	1	0.31514	0.34379
Metabolic pathways	3500	155	8	24	1	0.74845	0.74845
Intestinal immune network for IgA production	3501	155	5	2	2	0.00083787	0.0041894
Cytokine-cytokine receptor interaction	3501	155	5	3	2	0.0024808	0.0062019
Protein processing in endoplasmic reticulum	3501	155	5	6	2	0.011921	0.019868
Primary immunodeficiency	3501	155	5	1	1	0.032258	0.040323
Cellular senescence	3501	155	5	7	1	0.20878	0.20878
Intestinal immune network for IgA production	3502	155	10	2	2	0.0037704	0.067868
Cytokine-cytokine receptor interaction	3502	155	10	3	2	0.010917	0.098253
Protein processing in endoplasmic reticulum	3502	155	10	6	2	0.04907	0.14516
Glycine, serine and threonine metabolism	3502	155	10	1	1	0.064516	0.14516
Glyoxylate and dicarboxylate metabolism	3502	155	10	1	1	0.064516	0.14516
Carbon metabolism	3502	155	10	1	1	0.064516	0.14516
Protein export	3502	155	10	1	1	0.064516	0.14516
Primary immunodeficiency	3502	155	10	1	1	0.064516	0.14516
Cell cycle	3502	155	10	14	2	0.22414	0.4252
Ubiquitin mediated proteolysis	3502	155	10	4	1	0.23622	0.4252
Chemical carcinogenesis - receptor activation	3502	155	10	5	1	0.2868	0.4264
Parkinson disease	3502	155	10	6	1	0.33435	0.4264
Oocyte meiosis	3502	155	10	7	1	0.37902	0.4264
Cellular senescence	3502	155	10	7	1	0.37902	0.4264
Pathways of neurodegeneration - multiple diseases	3502	155	10	7	1	0.37902	0.4264
Human T-cell leukemia virus 1 infection	3502	155	10	7	1	0.37902	0.4264
Viral carcinogenesis	3502	155	10	13	1	0.59495	0.62995
Metabolic pathways	3502	155	10	24	1	0.82412	0.82412
Intestinal immune network for IgA production	3503	155	8	2	2	0.002346	0.028152
Cytokine-cytokine receptor interaction	3503	155	8	3	2	0.0068541	0.041125
Protein processing in endoplasmic reticulum	3503	155	8	6	2	0.031645	0.077419
Glycine, serine and threonine metabolism	3503	155	8	1	1	0.051613	0.077419
Glyoxylate and dicarboxylate metabolism	3503	155	8	1	1	0.051613	0.077419
Carbon metabolism	3503	155	8	1	1	0.051613	0.077419
Protein export	3503	155	8	1	1	0.051613	0.077419
Primary immunodeficiency	3503	155	8	1	1	0.051613	0.077419
Parkinson disease	3503	155	8	6	1	0.27628	0.34379
Cellular senescence	3503	155	8	7	1	0.31514	0.34379
Pathways of neurodegeneration - multiple diseases	3503	155	8	7	1	0.31514	0.34379
Metabolic pathways	3503	155	8	24	1	0.74845	0.74845
Intestinal immune network for IgA production	3507	155	7	2	2	0.0017595	0.012317
Cytokine-cytokine receptor interaction	3507	155	7	3	2	0.0051636	0.018073
Protein processing in endoplasmic reticulum	3507	155	7	6	2	0.02416	0.056374
Protein export	3507	155	7	1	1	0.045161	0.063226
Primary immunodeficiency	3507	155	7	1	1	0.045161	0.063226
Th17 cell differentiation	3507	155	7	2	1	0.088563	0.10332
Cellular senescence	3507	155	7	7	1	0.28114	0.28114
Pathways of neurodegeneration - multiple diseases	351	155	13	7	3	0.013425	0.27845
Gap junction	351	155	13	3	2	0.018666	0.27845
Alzheimer disease	351	155	13	8	3	0.020413	0.27845
Parkinson disease	351	155	13	6	2	0.080584	0.27845
EGFR tyrosine kinase inhibitor resistance	351	155	13	1	1	0.083871	0.27845
ErbB signaling pathway	351	155	13	1	1	0.083871	0.27845
Ras signaling pathway	351	155	13	1	1	0.083871	0.27845
Phospholipase D signaling pathway	351	155	13	1	1	0.083871	0.27845
Serotonergic synapse	351	155	13	1	1	0.083871	0.27845
Insulin signaling pathway	351	155	13	1	1	0.083871	0.27845
Epithelial cell signaling in Helicobacter pylori infection	351	155	13	1	1	0.083871	0.27845
Pathogenic Escherichia coli infection	351	155	13	1	1	0.083871	0.27845
Endometrial cancer	351	155	13	1	1	0.083871	0.27845
Choline metabolism in cancer	351	155	13	1	1	0.083871	0.27845
One carbon pool by folate	351	155	13	2	1	0.16121	0.27845
Folate biosynthesis	351	155	13	2	1	0.16121	0.27845
RNA degradation	351	155	13	2	1	0.16121	0.27845
MAPK signaling pathway	351	155	13	2	1	0.16121	0.27845
Rap1 signaling pathway	351	155	13	2	1	0.16121	0.27845
Calcium signaling pathway	351	155	13	2	1	0.16121	0.27845
HIF-1 signaling pathway	351	155	13	2	1	0.16121	0.27845
Notch signaling pathway	351	155	13	2	1	0.16121	0.27845
Focal adhesion	351	155	13	2	1	0.16121	0.27845
Complement and coagulation cascades	351	155	13	2	1	0.16121	0.27845
Regulation of actin cytoskeleton	351	155	13	2	1	0.16121	0.27845
Salmonella infection	351	155	13	2	1	0.16121	0.27845
Colorectal cancer	351	155	13	2	1	0.16121	0.27845
Glioma	351	155	13	2	1	0.16121	0.27845
Melanoma	351	155	13	2	1	0.16121	0.27845
Bladder cancer	351	155	13	2	1	0.16121	0.27845
Non-small cell lung cancer	351	155	13	2	1	0.16121	0.27845
Breast cancer	351	155	13	2	1	0.16121	0.27845
Gastric cancer	351	155	13	2	1	0.16121	0.27845
Coronavirus disease - COVID-19	351	155	13	11	2	0.23181	0.33128
Antifolate resistance	351	155	13	3	1	0.23248	0.33128
PI3K-Akt signaling pathway	351	155	13	3	1	0.23248	0.33128
JAK-STAT signaling pathway	351	155	13	3	1	0.23248	0.33128
Thyroid hormone signaling pathway	351	155	13	3	1	0.23248	0.33128
Pancreatic cancer	351	155	13	3	1	0.23248	0.33128
Prostate cancer	351	155	13	3	1	0.23248	0.33128
Biosynthesis of cofactors	351	155	13	4	1	0.29812	0.35402
FoxO signaling pathway	351	155	13	4	1	0.29812	0.35402
Ubiquitin mediated proteolysis	351	155	13	4	1	0.29812	0.35402
Amyotrophic lateral sclerosis	351	155	13	4	1	0.29812	0.35402
Huntington disease	351	155	13	4	1	0.29812	0.35402
Prion disease	351	155	13	4	1	0.29812	0.35402
Chemical carcinogenesis - reactive oxygen species	351	155	13	4	1	0.29812	0.35402
PD-L1 expression and PD-1 checkpoint pathway in cancer	351	155	13	4	1	0.29812	0.35402
Phagosome	351	155	13	5	1	0.35855	0.40874
Chemical carcinogenesis - receptor activation	351	155	13	5	1	0.35855	0.40874
Protein processing in endoplasmic reticulum	351	155	13	6	1	0.41414	0.46286
Oocyte meiosis	351	155	13	7	1	0.46525	0.50037
Progesterone-mediated oocyte maturation	351	155	13	7	1	0.46525	0.50037
Pathways in cancer	351	155	13	9	1	0.55536	0.58622
Human papillomavirus infection	351	155	13	10	1	0.59495	0.61659
Hepatitis C	351	155	13	12	1	0.66456	0.67642
Metabolic pathways	351	155	13	24	1	0.89822	0.89822
Protein processing in endoplasmic reticulum	3512	155	15	6	4	0.0007849	0.022762
Intestinal immune network for IgA production	3512	155	15	2	2	0.0087977	0.12757
Cytokine-cytokine receptor interaction	3512	155	15	3	2	0.024898	0.23387
Chemical carcinogenesis - receptor activation	3512	155	15	5	2	0.073894	0.23387
Glycine, serine and threonine metabolism	3512	155	15	1	1	0.096774	0.23387
Glyoxylate and dicarboxylate metabolism	3512	155	15	1	1	0.096774	0.23387
Carbon metabolism	3512	155	15	1	1	0.096774	0.23387
Biosynthesis of nucleotide sugars	3512	155	15	1	1	0.096774	0.23387
Protein export	3512	155	15	1	1	0.096774	0.23387
Estrogen signaling pathway	3512	155	15	1	1	0.096774	0.23387
Thyroid hormone synthesis	3512	155	15	1	1	0.096774	0.23387
Primary immunodeficiency	3512	155	15	1	1	0.096774	0.23387
Glutathione metabolism	3512	155	15	2	1	0.18475	0.29765
Amino sugar and nucleotide sugar metabolism	3512	155	15	2	1	0.18475	0.29765
IL-17 signaling pathway	3512	155	15	2	1	0.18475	0.29765
Th17 cell differentiation	3512	155	15	2	1	0.18475	0.29765
Salmonella infection	3512	155	15	2	1	0.18475	0.29765
Fluid shear stress and atherosclerosis	3512	155	15	2	1	0.18475	0.29765
PI3K-Akt signaling pathway	3512	155	15	3	1	0.26468	0.36551
Prostate cancer	3512	155	15	3	1	0.26468	0.36551
Lipid and atherosclerosis	3512	155	15	3	1	0.26468	0.36551
Cell cycle	3512	155	15	14	2	0.40316	0.52861
Metabolic pathways	3512	155	15	24	3	0.41925	0.52861
Parkinson disease	3512	155	15	6	1	0.46277	0.53531
Oocyte meiosis	3512	155	15	7	1	0.51685	0.53531
Cellular senescence	3512	155	15	7	1	0.51685	0.53531
Progesterone-mediated oocyte maturation	3512	155	15	7	1	0.51685	0.53531
Pathways of neurodegeneration - multiple diseases	3512	155	15	7	1	0.51685	0.53531
Pathways in cancer	3512	155	15	9	1	0.61013	0.61013
Intestinal immune network for IgA production	3514	155	7	2	2	0.0017595	0.017595
Cytokine-cytokine receptor interaction	3514	155	7	3	2	0.0051636	0.025818
Protein processing in endoplasmic reticulum	3514	155	7	6	2	0.02416	0.056452
Glycine, serine and threonine metabolism	3514	155	7	1	1	0.045161	0.056452
Glyoxylate and dicarboxylate metabolism	3514	155	7	1	1	0.045161	0.056452
Carbon metabolism	3514	155	7	1	1	0.045161	0.056452
Protein export	3514	155	7	1	1	0.045161	0.056452
Primary immunodeficiency	3514	155	7	1	1	0.045161	0.056452
Cellular senescence	3514	155	7	7	1	0.28114	0.31238
Metabolic pathways	3514	155	7	24	1	0.69977	0.69977
Intestinal immune network for IgA production	3537	155	6	2	2	0.0012568	0.0075408
Cytokine-cytokine receptor interaction	3537	155	6	3	2	0.0037047	0.011114
Protein processing in endoplasmic reticulum	3537	155	6	6	2	0.017567	0.035134
Protein export	3537	155	6	1	1	0.03871	0.046452
Primary immunodeficiency	3537	155	6	1	1	0.03871	0.046452
Cellular senescence	3537	155	6	7	1	0.2457	0.2457
Intestinal immune network for IgA production	3538	155	7	2	2	0.0017595	0.017595
Cytokine-cytokine receptor interaction	3538	155	7	3	2	0.0051636	0.025818
Protein processing in endoplasmic reticulum	3538	155	7	6	2	0.02416	0.056452
Glycine, serine and threonine metabolism	3538	155	7	1	1	0.045161	0.056452
Glyoxylate and dicarboxylate metabolism	3538	155	7	1	1	0.045161	0.056452
Carbon metabolism	3538	155	7	1	1	0.045161	0.056452
Protein export	3538	155	7	1	1	0.045161	0.056452
Primary immunodeficiency	3538	155	7	1	1	0.045161	0.056452
Cellular senescence	3538	155	7	7	1	0.28114	0.31238
Metabolic pathways	3538	155	7	24	1	0.69977	0.69977
Intestinal immune network for IgA production	3539	155	7	2	2	0.0017595	0.017595
Cytokine-cytokine receptor interaction	3539	155	7	3	2	0.0051636	0.025818
Protein processing in endoplasmic reticulum	3539	155	7	6	2	0.02416	0.056452
Glycine, serine and threonine metabolism	3539	155	7	1	1	0.045161	0.056452
Glyoxylate and dicarboxylate metabolism	3539	155	7	1	1	0.045161	0.056452
Carbon metabolism	3539	155	7	1	1	0.045161	0.056452
Protein export	3539	155	7	1	1	0.045161	0.056452
Primary immunodeficiency	3539	155	7	1	1	0.045161	0.056452
Cellular senescence	3539	155	7	7	1	0.28114	0.31238
Metabolic pathways	3539	155	7	24	1	0.69977	0.69977
Neurotrophin signaling pathway	3656	155	6	1	1	0.03871	0.27926
Glutamatergic synapse	3656	155	6	1	1	0.03871	0.27926
GABAergic synapse	3656	155	6	1	1	0.03871	0.27926
RNA degradation	3656	155	6	2	1	0.076163	0.27926
Cell adhesion molecules	3656	155	6	2	1	0.076163	0.27926
Protein digestion and absorption	3656	155	6	2	1	0.076163	0.27926
Necroptosis	3656	155	6	4	1	0.14743	0.32434
Tuberculosis	3656	155	6	4	1	0.14743	0.32434
Kaposi sarcoma-associated herpesvirus infection	3656	155	6	4	1	0.14743	0.32434
PD-L1 expression and PD-1 checkpoint pathway in cancer	3656	155	6	4	1	0.14743	0.32434
Viral life cycle - HIV-1	3656	155	6	5	1	0.18131	0.36261
Protein processing in endoplasmic reticulum	3656	155	6	6	1	0.21405	0.39243
Human immunodeficiency virus 1 infection	3656	155	6	7	1	0.2457	0.39808
Alzheimer disease	3656	155	6	8	1	0.27628	0.39808
Measles	3656	155	6	9	1	0.30582	0.39808
Herpes simplex virus 1 infection	3656	155	6	9	1	0.30582	0.39808
Influenza A	3656	155	6	10	1	0.33435	0.39808
Human papillomavirus infection	3656	155	6	10	1	0.33435	0.39808
Epstein-Barr virus infection	3656	155	6	11	1	0.36189	0.39808
Coronavirus disease - COVID-19	3656	155	6	11	1	0.36189	0.39808
Hepatitis C	3656	155	6	12	1	0.38848	0.40698
Viral carcinogenesis	3656	155	6	13	1	0.41414	0.41414
Protein processing in endoplasmic reticulum	3662	155	19	6	4	0.0021296	0.087315
DNA replication	3662	155	19	4	3	0.0058651	0.12023
Glutathione metabolism	3662	155	19	2	2	0.014328	0.14686
Intestinal immune network for IgA production	3662	155	19	2	2	0.014328	0.14686
Cytokine-cytokine receptor interaction	3662	155	19	3	2	0.039799	0.25129
Cell cycle	3662	155	19	14	4	0.072857	0.25129
Chemical carcinogenesis - receptor activation	3662	155	19	5	2	0.11388	0.25129
Purine metabolism	3662	155	19	1	1	0.12258	0.25129
Glycine, serine and threonine metabolism	3662	155	19	1	1	0.12258	0.25129
Glyoxylate and dicarboxylate metabolism	3662	155	19	1	1	0.12258	0.25129
Carbon metabolism	3662	155	19	1	1	0.12258	0.25129
Biosynthesis of nucleotide sugars	3662	155	19	1	1	0.12258	0.25129
Protein export	3662	155	19	1	1	0.12258	0.25129
Base excision repair	3662	155	19	1	1	0.12258	0.25129
Non-homologous end-joining	3662	155	19	1	1	0.12258	0.25129
Estrogen signaling pathway	3662	155	19	1	1	0.12258	0.25129
Thyroid hormone synthesis	3662	155	19	1	1	0.12258	0.25129
Oxytocin signaling pathway	3662	155	19	1	1	0.12258	0.25129
Pancreatic secretion	3662	155	19	1	1	0.12258	0.25129
Primary immunodeficiency	3662	155	19	1	1	0.12258	0.25129
Metabolic pathways	3662	155	19	24	5	0.1458	0.28465
Amino sugar and nucleotide sugar metabolism	3662	155	19	2	1	0.23083	0.32635
Nicotinate and nicotinamide metabolism	3662	155	19	2	1	0.23083	0.32635
Calcium signaling pathway	3662	155	19	2	1	0.23083	0.32635
IL-17 signaling pathway	3662	155	19	2	1	0.23083	0.32635
Th17 cell differentiation	3662	155	19	2	1	0.23083	0.32635
Salivary secretion	3662	155	19	2	1	0.23083	0.32635
Salmonella infection	3662	155	19	2	1	0.23083	0.32635
Fluid shear stress and atherosclerosis	3662	155	19	2	1	0.23083	0.32635
Drug metabolism - other enzymes	3662	155	19	3	1	0.32635	0.40547
PI3K-Akt signaling pathway	3662	155	19	3	1	0.32635	0.40547
Prostate cancer	3662	155	19	3	1	0.32635	0.40547
Lipid and atherosclerosis	3662	155	19	3	1	0.32635	0.40547
Pyrimidine metabolism	3662	155	19	4	1	0.41056	0.46758
Nucleotide metabolism	3662	155	19	4	1	0.41056	0.46758
p53 signaling pathway	3662	155	19	4	1	0.41056	0.46758
Viral life cycle - HIV-1	3662	155	19	5	1	0.48473	0.52299
Hematopoietic cell lineage	3662	155	19	5	1	0.48473	0.52299
Oocyte meiosis	3662	155	19	7	1	0.60738	0.62256
Progesterone-mediated oocyte maturation	3662	155	19	7	1	0.60738	0.62256
Pathways in cancer	3662	155	19	9	1	0.70201	0.70201
Rap1 signaling pathway	3690	155	6	2	2	0.0012568	0.024298
Focal adhesion	3690	155	6	2	2	0.0012568	0.024298
Regulation of actin cytoskeleton	3690	155	6	2	2	0.0012568	0.024298
PI3K-Akt signaling pathway	3690	155	6	3	2	0.0037047	0.042975
Gap junction	3690	155	6	3	2	0.0037047	0.042975
Phagosome	3690	155	6	5	2	0.011921	0.11226
EGFR tyrosine kinase inhibitor resistance	3690	155	6	1	1	0.03871	0.11226
ErbB signaling pathway	3690	155	6	1	1	0.03871	0.11226
Ras signaling pathway	3690	155	6	1	1	0.03871	0.11226
Phospholipase D signaling pathway	3690	155	6	1	1	0.03871	0.11226
Axon guidance	3690	155	6	1	1	0.03871	0.11226
Platelet activation	3690	155	6	1	1	0.03871	0.11226
Insulin signaling pathway	3690	155	6	1	1	0.03871	0.11226
Pathogenic Escherichia coli infection	3690	155	6	1	1	0.03871	0.11226
Proteoglycans in cancer	3690	155	6	1	1	0.03871	0.11226
Endometrial cancer	3690	155	6	1	1	0.03871	0.11226
Choline metabolism in cancer	3690	155	6	1	1	0.03871	0.11226
Hypertrophic cardiomyopathy	3690	155	6	1	1	0.03871	0.11226
Arrhythmogenic right ventricular cardiomyopathy	3690	155	6	1	1	0.03871	0.11226
Dilated cardiomyopathy	3690	155	6	1	1	0.03871	0.11226
Human papillomavirus infection	3690	155	6	10	2	0.04907	0.12271
MAPK signaling pathway	3690	155	6	2	1	0.076163	0.12271
Calcium signaling pathway	3690	155	6	2	1	0.076163	0.12271
HIF-1 signaling pathway	3690	155	6	2	1	0.076163	0.12271
ECM-receptor interaction	3690	155	6	2	1	0.076163	0.12271
Complement and coagulation cascades	3690	155	6	2	1	0.076163	0.12271
Salmonella infection	3690	155	6	2	1	0.076163	0.12271
Human cytomegalovirus infection	3690	155	6	2	1	0.076163	0.12271
Colorectal cancer	3690	155	6	2	1	0.076163	0.12271
Glioma	3690	155	6	2	1	0.076163	0.12271
Melanoma	3690	155	6	2	1	0.076163	0.12271
Bladder cancer	3690	155	6	2	1	0.076163	0.12271
Non-small cell lung cancer	3690	155	6	2	1	0.076163	0.12271
Breast cancer	3690	155	6	2	1	0.076163	0.12271
Gastric cancer	3690	155	6	2	1	0.076163	0.12271
Fluid shear stress and atherosclerosis	3690	155	6	2	1	0.076163	0.12271
JAK-STAT signaling pathway	3690	155	6	3	1	0.11239	0.16297
Thyroid hormone signaling pathway	3690	155	6	3	1	0.11239	0.16297
Pancreatic cancer	3690	155	6	3	1	0.11239	0.16297
Prostate cancer	3690	155	6	3	1	0.11239	0.16297
FoxO signaling pathway	3690	155	6	4	1	0.14743	0.17814
Osteoclast differentiation	3690	155	6	4	1	0.14743	0.17814
Amyotrophic lateral sclerosis	3690	155	6	4	1	0.14743	0.17814
Huntington disease	3690	155	6	4	1	0.14743	0.17814
Prion disease	3690	155	6	4	1	0.14743	0.17814
MicroRNAs in cancer	3690	155	6	4	1	0.14743	0.17814
Chemical carcinogenesis - reactive oxygen species	3690	155	6	4	1	0.14743	0.17814
PD-L1 expression and PD-1 checkpoint pathway in cancer	3690	155	6	4	1	0.14743	0.17814
Hematopoietic cell lineage	3690	155	6	5	1	0.18131	0.21031
Chemical carcinogenesis - receptor activation	3690	155	6	5	1	0.18131	0.21031
Parkinson disease	3690	155	6	6	1	0.21405	0.24343
Pathways of neurodegeneration - multiple diseases	3690	155	6	7	1	0.2457	0.27405
Alzheimer disease	3690	155	6	8	1	0.27628	0.30235
Herpes simplex virus 1 infection	3690	155	6	9	1	0.30582	0.3225
Pathways in cancer	3690	155	6	9	1	0.30582	0.3225
Coronavirus disease - COVID-19	3690	155	6	11	1	0.36189	0.37482
Hepatitis C	3690	155	6	12	1	0.38848	0.3953
Neutrophil extracellular trap formation	3690	155	6	13	1	0.41414	0.41414
Oxidative phosphorylation	374291	155	9	3	3	0.000138	0.001196
Thermogenesis	374291	155	9	3	3	0.000138	0.001196
Diabetic cardiomyopathy	374291	155	9	3	3	0.000138	0.001196
Amyotrophic lateral sclerosis	374291	155	9	4	3	0.00053567	0.0019896
Huntington disease	374291	155	9	4	3	0.00053567	0.0019896
Prion disease	374291	155	9	4	3	0.00053567	0.0019896
Chemical carcinogenesis - reactive oxygen species	374291	155	9	4	3	0.00053567	0.0019896
Parkinson disease	374291	155	9	6	3	0.0025214	0.0078425
Retrograde endocannabinoid signaling	374291	155	9	2	2	0.0030163	0.0078425
Non-alcoholic fatty liver disease	374291	155	9	2	2	0.0030163	0.0078425
Pathways of neurodegeneration - multiple diseases	374291	155	9	7	3	0.0042805	0.010118
Metabolic pathways	374291	155	9	24	5	0.0048997	0.010616
Alzheimer disease	374291	155	9	8	3	0.0066434	0.013287
Mucin type O-glycan biosynthesis	374291	155	9	1	1	0.058065	0.094355
Sphingolipid metabolism	374291	155	9	1	1	0.058065	0.094355
Renal cell carcinoma	374291	155	9	1	1	0.058065	0.094355
Nicotinate and nicotinamide metabolism	374291	155	9	2	1	0.11311	0.16339
HIF-1 signaling pathway	374291	155	9	2	1	0.11311	0.16339
Biosynthesis of cofactors	374291	155	9	4	1	0.21471	0.27912
Ubiquitin mediated proteolysis	374291	155	9	4	1	0.21471	0.27912
Hematopoietic cell lineage	374291	155	9	5	1	0.26151	0.32378
Oocyte meiosis	374291	155	9	7	1	0.34775	0.37673
Progesterone-mediated oocyte maturation	374291	155	9	7	1	0.34775	0.37673
Human immunodeficiency virus 1 infection	374291	155	9	7	1	0.34775	0.37673
Pathways in cancer	374291	155	9	9	1	0.42492	0.44192
NOD-like receptor signaling pathway	374291	155	9	15	1	0.61013	0.61013
Mucin type O-glycan biosynthesis	375298	155	9	1	1	0.058065	0.20903
Sphingolipid metabolism	375298	155	9	1	1	0.058065	0.20903
Glutamatergic synapse	375298	155	9	1	1	0.058065	0.20903
GABAergic synapse	375298	155	9	1	1	0.058065	0.20903
Epithelial cell signaling in Helicobacter pylori infection	375298	155	9	1	1	0.058065	0.20903
Notch signaling pathway	375298	155	9	2	1	0.11311	0.29086
Protein digestion and absorption	375298	155	9	2	1	0.11311	0.29086
Thyroid hormone signaling pathway	375298	155	9	3	1	0.16528	0.37189
Ubiquitin mediated proteolysis	375298	155	9	4	1	0.21471	0.42941
Protein processing in endoplasmic reticulum	375298	155	9	6	1	0.30582	0.44711
Parkinson disease	375298	155	9	6	1	0.30582	0.44711
Oocyte meiosis	375298	155	9	7	1	0.34775	0.44711
Progesterone-mediated oocyte maturation	375298	155	9	7	1	0.34775	0.44711
Pathways of neurodegeneration - multiple diseases	375298	155	9	7	1	0.34775	0.44711
Alzheimer disease	375298	155	9	8	1	0.38742	0.4649
Coronavirus disease - COVID-19	375298	155	9	11	1	0.49386	0.5556
NOD-like receptor signaling pathway	375298	155	9	15	1	0.61013	0.64602
Metabolic pathways	375298	155	9	24	1	0.78952	0.78952
Cell cycle	3832	155	27	14	12	4.9715e-09	2.1875e-07
Oocyte meiosis	3832	155	27	7	6	0.00010432	0.002295
DNA replication	3832	155	27	4	4	0.00075875	0.0083463
p53 signaling pathway	3832	155	27	4	4	0.00075875	0.0083463
Cellular senescence	3832	155	27	7	5	0.0018696	0.01371
Progesterone-mediated oocyte maturation	3832	155	27	7	5	0.0018696	0.01371
Human T-cell leukemia virus 1 infection	3832	155	27	7	4	0.017987	0.11306
Glutathione metabolism	3832	155	27	2	2	0.029409	0.1294
One carbon pool by folate	3832	155	27	2	2	0.029409	0.1294
Platinum drug resistance	3832	155	27	2	2	0.029409	0.1294
Antifolate resistance	3832	155	27	3	2	0.078617	0.31447
Human immunodeficiency virus 1 infection	3832	155	27	7	3	0.10193	0.33324
Pyrimidine metabolism	3832	155	27	4	2	0.14029	0.33324
Nucleotide metabolism	3832	155	27	4	2	0.14029	0.33324
FoxO signaling pathway	3832	155	27	4	2	0.14029	0.33324
Ubiquitin mediated proteolysis	3832	155	27	4	2	0.14029	0.33324
MicroRNAs in cancer	3832	155	27	4	2	0.14029	0.33324
Purine metabolism	3832	155	27	1	1	0.17419	0.33324
Biosynthesis of nucleotide sugars	3832	155	27	1	1	0.17419	0.33324
Base excision repair	3832	155	27	1	1	0.17419	0.33324
Non-homologous end-joining	3832	155	27	1	1	0.17419	0.33324
Fanconi anemia pathway	3832	155	27	1	1	0.17419	0.33324
Hippo signaling pathway	3832	155	27	1	1	0.17419	0.33324
Chemical carcinogenesis - receptor activation	3832	155	27	5	2	0.2089	0.38299
Amino sugar and nucleotide sugar metabolism	3832	155	27	2	1	0.31898	0.45274
Folate biosynthesis	3832	155	27	2	1	0.31898	0.45274
MAPK signaling pathway	3832	155	27	2	1	0.31898	0.45274
Apoptosis	3832	155	27	2	1	0.31898	0.45274
Apoptosis - multiple species	3832	155	27	2	1	0.31898	0.45274
ECM-receptor interaction	3832	155	27	2	1	0.31898	0.45274
Colorectal cancer	3832	155	27	2	1	0.31898	0.45274
Viral carcinogenesis	3832	155	27	13	3	0.40196	0.5085
Metabolic pathways	3832	155	27	24	5	0.40918	0.5085
Hepatitis B	3832	155	27	8	2	0.42096	0.5085
Drug metabolism - other enzymes	3832	155	27	3	1	0.43916	0.5085
AMPK signaling pathway	3832	155	27	3	1	0.43916	0.5085
Gap junction	3832	155	27	3	1	0.43916	0.5085
Acute myeloid leukemia	3832	155	27	3	1	0.43916	0.5085
Pathways in cancer	3832	155	27	9	2	0.4866	0.54899
Biosynthesis of cofactors	3832	155	27	4	1	0.53878	0.59266
Protein processing in endoplasmic reticulum	3832	155	27	6	1	0.68943	0.73987
Transcriptional misregulation in cancer	3832	155	27	8	1	0.7921	0.82981
Human papillomavirus infection	3832	155	27	10	1	0.86167	0.88171
Epstein-Barr virus infection	3832	155	27	11	1	0.88743	0.88743
Cell cycle	3833	155	25	14	12	1.5302e-09	6.1206e-08
Oocyte meiosis	3833	155	25	7	6	6.323e-05	0.0012646
DNA replication	3833	155	25	4	4	0.00054691	0.0054691
p53 signaling pathway	3833	155	25	4	4	0.00054691	0.0054691
Cellular senescence	3833	155	25	7	5	0.0012617	0.0084114
Progesterone-mediated oocyte maturation	3833	155	25	7	5	0.0012617	0.0084114
Human T-cell leukemia virus 1 infection	3833	155	25	7	4	0.013437	0.059884
Pyrimidine metabolism	3833	155	25	4	3	0.013474	0.059884
Nucleotide metabolism	3833	155	25	4	3	0.013474	0.059884
Platinum drug resistance	3833	155	25	2	2	0.025136	0.10054
Drug metabolism - other enzymes	3833	155	25	3	2	0.067851	0.24673
Human immunodeficiency virus 1 infection	3833	155	25	7	3	0.08372	0.27907
FoxO signaling pathway	3833	155	25	4	2	0.12223	0.30722
Ubiquitin mediated proteolysis	3833	155	25	4	2	0.12223	0.30722
MicroRNAs in cancer	3833	155	25	4	2	0.12223	0.30722
Purine metabolism	3833	155	25	1	1	0.16129	0.30722
Base excision repair	3833	155	25	1	1	0.16129	0.30722
Non-homologous end-joining	3833	155	25	1	1	0.16129	0.30722
Fanconi anemia pathway	3833	155	25	1	1	0.16129	0.30722
Hippo signaling pathway	3833	155	25	1	1	0.16129	0.30722
Carbohydrate digestion and absorption	3833	155	25	1	1	0.16129	0.30722
Chemical carcinogenesis - receptor activation	3833	155	25	5	2	0.18369	0.33398
Glutathione metabolism	3833	155	25	2	1	0.29744	0.41027
One carbon pool by folate	3833	155	25	2	1	0.29744	0.41027
MAPK signaling pathway	3833	155	25	2	1	0.29744	0.41027
Apoptosis	3833	155	25	2	1	0.29744	0.41027
Apoptosis - multiple species	3833	155	25	2	1	0.29744	0.41027
ECM-receptor interaction	3833	155	25	2	1	0.29744	0.41027
Colorectal cancer	3833	155	25	2	1	0.29744	0.41027
Viral carcinogenesis	3833	155	25	13	3	0.35026	0.46702
Hepatitis B	3833	155	25	8	2	0.37978	0.47113
Antifolate resistance	3833	155	25	3	1	0.41224	0.47113
AMPK signaling pathway	3833	155	25	3	1	0.41224	0.47113
Gap junction	3833	155	25	3	1	0.41224	0.47113
Acute myeloid leukemia	3833	155	25	3	1	0.41224	0.47113
Pathways in cancer	3833	155	25	9	2	0.44248	0.49164
Transcriptional misregulation in cancer	3833	155	25	8	1	0.76382	0.82575
Metabolic pathways	3833	155	25	24	3	0.79105	0.83269
Human papillomavirus infection	3833	155	25	10	1	0.83755	0.85902
Epstein-Barr virus infection	3833	155	25	11	1	0.86556	0.86556
Biosynthesis of nucleotide sugars	387882	155	6	1	1	0.03871	0.12376
EGFR tyrosine kinase inhibitor resistance	387882	155	6	1	1	0.03871	0.12376
ErbB signaling pathway	387882	155	6	1	1	0.03871	0.12376
Ras signaling pathway	387882	155	6	1	1	0.03871	0.12376
Phospholipase D signaling pathway	387882	155	6	1	1	0.03871	0.12376
Insulin signaling pathway	387882	155	6	1	1	0.03871	0.12376
Endometrial cancer	387882	155	6	1	1	0.03871	0.12376
Choline metabolism in cancer	387882	155	6	1	1	0.03871	0.12376
Amino sugar and nucleotide sugar metabolism	387882	155	6	2	1	0.076163	0.12376
MAPK signaling pathway	387882	155	6	2	1	0.076163	0.12376
Rap1 signaling pathway	387882	155	6	2	1	0.076163	0.12376
Calcium signaling pathway	387882	155	6	2	1	0.076163	0.12376
HIF-1 signaling pathway	387882	155	6	2	1	0.076163	0.12376
Focal adhesion	387882	155	6	2	1	0.076163	0.12376
Complement and coagulation cascades	387882	155	6	2	1	0.076163	0.12376
Th17 cell differentiation	387882	155	6	2	1	0.076163	0.12376
Regulation of actin cytoskeleton	387882	155	6	2	1	0.076163	0.12376
Colorectal cancer	387882	155	6	2	1	0.076163	0.12376
Glioma	387882	155	6	2	1	0.076163	0.12376
Melanoma	387882	155	6	2	1	0.076163	0.12376
Bladder cancer	387882	155	6	2	1	0.076163	0.12376
Non-small cell lung cancer	387882	155	6	2	1	0.076163	0.12376
Breast cancer	387882	155	6	2	1	0.076163	0.12376
Gastric cancer	387882	155	6	2	1	0.076163	0.12376
PI3K-Akt signaling pathway	387882	155	6	3	1	0.11239	0.15115
Gap junction	387882	155	6	3	1	0.11239	0.15115
JAK-STAT signaling pathway	387882	155	6	3	1	0.11239	0.15115
Pancreatic cancer	387882	155	6	3	1	0.11239	0.15115
Prostate cancer	387882	155	6	3	1	0.11239	0.15115
FoxO signaling pathway	387882	155	6	4	1	0.14743	0.17968
Chemical carcinogenesis - reactive oxygen species	387882	155	6	4	1	0.14743	0.17968
PD-L1 expression and PD-1 checkpoint pathway in cancer	387882	155	6	4	1	0.14743	0.17968
Chemical carcinogenesis - receptor activation	387882	155	6	5	1	0.18131	0.21427
Protein processing in endoplasmic reticulum	387882	155	6	6	1	0.21405	0.24553
Pathways in cancer	387882	155	6	9	1	0.30582	0.34077
Human papillomavirus infection	387882	155	6	10	1	0.33435	0.36221
Coronavirus disease - COVID-19	387882	155	6	11	1	0.36189	0.38146
Hepatitis C	387882	155	6	12	1	0.38848	0.3987
Metabolic pathways	387882	155	6	24	1	0.64212	0.64212
Cell cycle	3925	155	23	14	12	4.0917e-10	1.5958e-08
Oocyte meiosis	3925	155	23	7	6	3.6507e-05	0.00071188
DNA replication	3925	155	23	4	4	0.00038284	0.0037326
p53 signaling pathway	3925	155	23	4	4	0.00038284	0.0037326
Cellular senescence	3925	155	23	7	5	0.00081917	0.0053246
Progesterone-mediated oocyte maturation	3925	155	23	7	5	0.00081917	0.0053246
Human T-cell leukemia virus 1 infection	3925	155	23	7	4	0.0097443	0.045455
Pyrimidine metabolism	3925	155	23	4	3	0.01049	0.045455
Nucleotide metabolism	3925	155	23	4	3	0.01049	0.045455
Platinum drug resistance	3925	155	23	2	2	0.021198	0.082673
Drug metabolism - other enzymes	3925	155	23	3	2	0.057775	0.20484
Human immunodeficiency virus 1 infection	3925	155	23	7	3	0.067311	0.21876
FoxO signaling pathway	3925	155	23	4	2	0.10506	0.29267
MicroRNAs in cancer	3925	155	23	4	2	0.10506	0.29267
Purine metabolism	3925	155	23	1	1	0.14839	0.30458
Base excision repair	3925	155	23	1	1	0.14839	0.30458
Non-homologous end-joining	3925	155	23	1	1	0.14839	0.30458
Fanconi anemia pathway	3925	155	23	1	1	0.14839	0.30458
Hippo signaling pathway	3925	155	23	1	1	0.14839	0.30458
Chemical carcinogenesis - receptor activation	3925	155	23	5	2	0.15934	0.31071
Glutathione metabolism	3925	155	23	2	1	0.27558	0.39805
One carbon pool by folate	3925	155	23	2	1	0.27558	0.39805
MAPK signaling pathway	3925	155	23	2	1	0.27558	0.39805
Apoptosis	3925	155	23	2	1	0.27558	0.39805
Apoptosis - multiple species	3925	155	23	2	1	0.27558	0.39805
ECM-receptor interaction	3925	155	23	2	1	0.27558	0.39805
Colorectal cancer	3925	155	23	2	1	0.27558	0.39805
Viral carcinogenesis	3925	155	23	13	3	0.29892	0.41636
Hepatitis B	3925	155	23	8	2	0.33806	0.45438
Antifolate resistance	3925	155	23	3	1	0.38448	0.45438
AMPK signaling pathway	3925	155	23	3	1	0.38448	0.45438
Gap junction	3925	155	23	3	1	0.38448	0.45438
Acute myeloid leukemia	3925	155	23	3	1	0.38448	0.45438
Pathways in cancer	3925	155	23	9	2	0.39705	0.45544
Ubiquitin mediated proteolysis	3925	155	23	4	1	0.47761	0.5322
Transcriptional misregulation in cancer	3925	155	23	8	1	0.73223	0.77527
Metabolic pathways	3925	155	23	24	3	0.73551	0.77527
Human papillomavirus infection	3925	155	23	10	1	0.80971	0.83101
Epstein-Barr virus infection	3925	155	23	11	1	0.83989	0.83989
Staphylococcus aureus infection	3934	155	12	6	4	0.00029433	0.0061809
Transcriptional misregulation in cancer	3934	155	12	8	4	0.0012586	0.013215
Amoebiasis	3934	155	12	2	2	0.00553	0.03871
NOD-like receptor signaling pathway	3934	155	12	15	4	0.017982	0.094407
Phagosome	3934	155	12	5	2	0.048387	0.20323
Neutrophil extracellular trap formation	3934	155	12	13	3	0.065366	0.22878
Asthma	3934	155	12	1	1	0.077419	0.23226
Amino sugar and nucleotide sugar metabolism	3934	155	12	2	1	0.14931	0.24119
PPAR signaling pathway	3934	155	12	2	1	0.14931	0.24119
Lysosome	3934	155	12	2	1	0.14931	0.24119
Renin-angiotensin system	3934	155	12	2	1	0.14931	0.24119
IL-17 signaling pathway	3934	155	12	2	1	0.14931	0.24119
Salivary secretion	3934	155	12	2	1	0.14931	0.24119
Drug metabolism - other enzymes	3934	155	12	3	1	0.21603	0.26686
Neuroactive ligand-receptor interaction	3934	155	12	3	1	0.21603	0.26686
Acute myeloid leukemia	3934	155	12	3	1	0.21603	0.26686
Lipid and atherosclerosis	3934	155	12	3	1	0.21603	0.26686
Tuberculosis	3934	155	12	4	1	0.27792	0.32424
Hematopoietic cell lineage	3934	155	12	5	1	0.33531	0.3706
Systemic lupus erythematosus	3934	155	12	10	1	0.5645	0.59272
Metabolic pathways	3934	155	12	24	1	0.87769	0.87769
Glutathione metabolism	3998	155	16	2	2	0.010054	0.24516
Protein processing in endoplasmic reticulum	3998	155	16	6	3	0.01508	0.24516
Cell cycle	3998	155	16	14	4	0.040533	0.24516
DNA replication	3998	155	16	4	2	0.053203	0.24516
Metabolic pathways	3998	155	16	24	5	0.076995	0.24516
Chemical carcinogenesis - receptor activation	3998	155	16	5	2	0.0833	0.24516
Purine metabolism	3998	155	16	1	1	0.10323	0.24516
Glycine, serine and threonine metabolism	3998	155	16	1	1	0.10323	0.24516
Glyoxylate and dicarboxylate metabolism	3998	155	16	1	1	0.10323	0.24516
Carbon metabolism	3998	155	16	1	1	0.10323	0.24516
Biosynthesis of nucleotide sugars	3998	155	16	1	1	0.10323	0.24516
Protein export	3998	155	16	1	1	0.10323	0.24516
Estrogen signaling pathway	3998	155	16	1	1	0.10323	0.24516
Thyroid hormone synthesis	3998	155	16	1	1	0.10323	0.24516
Oxytocin signaling pathway	3998	155	16	1	1	0.10323	0.24516
Pancreatic secretion	3998	155	16	1	1	0.10323	0.24516
Amino sugar and nucleotide sugar metabolism	3998	155	16	2	1	0.1964	0.29852
Nicotinate and nicotinamide metabolism	3998	155	16	2	1	0.1964	0.29852
Calcium signaling pathway	3998	155	16	2	1	0.1964	0.29852
IL-17 signaling pathway	3998	155	16	2	1	0.1964	0.29852
Th17 cell differentiation	3998	155	16	2	1	0.1964	0.29852
Intestinal immune network for IgA production	3998	155	16	2	1	0.1964	0.29852
Salivary secretion	3998	155	16	2	1	0.1964	0.29852
Salmonella infection	3998	155	16	2	1	0.1964	0.29852
Fluid shear stress and atherosclerosis	3998	155	16	2	1	0.1964	0.29852
Drug metabolism - other enzymes	3998	155	16	3	1	0.28043	0.35522
Cytokine-cytokine receptor interaction	3998	155	16	3	1	0.28043	0.35522
PI3K-Akt signaling pathway	3998	155	16	3	1	0.28043	0.35522
Prostate cancer	3998	155	16	3	1	0.28043	0.35522
Lipid and atherosclerosis	3998	155	16	3	1	0.28043	0.35522
Pyrimidine metabolism	3998	155	16	4	1	0.35618	0.41014
Nucleotide metabolism	3998	155	16	4	1	0.35618	0.41014
p53 signaling pathway	3998	155	16	4	1	0.35618	0.41014
Viral life cycle - HIV-1	3998	155	16	5	1	0.4244	0.46077
Hematopoietic cell lineage	3998	155	16	5	1	0.4244	0.46077
Oocyte meiosis	3998	155	16	7	1	0.54101	0.55563
Progesterone-mediated oocyte maturation	3998	155	16	7	1	0.54101	0.55563
Pathways in cancer	3998	155	16	9	1	0.63519	0.63519
Glycerolipid metabolism	4051	155	5	1	1	0.032258	0.10484
Glycerophospholipid metabolism	4051	155	5	1	1	0.032258	0.10484
Arachidonic acid metabolism	4051	155	5	1	1	0.032258	0.10484
mTOR signaling pathway	4051	155	5	1	1	0.032258	0.10484
Renin-angiotensin system	4051	155	5	2	1	0.063678	0.11826
Alcoholic liver disease	4051	155	5	2	1	0.063678	0.11826
Protein digestion and absorption	4051	155	5	2	1	0.063678	0.11826
Thyroid hormone signaling pathway	4051	155	5	3	1	0.094277	0.1532
Hematopoietic cell lineage	4051	155	5	5	1	0.15307	0.21427
Metabolic pathways	4051	155	5	24	2	0.1714	0.21427
Parkinson disease	4051	155	5	6	1	0.18131	0.21427
Pathways of neurodegeneration - multiple diseases	4051	155	5	7	1	0.20878	0.22618
Alzheimer disease	4051	155	5	8	1	0.23551	0.23551
Staphylococcus aureus infection	4057	155	13	6	4	0.00042045	0.0092498
Transcriptional misregulation in cancer	4057	155	13	8	4	0.0017779	0.019557
Amoebiasis	4057	155	13	2	2	0.0065354	0.047926
NOD-like receptor signaling pathway	4057	155	13	15	4	0.024428	0.13435
Phagosome	4057	155	13	5	2	0.056413	0.23065
Neutrophil extracellular trap formation	4057	155	13	13	3	0.08073	0.23065
Carbohydrate digestion and absorption	4057	155	13	1	1	0.083871	0.23065
Asthma	4057	155	13	1	1	0.083871	0.23065
Amino sugar and nucleotide sugar metabolism	4057	155	13	2	1	0.16121	0.25332
PPAR signaling pathway	4057	155	13	2	1	0.16121	0.25332
Lysosome	4057	155	13	2	1	0.16121	0.25332
Renin-angiotensin system	4057	155	13	2	1	0.16121	0.25332
IL-17 signaling pathway	4057	155	13	2	1	0.16121	0.25332
Salivary secretion	4057	155	13	2	1	0.16121	0.25332
Drug metabolism - other enzymes	4057	155	13	3	1	0.23248	0.28414
Neuroactive ligand-receptor interaction	4057	155	13	3	1	0.23248	0.28414
Acute myeloid leukemia	4057	155	13	3	1	0.23248	0.28414
Lipid and atherosclerosis	4057	155	13	3	1	0.23248	0.28414
Tuberculosis	4057	155	13	4	1	0.29812	0.34519
Hematopoietic cell lineage	4057	155	13	5	1	0.35855	0.3944
Systemic lupus erythematosus	4057	155	13	10	1	0.59495	0.62328
Metabolic pathways	4057	155	13	24	1	0.89822	0.89822
Hepatitis C	4061	155	13	12	6	7.0727e-05	0.0014145
Influenza A	4061	155	13	10	5	0.00036914	0.0036914
Measles	4061	155	13	9	4	0.0030456	0.020304
Coronavirus disease - COVID-19	4061	155	13	11	4	0.0072208	0.036104
Herpes simplex virus 1 infection	4061	155	13	9	3	0.029097	0.11639
Epstein-Barr virus infection	4061	155	13	11	3	0.0516	0.172
Pertussis	4061	155	13	1	1	0.083871	0.23963
NOD-like receptor signaling pathway	4061	155	13	15	3	0.1159	0.28976
Cell adhesion molecules	4061	155	13	2	1	0.16121	0.2931
Complement and coagulation cascades	4061	155	13	2	1	0.16121	0.2931
Cytosolic DNA-sensing pathway	4061	155	13	2	1	0.16121	0.2931
Human papillomavirus infection	4061	155	13	10	2	0.19904	0.33174
Pyrimidine metabolism	4061	155	13	4	1	0.29812	0.35073
Nucleotide metabolism	4061	155	13	4	1	0.29812	0.35073
Biosynthesis of cofactors	4061	155	13	4	1	0.29812	0.35073
Necroptosis	4061	155	13	4	1	0.29812	0.35073
PD-L1 expression and PD-1 checkpoint pathway in cancer	4061	155	13	4	1	0.29812	0.35073
Viral life cycle - HIV-1	4061	155	13	5	1	0.35855	0.39839
Transcriptional misregulation in cancer	4061	155	13	8	1	0.51223	0.53918
Metabolic pathways	4061	155	13	24	1	0.89822	0.89822
Cell cycle	4171	155	25	14	12	1.5302e-09	6.1206e-08
Oocyte meiosis	4171	155	25	7	6	6.323e-05	0.0012646
DNA replication	4171	155	25	4	4	0.00054691	0.0054691
p53 signaling pathway	4171	155	25	4	4	0.00054691	0.0054691
Cellular senescence	4171	155	25	7	5	0.0012617	0.0084114
Progesterone-mediated oocyte maturation	4171	155	25	7	5	0.0012617	0.0084114
Human T-cell leukemia virus 1 infection	4171	155	25	7	4	0.013437	0.059884
Pyrimidine metabolism	4171	155	25	4	3	0.013474	0.059884
Nucleotide metabolism	4171	155	25	4	3	0.013474	0.059884
Platinum drug resistance	4171	155	25	2	2	0.025136	0.10054
Drug metabolism - other enzymes	4171	155	25	3	2	0.067851	0.24673
Human immunodeficiency virus 1 infection	4171	155	25	7	3	0.08372	0.27907
FoxO signaling pathway	4171	155	25	4	2	0.12223	0.30722
Ubiquitin mediated proteolysis	4171	155	25	4	2	0.12223	0.30722
MicroRNAs in cancer	4171	155	25	4	2	0.12223	0.30722
Purine metabolism	4171	155	25	1	1	0.16129	0.30722
Base excision repair	4171	155	25	1	1	0.16129	0.30722
Non-homologous end-joining	4171	155	25	1	1	0.16129	0.30722
Fanconi anemia pathway	4171	155	25	1	1	0.16129	0.30722
Hippo signaling pathway	4171	155	25	1	1	0.16129	0.30722
Carbohydrate digestion and absorption	4171	155	25	1	1	0.16129	0.30722
Chemical carcinogenesis - receptor activation	4171	155	25	5	2	0.18369	0.33398
Glutathione metabolism	4171	155	25	2	1	0.29744	0.42492
One carbon pool by folate	4171	155	25	2	1	0.29744	0.42492
MAPK signaling pathway	4171	155	25	2	1	0.29744	0.42492
Apoptosis	4171	155	25	2	1	0.29744	0.42492
Apoptosis - multiple species	4171	155	25	2	1	0.29744	0.42492
Colorectal cancer	4171	155	25	2	1	0.29744	0.42492
Viral carcinogenesis	4171	155	25	13	3	0.35026	0.48312
Hepatitis B	4171	155	25	8	2	0.37978	0.48499
Antifolate resistance	4171	155	25	3	1	0.41224	0.48499
AMPK signaling pathway	4171	155	25	3	1	0.41224	0.48499
Gap junction	4171	155	25	3	1	0.41224	0.48499
Acute myeloid leukemia	4171	155	25	3	1	0.41224	0.48499
Pathways in cancer	4171	155	25	9	2	0.44248	0.50569
Protein processing in endoplasmic reticulum	4171	155	25	6	1	0.65851	0.73168
Transcriptional misregulation in cancer	4171	155	25	8	1	0.76382	0.82575
Metabolic pathways	4171	155	25	24	3	0.79105	0.83269
Human papillomavirus infection	4171	155	25	10	1	0.83755	0.85902
Epstein-Barr virus infection	4171	155	25	11	1	0.86556	0.86556
Cell cycle	4173	155	32	14	12	6.0029e-08	3.7818e-06
Oocyte meiosis	4173	155	32	7	6	0.00030891	0.0097307
DNA replication	4173	155	32	4	4	0.0015547	0.024486
p53 signaling pathway	4173	155	32	4	4	0.0015547	0.024486
Cellular senescence	4173	155	32	7	5	0.0043736	0.045923
Progesterone-mediated oocyte maturation	4173	155	32	7	5	0.0043736	0.045923
Human T-cell leukemia virus 1 infection	4173	155	32	7	4	0.033649	0.26182
Glutathione metabolism	4173	155	32	2	2	0.041558	0.26182
One carbon pool by folate	4173	155	32	2	2	0.041558	0.26182
Platinum drug resistance	4173	155	32	2	2	0.041558	0.26182
Chemical carcinogenesis - receptor activation	4173	155	32	5	3	0.059897	0.34304
Protein processing in endoplasmic reticulum	4173	155	32	6	3	0.10287	0.39413
Antifolate resistance	4173	155	32	3	2	0.10838	0.39413
AMPK signaling pathway	4173	155	32	3	2	0.10838	0.39413
Human immunodeficiency virus 1 infection	4173	155	32	7	3	0.15479	0.39413
Pyrimidine metabolism	4173	155	32	4	2	0.18883	0.39413
Nucleotide metabolism	4173	155	32	4	2	0.18883	0.39413
FoxO signaling pathway	4173	155	32	4	2	0.18883	0.39413
Ubiquitin mediated proteolysis	4173	155	32	4	2	0.18883	0.39413
MicroRNAs in cancer	4173	155	32	4	2	0.18883	0.39413
Metabolic pathways	4173	155	32	24	7	0.19527	0.39413
Purine metabolism	4173	155	32	1	1	0.20645	0.39413
Biosynthesis of unsaturated fatty acids	4173	155	32	1	1	0.20645	0.39413
Fatty acid metabolism	4173	155	32	1	1	0.20645	0.39413
Biosynthesis of nucleotide sugars	4173	155	32	1	1	0.20645	0.39413
Base excision repair	4173	155	32	1	1	0.20645	0.39413
Non-homologous end-joining	4173	155	32	1	1	0.20645	0.39413
Fanconi anemia pathway	4173	155	32	1	1	0.20645	0.39413
Hippo signaling pathway	4173	155	32	1	1	0.20645	0.39413
Estrogen signaling pathway	4173	155	32	1	1	0.20645	0.39413
Thyroid hormone synthesis	4173	155	32	1	1	0.20645	0.39413
Oxytocin signaling pathway	4173	155	32	1	1	0.20645	0.39413
Pancreatic secretion	4173	155	32	1	1	0.20645	0.39413
Pathways in cancer	4173	155	32	9	3	0.27578	0.46789
Amino sugar and nucleotide sugar metabolism	4173	155	32	2	1	0.37134	0.46789
Nicotinate and nicotinamide metabolism	4173	155	32	2	1	0.37134	0.46789
Folate biosynthesis	4173	155	32	2	1	0.37134	0.46789
PPAR signaling pathway	4173	155	32	2	1	0.37134	0.46789
MAPK signaling pathway	4173	155	32	2	1	0.37134	0.46789
Calcium signaling pathway	4173	155	32	2	1	0.37134	0.46789
Apoptosis	4173	155	32	2	1	0.37134	0.46789
Apoptosis - multiple species	4173	155	32	2	1	0.37134	0.46789
ECM-receptor interaction	4173	155	32	2	1	0.37134	0.46789
IL-17 signaling pathway	4173	155	32	2	1	0.37134	0.46789
Th17 cell differentiation	4173	155	32	2	1	0.37134	0.46789
Alcoholic liver disease	4173	155	32	2	1	0.37134	0.46789
Salivary secretion	4173	155	32	2	1	0.37134	0.46789
Salmonella infection	4173	155	32	2	1	0.37134	0.46789
Colorectal cancer	4173	155	32	2	1	0.37134	0.46789
Fluid shear stress and atherosclerosis	4173	155	32	2	1	0.37134	0.46789
Drug metabolism - other enzymes	4173	155	32	3	1	0.50283	0.56568
PI3K-Akt signaling pathway	4173	155	32	3	1	0.50283	0.56568
Gap junction	4173	155	32	3	1	0.50283	0.56568
Prostate cancer	4173	155	32	3	1	0.50283	0.56568
Acute myeloid leukemia	4173	155	32	3	1	0.50283	0.56568
Lipid and atherosclerosis	4173	155	32	3	1	0.50283	0.56568
Hepatitis B	4173	155	32	8	2	0.51973	0.57326
Viral carcinogenesis	4173	155	32	13	3	0.52776	0.57326
Biosynthesis of cofactors	4173	155	32	4	1	0.6075	0.64868
Hematopoietic cell lineage	4173	155	32	5	1	0.69068	0.72521
Transcriptional misregulation in cancer	4173	155	32	8	1	0.85024	0.87811
Human papillomavirus infection	4173	155	32	10	1	0.90852	0.92317
Epstein-Barr virus infection	4173	155	32	11	1	0.92871	0.92871
Cell cycle	4175	155	23	14	9	9.2295e-06	0.00048916
DNA replication	4175	155	23	4	4	0.00038284	0.010145
Progesterone-mediated oocyte maturation	4175	155	23	7	4	0.0097443	0.13899
p53 signaling pathway	4175	155	23	4	3	0.01049	0.13899
Glutathione metabolism	4175	155	23	2	2	0.021198	0.18725
One carbon pool by folate	4175	155	23	2	2	0.021198	0.18725
Antifolate resistance	4175	155	23	3	2	0.057775	0.3745
Oocyte meiosis	4175	155	23	7	3	0.067311	0.3745
Cellular senescence	4175	155	23	7	3	0.067311	0.3745
Pyrimidine metabolism	4175	155	23	4	2	0.10506	0.3745
Nucleotide metabolism	4175	155	23	4	2	0.10506	0.3745
MicroRNAs in cancer	4175	155	23	4	2	0.10506	0.3745
Metabolic pathways	4175	155	23	24	6	0.1158	0.3745
Purine metabolism	4175	155	23	1	1	0.14839	0.3745
Biosynthesis of nucleotide sugars	4175	155	23	1	1	0.14839	0.3745
Base excision repair	4175	155	23	1	1	0.14839	0.3745
Non-homologous end-joining	4175	155	23	1	1	0.14839	0.3745
Estrogen signaling pathway	4175	155	23	1	1	0.14839	0.3745
Thyroid hormone synthesis	4175	155	23	1	1	0.14839	0.3745
Oxytocin signaling pathway	4175	155	23	1	1	0.14839	0.3745
Pancreatic secretion	4175	155	23	1	1	0.14839	0.3745
Chemical carcinogenesis - receptor activation	4175	155	23	5	2	0.15934	0.38387
Protein processing in endoplasmic reticulum	4175	155	23	6	2	0.21769	0.40905
Amino sugar and nucleotide sugar metabolism	4175	155	23	2	1	0.27558	0.40905
Nicotinate and nicotinamide metabolism	4175	155	23	2	1	0.27558	0.40905
Folate biosynthesis	4175	155	23	2	1	0.27558	0.40905
Platinum drug resistance	4175	155	23	2	1	0.27558	0.40905
MAPK signaling pathway	4175	155	23	2	1	0.27558	0.40905
Calcium signaling pathway	4175	155	23	2	1	0.27558	0.40905
ECM-receptor interaction	4175	155	23	2	1	0.27558	0.40905
IL-17 signaling pathway	4175	155	23	2	1	0.27558	0.40905
Th17 cell differentiation	4175	155	23	2	1	0.27558	0.40905
Salivary secretion	4175	155	23	2	1	0.27558	0.40905
Salmonella infection	4175	155	23	2	1	0.27558	0.40905
Fluid shear stress and atherosclerosis	4175	155	23	2	1	0.27558	0.40905
Human immunodeficiency virus 1 infection	4175	155	23	7	2	0.27784	0.40905
Drug metabolism - other enzymes	4175	155	23	3	1	0.38448	0.47389
PI3K-Akt signaling pathway	4175	155	23	3	1	0.38448	0.47389
AMPK signaling pathway	4175	155	23	3	1	0.38448	0.47389
Gap junction	4175	155	23	3	1	0.38448	0.47389
Prostate cancer	4175	155	23	3	1	0.38448	0.47389
Acute myeloid leukemia	4175	155	23	3	1	0.38448	0.47389
Lipid and atherosclerosis	4175	155	23	3	1	0.38448	0.47389
Pathways in cancer	4175	155	23	9	2	0.39705	0.47827
Biosynthesis of cofactors	4175	155	23	4	1	0.47761	0.5503
FoxO signaling pathway	4175	155	23	4	1	0.47761	0.5503
Hematopoietic cell lineage	4175	155	23	5	1	0.55718	0.62831
Viral carcinogenesis	4175	155	23	13	2	0.6058	0.6689
Human T-cell leukemia virus 1 infection	4175	155	23	7	1	0.68296	0.73871
Hepatitis B	4175	155	23	8	1	0.73223	0.76094
Transcriptional misregulation in cancer	4175	155	23	8	1	0.73223	0.76094
Human papillomavirus infection	4175	155	23	10	1	0.80971	0.82528
Epstein-Barr virus infection	4175	155	23	11	1	0.83989	0.83989
Cell cycle	4288	155	25	14	12	1.5302e-09	7.0387e-08
Oocyte meiosis	4288	155	25	7	6	6.323e-05	0.0014543
DNA replication	4288	155	25	4	4	0.00054691	0.0062894
p53 signaling pathway	4288	155	25	4	4	0.00054691	0.0062894
Progesterone-mediated oocyte maturation	4288	155	25	7	5	0.0012617	0.011608
Cellular senescence	4288	155	25	7	4	0.013437	0.088299
Human T-cell leukemia virus 1 infection	4288	155	25	7	4	0.013437	0.088299
One carbon pool by folate	4288	155	25	2	2	0.025136	0.12847
Platinum drug resistance	4288	155	25	2	2	0.025136	0.12847
Antifolate resistance	4288	155	25	3	2	0.067851	0.28374
AMPK signaling pathway	4288	155	25	3	2	0.067851	0.28374
Human immunodeficiency virus 1 infection	4288	155	25	7	3	0.08372	0.29677
Pyrimidine metabolism	4288	155	25	4	2	0.12223	0.29677
Nucleotide metabolism	4288	155	25	4	2	0.12223	0.29677
FoxO signaling pathway	4288	155	25	4	2	0.12223	0.29677
Ubiquitin mediated proteolysis	4288	155	25	4	2	0.12223	0.29677
MicroRNAs in cancer	4288	155	25	4	2	0.12223	0.29677
Purine metabolism	4288	155	25	1	1	0.16129	0.29677
Biosynthesis of unsaturated fatty acids	4288	155	25	1	1	0.16129	0.29677
Fatty acid metabolism	4288	155	25	1	1	0.16129	0.29677
Base excision repair	4288	155	25	1	1	0.16129	0.29677
Non-homologous end-joining	4288	155	25	1	1	0.16129	0.29677
Fanconi anemia pathway	4288	155	25	1	1	0.16129	0.29677
Hippo signaling pathway	4288	155	25	1	1	0.16129	0.29677
Carbohydrate digestion and absorption	4288	155	25	1	1	0.16129	0.29677
Chemical carcinogenesis - receptor activation	4288	155	25	5	2	0.18369	0.32499
Glutathione metabolism	4288	155	25	2	1	0.29744	0.39093
Folate biosynthesis	4288	155	25	2	1	0.29744	0.39093
PPAR signaling pathway	4288	155	25	2	1	0.29744	0.39093
MAPK signaling pathway	4288	155	25	2	1	0.29744	0.39093
Apoptosis	4288	155	25	2	1	0.29744	0.39093
Apoptosis - multiple species	4288	155	25	2	1	0.29744	0.39093
ECM-receptor interaction	4288	155	25	2	1	0.29744	0.39093
Alcoholic liver disease	4288	155	25	2	1	0.29744	0.39093
Colorectal cancer	4288	155	25	2	1	0.29744	0.39093
Viral carcinogenesis	4288	155	25	13	3	0.35026	0.44756
Hepatitis B	4288	155	25	8	2	0.37978	0.47216
Drug metabolism - other enzymes	4288	155	25	3	1	0.41224	0.47408
Gap junction	4288	155	25	3	1	0.41224	0.47408
Acute myeloid leukemia	4288	155	25	3	1	0.41224	0.47408
Pathways in cancer	4288	155	25	9	2	0.44248	0.49644
Biosynthesis of cofactors	4288	155	25	4	1	0.50891	0.55738
Metabolic pathways	4288	155	25	24	4	0.56976	0.60951
Transcriptional misregulation in cancer	4288	155	25	8	1	0.76382	0.79853
Human papillomavirus infection	4288	155	25	10	1	0.83755	0.85616
Epstein-Barr virus infection	4288	155	25	11	1	0.86556	0.86556
Glycerolipid metabolism	4311	155	7	1	1	0.045161	0.13548
Glycerophospholipid metabolism	4311	155	7	1	1	0.045161	0.13548
Arachidonic acid metabolism	4311	155	7	1	1	0.045161	0.13548
ABC transporters	4311	155	7	1	1	0.045161	0.13548
mTOR signaling pathway	4311	155	7	1	1	0.045161	0.13548
Fat digestion and absorption	4311	155	7	1	1	0.045161	0.13548
Renin-angiotensin system	4311	155	7	2	1	0.088563	0.15941
Alcoholic liver disease	4311	155	7	2	1	0.088563	0.15941
Protein digestion and absorption	4311	155	7	2	1	0.088563	0.15941
Cholesterol metabolism	4311	155	7	2	1	0.088563	0.15941
Thyroid hormone signaling pathway	4311	155	7	3	1	0.13026	0.19539
Lipid and atherosclerosis	4311	155	7	3	1	0.13026	0.19539
Hematopoietic cell lineage	4311	155	7	5	1	0.20878	0.28908
Parkinson disease	4311	155	7	6	1	0.2457	0.3159
Pathways of neurodegeneration - multiple diseases	4311	155	7	7	1	0.28114	0.33329
Metabolic pathways	4311	155	7	24	2	0.29626	0.33329
Alzheimer disease	4311	155	7	8	1	0.31514	0.33368
NOD-like receptor signaling pathway	4311	155	7	15	1	0.51685	0.51685
Phagosome	4317	155	7	5	2	0.016468	0.20263
Transcriptional misregulation in cancer	4317	155	7	8	2	0.043138	0.20263
Amino sugar and nucleotide sugar metabolism	4317	155	7	2	1	0.088563	0.20263
PPAR signaling pathway	4317	155	7	2	1	0.088563	0.20263
IL-17 signaling pathway	4317	155	7	2	1	0.088563	0.20263
Amoebiasis	4317	155	7	2	1	0.088563	0.20263
Drug metabolism - other enzymes	4317	155	7	3	1	0.13026	0.20263
Acute myeloid leukemia	4317	155	7	3	1	0.13026	0.20263
Lipid and atherosclerosis	4317	155	7	3	1	0.13026	0.20263
Hematopoietic cell lineage	4317	155	7	5	1	0.20878	0.29229
Staphylococcus aureus infection	4317	155	7	6	1	0.2457	0.31271
Neutrophil extracellular trap formation	4317	155	7	13	1	0.46525	0.5428
NOD-like receptor signaling pathway	4317	155	7	15	1	0.51685	0.55661
Metabolic pathways	4317	155	7	24	1	0.69977	0.69977
Staphylococcus aureus infection	4353	155	13	6	4	0.00042045	0.0092498
Transcriptional misregulation in cancer	4353	155	13	8	4	0.0017779	0.019557
Amoebiasis	4353	155	13	2	2	0.0065354	0.047926
NOD-like receptor signaling pathway	4353	155	13	15	4	0.024428	0.13435
Phagosome	4353	155	13	5	2	0.056413	0.23065
Neutrophil extracellular trap formation	4353	155	13	13	3	0.08073	0.23065
Carbohydrate digestion and absorption	4353	155	13	1	1	0.083871	0.23065
Asthma	4353	155	13	1	1	0.083871	0.23065
Amino sugar and nucleotide sugar metabolism	4353	155	13	2	1	0.16121	0.25332
PPAR signaling pathway	4353	155	13	2	1	0.16121	0.25332
Lysosome	4353	155	13	2	1	0.16121	0.25332
Renin-angiotensin system	4353	155	13	2	1	0.16121	0.25332
IL-17 signaling pathway	4353	155	13	2	1	0.16121	0.25332
Salivary secretion	4353	155	13	2	1	0.16121	0.25332
Drug metabolism - other enzymes	4353	155	13	3	1	0.23248	0.28414
Neuroactive ligand-receptor interaction	4353	155	13	3	1	0.23248	0.28414
Acute myeloid leukemia	4353	155	13	3	1	0.23248	0.28414
Lipid and atherosclerosis	4353	155	13	3	1	0.23248	0.28414
Tuberculosis	4353	155	13	4	1	0.29812	0.34519
Hematopoietic cell lineage	4353	155	13	5	1	0.35855	0.3944
Systemic lupus erythematosus	4353	155	13	10	1	0.59495	0.62328
Metabolic pathways	4353	155	13	24	1	0.89822	0.89822
PD-L1 expression and PD-1 checkpoint pathway in cancer	440068	155	12	4	3	0.0013815	0.031074
Measles	440068	155	12	9	4	0.002168	0.031074
Herpes simplex virus 1 infection	440068	155	12	9	4	0.002168	0.031074
Influenza A	440068	155	12	10	4	0.0034574	0.037167
Coronavirus disease - COVID-19	440068	155	12	11	4	0.0051978	0.039631
RIG-I-like receptor signaling pathway	440068	155	12	2	2	0.00553	0.039631
Hepatitis B	440068	155	12	8	3	0.016113	0.098977
Necroptosis	440068	155	12	4	2	0.030352	0.14502
Kaposi sarcoma-associated herpesvirus infection	440068	155	12	4	2	0.030352	0.14502
Epstein-Barr virus infection	440068	155	12	11	3	0.041359	0.17521
Hepatitis C	440068	155	12	12	3	0.052659	0.17521
NF-kappa B signaling pathway	440068	155	12	1	1	0.077419	0.17521
Toll-like receptor signaling pathway	440068	155	12	1	1	0.077419	0.17521
Th1 and Th2 cell differentiation	440068	155	12	1	1	0.077419	0.17521
Prolactin signaling pathway	440068	155	12	1	1	0.077419	0.17521
AGE-RAGE signaling pathway in diabetic complications	440068	155	12	1	1	0.077419	0.17521
Growth hormone synthesis, secretion and action	440068	155	12	1	1	0.077419	0.17521
Pertussis	440068	155	12	1	1	0.077419	0.17521
Toxoplasmosis	440068	155	12	1	1	0.077419	0.17521
NOD-like receptor signaling pathway	440068	155	12	15	3	0.094794	0.20381
Chemokine signaling pathway	440068	155	12	2	1	0.14931	0.20711
Apoptosis	440068	155	12	2	1	0.14931	0.20711
Apoptosis - multiple species	440068	155	12	2	1	0.14931	0.20711
Notch signaling pathway	440068	155	12	2	1	0.14931	0.20711
Cell adhesion molecules	440068	155	12	2	1	0.14931	0.20711
Complement and coagulation cascades	440068	155	12	2	1	0.14931	0.20711
Cytosolic DNA-sensing pathway	440068	155	12	2	1	0.14931	0.20711
C-type lectin receptor signaling pathway	440068	155	12	2	1	0.14931	0.20711
Th17 cell differentiation	440068	155	12	2	1	0.14931	0.20711
Leishmaniasis	440068	155	12	2	1	0.14931	0.20711
Inflammatory bowel disease	440068	155	12	2	1	0.14931	0.20711
Human papillomavirus infection	440068	155	12	10	2	0.1745	0.23448
JAK-STAT signaling pathway	440068	155	12	3	1	0.21603	0.26541
Thyroid hormone signaling pathway	440068	155	12	3	1	0.21603	0.26541
Pancreatic cancer	440068	155	12	3	1	0.21603	0.26541
Osteoclast differentiation	440068	155	12	4	1	0.27792	0.32299
Tuberculosis	440068	155	12	4	1	0.27792	0.32299
Viral life cycle - HIV-1	440068	155	12	5	1	0.33531	0.37942
Protein processing in endoplasmic reticulum	440068	155	12	6	1	0.38848	0.42833
Human immunodeficiency virus 1 infection	440068	155	12	7	1	0.43773	0.47056
Alzheimer disease	440068	155	12	8	1	0.48332	0.5069
Pathways in cancer	440068	155	12	9	1	0.5255	0.53801
Viral carcinogenesis	440068	155	12	13	1	0.66456	0.66456
Staphylococcus aureus infection	441864	155	11	6	4	0.0001984	0.0037696
Transcriptional misregulation in cancer	441864	155	11	8	4	0.00085782	0.0081493
Amoebiasis	441864	155	11	2	2	0.0046083	0.029186
NOD-like receptor signaling pathway	441864	155	11	15	4	0.012745	0.06054
Phagosome	441864	155	11	5	2	0.040873	0.15532
Neutrophil extracellular trap formation	441864	155	11	13	3	0.0516	0.1634
Carbohydrate digestion and absorption	441864	155	11	1	1	0.070968	0.19263
PPAR signaling pathway	441864	155	11	2	1	0.13733	0.21743
Lysosome	441864	155	11	2	1	0.13733	0.21743
Renin-angiotensin system	441864	155	11	2	1	0.13733	0.21743
IL-17 signaling pathway	441864	155	11	2	1	0.13733	0.21743
Salivary secretion	441864	155	11	2	1	0.13733	0.21743
Drug metabolism - other enzymes	441864	155	11	3	1	0.19935	0.23673
Neuroactive ligand-receptor interaction	441864	155	11	3	1	0.19935	0.23673
Acute myeloid leukemia	441864	155	11	3	1	0.19935	0.23673
Lipid and atherosclerosis	441864	155	11	3	1	0.19935	0.23673
Tuberculosis	441864	155	11	4	1	0.25729	0.28756
Hematopoietic cell lineage	441864	155	11	5	1	0.3114	0.3287
Systemic lupus erythematosus	441864	155	11	10	1	0.532	0.532
RNA degradation	444882	155	16	2	2	0.010054	0.26544
Pathways of neurodegeneration - multiple diseases	444882	155	16	7	3	0.024695	0.26544
Alzheimer disease	444882	155	16	8	3	0.036973	0.26544
Glycerolipid metabolism	444882	155	16	1	1	0.10323	0.26544
Glycerophospholipid metabolism	444882	155	16	1	1	0.10323	0.26544
ABC transporters	444882	155	16	1	1	0.10323	0.26544
mTOR signaling pathway	444882	155	16	1	1	0.10323	0.26544
Signaling pathways regulating pluripotency of stem cells	444882	155	16	1	1	0.10323	0.26544
Glutamatergic synapse	444882	155	16	1	1	0.10323	0.26544
Serotonergic synapse	444882	155	16	1	1	0.10323	0.26544
GABAergic synapse	444882	155	16	1	1	0.10323	0.26544
Fat digestion and absorption	444882	155	16	1	1	0.10323	0.26544
Epithelial cell signaling in Helicobacter pylori infection	444882	155	16	1	1	0.10323	0.26544
Pathogenic Escherichia coli infection	444882	155	16	1	1	0.10323	0.26544
Parkinson disease	444882	155	16	6	2	0.11741	0.28178
Notch signaling pathway	444882	155	16	2	1	0.1964	0.33668
Complement and coagulation cascades	444882	155	16	2	1	0.1964	0.33668
Alcoholic liver disease	444882	155	16	2	1	0.1964	0.33668
Protein digestion and absorption	444882	155	16	2	1	0.1964	0.33668
Cholesterol metabolism	444882	155	16	2	1	0.1964	0.33668
Salmonella infection	444882	155	16	2	1	0.1964	0.33668
Gap junction	444882	155	16	3	1	0.28043	0.42065
Thyroid hormone signaling pathway	444882	155	16	3	1	0.28043	0.42065
Lipid and atherosclerosis	444882	155	16	3	1	0.28043	0.42065
Coronavirus disease - COVID-19	444882	155	16	11	2	0.31673	0.44215
Ubiquitin mediated proteolysis	444882	155	16	4	1	0.35618	0.44215
Amyotrophic lateral sclerosis	444882	155	16	4	1	0.35618	0.44215
Huntington disease	444882	155	16	4	1	0.35618	0.44215
Prion disease	444882	155	16	4	1	0.35618	0.44215
Phagosome	444882	155	16	5	1	0.4244	0.50928
Protein processing in endoplasmic reticulum	444882	155	16	6	1	0.4858	0.56415
Oocyte meiosis	444882	155	16	7	1	0.54101	0.59019
Progesterone-mediated oocyte maturation	444882	155	16	7	1	0.54101	0.59019
NOD-like receptor signaling pathway	444882	155	16	15	1	0.82054	0.86881
Ribosome biogenesis in eukaryotes	444882	155	16	18	1	0.87565	0.90067
Metabolic pathways	444882	155	16	24	1	0.94185	0.94185
Salmonella infection	445815	155	8	2	2	0.002346	0.077419
Protein processing in endoplasmic reticulum	445815	155	8	6	2	0.031645	0.18925
Biosynthesis of nucleotide sugars	445815	155	8	1	1	0.051613	0.18925
Signaling pathways regulating pluripotency of stem cells	445815	155	8	1	1	0.051613	0.18925
Estrogen signaling pathway	445815	155	8	1	1	0.051613	0.18925
Thyroid hormone synthesis	445815	155	8	1	1	0.051613	0.18925
Oxytocin signaling pathway	445815	155	8	1	1	0.051613	0.18925
Pancreatic secretion	445815	155	8	1	1	0.051613	0.18925
Pathogenic Escherichia coli infection	445815	155	8	1	1	0.051613	0.18925
Amino sugar and nucleotide sugar metabolism	445815	155	8	2	1	0.10088	0.20806
Nicotinate and nicotinamide metabolism	445815	155	8	2	1	0.10088	0.20806
Calcium signaling pathway	445815	155	8	2	1	0.10088	0.20806
IL-17 signaling pathway	445815	155	8	2	1	0.10088	0.20806
Th17 cell differentiation	445815	155	8	2	1	0.10088	0.20806
Salivary secretion	445815	155	8	2	1	0.10088	0.20806
Fluid shear stress and atherosclerosis	445815	155	8	2	1	0.10088	0.20806
PI3K-Akt signaling pathway	445815	155	8	3	1	0.14789	0.24402
Gap junction	445815	155	8	3	1	0.14789	0.24402
Prostate cancer	445815	155	8	3	1	0.14789	0.24402
Lipid and atherosclerosis	445815	155	8	3	1	0.14789	0.24402
DNA replication	445815	155	8	4	1	0.19274	0.26502
Amyotrophic lateral sclerosis	445815	155	8	4	1	0.19274	0.26502
Huntington disease	445815	155	8	4	1	0.19274	0.26502
Prion disease	445815	155	8	4	1	0.19274	0.26502
Phagosome	445815	155	8	5	1	0.23551	0.28784
Hematopoietic cell lineage	445815	155	8	5	1	0.23551	0.28784
Chemical carcinogenesis - receptor activation	445815	155	8	5	1	0.23551	0.28784
Parkinson disease	445815	155	8	6	1	0.27628	0.32562
Pathways of neurodegeneration - multiple diseases	445815	155	8	7	1	0.31514	0.35861
Alzheimer disease	445815	155	8	8	1	0.35216	0.38212
Metabolic pathways	445815	155	8	24	2	0.35896	0.38212
Pathways in cancer	445815	155	8	9	1	0.38742	0.39952
Cell cycle	445815	155	8	14	1	0.53971	0.53971
Influenza A	4599	155	25	10	10	1.9933e-09	1.0166e-07
Measles	4599	155	25	9	9	1.8189e-08	4.6382e-07
Hepatitis C	4599	155	25	12	10	1.0792e-07	1.8346e-06
Coronavirus disease - COVID-19	4599	155	25	11	9	8.1233e-07	1.0357e-05
Herpes simplex virus 1 infection	4599	155	25	9	8	1.27e-06	1.2954e-05
Epstein-Barr virus infection	4599	155	25	11	7	0.00027131	0.0023061
Necroptosis	4599	155	25	4	4	0.00054691	0.0039846
NOD-like receptor signaling pathway	4599	155	25	15	7	0.0033382	0.021281
Human papillomavirus infection	4599	155	25	10	5	0.010611	0.06013
Kaposi sarcoma-associated herpesvirus infection	4599	155	25	4	3	0.013474	0.068717
Hepatitis B	4599	155	25	8	4	0.023884	0.085463
Chemokine signaling pathway	4599	155	25	2	2	0.025136	0.085463
RIG-I-like receptor signaling pathway	4599	155	25	2	2	0.025136	0.085463
Cytosolic DNA-sensing pathway	4599	155	25	2	2	0.025136	0.085463
C-type lectin receptor signaling pathway	4599	155	25	2	2	0.025136	0.085463
JAK-STAT signaling pathway	4599	155	25	3	2	0.067851	0.21628
Osteoclast differentiation	4599	155	25	4	2	0.12223	0.29378
PD-L1 expression and PD-1 checkpoint pathway in cancer	4599	155	25	4	2	0.12223	0.29378
Glycolysis / Gluconeogenesis	4599	155	25	1	1	0.16129	0.29378
Galactose metabolism	4599	155	25	1	1	0.16129	0.29378
NF-kappa B signaling pathway	4599	155	25	1	1	0.16129	0.29378
Toll-like receptor signaling pathway	4599	155	25	1	1	0.16129	0.29378
Th1 and Th2 cell differentiation	4599	155	25	1	1	0.16129	0.29378
Prolactin signaling pathway	4599	155	25	1	1	0.16129	0.29378
AGE-RAGE signaling pathway in diabetic complications	4599	155	25	1	1	0.16129	0.29378
Growth hormone synthesis, secretion and action	4599	155	25	1	1	0.16129	0.29378
Pertussis	4599	155	25	1	1	0.16129	0.29378
Toxoplasmosis	4599	155	25	1	1	0.16129	0.29378
Viral life cycle - HIV-1	4599	155	25	5	2	0.18369	0.32304
Lysosome	4599	155	25	2	1	0.29744	0.3992
Apoptosis	4599	155	25	2	1	0.29744	0.3992
Apoptosis - multiple species	4599	155	25	2	1	0.29744	0.3992
Notch signaling pathway	4599	155	25	2	1	0.29744	0.3992
Cell adhesion molecules	4599	155	25	2	1	0.29744	0.3992
Complement and coagulation cascades	4599	155	25	2	1	0.29744	0.3992
Th17 cell differentiation	4599	155	25	2	1	0.29744	0.3992
Leishmaniasis	4599	155	25	2	1	0.29744	0.3992
Inflammatory bowel disease	4599	155	25	2	1	0.29744	0.3992
Thyroid hormone signaling pathway	4599	155	25	3	1	0.41224	0.52561
Pancreatic cancer	4599	155	25	3	1	0.41224	0.52561
Pathways in cancer	4599	155	25	9	2	0.44248	0.5504
Pyrimidine metabolism	4599	155	25	4	1	0.50891	0.57677
Nucleotide metabolism	4599	155	25	4	1	0.50891	0.57677
Biosynthesis of cofactors	4599	155	25	4	1	0.50891	0.57677
Tuberculosis	4599	155	25	4	1	0.50891	0.57677
Protein processing in endoplasmic reticulum	4599	155	25	6	1	0.65851	0.73009
Human immunodeficiency virus 1 infection	4599	155	25	7	1	0.71581	0.77673
Alzheimer disease	4599	155	25	8	1	0.76382	0.79499
Transcriptional misregulation in cancer	4599	155	25	8	1	0.76382	0.79499
Viral carcinogenesis	4599	155	25	13	1	0.90832	0.92649
Metabolic pathways	4599	155	25	24	2	0.93406	0.93406
Cell cycle	4605	155	29	14	11	4.0353e-07	1.9369e-05
Oocyte meiosis	4605	155	29	7	6	0.00016522	0.0039652
p53 signaling pathway	4605	155	29	4	4	0.0010268	0.01643
Cellular senescence	4605	155	29	7	5	0.0026811	0.025739
Progesterone-mediated oocyte maturation	4605	155	29	7	5	0.0026811	0.025739
Pyrimidine metabolism	4605	155	29	4	3	0.020932	0.12522
Nucleotide metabolism	4605	155	29	4	3	0.020932	0.12522
DNA replication	4605	155	29	4	3	0.020932	0.12522
Human T-cell leukemia virus 1 infection	4605	155	29	7	4	0.023479	0.12522
Glutathione metabolism	4605	155	29	2	2	0.034018	0.14844
Intestinal immune network for IgA production	4605	155	29	2	2	0.034018	0.14844
Drug metabolism - other enzymes	4605	155	29	3	2	0.090047	0.33248
Cytokine-cytokine receptor interaction	4605	155	29	3	2	0.090047	0.33248
Human immunodeficiency virus 1 infection	4605	155	29	7	3	0.12187	0.33262
FoxO signaling pathway	4605	155	29	4	2	0.15916	0.33262
Ubiquitin mediated proteolysis	4605	155	29	4	2	0.15916	0.33262
MicroRNAs in cancer	4605	155	29	4	2	0.15916	0.33262
Purine metabolism	4605	155	29	1	1	0.1871	0.33262
Glycine, serine and threonine metabolism	4605	155	29	1	1	0.1871	0.33262
Glyoxylate and dicarboxylate metabolism	4605	155	29	1	1	0.1871	0.33262
Carbon metabolism	4605	155	29	1	1	0.1871	0.33262
Protein export	4605	155	29	1	1	0.1871	0.33262
Base excision repair	4605	155	29	1	1	0.1871	0.33262
Non-homologous end-joining	4605	155	29	1	1	0.1871	0.33262
Fanconi anemia pathway	4605	155	29	1	1	0.1871	0.33262
Hippo signaling pathway	4605	155	29	1	1	0.1871	0.33262
Primary immunodeficiency	4605	155	29	1	1	0.1871	0.33262
Chemical carcinogenesis - receptor activation	4605	155	29	5	2	0.23484	0.40258
Protein processing in endoplasmic reticulum	4605	155	29	6	2	0.3124	0.46653
One carbon pool by folate	4605	155	29	2	1	0.34018	0.46653
Platinum drug resistance	4605	155	29	2	1	0.34018	0.46653
MAPK signaling pathway	4605	155	29	2	1	0.34018	0.46653
Apoptosis	4605	155	29	2	1	0.34018	0.46653
Apoptosis - multiple species	4605	155	29	2	1	0.34018	0.46653
Colorectal cancer	4605	155	29	2	1	0.34018	0.46653
Viral carcinogenesis	4605	155	29	13	3	0.4532	0.54467
Hepatitis B	4605	155	29	8	2	0.46131	0.54467
Antifolate resistance	4605	155	29	3	1	0.46524	0.54467
AMPK signaling pathway	4605	155	29	3	1	0.46524	0.54467
Gap junction	4605	155	29	3	1	0.46524	0.54467
Acute myeloid leukemia	4605	155	29	3	1	0.46524	0.54467
Metabolic pathways	4605	155	29	24	5	0.48092	0.54962
Pathways in cancer	4605	155	29	9	2	0.52913	0.59066
Parkinson disease	4605	155	29	6	1	0.71797	0.78324
Pathways of neurodegeneration - multiple diseases	4605	155	29	7	1	0.77286	0.82438
Transcriptional misregulation in cancer	4605	155	29	8	1	0.81737	0.85291
Human papillomavirus infection	4605	155	29	10	1	0.88252	0.90129
Epstein-Barr virus infection	4605	155	29	11	1	0.90601	0.90601
Staphylococcus aureus infection	4680	155	13	6	4	0.00042045	0.0092498
Transcriptional misregulation in cancer	4680	155	13	8	4	0.0017779	0.019557
Amoebiasis	4680	155	13	2	2	0.0065354	0.047926
NOD-like receptor signaling pathway	4680	155	13	15	4	0.024428	0.13435
Phagosome	4680	155	13	5	2	0.056413	0.23065
Neutrophil extracellular trap formation	4680	155	13	13	3	0.08073	0.23065
Carbohydrate digestion and absorption	4680	155	13	1	1	0.083871	0.23065
Asthma	4680	155	13	1	1	0.083871	0.23065
Amino sugar and nucleotide sugar metabolism	4680	155	13	2	1	0.16121	0.25332
PPAR signaling pathway	4680	155	13	2	1	0.16121	0.25332
Lysosome	4680	155	13	2	1	0.16121	0.25332
Renin-angiotensin system	4680	155	13	2	1	0.16121	0.25332
IL-17 signaling pathway	4680	155	13	2	1	0.16121	0.25332
Salivary secretion	4680	155	13	2	1	0.16121	0.25332
Drug metabolism - other enzymes	4680	155	13	3	1	0.23248	0.28414
Neuroactive ligand-receptor interaction	4680	155	13	3	1	0.23248	0.28414
Acute myeloid leukemia	4680	155	13	3	1	0.23248	0.28414
Lipid and atherosclerosis	4680	155	13	3	1	0.23248	0.28414
Tuberculosis	4680	155	13	4	1	0.29812	0.34519
Hematopoietic cell lineage	4680	155	13	5	1	0.35855	0.3944
Systemic lupus erythematosus	4680	155	13	10	1	0.59495	0.62328
Metabolic pathways	4680	155	13	24	1	0.89822	0.89822
Oxidative phosphorylation	4713	155	10	3	3	0.00019715	0.0019057
Thermogenesis	4713	155	10	3	3	0.00019715	0.0019057
Diabetic cardiomyopathy	4713	155	10	3	3	0.00019715	0.0019057
Amyotrophic lateral sclerosis	4713	155	10	4	3	0.00076135	0.0031542
Huntington disease	4713	155	10	4	3	0.00076135	0.0031542
Prion disease	4713	155	10	4	3	0.00076135	0.0031542
Chemical carcinogenesis - reactive oxygen species	4713	155	10	4	3	0.00076135	0.0031542
Parkinson disease	4713	155	10	6	3	0.0035472	0.010934
Retrograde endocannabinoid signaling	4713	155	10	2	2	0.0037704	0.010934
Non-alcoholic fatty liver disease	4713	155	10	2	2	0.0037704	0.010934
Pathways of neurodegeneration - multiple diseases	4713	155	10	7	3	0.0059914	0.015796
Metabolic pathways	4713	155	10	24	5	0.0087564	0.020638
Alzheimer disease	4713	155	10	8	3	0.0092515	0.020638
Mucin type O-glycan biosynthesis	4713	155	10	1	1	0.064516	0.11006
Sphingolipid metabolism	4713	155	10	1	1	0.064516	0.11006
Sphingolipid signaling pathway	4713	155	10	1	1	0.064516	0.11006
Renal cell carcinoma	4713	155	10	1	1	0.064516	0.11006
Nicotinate and nicotinamide metabolism	4713	155	10	2	1	0.12526	0.19119
HIF-1 signaling pathway	4713	155	10	2	1	0.12526	0.19119
Neuroactive ligand-receptor interaction	4713	155	10	3	1	0.18243	0.26453
Biosynthesis of cofactors	4713	155	10	4	1	0.23622	0.29784
FoxO signaling pathway	4713	155	10	4	1	0.23622	0.29784
Ubiquitin mediated proteolysis	4713	155	10	4	1	0.23622	0.29784
Hematopoietic cell lineage	4713	155	10	5	1	0.2868	0.34655
Oocyte meiosis	4713	155	10	7	1	0.37902	0.4071
Progesterone-mediated oocyte maturation	4713	155	10	7	1	0.37902	0.4071
Human immunodeficiency virus 1 infection	4713	155	10	7	1	0.37902	0.4071
Pathways in cancer	4713	155	10	9	1	0.46037	0.47681
NOD-like receptor signaling pathway	4713	155	10	15	1	0.65018	0.65018
Influenza A	4938	155	27	10	10	5.1445e-09	2.6237e-07
Measles	4938	155	27	9	9	4.1727e-08	1.064e-06
Hepatitis C	4938	155	27	12	10	2.7084e-07	4.6043e-06
Coronavirus disease - COVID-19	4938	155	27	11	9	1.8128e-06	2.3114e-05
Herpes simplex virus 1 infection	4938	155	27	9	8	2.5717e-06	2.6232e-05
NOD-like receptor signaling pathway	4938	155	27	15	9	0.00010217	0.00086849
Epstein-Barr virus infection	4938	155	27	11	7	0.00047513	0.0034616
Necroptosis	4938	155	27	4	4	0.00075875	0.0048371
Human papillomavirus infection	4938	155	27	10	5	0.015146	0.085829
Kaposi sarcoma-associated herpesvirus infection	4938	155	27	4	3	0.016946	0.086422
Chemokine signaling pathway	4938	155	27	2	2	0.029409	0.10713
RIG-I-like receptor signaling pathway	4938	155	27	2	2	0.029409	0.10713
Cytosolic DNA-sensing pathway	4938	155	27	2	2	0.029409	0.10713
C-type lectin receptor signaling pathway	4938	155	27	2	2	0.029409	0.10713
Hepatitis B	4938	155	27	8	4	0.0316	0.10744
JAK-STAT signaling pathway	4938	155	27	3	2	0.078617	0.25059
Osteoclast differentiation	4938	155	27	4	2	0.14029	0.31728
PD-L1 expression and PD-1 checkpoint pathway in cancer	4938	155	27	4	2	0.14029	0.31728
Glycolysis / Gluconeogenesis	4938	155	27	1	1	0.17419	0.31728
Galactose metabolism	4938	155	27	1	1	0.17419	0.31728
NF-kappa B signaling pathway	4938	155	27	1	1	0.17419	0.31728
Toll-like receptor signaling pathway	4938	155	27	1	1	0.17419	0.31728
Th1 and Th2 cell differentiation	4938	155	27	1	1	0.17419	0.31728
Prolactin signaling pathway	4938	155	27	1	1	0.17419	0.31728
AGE-RAGE signaling pathway in diabetic complications	4938	155	27	1	1	0.17419	0.31728
Growth hormone synthesis, secretion and action	4938	155	27	1	1	0.17419	0.31728
Pertussis	4938	155	27	1	1	0.17419	0.31728
Toxoplasmosis	4938	155	27	1	1	0.17419	0.31728
Viral life cycle - HIV-1	4938	155	27	5	2	0.2089	0.36738
Lysosome	4938	155	27	2	1	0.31898	0.4281
Apoptosis	4938	155	27	2	1	0.31898	0.4281
Apoptosis - multiple species	4938	155	27	2	1	0.31898	0.4281
Notch signaling pathway	4938	155	27	2	1	0.31898	0.4281
Cell adhesion molecules	4938	155	27	2	1	0.31898	0.4281
Complement and coagulation cascades	4938	155	27	2	1	0.31898	0.4281
Th17 cell differentiation	4938	155	27	2	1	0.31898	0.4281
Leishmaniasis	4938	155	27	2	1	0.31898	0.4281
Inflammatory bowel disease	4938	155	27	2	1	0.31898	0.4281
Thyroid hormone signaling pathway	4938	155	27	3	1	0.43916	0.55993
Pancreatic cancer	4938	155	27	3	1	0.43916	0.55993
Pathways in cancer	4938	155	27	9	2	0.4866	0.60529
Pyrimidine metabolism	4938	155	27	4	1	0.53878	0.61062
Nucleotide metabolism	4938	155	27	4	1	0.53878	0.61062
Biosynthesis of cofactors	4938	155	27	4	1	0.53878	0.61062
Tuberculosis	4938	155	27	4	1	0.53878	0.61062
Protein processing in endoplasmic reticulum	4938	155	27	6	1	0.68943	0.76436
Human immunodeficiency virus 1 infection	4938	155	27	7	1	0.7457	0.80917
Alzheimer disease	4938	155	27	8	1	0.7921	0.82443
Transcriptional misregulation in cancer	4938	155	27	8	1	0.7921	0.82443
Viral carcinogenesis	4938	155	27	13	1	0.9258	0.94432
Metabolic pathways	4938	155	27	24	2	0.9525	0.9525
Influenza A	4939	155	28	10	10	8.0025e-09	4.1613e-07
Measles	4939	155	28	9	9	6.1493e-08	1.5988e-06
Hepatitis C	4939	155	28	12	10	4.1541e-07	7.2004e-06
Coronavirus disease - COVID-19	4939	155	28	11	9	2.6346e-06	3.4249e-05
Herpes simplex virus 1 infection	4939	155	28	9	8	3.5758e-06	3.7188e-05
NOD-like receptor signaling pathway	4939	155	28	15	9	0.00014436	0.0012511
Epstein-Barr virus infection	4939	155	28	11	7	0.00061664	0.0045808
Necroptosis	4939	155	28	4	4	0.00088521	0.0057539
Human papillomavirus infection	4939	155	28	10	5	0.017867	0.098138
Kaposi sarcoma-associated herpesvirus infection	4939	155	28	4	3	0.018873	0.098138
Chemokine signaling pathway	4939	155	28	2	2	0.031672	0.11764
RIG-I-like receptor signaling pathway	4939	155	28	2	2	0.031672	0.11764
Cytosolic DNA-sensing pathway	4939	155	28	2	2	0.031672	0.11764
C-type lectin receptor signaling pathway	4939	155	28	2	2	0.031672	0.11764
Hepatitis B	4939	155	28	8	4	0.035996	0.12479
JAK-STAT signaling pathway	4939	155	28	3	2	0.08425	0.27381
Osteoclast differentiation	4939	155	28	4	2	0.14963	0.32392
PD-L1 expression and PD-1 checkpoint pathway in cancer	4939	155	28	4	2	0.14963	0.32392
Glycolysis / Gluconeogenesis	4939	155	28	1	1	0.18065	0.32392
Galactose metabolism	4939	155	28	1	1	0.18065	0.32392
NF-kappa B signaling pathway	4939	155	28	1	1	0.18065	0.32392
Signaling pathways regulating pluripotency of stem cells	4939	155	28	1	1	0.18065	0.32392
Toll-like receptor signaling pathway	4939	155	28	1	1	0.18065	0.32392
Th1 and Th2 cell differentiation	4939	155	28	1	1	0.18065	0.32392
Prolactin signaling pathway	4939	155	28	1	1	0.18065	0.32392
AGE-RAGE signaling pathway in diabetic complications	4939	155	28	1	1	0.18065	0.32392
Growth hormone synthesis, secretion and action	4939	155	28	1	1	0.18065	0.32392
Pertussis	4939	155	28	1	1	0.18065	0.32392
Toxoplasmosis	4939	155	28	1	1	0.18065	0.32392
Viral life cycle - HIV-1	4939	155	28	5	2	0.22179	0.38443
Lysosome	4939	155	28	2	1	0.32962	0.43949
Apoptosis	4939	155	28	2	1	0.32962	0.43949
Apoptosis - multiple species	4939	155	28	2	1	0.32962	0.43949
Notch signaling pathway	4939	155	28	2	1	0.32962	0.43949
Cell adhesion molecules	4939	155	28	2	1	0.32962	0.43949
Complement and coagulation cascades	4939	155	28	2	1	0.32962	0.43949
Th17 cell differentiation	4939	155	28	2	1	0.32962	0.43949
Leishmaniasis	4939	155	28	2	1	0.32962	0.43949
Inflammatory bowel disease	4939	155	28	2	1	0.32962	0.43949
Thyroid hormone signaling pathway	4939	155	28	3	1	0.4523	0.57365
Pancreatic cancer	4939	155	28	3	1	0.4523	0.57365
Pathways in cancer	4939	155	28	9	2	0.50808	0.62535
Pyrimidine metabolism	4939	155	28	4	1	0.55319	0.62535
Nucleotide metabolism	4939	155	28	4	1	0.55319	0.62535
Biosynthesis of cofactors	4939	155	28	4	1	0.55319	0.62535
Tuberculosis	4939	155	28	4	1	0.55319	0.62535
Protein processing in endoplasmic reticulum	4939	155	28	6	1	0.70398	0.77888
Human immunodeficiency virus 1 infection	4939	155	28	7	1	0.75961	0.82291
Alzheimer disease	4939	155	28	8	1	0.80509	0.83729
Transcriptional misregulation in cancer	4939	155	28	8	1	0.80509	0.83729
Viral carcinogenesis	4939	155	28	13	1	0.93334	0.95164
Metabolic pathways	4939	155	28	24	2	0.95985	0.95985
Influenza A	4940	155	29	10	10	1.2214e-08	6.4736e-07
Measles	4940	155	29	9	9	8.9165e-08	2.3629e-06
Hepatitis C	4940	155	29	12	10	6.2509e-07	1.1043e-05
Coronavirus disease - COVID-19	4940	155	29	11	9	3.7669e-06	4.9911e-05
Herpes simplex virus 1 infection	4940	155	29	9	8	4.9041e-06	5.1983e-05
NOD-like receptor signaling pathway	4940	155	29	15	9	0.00020063	0.0017722
Epstein-Barr virus infection	4940	155	29	11	7	0.00079109	0.0059897
Necroptosis	4940	155	29	4	4	0.0010268	0.0068029
Human papillomavirus infection	4940	155	29	10	5	0.020916	0.11094
Kaposi sarcoma-associated herpesvirus infection	4940	155	29	4	3	0.020932	0.11094
Chemokine signaling pathway	4940	155	29	2	2	0.034018	0.12878
RIG-I-like receptor signaling pathway	4940	155	29	2	2	0.034018	0.12878
Cytosolic DNA-sensing pathway	4940	155	29	2	2	0.034018	0.12878
C-type lectin receptor signaling pathway	4940	155	29	2	2	0.034018	0.12878
Hepatitis B	4940	155	29	8	4	0.040764	0.14403
JAK-STAT signaling pathway	4940	155	29	3	2	0.090047	0.29828
Osteoclast differentiation	4940	155	29	4	2	0.15916	0.34194
PD-L1 expression and PD-1 checkpoint pathway in cancer	4940	155	29	4	2	0.15916	0.34194
Glycolysis / Gluconeogenesis	4940	155	29	1	1	0.1871	0.34194
Galactose metabolism	4940	155	29	1	1	0.1871	0.34194
NF-kappa B signaling pathway	4940	155	29	1	1	0.1871	0.34194
Signaling pathways regulating pluripotency of stem cells	4940	155	29	1	1	0.1871	0.34194
Toll-like receptor signaling pathway	4940	155	29	1	1	0.1871	0.34194
Th1 and Th2 cell differentiation	4940	155	29	1	1	0.1871	0.34194
Prolactin signaling pathway	4940	155	29	1	1	0.1871	0.34194
AGE-RAGE signaling pathway in diabetic complications	4940	155	29	1	1	0.1871	0.34194
Growth hormone synthesis, secretion and action	4940	155	29	1	1	0.1871	0.34194
Pertussis	4940	155	29	1	1	0.1871	0.34194
Toxoplasmosis	4940	155	29	1	1	0.1871	0.34194
Viral life cycle - HIV-1	4940	155	29	5	2	0.23484	0.41488
RNA degradation	4940	155	29	2	1	0.34018	0.45073
Lysosome	4940	155	29	2	1	0.34018	0.45073
Apoptosis	4940	155	29	2	1	0.34018	0.45073
Apoptosis - multiple species	4940	155	29	2	1	0.34018	0.45073
Notch signaling pathway	4940	155	29	2	1	0.34018	0.45073
Cell adhesion molecules	4940	155	29	2	1	0.34018	0.45073
Complement and coagulation cascades	4940	155	29	2	1	0.34018	0.45073
Th17 cell differentiation	4940	155	29	2	1	0.34018	0.45073
Leishmaniasis	4940	155	29	2	1	0.34018	0.45073
Inflammatory bowel disease	4940	155	29	2	1	0.34018	0.45073
Thyroid hormone signaling pathway	4940	155	29	3	1	0.46524	0.58709
Pancreatic cancer	4940	155	29	3	1	0.46524	0.58709
Pathways in cancer	4940	155	29	9	2	0.52913	0.63968
Pyrimidine metabolism	4940	155	29	4	1	0.56727	0.63968
Nucleotide metabolism	4940	155	29	4	1	0.56727	0.63968
Biosynthesis of cofactors	4940	155	29	4	1	0.56727	0.63968
Tuberculosis	4940	155	29	4	1	0.56727	0.63968
Protein processing in endoplasmic reticulum	4940	155	29	6	1	0.71797	0.79276
Human immunodeficiency virus 1 infection	4940	155	29	7	1	0.77286	0.83595
Alzheimer disease	4940	155	29	8	1	0.81737	0.84942
Transcriptional misregulation in cancer	4940	155	29	8	1	0.81737	0.84942
Viral carcinogenesis	4940	155	29	13	1	0.94016	0.95824
Metabolic pathways	4940	155	29	24	2	0.96614	0.96614
Cell cycle	494143	155	24	14	6	0.0095524	0.33532
DNA replication	494143	155	24	4	3	0.011923	0.33532
Glutathione metabolism	494143	155	24	2	2	0.023125	0.33532
Intestinal immune network for IgA production	494143	155	24	2	2	0.023125	0.33532
Protein processing in endoplasmic reticulum	494143	155	24	6	3	0.047944	0.40821
Cytokine-cytokine receptor interaction	494143	155	24	3	2	0.062725	0.40821
Cellular senescence	494143	155	24	7	3	0.075286	0.40821
Progesterone-mediated oocyte maturation	494143	155	24	7	3	0.075286	0.40821
p53 signaling pathway	494143	155	24	4	2	0.11353	0.40821
Purine metabolism	494143	155	24	1	1	0.15484	0.40821
Glycine, serine and threonine metabolism	494143	155	24	1	1	0.15484	0.40821
Glyoxylate and dicarboxylate metabolism	494143	155	24	1	1	0.15484	0.40821
Carbon metabolism	494143	155	24	1	1	0.15484	0.40821
Biosynthesis of nucleotide sugars	494143	155	24	1	1	0.15484	0.40821
Protein export	494143	155	24	1	1	0.15484	0.40821
Base excision repair	494143	155	24	1	1	0.15484	0.40821
Non-homologous end-joining	494143	155	24	1	1	0.15484	0.40821
Estrogen signaling pathway	494143	155	24	1	1	0.15484	0.40821
Thyroid hormone synthesis	494143	155	24	1	1	0.15484	0.40821
Oxytocin signaling pathway	494143	155	24	1	1	0.15484	0.40821
Pancreatic secretion	494143	155	24	1	1	0.15484	0.40821
Primary immunodeficiency	494143	155	24	1	1	0.15484	0.40821
Chemical carcinogenesis - receptor activation	494143	155	24	5	2	0.1714	0.43222
Amino sugar and nucleotide sugar metabolism	494143	155	24	2	1	0.28655	0.50085
Nicotinate and nicotinamide metabolism	494143	155	24	2	1	0.28655	0.50085
Folate biosynthesis	494143	155	24	2	1	0.28655	0.50085
Calcium signaling pathway	494143	155	24	2	1	0.28655	0.50085
ECM-receptor interaction	494143	155	24	2	1	0.28655	0.50085
IL-17 signaling pathway	494143	155	24	2	1	0.28655	0.50085
Th17 cell differentiation	494143	155	24	2	1	0.28655	0.50085
Salivary secretion	494143	155	24	2	1	0.28655	0.50085
Salmonella infection	494143	155	24	2	1	0.28655	0.50085
Fluid shear stress and atherosclerosis	494143	155	24	2	1	0.28655	0.50085
Oocyte meiosis	494143	155	24	7	2	0.29626	0.50085
Metabolic pathways	494143	155	24	24	5	0.30224	0.50085
Drug metabolism - other enzymes	494143	155	24	3	1	0.39847	0.55026
Antifolate resistance	494143	155	24	3	1	0.39847	0.55026
PI3K-Akt signaling pathway	494143	155	24	3	1	0.39847	0.55026
AMPK signaling pathway	494143	155	24	3	1	0.39847	0.55026
Prostate cancer	494143	155	24	3	1	0.39847	0.55026
Acute myeloid leukemia	494143	155	24	3	1	0.39847	0.55026
Lipid and atherosclerosis	494143	155	24	3	1	0.39847	0.55026
Pathways in cancer	494143	155	24	9	2	0.41991	0.56638
Pyrimidine metabolism	494143	155	24	4	1	0.49344	0.60893
Nucleotide metabolism	494143	155	24	4	1	0.49344	0.60893
Biosynthesis of cofactors	494143	155	24	4	1	0.49344	0.60893
FoxO signaling pathway	494143	155	24	4	1	0.49344	0.60893
Viral life cycle - HIV-1	494143	155	24	5	1	0.57396	0.67938
Hematopoietic cell lineage	494143	155	24	5	1	0.57396	0.67938
Parkinson disease	494143	155	24	6	1	0.64212	0.74486
Pathways of neurodegeneration - multiple diseases	494143	155	24	7	1	0.69977	0.76578
Human T-cell leukemia virus 1 infection	494143	155	24	7	1	0.69977	0.76578
Human immunodeficiency virus 1 infection	494143	155	24	7	1	0.69977	0.76578
Hepatitis B	494143	155	24	8	1	0.74845	0.78928
Transcriptional misregulation in cancer	494143	155	24	8	1	0.74845	0.78928
Human papillomavirus infection	494143	155	24	10	1	0.82412	0.85355
Epstein-Barr virus infection	494143	155	24	11	1	0.85323	0.8682
Viral carcinogenesis	494143	155	24	13	1	0.89822	0.89822
Staphylococcus aureus infection	4973	155	11	6	4	0.0001984	0.0037696
Transcriptional misregulation in cancer	4973	155	11	8	4	0.00085782	0.0081493
Amoebiasis	4973	155	11	2	2	0.0046083	0.029186
NOD-like receptor signaling pathway	4973	155	11	15	4	0.012745	0.06054
Phagosome	4973	155	11	5	2	0.040873	0.15532
Neutrophil extracellular trap formation	4973	155	11	13	3	0.0516	0.1634
Carbohydrate digestion and absorption	4973	155	11	1	1	0.070968	0.19263
PPAR signaling pathway	4973	155	11	2	1	0.13733	0.21743
Lysosome	4973	155	11	2	1	0.13733	0.21743
Renin-angiotensin system	4973	155	11	2	1	0.13733	0.21743
IL-17 signaling pathway	4973	155	11	2	1	0.13733	0.21743
Salivary secretion	4973	155	11	2	1	0.13733	0.21743
Drug metabolism - other enzymes	4973	155	11	3	1	0.19935	0.23673
Neuroactive ligand-receptor interaction	4973	155	11	3	1	0.19935	0.23673
Acute myeloid leukemia	4973	155	11	3	1	0.19935	0.23673
Lipid and atherosclerosis	4973	155	11	3	1	0.19935	0.23673
Tuberculosis	4973	155	11	4	1	0.25729	0.28756
Hematopoietic cell lineage	4973	155	11	5	1	0.3114	0.3287
Systemic lupus erythematosus	4973	155	11	10	1	0.532	0.532
Cell cycle	51053	155	27	14	12	4.9715e-09	2.1378e-07
Oocyte meiosis	51053	155	27	7	6	0.00010432	0.0022429
DNA replication	51053	155	27	4	4	0.00075875	0.0081566
p53 signaling pathway	51053	155	27	4	4	0.00075875	0.0081566
Cellular senescence	51053	155	27	7	5	0.0018696	0.013399
Progesterone-mediated oocyte maturation	51053	155	27	7	5	0.0018696	0.013399
Pyrimidine metabolism	51053	155	27	4	3	0.016946	0.085938
Nucleotide metabolism	51053	155	27	4	3	0.016946	0.085938
Human T-cell leukemia virus 1 infection	51053	155	27	7	4	0.017987	0.085938
Glutathione metabolism	51053	155	27	2	2	0.029409	0.12646
Drug metabolism - other enzymes	51053	155	27	3	2	0.078617	0.30732
Human immunodeficiency virus 1 infection	51053	155	27	7	3	0.10193	0.34047
FoxO signaling pathway	51053	155	27	4	2	0.14029	0.34047
Ubiquitin mediated proteolysis	51053	155	27	4	2	0.14029	0.34047
MicroRNAs in cancer	51053	155	27	4	2	0.14029	0.34047
Purine metabolism	51053	155	27	1	1	0.17419	0.34047
Biosynthesis of nucleotide sugars	51053	155	27	1	1	0.17419	0.34047
Protein export	51053	155	27	1	1	0.17419	0.34047
Base excision repair	51053	155	27	1	1	0.17419	0.34047
Non-homologous end-joining	51053	155	27	1	1	0.17419	0.34047
Fanconi anemia pathway	51053	155	27	1	1	0.17419	0.34047
Hippo signaling pathway	51053	155	27	1	1	0.17419	0.34047
Chemical carcinogenesis - receptor activation	51053	155	27	5	2	0.2089	0.39056
Amino sugar and nucleotide sugar metabolism	51053	155	27	2	1	0.31898	0.44245
One carbon pool by folate	51053	155	27	2	1	0.31898	0.44245
Platinum drug resistance	51053	155	27	2	1	0.31898	0.44245
MAPK signaling pathway	51053	155	27	2	1	0.31898	0.44245
Apoptosis	51053	155	27	2	1	0.31898	0.44245
Apoptosis - multiple species	51053	155	27	2	1	0.31898	0.44245
ECM-receptor interaction	51053	155	27	2	1	0.31898	0.44245
Colorectal cancer	51053	155	27	2	1	0.31898	0.44245
Viral carcinogenesis	51053	155	27	13	3	0.40196	0.49694
Metabolic pathways	51053	155	27	24	5	0.40918	0.49694
Hepatitis B	51053	155	27	8	2	0.42096	0.49694
Antifolate resistance	51053	155	27	3	1	0.43916	0.49694
AMPK signaling pathway	51053	155	27	3	1	0.43916	0.49694
Gap junction	51053	155	27	3	1	0.43916	0.49694
Acute myeloid leukemia	51053	155	27	3	1	0.43916	0.49694
Pathways in cancer	51053	155	27	9	2	0.4866	0.53651
Protein processing in endoplasmic reticulum	51053	155	27	6	1	0.68943	0.74113
Transcriptional misregulation in cancer	51053	155	27	8	1	0.7921	0.83073
Human papillomavirus infection	51053	155	27	10	1	0.86167	0.88218
Epstein-Barr virus infection	51053	155	27	11	1	0.88743	0.88743
Influenza A	51191	155	27	10	10	5.1445e-09	2.6237e-07
Measles	51191	155	27	9	9	4.1727e-08	1.064e-06
Hepatitis C	51191	155	27	12	10	2.7084e-07	4.6043e-06
Coronavirus disease - COVID-19	51191	155	27	11	9	1.8128e-06	2.3114e-05
Herpes simplex virus 1 infection	51191	155	27	9	8	2.5717e-06	2.6232e-05
NOD-like receptor signaling pathway	51191	155	27	15	9	0.00010217	0.00086849
Epstein-Barr virus infection	51191	155	27	11	7	0.00047513	0.0034616
Necroptosis	51191	155	27	4	4	0.00075875	0.0048371
Human papillomavirus infection	51191	155	27	10	5	0.015146	0.085829
Kaposi sarcoma-associated herpesvirus infection	51191	155	27	4	3	0.016946	0.086422
Chemokine signaling pathway	51191	155	27	2	2	0.029409	0.10713
RIG-I-like receptor signaling pathway	51191	155	27	2	2	0.029409	0.10713
Cytosolic DNA-sensing pathway	51191	155	27	2	2	0.029409	0.10713
C-type lectin receptor signaling pathway	51191	155	27	2	2	0.029409	0.10713
Hepatitis B	51191	155	27	8	4	0.0316	0.10744
JAK-STAT signaling pathway	51191	155	27	3	2	0.078617	0.25059
Osteoclast differentiation	51191	155	27	4	2	0.14029	0.31728
PD-L1 expression and PD-1 checkpoint pathway in cancer	51191	155	27	4	2	0.14029	0.31728
Glycolysis / Gluconeogenesis	51191	155	27	1	1	0.17419	0.31728
Galactose metabolism	51191	155	27	1	1	0.17419	0.31728
NF-kappa B signaling pathway	51191	155	27	1	1	0.17419	0.31728
Toll-like receptor signaling pathway	51191	155	27	1	1	0.17419	0.31728
Th1 and Th2 cell differentiation	51191	155	27	1	1	0.17419	0.31728
Prolactin signaling pathway	51191	155	27	1	1	0.17419	0.31728
AGE-RAGE signaling pathway in diabetic complications	51191	155	27	1	1	0.17419	0.31728
Growth hormone synthesis, secretion and action	51191	155	27	1	1	0.17419	0.31728
Pertussis	51191	155	27	1	1	0.17419	0.31728
Toxoplasmosis	51191	155	27	1	1	0.17419	0.31728
Viral life cycle - HIV-1	51191	155	27	5	2	0.2089	0.36738
Lysosome	51191	155	27	2	1	0.31898	0.4281
Apoptosis	51191	155	27	2	1	0.31898	0.4281
Apoptosis - multiple species	51191	155	27	2	1	0.31898	0.4281
Notch signaling pathway	51191	155	27	2	1	0.31898	0.4281
Cell adhesion molecules	51191	155	27	2	1	0.31898	0.4281
Complement and coagulation cascades	51191	155	27	2	1	0.31898	0.4281
Th17 cell differentiation	51191	155	27	2	1	0.31898	0.4281
Leishmaniasis	51191	155	27	2	1	0.31898	0.4281
Inflammatory bowel disease	51191	155	27	2	1	0.31898	0.4281
Thyroid hormone signaling pathway	51191	155	27	3	1	0.43916	0.55993
Pancreatic cancer	51191	155	27	3	1	0.43916	0.55993
Pathways in cancer	51191	155	27	9	2	0.4866	0.60529
Pyrimidine metabolism	51191	155	27	4	1	0.53878	0.61062
Nucleotide metabolism	51191	155	27	4	1	0.53878	0.61062
Biosynthesis of cofactors	51191	155	27	4	1	0.53878	0.61062
Tuberculosis	51191	155	27	4	1	0.53878	0.61062
Protein processing in endoplasmic reticulum	51191	155	27	6	1	0.68943	0.76436
Human immunodeficiency virus 1 infection	51191	155	27	7	1	0.7457	0.80917
Alzheimer disease	51191	155	27	8	1	0.7921	0.82443
Transcriptional misregulation in cancer	51191	155	27	8	1	0.7921	0.82443
Viral carcinogenesis	51191	155	27	13	1	0.9258	0.94432
Metabolic pathways	51191	155	27	24	2	0.9525	0.9525
Cell cycle	51203	155	25	14	12	1.5302e-09	7.0387e-08
Oocyte meiosis	51203	155	25	7	6	6.323e-05	0.0014543
DNA replication	51203	155	25	4	4	0.00054691	0.0062894
p53 signaling pathway	51203	155	25	4	4	0.00054691	0.0062894
Progesterone-mediated oocyte maturation	51203	155	25	7	5	0.0012617	0.011608
Cellular senescence	51203	155	25	7	4	0.013437	0.088299
Human T-cell leukemia virus 1 infection	51203	155	25	7	4	0.013437	0.088299
One carbon pool by folate	51203	155	25	2	2	0.025136	0.12847
Platinum drug resistance	51203	155	25	2	2	0.025136	0.12847
Antifolate resistance	51203	155	25	3	2	0.067851	0.28374
AMPK signaling pathway	51203	155	25	3	2	0.067851	0.28374
Human immunodeficiency virus 1 infection	51203	155	25	7	3	0.08372	0.29677
Pyrimidine metabolism	51203	155	25	4	2	0.12223	0.29677
Nucleotide metabolism	51203	155	25	4	2	0.12223	0.29677
FoxO signaling pathway	51203	155	25	4	2	0.12223	0.29677
Ubiquitin mediated proteolysis	51203	155	25	4	2	0.12223	0.29677
MicroRNAs in cancer	51203	155	25	4	2	0.12223	0.29677
Purine metabolism	51203	155	25	1	1	0.16129	0.29677
Biosynthesis of unsaturated fatty acids	51203	155	25	1	1	0.16129	0.29677
Fatty acid metabolism	51203	155	25	1	1	0.16129	0.29677
Base excision repair	51203	155	25	1	1	0.16129	0.29677
Non-homologous end-joining	51203	155	25	1	1	0.16129	0.29677
Fanconi anemia pathway	51203	155	25	1	1	0.16129	0.29677
Hippo signaling pathway	51203	155	25	1	1	0.16129	0.29677
Carbohydrate digestion and absorption	51203	155	25	1	1	0.16129	0.29677
Chemical carcinogenesis - receptor activation	51203	155	25	5	2	0.18369	0.32499
Glutathione metabolism	51203	155	25	2	1	0.29744	0.39093
Folate biosynthesis	51203	155	25	2	1	0.29744	0.39093
PPAR signaling pathway	51203	155	25	2	1	0.29744	0.39093
MAPK signaling pathway	51203	155	25	2	1	0.29744	0.39093
Apoptosis	51203	155	25	2	1	0.29744	0.39093
Apoptosis - multiple species	51203	155	25	2	1	0.29744	0.39093
ECM-receptor interaction	51203	155	25	2	1	0.29744	0.39093
Alcoholic liver disease	51203	155	25	2	1	0.29744	0.39093
Colorectal cancer	51203	155	25	2	1	0.29744	0.39093
Viral carcinogenesis	51203	155	25	13	3	0.35026	0.44756
Hepatitis B	51203	155	25	8	2	0.37978	0.47216
Drug metabolism - other enzymes	51203	155	25	3	1	0.41224	0.47408
Gap junction	51203	155	25	3	1	0.41224	0.47408
Acute myeloid leukemia	51203	155	25	3	1	0.41224	0.47408
Pathways in cancer	51203	155	25	9	2	0.44248	0.49644
Biosynthesis of cofactors	51203	155	25	4	1	0.50891	0.55738
Metabolic pathways	51203	155	25	24	4	0.56976	0.60951
Transcriptional misregulation in cancer	51203	155	25	8	1	0.76382	0.79853
Human papillomavirus infection	51203	155	25	10	1	0.83755	0.85616
Epstein-Barr virus infection	51203	155	25	11	1	0.86556	0.86556
Intestinal immune network for IgA production	51237	155	14	2	2	0.0076246	0.16183
Protein processing in endoplasmic reticulum	51237	155	14	6	3	0.010114	0.16183
Cytokine-cytokine receptor interaction	51237	155	14	3	2	0.021678	0.22233
Chemical carcinogenesis - receptor activation	51237	155	14	5	2	0.064924	0.22233
Glycine, serine and threonine metabolism	51237	155	14	1	1	0.090323	0.22233
Glyoxylate and dicarboxylate metabolism	51237	155	14	1	1	0.090323	0.22233
Carbon metabolism	51237	155	14	1	1	0.090323	0.22233
Protein export	51237	155	14	1	1	0.090323	0.22233
Base excision repair	51237	155	14	1	1	0.090323	0.22233
Non-homologous end-joining	51237	155	14	1	1	0.090323	0.22233
Estrogen signaling pathway	51237	155	14	1	1	0.090323	0.22233
Thyroid hormone synthesis	51237	155	14	1	1	0.090323	0.22233
Primary immunodeficiency	51237	155	14	1	1	0.090323	0.22233
Cell cycle	51237	155	14	14	3	0.11743	0.26147
Oocyte meiosis	51237	155	14	7	2	0.12257	0.26147
IL-17 signaling pathway	51237	155	14	2	1	0.17302	0.2914
Th17 cell differentiation	51237	155	14	2	1	0.17302	0.2914
Salmonella infection	51237	155	14	2	1	0.17302	0.2914
Fluid shear stress and atherosclerosis	51237	155	14	2	1	0.17302	0.2914
PI3K-Akt signaling pathway	51237	155	14	3	1	0.24869	0.36173
Prostate cancer	51237	155	14	3	1	0.24869	0.36173
Lipid and atherosclerosis	51237	155	14	3	1	0.24869	0.36173
DNA replication	51237	155	14	4	1	0.31789	0.42386
Ubiquitin mediated proteolysis	51237	155	14	4	1	0.31789	0.42386
Parkinson disease	51237	155	14	6	1	0.43889	0.54247
Cellular senescence	51237	155	14	7	1	0.49162	0.54247
Progesterone-mediated oocyte maturation	51237	155	14	7	1	0.49162	0.54247
Pathways of neurodegeneration - multiple diseases	51237	155	14	7	1	0.49162	0.54247
Human T-cell leukemia virus 1 infection	51237	155	14	7	1	0.49162	0.54247
Pathways in cancer	51237	155	14	9	1	0.58354	0.62245
Viral carcinogenesis	51237	155	14	13	1	0.72297	0.74629
Metabolic pathways	51237	155	14	24	1	0.91542	0.91542
Oxidative phosphorylation	513	155	10	3	3	0.00019715	0.0019057
Thermogenesis	513	155	10	3	3	0.00019715	0.0019057
Diabetic cardiomyopathy	513	155	10	3	3	0.00019715	0.0019057
Amyotrophic lateral sclerosis	513	155	10	4	3	0.00076135	0.0031542
Huntington disease	513	155	10	4	3	0.00076135	0.0031542
Prion disease	513	155	10	4	3	0.00076135	0.0031542
Chemical carcinogenesis - reactive oxygen species	513	155	10	4	3	0.00076135	0.0031542
Parkinson disease	513	155	10	6	3	0.0035472	0.010934
Retrograde endocannabinoid signaling	513	155	10	2	2	0.0037704	0.010934
Non-alcoholic fatty liver disease	513	155	10	2	2	0.0037704	0.010934
Pathways of neurodegeneration - multiple diseases	513	155	10	7	3	0.0059914	0.015796
Metabolic pathways	513	155	10	24	5	0.0087564	0.020638
Alzheimer disease	513	155	10	8	3	0.0092515	0.020638
Mucin type O-glycan biosynthesis	513	155	10	1	1	0.064516	0.10394
Sphingolipid metabolism	513	155	10	1	1	0.064516	0.10394
Glutamatergic synapse	513	155	10	1	1	0.064516	0.10394
GABAergic synapse	513	155	10	1	1	0.064516	0.10394
Renal cell carcinoma	513	155	10	1	1	0.064516	0.10394
Nicotinate and nicotinamide metabolism	513	155	10	2	1	0.12526	0.17298
HIF-1 signaling pathway	513	155	10	2	1	0.12526	0.17298
Protein digestion and absorption	513	155	10	2	1	0.12526	0.17298
Biosynthesis of cofactors	513	155	10	4	1	0.23622	0.29784
Ubiquitin mediated proteolysis	513	155	10	4	1	0.23622	0.29784
Hematopoietic cell lineage	513	155	10	5	1	0.2868	0.34655
Oocyte meiosis	513	155	10	7	1	0.37902	0.4071
Progesterone-mediated oocyte maturation	513	155	10	7	1	0.37902	0.4071
Human immunodeficiency virus 1 infection	513	155	10	7	1	0.37902	0.4071
Pathways in cancer	513	155	10	9	1	0.46037	0.47681
NOD-like receptor signaling pathway	513	155	10	15	1	0.65018	0.65018
Protein processing in endoplasmic reticulum	51303	155	17	6	4	0.0013379	0.050841
Intestinal immune network for IgA production	51303	155	17	2	2	0.011395	0.21651
Cytokine-cytokine receptor interaction	51303	155	17	3	2	0.031951	0.26048
Chemical carcinogenesis - receptor activation	51303	155	17	5	2	0.093115	0.26048
Glycine, serine and threonine metabolism	51303	155	17	1	1	0.10968	0.26048
Glyoxylate and dicarboxylate metabolism	51303	155	17	1	1	0.10968	0.26048
Carbon metabolism	51303	155	17	1	1	0.10968	0.26048
Biosynthesis of nucleotide sugars	51303	155	17	1	1	0.10968	0.26048
Protein export	51303	155	17	1	1	0.10968	0.26048
Base excision repair	51303	155	17	1	1	0.10968	0.26048
Non-homologous end-joining	51303	155	17	1	1	0.10968	0.26048
Estrogen signaling pathway	51303	155	17	1	1	0.10968	0.26048
Thyroid hormone synthesis	51303	155	17	1	1	0.10968	0.26048
Oxytocin signaling pathway	51303	155	17	1	1	0.10968	0.26048
Pancreatic secretion	51303	155	17	1	1	0.10968	0.26048
Primary immunodeficiency	51303	155	17	1	1	0.10968	0.26048
Glutathione metabolism	51303	155	17	2	1	0.20796	0.3161
Amino sugar and nucleotide sugar metabolism	51303	155	17	2	1	0.20796	0.3161
Nicotinate and nicotinamide metabolism	51303	155	17	2	1	0.20796	0.3161
Calcium signaling pathway	51303	155	17	2	1	0.20796	0.3161
IL-17 signaling pathway	51303	155	17	2	1	0.20796	0.3161
Th17 cell differentiation	51303	155	17	2	1	0.20796	0.3161
Salivary secretion	51303	155	17	2	1	0.20796	0.3161
Salmonella infection	51303	155	17	2	1	0.20796	0.3161
Fluid shear stress and atherosclerosis	51303	155	17	2	1	0.20796	0.3161
Metabolic pathways	51303	155	17	24	4	0.25592	0.37404
PI3K-Akt signaling pathway	51303	155	17	3	1	0.29596	0.38782
Prostate cancer	51303	155	17	3	1	0.29596	0.38782
Lipid and atherosclerosis	51303	155	17	3	1	0.29596	0.38782
DNA replication	51303	155	17	4	1	0.37471	0.47463
Hematopoietic cell lineage	51303	155	17	5	1	0.4451	0.54561
Cell cycle	51303	155	17	14	2	0.47135	0.55973
Parkinson disease	51303	155	17	6	1	0.50799	0.57937
Oocyte meiosis	51303	155	17	7	1	0.56413	0.57937
Cellular senescence	51303	155	17	7	1	0.56413	0.57937
Progesterone-mediated oocyte maturation	51303	155	17	7	1	0.56413	0.57937
Pathways of neurodegeneration - multiple diseases	51303	155	17	7	1	0.56413	0.57937
Pathways in cancer	51303	155	17	9	1	0.65881	0.65881
Tuberculosis	51439	155	27	4	3	0.016946	0.3025
Coronavirus disease - COVID-19	51439	155	27	11	5	0.024353	0.3025
RNA degradation	51439	155	27	2	2	0.029409	0.3025
Notch signaling pathway	51439	155	27	2	2	0.029409	0.3025
RIG-I-like receptor signaling pathway	51439	155	27	2	2	0.029409	0.3025
Protein digestion and absorption	51439	155	27	2	2	0.029409	0.3025
Leishmaniasis	51439	155	27	2	2	0.029409	0.3025
Measles	51439	155	27	9	4	0.049973	0.33897
Herpes simplex virus 1 infection	51439	155	27	9	4	0.049973	0.33897
Influenza A	51439	155	27	10	4	0.07319	0.33897
Thyroid hormone signaling pathway	51439	155	27	3	2	0.078617	0.33897
Necroptosis	51439	155	27	4	2	0.14029	0.33897
Osteoclast differentiation	51439	155	27	4	2	0.14029	0.33897
Kaposi sarcoma-associated herpesvirus infection	51439	155	27	4	2	0.14029	0.33897
Alzheimer disease	51439	155	27	8	3	0.14413	0.33897
Hepatitis B	51439	155	27	8	3	0.14413	0.33897
Mucin type O-glycan biosynthesis	51439	155	27	1	1	0.17419	0.33897
Glycerolipid metabolism	51439	155	27	1	1	0.17419	0.33897
Glycerophospholipid metabolism	51439	155	27	1	1	0.17419	0.33897
Sphingolipid metabolism	51439	155	27	1	1	0.17419	0.33897
ABC transporters	51439	155	27	1	1	0.17419	0.33897
NF-kappa B signaling pathway	51439	155	27	1	1	0.17419	0.33897
mTOR signaling pathway	51439	155	27	1	1	0.17419	0.33897
Signaling pathways regulating pluripotency of stem cells	51439	155	27	1	1	0.17419	0.33897
Toll-like receptor signaling pathway	51439	155	27	1	1	0.17419	0.33897
Natural killer cell mediated cytotoxicity	51439	155	27	1	1	0.17419	0.33897
Th1 and Th2 cell differentiation	51439	155	27	1	1	0.17419	0.33897
Fc gamma R-mediated phagocytosis	51439	155	27	1	1	0.17419	0.33897
Neurotrophin signaling pathway	51439	155	27	1	1	0.17419	0.33897
Glutamatergic synapse	51439	155	27	1	1	0.17419	0.33897
GABAergic synapse	51439	155	27	1	1	0.17419	0.33897
Prolactin signaling pathway	51439	155	27	1	1	0.17419	0.33897
AGE-RAGE signaling pathway in diabetic complications	51439	155	27	1	1	0.17419	0.33897
Growth hormone synthesis, secretion and action	51439	155	27	1	1	0.17419	0.33897
Fat digestion and absorption	51439	155	27	1	1	0.17419	0.33897
Epithelial cell signaling in Helicobacter pylori infection	51439	155	27	1	1	0.17419	0.33897
Toxoplasmosis	51439	155	27	1	1	0.17419	0.33897
Viral life cycle - HIV-1	51439	155	27	5	2	0.2089	0.39582
Systemic lupus erythematosus	51439	155	27	10	3	0.24179	0.44639
Protein processing in endoplasmic reticulum	51439	155	27	6	2	0.28038	0.45933
Epstein-Barr virus infection	51439	155	27	11	3	0.29455	0.45933
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	51439	155	27	2	1	0.31898	0.45933
Chemokine signaling pathway	51439	155	27	2	1	0.31898	0.45933
Renin-angiotensin system	51439	155	27	2	1	0.31898	0.45933
Cytosolic DNA-sensing pathway	51439	155	27	2	1	0.31898	0.45933
C-type lectin receptor signaling pathway	51439	155	27	2	1	0.31898	0.45933
Th17 cell differentiation	51439	155	27	2	1	0.31898	0.45933
Alcoholic liver disease	51439	155	27	2	1	0.31898	0.45933
Cholesterol metabolism	51439	155	27	2	1	0.31898	0.45933
Inflammatory bowel disease	51439	155	27	2	1	0.31898	0.45933
Hepatitis C	51439	155	27	12	3	0.34829	0.48704
Human immunodeficiency virus 1 infection	51439	155	27	7	2	0.35175	0.48704
Neutrophil extracellular trap formation	51439	155	27	13	3	0.40196	0.53594
Viral carcinogenesis	51439	155	27	13	3	0.40196	0.53594
Alcoholism	51439	155	27	8	2	0.42096	0.54516
JAK-STAT signaling pathway	51439	155	27	3	1	0.43916	0.54516
Pancreatic cancer	51439	155	27	3	1	0.43916	0.54516
Lipid and atherosclerosis	51439	155	27	3	1	0.43916	0.54516
Ubiquitin mediated proteolysis	51439	155	27	4	1	0.53878	0.64654
PD-L1 expression and PD-1 checkpoint pathway in cancer	51439	155	27	4	1	0.53878	0.64654
Human papillomavirus infection	51439	155	27	10	2	0.54781	0.64659
Phagosome	51439	155	27	5	1	0.62125	0.71
Hematopoietic cell lineage	51439	155	27	5	1	0.62125	0.71
Parkinson disease	51439	155	27	6	1	0.68943	0.76367
Staphylococcus aureus infection	51439	155	27	6	1	0.68943	0.76367
Oocyte meiosis	51439	155	27	7	1	0.7457	0.78957
Progesterone-mediated oocyte maturation	51439	155	27	7	1	0.7457	0.78957
Pathways of neurodegeneration - multiple diseases	51439	155	27	7	1	0.7457	0.78957
NOD-like receptor signaling pathway	51439	155	27	15	2	0.77882	0.81269
Pathways in cancer	51439	155	27	9	1	0.83028	0.849
Metabolic pathways	51439	155	27	24	3	0.8372	0.849
Ribosome biogenesis in eukaryotes	51439	155	27	18	1	0.97459	0.97459
Influenza A	51513	155	21	10	8	1.13e-06	3.729e-05
Measles	51513	155	21	9	7	9.4705e-06	0.00011583
Hepatitis C	51513	155	21	12	8	1.053e-05	0.00011583
Coronavirus disease - COVID-19	51513	155	21	11	7	7.2887e-05	0.00060132
Herpes simplex virus 1 infection	51513	155	21	9	6	0.00019889	0.0013127
NOD-like receptor signaling pathway	51513	155	21	15	7	0.00099699	0.0054834
Epstein-Barr virus infection	51513	155	21	11	5	0.0076681	0.036149
RIG-I-like receptor signaling pathway	51513	155	21	2	2	0.017595	0.064516
Cytosolic DNA-sensing pathway	51513	155	21	2	2	0.017595	0.064516
Hepatitis B	51513	155	21	8	3	0.076979	0.25403
Necroptosis	51513	155	21	4	2	0.088868	0.2666
Glycolysis / Gluconeogenesis	51513	155	21	1	1	0.13548	0.28307
Galactose metabolism	51513	155	21	1	1	0.13548	0.28307
NF-kappa B signaling pathway	51513	155	21	1	1	0.13548	0.28307
Pertussis	51513	155	21	1	1	0.13548	0.28307
Human papillomavirus infection	51513	155	21	10	3	0.13725	0.28307
Chemokine signaling pathway	51513	155	21	2	1	0.25337	0.38006
Apoptosis	51513	155	21	2	1	0.25337	0.38006
Apoptosis - multiple species	51513	155	21	2	1	0.25337	0.38006
Cell adhesion molecules	51513	155	21	2	1	0.25337	0.38006
Complement and coagulation cascades	51513	155	21	2	1	0.25337	0.38006
C-type lectin receptor signaling pathway	51513	155	21	2	1	0.25337	0.38006
JAK-STAT signaling pathway	51513	155	21	3	1	0.35585	0.5062
Pyrimidine metabolism	51513	155	21	4	1	0.44485	0.5062
Nucleotide metabolism	51513	155	21	4	1	0.44485	0.5062
Biosynthesis of cofactors	51513	155	21	4	1	0.44485	0.5062
Osteoclast differentiation	51513	155	21	4	1	0.44485	0.5062
Kaposi sarcoma-associated herpesvirus infection	51513	155	21	4	1	0.44485	0.5062
PD-L1 expression and PD-1 checkpoint pathway in cancer	51513	155	21	4	1	0.44485	0.5062
Viral life cycle - HIV-1	51513	155	21	5	1	0.52205	0.57426
Transcriptional misregulation in cancer	51513	155	21	8	1	0.697	0.74197
Pathways in cancer	51513	155	21	9	1	0.74028	0.76342
Metabolic pathways	51513	155	21	24	2	0.87702	0.87702
Cell cycle	51659	155	23	14	11	1.7912e-08	7.165e-07
Oocyte meiosis	51659	155	23	7	6	3.6507e-05	0.00073014
p53 signaling pathway	51659	155	23	4	4	0.00038284	0.0051045
Cellular senescence	51659	155	23	7	5	0.00081917	0.0065534
Progesterone-mediated oocyte maturation	51659	155	23	7	5	0.00081917	0.0065534
Human T-cell leukemia virus 1 infection	51659	155	23	7	4	0.0097443	0.046621
Pyrimidine metabolism	51659	155	23	4	3	0.01049	0.046621
Nucleotide metabolism	51659	155	23	4	3	0.01049	0.046621
DNA replication	51659	155	23	4	3	0.01049	0.046621
Drug metabolism - other enzymes	51659	155	23	3	2	0.057775	0.2311
Human immunodeficiency virus 1 infection	51659	155	23	7	3	0.067311	0.24477
FoxO signaling pathway	51659	155	23	4	2	0.10506	0.29677
Ubiquitin mediated proteolysis	51659	155	23	4	2	0.10506	0.29677
MicroRNAs in cancer	51659	155	23	4	2	0.10506	0.29677
Purine metabolism	51659	155	23	1	1	0.14839	0.29677
Base excision repair	51659	155	23	1	1	0.14839	0.29677
Non-homologous end-joining	51659	155	23	1	1	0.14839	0.29677
Fanconi anemia pathway	51659	155	23	1	1	0.14839	0.29677
Hippo signaling pathway	51659	155	23	1	1	0.14839	0.29677
Carbohydrate digestion and absorption	51659	155	23	1	1	0.14839	0.29677
Chemical carcinogenesis - receptor activation	51659	155	23	5	2	0.15934	0.30351
Glutathione metabolism	51659	155	23	2	1	0.27558	0.3801
One carbon pool by folate	51659	155	23	2	1	0.27558	0.3801
Platinum drug resistance	51659	155	23	2	1	0.27558	0.3801
MAPK signaling pathway	51659	155	23	2	1	0.27558	0.3801
Apoptosis	51659	155	23	2	1	0.27558	0.3801
Apoptosis - multiple species	51659	155	23	2	1	0.27558	0.3801
ECM-receptor interaction	51659	155	23	2	1	0.27558	0.3801
Colorectal cancer	51659	155	23	2	1	0.27558	0.3801
Viral carcinogenesis	51659	155	23	13	3	0.29892	0.39856
Hepatitis B	51659	155	23	8	2	0.33806	0.43621
Antifolate resistance	51659	155	23	3	1	0.38448	0.4394
AMPK signaling pathway	51659	155	23	3	1	0.38448	0.4394
Gap junction	51659	155	23	3	1	0.38448	0.4394
Acute myeloid leukemia	51659	155	23	3	1	0.38448	0.4394
Pathways in cancer	51659	155	23	9	2	0.39705	0.44117
Transcriptional misregulation in cancer	51659	155	23	8	1	0.73223	0.77422
Metabolic pathways	51659	155	23	24	3	0.73551	0.77422
Human papillomavirus infection	51659	155	23	10	1	0.80971	0.83047
Epstein-Barr virus infection	51659	155	23	11	1	0.83989	0.83989
Viral protein interaction with cytokine and cytokine receptor	51673	155	1	1	1	0.0064516	0.012903
TNF signaling pathway	51673	155	1	1	1	0.0064516	0.012903
Inflammatory bowel disease	51673	155	1	2	1	0.012903	0.017204
Cytokine-cytokine receptor interaction	51673	155	1	3	1	0.019355	0.019355
Transcriptional misregulation in cancer	5273	155	7	8	3	0.0029123	0.034947
Phagosome	5273	155	7	5	2	0.016468	0.096641
Staphylococcus aureus infection	5273	155	7	6	2	0.02416	0.096641
PPAR signaling pathway	5273	155	7	2	1	0.088563	0.16592
IL-17 signaling pathway	5273	155	7	2	1	0.088563	0.16592
Amoebiasis	5273	155	7	2	1	0.088563	0.16592
Drug metabolism - other enzymes	5273	155	7	3	1	0.13026	0.16592
Acute myeloid leukemia	5273	155	7	3	1	0.13026	0.16592
Lipid and atherosclerosis	5273	155	7	3	1	0.13026	0.16592
NOD-like receptor signaling pathway	5273	155	7	15	2	0.13827	0.16592
Hematopoietic cell lineage	5273	155	7	5	1	0.20878	0.22776
Neutrophil extracellular trap formation	5273	155	7	13	1	0.46525	0.46525
Influenza A	5414	155	18	10	7	8.3882e-06	0.00026003
Hepatitis C	5414	155	18	12	7	4.828e-05	0.0007438
Measles	5414	155	18	9	6	7.1981e-05	0.0007438
Coronavirus disease - COVID-19	5414	155	18	11	6	0.00034236	0.0026533
Herpes simplex virus 1 infection	5414	155	18	9	5	0.0011433	0.0070883
NOD-like receptor signaling pathway	5414	155	18	15	6	0.0027631	0.014276
Epstein-Barr virus infection	5414	155	18	11	4	0.025372	0.11236
Necroptosis	5414	155	18	4	2	0.066589	0.25803
Human papillomavirus infection	5414	155	18	10	3	0.093987	0.3
Glycolysis / Gluconeogenesis	5414	155	18	1	1	0.11613	0.3
Galactose metabolism	5414	155	18	1	1	0.11613	0.3
Pertussis	5414	155	18	1	1	0.11613	0.3
Chemokine signaling pathway	5414	155	18	2	1	0.21944	0.35803
Apoptosis	5414	155	18	2	1	0.21944	0.35803
Apoptosis - multiple species	5414	155	18	2	1	0.21944	0.35803
Complement and coagulation cascades	5414	155	18	2	1	0.21944	0.35803
RIG-I-like receptor signaling pathway	5414	155	18	2	1	0.21944	0.35803
Cytosolic DNA-sensing pathway	5414	155	18	2	1	0.21944	0.35803
C-type lectin receptor signaling pathway	5414	155	18	2	1	0.21944	0.35803
Hepatitis B	5414	155	18	8	2	0.23398	0.36266
JAK-STAT signaling pathway	5414	155	18	3	1	0.31127	0.45103
Pyrimidine metabolism	5414	155	18	4	1	0.39283	0.45103
Nucleotide metabolism	5414	155	18	4	1	0.39283	0.45103
Biosynthesis of cofactors	5414	155	18	4	1	0.39283	0.45103
Osteoclast differentiation	5414	155	18	4	1	0.39283	0.45103
Kaposi sarcoma-associated herpesvirus infection	5414	155	18	4	1	0.39283	0.45103
PD-L1 expression and PD-1 checkpoint pathway in cancer	5414	155	18	4	1	0.39283	0.45103
Viral life cycle - HIV-1	5414	155	18	5	1	0.46521	0.51505
Transcriptional misregulation in cancer	5414	155	18	8	1	0.63656	0.68046
Pathways in cancer	5414	155	18	9	1	0.68106	0.70376
Metabolic pathways	5414	155	18	24	2	0.80965	0.80965
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	54407	155	17	2	2	0.011395	0.21651
RNA degradation	54407	155	17	2	2	0.011395	0.21651
Metabolic pathways	54407	155	17	24	5	0.097372	0.2977
Mucin type O-glycan biosynthesis	54407	155	17	1	1	0.10968	0.2977
Glycerolipid metabolism	54407	155	17	1	1	0.10968	0.2977
Glycerophospholipid metabolism	54407	155	17	1	1	0.10968	0.2977
Sphingolipid metabolism	54407	155	17	1	1	0.10968	0.2977
ABC transporters	54407	155	17	1	1	0.10968	0.2977
mTOR signaling pathway	54407	155	17	1	1	0.10968	0.2977
Neurotrophin signaling pathway	54407	155	17	1	1	0.10968	0.2977
Glutamatergic synapse	54407	155	17	1	1	0.10968	0.2977
GABAergic synapse	54407	155	17	1	1	0.10968	0.2977
Fat digestion and absorption	54407	155	17	1	1	0.10968	0.2977
Epithelial cell signaling in Helicobacter pylori infection	54407	155	17	1	1	0.10968	0.2977
Parkinson disease	54407	155	17	6	2	0.13066	0.33101
Pathways of neurodegeneration - multiple diseases	54407	155	17	7	2	0.17118	0.38662
Notch signaling pathway	54407	155	17	2	1	0.20796	0.38662
Alcoholic liver disease	54407	155	17	2	1	0.20796	0.38662
Protein digestion and absorption	54407	155	17	2	1	0.20796	0.38662
Cholesterol metabolism	54407	155	17	2	1	0.20796	0.38662
Alzheimer disease	54407	155	17	8	2	0.21366	0.38662
Oxidative phosphorylation	54407	155	17	3	1	0.29596	0.43256
Thermogenesis	54407	155	17	3	1	0.29596	0.43256
Thyroid hormone signaling pathway	54407	155	17	3	1	0.29596	0.43256
Diabetic cardiomyopathy	54407	155	17	3	1	0.29596	0.43256
Lipid and atherosclerosis	54407	155	17	3	1	0.29596	0.43256
Ubiquitin mediated proteolysis	54407	155	17	4	1	0.37471	0.44496
Amyotrophic lateral sclerosis	54407	155	17	4	1	0.37471	0.44496
Huntington disease	54407	155	17	4	1	0.37471	0.44496
Prion disease	54407	155	17	4	1	0.37471	0.44496
Tuberculosis	54407	155	17	4	1	0.37471	0.44496
Chemical carcinogenesis - reactive oxygen species	54407	155	17	4	1	0.37471	0.44496
Protein processing in endoplasmic reticulum	54407	155	17	6	1	0.50799	0.58496
Oocyte meiosis	54407	155	17	7	1	0.56413	0.61248
Progesterone-mediated oocyte maturation	54407	155	17	7	1	0.56413	0.61248
Coronavirus disease - COVID-19	54407	155	17	11	1	0.73388	0.77465
NOD-like receptor signaling pathway	54407	155	17	15	1	0.83991	0.86261
Ribosome biogenesis in eukaryotes	54407	155	17	18	1	0.89176	0.89176
Coronavirus disease - COVID-19	54464	155	29	11	6	0.0061578	0.22266
Measles	54464	155	29	9	5	0.012073	0.22266
Herpes simplex virus 1 infection	54464	155	29	9	5	0.012073	0.22266
Influenza A	54464	155	29	10	5	0.020916	0.22266
Necroptosis	54464	155	29	4	3	0.020932	0.22266
Kaposi sarcoma-associated herpesvirus infection	54464	155	29	4	3	0.020932	0.22266
RNA degradation	54464	155	29	2	2	0.034018	0.22266
Chemokine signaling pathway	54464	155	29	2	2	0.034018	0.22266
Notch signaling pathway	54464	155	29	2	2	0.034018	0.22266
RIG-I-like receptor signaling pathway	54464	155	29	2	2	0.034018	0.22266
C-type lectin receptor signaling pathway	54464	155	29	2	2	0.034018	0.22266
NOD-like receptor signaling pathway	54464	155	29	15	6	0.03749	0.22494
Hepatitis B	54464	155	29	8	4	0.040764	0.22577
JAK-STAT signaling pathway	54464	155	29	3	2	0.090047	0.3545
Thyroid hormone signaling pathway	54464	155	29	3	2	0.090047	0.3545
Epstein-Barr virus infection	54464	155	29	11	4	0.12598	0.3545
Osteoclast differentiation	54464	155	29	4	2	0.15916	0.3545
Hepatitis C	54464	155	29	12	4	0.16431	0.3545
Alzheimer disease	54464	155	29	8	3	0.17053	0.3545
Mucin type O-glycan biosynthesis	54464	155	29	1	1	0.1871	0.3545
Glycerolipid metabolism	54464	155	29	1	1	0.1871	0.3545
Glycerophospholipid metabolism	54464	155	29	1	1	0.1871	0.3545
Sphingolipid metabolism	54464	155	29	1	1	0.1871	0.3545
ABC transporters	54464	155	29	1	1	0.1871	0.3545
NF-kappa B signaling pathway	54464	155	29	1	1	0.1871	0.3545
mTOR signaling pathway	54464	155	29	1	1	0.1871	0.3545
Signaling pathways regulating pluripotency of stem cells	54464	155	29	1	1	0.1871	0.3545
Toll-like receptor signaling pathway	54464	155	29	1	1	0.1871	0.3545
Th1 and Th2 cell differentiation	54464	155	29	1	1	0.1871	0.3545
Glutamatergic synapse	54464	155	29	1	1	0.1871	0.3545
GABAergic synapse	54464	155	29	1	1	0.1871	0.3545
Prolactin signaling pathway	54464	155	29	1	1	0.1871	0.3545
AGE-RAGE signaling pathway in diabetic complications	54464	155	29	1	1	0.1871	0.3545
Growth hormone synthesis, secretion and action	54464	155	29	1	1	0.1871	0.3545
Fat digestion and absorption	54464	155	29	1	1	0.1871	0.3545
Epithelial cell signaling in Helicobacter pylori infection	54464	155	29	1	1	0.1871	0.3545
Pathogenic Escherichia coli infection	54464	155	29	1	1	0.1871	0.3545
Toxoplasmosis	54464	155	29	1	1	0.1871	0.3545
Viral life cycle - HIV-1	54464	155	29	5	2	0.23484	0.43354
Human papillomavirus infection	54464	155	29	10	3	0.28038	0.48025
Protein processing in endoplasmic reticulum	54464	155	29	6	2	0.3124	0.48025
Parkinson disease	54464	155	29	6	2	0.3124	0.48025
Lysosome	54464	155	29	2	1	0.34018	0.48025
Cytosolic DNA-sensing pathway	54464	155	29	2	1	0.34018	0.48025
Th17 cell differentiation	54464	155	29	2	1	0.34018	0.48025
Alcoholic liver disease	54464	155	29	2	1	0.34018	0.48025
Protein digestion and absorption	54464	155	29	2	1	0.34018	0.48025
Cholesterol metabolism	54464	155	29	2	1	0.34018	0.48025
Salmonella infection	54464	155	29	2	1	0.34018	0.48025
Leishmaniasis	54464	155	29	2	1	0.34018	0.48025
Inflammatory bowel disease	54464	155	29	2	1	0.34018	0.48025
Pathways of neurodegeneration - multiple diseases	54464	155	29	7	2	0.38862	0.52793
Human immunodeficiency virus 1 infection	54464	155	29	7	2	0.38862	0.52793
Viral carcinogenesis	54464	155	29	13	3	0.4532	0.57754
Alcoholism	54464	155	29	8	2	0.46131	0.57754
Gap junction	54464	155	29	3	1	0.46524	0.57754
Pancreatic cancer	54464	155	29	3	1	0.46524	0.57754
Lipid and atherosclerosis	54464	155	29	3	1	0.46524	0.57754
Pathways in cancer	54464	155	29	9	2	0.52913	0.62836
Ubiquitin mediated proteolysis	54464	155	29	4	1	0.56727	0.62836
Amyotrophic lateral sclerosis	54464	155	29	4	1	0.56727	0.62836
Huntington disease	54464	155	29	4	1	0.56727	0.62836
Prion disease	54464	155	29	4	1	0.56727	0.62836
Tuberculosis	54464	155	29	4	1	0.56727	0.62836
PD-L1 expression and PD-1 checkpoint pathway in cancer	54464	155	29	4	1	0.56727	0.62836
Systemic lupus erythematosus	54464	155	29	10	2	0.59132	0.64508
Phagosome	54464	155	29	5	1	0.65037	0.69891
Neutrophil extracellular trap formation	54464	155	29	13	2	0.74228	0.78595
Oocyte meiosis	54464	155	29	7	1	0.77286	0.79494
Progesterone-mediated oocyte maturation	54464	155	29	7	1	0.77286	0.79494
Metabolic pathways	54464	155	29	24	2	0.96614	0.97975
Ribosome biogenesis in eukaryotes	54464	155	29	18	1	0.98126	0.98126
Protein processing in endoplasmic reticulum	5450	155	17	6	4	0.0013379	0.050841
Intestinal immune network for IgA production	5450	155	17	2	2	0.011395	0.21651
Cytokine-cytokine receptor interaction	5450	155	17	3	2	0.031951	0.26048
Chemical carcinogenesis - receptor activation	5450	155	17	5	2	0.093115	0.26048
Glycine, serine and threonine metabolism	5450	155	17	1	1	0.10968	0.26048
Glyoxylate and dicarboxylate metabolism	5450	155	17	1	1	0.10968	0.26048
Carbon metabolism	5450	155	17	1	1	0.10968	0.26048
Biosynthesis of nucleotide sugars	5450	155	17	1	1	0.10968	0.26048
Protein export	5450	155	17	1	1	0.10968	0.26048
Base excision repair	5450	155	17	1	1	0.10968	0.26048
Non-homologous end-joining	5450	155	17	1	1	0.10968	0.26048
Estrogen signaling pathway	5450	155	17	1	1	0.10968	0.26048
Thyroid hormone synthesis	5450	155	17	1	1	0.10968	0.26048
Oxytocin signaling pathway	5450	155	17	1	1	0.10968	0.26048
Pancreatic secretion	5450	155	17	1	1	0.10968	0.26048
Primary immunodeficiency	5450	155	17	1	1	0.10968	0.26048
Glutathione metabolism	5450	155	17	2	1	0.20796	0.3161
Amino sugar and nucleotide sugar metabolism	5450	155	17	2	1	0.20796	0.3161
Nicotinate and nicotinamide metabolism	5450	155	17	2	1	0.20796	0.3161
Calcium signaling pathway	5450	155	17	2	1	0.20796	0.3161
IL-17 signaling pathway	5450	155	17	2	1	0.20796	0.3161
Th17 cell differentiation	5450	155	17	2	1	0.20796	0.3161
Salivary secretion	5450	155	17	2	1	0.20796	0.3161
Salmonella infection	5450	155	17	2	1	0.20796	0.3161
Fluid shear stress and atherosclerosis	5450	155	17	2	1	0.20796	0.3161
Metabolic pathways	5450	155	17	24	4	0.25592	0.37404
PI3K-Akt signaling pathway	5450	155	17	3	1	0.29596	0.38782
Prostate cancer	5450	155	17	3	1	0.29596	0.38782
Lipid and atherosclerosis	5450	155	17	3	1	0.29596	0.38782
DNA replication	5450	155	17	4	1	0.37471	0.47463
Hematopoietic cell lineage	5450	155	17	5	1	0.4451	0.54561
Cell cycle	5450	155	17	14	2	0.47135	0.55973
Parkinson disease	5450	155	17	6	1	0.50799	0.57937
Oocyte meiosis	5450	155	17	7	1	0.56413	0.57937
Cellular senescence	5450	155	17	7	1	0.56413	0.57937
Progesterone-mediated oocyte maturation	5450	155	17	7	1	0.56413	0.57937
Pathways of neurodegeneration - multiple diseases	5450	155	17	7	1	0.56413	0.57937
Pathways in cancer	5450	155	17	9	1	0.65881	0.65881
Influenza A	54625	155	29	10	10	1.2214e-08	6.7179e-07
Measles	54625	155	29	9	9	8.9165e-08	2.452e-06
Hepatitis C	54625	155	29	12	10	6.2509e-07	1.146e-05
Coronavirus disease - COVID-19	54625	155	29	11	9	3.7669e-06	5.1794e-05
Herpes simplex virus 1 infection	54625	155	29	9	8	4.9041e-06	5.3945e-05
NOD-like receptor signaling pathway	54625	155	29	15	9	0.00020063	0.0018391
Epstein-Barr virus infection	54625	155	29	11	7	0.00079109	0.0062157
Necroptosis	54625	155	29	4	4	0.0010268	0.0070596
Human papillomavirus infection	54625	155	29	10	5	0.020916	0.11513
Kaposi sarcoma-associated herpesvirus infection	54625	155	29	4	3	0.020932	0.11513
RNA degradation	54625	155	29	2	2	0.034018	0.12473
Chemokine signaling pathway	54625	155	29	2	2	0.034018	0.12473
RIG-I-like receptor signaling pathway	54625	155	29	2	2	0.034018	0.12473
Cytosolic DNA-sensing pathway	54625	155	29	2	2	0.034018	0.12473
C-type lectin receptor signaling pathway	54625	155	29	2	2	0.034018	0.12473
Hepatitis B	54625	155	29	8	4	0.040764	0.14013
JAK-STAT signaling pathway	54625	155	29	3	2	0.090047	0.29133
Osteoclast differentiation	54625	155	29	4	2	0.15916	0.32157
PD-L1 expression and PD-1 checkpoint pathway in cancer	54625	155	29	4	2	0.15916	0.32157
Glycolysis / Gluconeogenesis	54625	155	29	1	1	0.1871	0.32157
Galactose metabolism	54625	155	29	1	1	0.1871	0.32157
ABC transporters	54625	155	29	1	1	0.1871	0.32157
NF-kappa B signaling pathway	54625	155	29	1	1	0.1871	0.32157
Signaling pathways regulating pluripotency of stem cells	54625	155	29	1	1	0.1871	0.32157
Toll-like receptor signaling pathway	54625	155	29	1	1	0.1871	0.32157
Th1 and Th2 cell differentiation	54625	155	29	1	1	0.1871	0.32157
Prolactin signaling pathway	54625	155	29	1	1	0.1871	0.32157
AGE-RAGE signaling pathway in diabetic complications	54625	155	29	1	1	0.1871	0.32157
Growth hormone synthesis, secretion and action	54625	155	29	1	1	0.1871	0.32157
Fat digestion and absorption	54625	155	29	1	1	0.1871	0.32157
Pertussis	54625	155	29	1	1	0.1871	0.32157
Toxoplasmosis	54625	155	29	1	1	0.1871	0.32157
Viral life cycle - HIV-1	54625	155	29	5	2	0.23484	0.39139
Lysosome	54625	155	29	2	1	0.34018	0.46774
Notch signaling pathway	54625	155	29	2	1	0.34018	0.46774
Complement and coagulation cascades	54625	155	29	2	1	0.34018	0.46774
Th17 cell differentiation	54625	155	29	2	1	0.34018	0.46774
Cholesterol metabolism	54625	155	29	2	1	0.34018	0.46774
Leishmaniasis	54625	155	29	2	1	0.34018	0.46774
Inflammatory bowel disease	54625	155	29	2	1	0.34018	0.46774
Thyroid hormone signaling pathway	54625	155	29	3	1	0.46524	0.59508
Pancreatic cancer	54625	155	29	3	1	0.46524	0.59508
Lipid and atherosclerosis	54625	155	29	3	1	0.46524	0.59508
Pathways in cancer	54625	155	29	9	2	0.52913	0.64999
Pyrimidine metabolism	54625	155	29	4	1	0.56727	0.64999
Nucleotide metabolism	54625	155	29	4	1	0.56727	0.64999
Biosynthesis of cofactors	54625	155	29	4	1	0.56727	0.64999
Tuberculosis	54625	155	29	4	1	0.56727	0.64999
Protein processing in endoplasmic reticulum	54625	155	29	6	1	0.71797	0.80588
Human immunodeficiency virus 1 infection	54625	155	29	7	1	0.77286	0.85015
Alzheimer disease	54625	155	29	8	1	0.81737	0.86452
Transcriptional misregulation in cancer	54625	155	29	8	1	0.81737	0.86452
Viral carcinogenesis	54625	155	29	13	1	0.94016	0.97564
Metabolic pathways	54625	155	29	24	2	0.96614	0.98126
Ribosome biogenesis in eukaryotes	54625	155	29	18	1	0.98126	0.98126
Influenza A	54739	155	28	10	10	8.0025e-09	4.1613e-07
Measles	54739	155	28	9	9	6.1493e-08	1.5988e-06
Hepatitis C	54739	155	28	12	10	4.1541e-07	7.2004e-06
Coronavirus disease - COVID-19	54739	155	28	11	9	2.6346e-06	3.4249e-05
Herpes simplex virus 1 infection	54739	155	28	9	8	3.5758e-06	3.7188e-05
NOD-like receptor signaling pathway	54739	155	28	15	9	0.00014436	0.0012511
Epstein-Barr virus infection	54739	155	28	11	7	0.00061664	0.0045808
Necroptosis	54739	155	28	4	4	0.00088521	0.0057539
Human papillomavirus infection	54739	155	28	10	5	0.017867	0.098138
Kaposi sarcoma-associated herpesvirus infection	54739	155	28	4	3	0.018873	0.098138
Chemokine signaling pathway	54739	155	28	2	2	0.031672	0.11764
RIG-I-like receptor signaling pathway	54739	155	28	2	2	0.031672	0.11764
Cytosolic DNA-sensing pathway	54739	155	28	2	2	0.031672	0.11764
C-type lectin receptor signaling pathway	54739	155	28	2	2	0.031672	0.11764
Hepatitis B	54739	155	28	8	4	0.035996	0.12479
JAK-STAT signaling pathway	54739	155	28	3	2	0.08425	0.27381
Osteoclast differentiation	54739	155	28	4	2	0.14963	0.32392
PD-L1 expression and PD-1 checkpoint pathway in cancer	54739	155	28	4	2	0.14963	0.32392
Glycolysis / Gluconeogenesis	54739	155	28	1	1	0.18065	0.32392
Galactose metabolism	54739	155	28	1	1	0.18065	0.32392
NF-kappa B signaling pathway	54739	155	28	1	1	0.18065	0.32392
Signaling pathways regulating pluripotency of stem cells	54739	155	28	1	1	0.18065	0.32392
Toll-like receptor signaling pathway	54739	155	28	1	1	0.18065	0.32392
Th1 and Th2 cell differentiation	54739	155	28	1	1	0.18065	0.32392
Prolactin signaling pathway	54739	155	28	1	1	0.18065	0.32392
AGE-RAGE signaling pathway in diabetic complications	54739	155	28	1	1	0.18065	0.32392
Growth hormone synthesis, secretion and action	54739	155	28	1	1	0.18065	0.32392
Pertussis	54739	155	28	1	1	0.18065	0.32392
Toxoplasmosis	54739	155	28	1	1	0.18065	0.32392
Viral life cycle - HIV-1	54739	155	28	5	2	0.22179	0.38443
Lysosome	54739	155	28	2	1	0.32962	0.43949
Apoptosis	54739	155	28	2	1	0.32962	0.43949
Apoptosis - multiple species	54739	155	28	2	1	0.32962	0.43949
Notch signaling pathway	54739	155	28	2	1	0.32962	0.43949
Cell adhesion molecules	54739	155	28	2	1	0.32962	0.43949
Complement and coagulation cascades	54739	155	28	2	1	0.32962	0.43949
Th17 cell differentiation	54739	155	28	2	1	0.32962	0.43949
Leishmaniasis	54739	155	28	2	1	0.32962	0.43949
Inflammatory bowel disease	54739	155	28	2	1	0.32962	0.43949
Thyroid hormone signaling pathway	54739	155	28	3	1	0.4523	0.57365
Pancreatic cancer	54739	155	28	3	1	0.4523	0.57365
Pathways in cancer	54739	155	28	9	2	0.50808	0.62535
Pyrimidine metabolism	54739	155	28	4	1	0.55319	0.62535
Nucleotide metabolism	54739	155	28	4	1	0.55319	0.62535
Biosynthesis of cofactors	54739	155	28	4	1	0.55319	0.62535
Tuberculosis	54739	155	28	4	1	0.55319	0.62535
Protein processing in endoplasmic reticulum	54739	155	28	6	1	0.70398	0.77888
Human immunodeficiency virus 1 infection	54739	155	28	7	1	0.75961	0.82291
Alzheimer disease	54739	155	28	8	1	0.80509	0.83729
Transcriptional misregulation in cancer	54739	155	28	8	1	0.80509	0.83729
Viral carcinogenesis	54739	155	28	13	1	0.93334	0.95164
Metabolic pathways	54739	155	28	24	2	0.95985	0.95985
Influenza A	54809	155	30	10	10	1.8322e-08	1.026e-06
Measles	54809	155	30	9	9	1.2738e-07	3.5666e-06
Hepatitis C	54809	155	30	12	10	9.2431e-07	1.7254e-05
Coronavirus disease - COVID-19	54809	155	30	11	9	5.3057e-06	7.428e-05
Herpes simplex virus 1 infection	54809	155	30	9	8	6.641e-06	7.438e-05
NOD-like receptor signaling pathway	54809	155	30	15	10	2.7952e-05	0.00026089
Epstein-Barr virus infection	54809	155	30	11	7	0.0010041	0.0080324
Necroptosis	54809	155	30	4	4	0.0011848	0.0082938
Kaposi sarcoma-associated herpesvirus infection	54809	155	30	4	3	0.023126	0.1439
RNA degradation	54809	155	30	2	2	0.036447	0.14579
Chemokine signaling pathway	54809	155	30	2	2	0.036447	0.14579
RIG-I-like receptor signaling pathway	54809	155	30	2	2	0.036447	0.14579
Cytosolic DNA-sensing pathway	54809	155	30	2	2	0.036447	0.14579
C-type lectin receptor signaling pathway	54809	155	30	2	2	0.036447	0.14579
Hepatitis B	54809	155	30	8	4	0.045913	0.17141
JAK-STAT signaling pathway	54809	155	30	3	2	0.096002	0.31624
Thyroid hormone signaling pathway	54809	155	30	3	2	0.096002	0.31624
Human papillomavirus infection	54809	155	30	10	4	0.1027	0.31952
Osteoclast differentiation	54809	155	30	4	2	0.16888	0.37375
ABC transporters	54809	155	30	1	1	0.19355	0.37375
NF-kappa B signaling pathway	54809	155	30	1	1	0.19355	0.37375
Signaling pathways regulating pluripotency of stem cells	54809	155	30	1	1	0.19355	0.37375
Toll-like receptor signaling pathway	54809	155	30	1	1	0.19355	0.37375
Th1 and Th2 cell differentiation	54809	155	30	1	1	0.19355	0.37375
Prolactin signaling pathway	54809	155	30	1	1	0.19355	0.37375
AGE-RAGE signaling pathway in diabetic complications	54809	155	30	1	1	0.19355	0.37375
Growth hormone synthesis, secretion and action	54809	155	30	1	1	0.19355	0.37375
Fat digestion and absorption	54809	155	30	1	1	0.19355	0.37375
Toxoplasmosis	54809	155	30	1	1	0.19355	0.37375
Viral life cycle - HIV-1	54809	155	30	5	2	0.24803	0.46299
Protein processing in endoplasmic reticulum	54809	155	30	6	2	0.3285	0.53071
Lysosome	54809	155	30	2	1	0.35065	0.53071
Notch signaling pathway	54809	155	30	2	1	0.35065	0.53071
Th17 cell differentiation	54809	155	30	2	1	0.35065	0.53071
Cholesterol metabolism	54809	155	30	2	1	0.35065	0.53071
Leishmaniasis	54809	155	30	2	1	0.35065	0.53071
Inflammatory bowel disease	54809	155	30	2	1	0.35065	0.53071
Pancreatic cancer	54809	155	30	3	1	0.47797	0.68632
Lipid and atherosclerosis	54809	155	30	3	1	0.47797	0.68632
Pathways in cancer	54809	155	30	9	2	0.54972	0.70731
Pyrimidine metabolism	54809	155	30	4	1	0.581	0.70731
Nucleotide metabolism	54809	155	30	4	1	0.581	0.70731
Biosynthesis of cofactors	54809	155	30	4	1	0.581	0.70731
Ubiquitin mediated proteolysis	54809	155	30	4	1	0.581	0.70731
Tuberculosis	54809	155	30	4	1	0.581	0.70731
PD-L1 expression and PD-1 checkpoint pathway in cancer	54809	155	30	4	1	0.581	0.70731
Parkinson disease	54809	155	30	6	1	0.7314	0.87145
Viral carcinogenesis	54809	155	30	13	2	0.76113	0.87974
Pathways of neurodegeneration - multiple diseases	54809	155	30	7	1	0.78548	0.87974
Human immunodeficiency virus 1 infection	54809	155	30	7	1	0.78548	0.87974
Alzheimer disease	54809	155	30	8	1	0.82896	0.89273
Alcoholism	54809	155	30	8	1	0.82896	0.89273
Systemic lupus erythematosus	54809	155	30	10	1	0.89184	0.94232
Neutrophil extracellular trap formation	54809	155	30	13	1	0.94634	0.98139
Ribosome biogenesis in eukaryotes	54809	155	30	18	1	0.98393	0.99647
Metabolic pathways	54809	155	30	24	1	0.99647	0.99647
Cell cycle	54855	155	25	14	7	0.001999	0.10994
Protein processing in endoplasmic reticulum	54855	155	25	6	4	0.0064796	0.17819
DNA replication	54855	155	25	4	3	0.013474	0.24702
Glutathione metabolism	54855	155	25	2	2	0.025136	0.2765
Intestinal immune network for IgA production	54855	155	25	2	2	0.025136	0.2765
Cytokine-cytokine receptor interaction	54855	155	25	3	2	0.067851	0.40323
Cellular senescence	54855	155	25	7	3	0.08372	0.40323
Progesterone-mediated oocyte maturation	54855	155	25	7	3	0.08372	0.40323
p53 signaling pathway	54855	155	25	4	2	0.12223	0.40323
Purine metabolism	54855	155	25	1	1	0.16129	0.40323
Glycine, serine and threonine metabolism	54855	155	25	1	1	0.16129	0.40323
Glyoxylate and dicarboxylate metabolism	54855	155	25	1	1	0.16129	0.40323
Carbon metabolism	54855	155	25	1	1	0.16129	0.40323
Biosynthesis of nucleotide sugars	54855	155	25	1	1	0.16129	0.40323
Protein export	54855	155	25	1	1	0.16129	0.40323
Base excision repair	54855	155	25	1	1	0.16129	0.40323
Non-homologous end-joining	54855	155	25	1	1	0.16129	0.40323
Estrogen signaling pathway	54855	155	25	1	1	0.16129	0.40323
Thyroid hormone synthesis	54855	155	25	1	1	0.16129	0.40323
Oxytocin signaling pathway	54855	155	25	1	1	0.16129	0.40323
Pancreatic secretion	54855	155	25	1	1	0.16129	0.40323
Primary immunodeficiency	54855	155	25	1	1	0.16129	0.40323
Chemical carcinogenesis - receptor activation	54855	155	25	5	2	0.18369	0.43925
Amino sugar and nucleotide sugar metabolism	54855	155	25	2	1	0.29744	0.51123
Nicotinate and nicotinamide metabolism	54855	155	25	2	1	0.29744	0.51123
Calcium signaling pathway	54855	155	25	2	1	0.29744	0.51123
ECM-receptor interaction	54855	155	25	2	1	0.29744	0.51123
IL-17 signaling pathway	54855	155	25	2	1	0.29744	0.51123
Th17 cell differentiation	54855	155	25	2	1	0.29744	0.51123
Salivary secretion	54855	155	25	2	1	0.29744	0.51123
Salmonella infection	54855	155	25	2	1	0.29744	0.51123
Fluid shear stress and atherosclerosis	54855	155	25	2	1	0.29744	0.51123
Oocyte meiosis	54855	155	25	7	2	0.31474	0.52456
Metabolic pathways	54855	155	25	24	5	0.3374	0.5458
Drug metabolism - other enzymes	54855	155	25	3	1	0.41224	0.56683
PI3K-Akt signaling pathway	54855	155	25	3	1	0.41224	0.56683
AMPK signaling pathway	54855	155	25	3	1	0.41224	0.56683
Prostate cancer	54855	155	25	3	1	0.41224	0.56683
Acute myeloid leukemia	54855	155	25	3	1	0.41224	0.56683
Lipid and atherosclerosis	54855	155	25	3	1	0.41224	0.56683
Pathways in cancer	54855	155	25	9	2	0.44248	0.59357
Pyrimidine metabolism	54855	155	25	4	1	0.50891	0.63614
Nucleotide metabolism	54855	155	25	4	1	0.50891	0.63614
FoxO signaling pathway	54855	155	25	4	1	0.50891	0.63614
Viral life cycle - HIV-1	54855	155	25	5	1	0.59022	0.7057
Hematopoietic cell lineage	54855	155	25	5	1	0.59022	0.7057
Parkinson disease	54855	155	25	6	1	0.65851	0.7706
Pathways of neurodegeneration - multiple diseases	54855	155	25	7	1	0.71581	0.78739
Human T-cell leukemia virus 1 infection	54855	155	25	7	1	0.71581	0.78739
Human immunodeficiency virus 1 infection	54855	155	25	7	1	0.71581	0.78739
Hepatitis B	54855	155	25	8	1	0.76382	0.80788
Transcriptional misregulation in cancer	54855	155	25	8	1	0.76382	0.80788
Human papillomavirus infection	54855	155	25	10	1	0.83755	0.86915
Epstein-Barr virus infection	54855	155	25	11	1	0.86556	0.88159
Viral carcinogenesis	54855	155	25	13	1	0.90832	0.90832
Influenza A	54877	155	28	10	10	8.0025e-09	4.4014e-07
Measles	54877	155	28	9	9	6.1493e-08	1.6911e-06
Hepatitis C	54877	155	28	12	10	4.1541e-07	7.6158e-06
Coronavirus disease - COVID-19	54877	155	28	11	9	2.6346e-06	3.6225e-05
Herpes simplex virus 1 infection	54877	155	28	9	8	3.5758e-06	3.9334e-05
NOD-like receptor signaling pathway	54877	155	28	15	9	0.00014436	0.0013233
Epstein-Barr virus infection	54877	155	28	11	7	0.00061664	0.0048451
Necroptosis	54877	155	28	4	4	0.00088521	0.0060858
Human papillomavirus infection	54877	155	28	10	5	0.017867	0.1038
Kaposi sarcoma-associated herpesvirus infection	54877	155	28	4	3	0.018873	0.1038
RNA degradation	54877	155	28	2	2	0.031672	0.11613
Chemokine signaling pathway	54877	155	28	2	2	0.031672	0.11613
RIG-I-like receptor signaling pathway	54877	155	28	2	2	0.031672	0.11613
Cytosolic DNA-sensing pathway	54877	155	28	2	2	0.031672	0.11613
C-type lectin receptor signaling pathway	54877	155	28	2	2	0.031672	0.11613
Hepatitis B	54877	155	28	8	4	0.035996	0.12374
JAK-STAT signaling pathway	54877	155	28	3	2	0.08425	0.27258
Osteoclast differentiation	54877	155	28	4	2	0.14963	0.33118
Glycolysis / Gluconeogenesis	54877	155	28	1	1	0.18065	0.33118
Galactose metabolism	54877	155	28	1	1	0.18065	0.33118
ABC transporters	54877	155	28	1	1	0.18065	0.33118
NF-kappa B signaling pathway	54877	155	28	1	1	0.18065	0.33118
Signaling pathways regulating pluripotency of stem cells	54877	155	28	1	1	0.18065	0.33118
Toll-like receptor signaling pathway	54877	155	28	1	1	0.18065	0.33118
Th1 and Th2 cell differentiation	54877	155	28	1	1	0.18065	0.33118
Prolactin signaling pathway	54877	155	28	1	1	0.18065	0.33118
AGE-RAGE signaling pathway in diabetic complications	54877	155	28	1	1	0.18065	0.33118
Growth hormone synthesis, secretion and action	54877	155	28	1	1	0.18065	0.33118
Fat digestion and absorption	54877	155	28	1	1	0.18065	0.33118
Toxoplasmosis	54877	155	28	1	1	0.18065	0.33118
Viral life cycle - HIV-1	54877	155	28	5	2	0.22179	0.3935
Lysosome	54877	155	28	2	1	0.32962	0.48997
Notch signaling pathway	54877	155	28	2	1	0.32962	0.48997
Th17 cell differentiation	54877	155	28	2	1	0.32962	0.48997
Cholesterol metabolism	54877	155	28	2	1	0.32962	0.48997
Leishmaniasis	54877	155	28	2	1	0.32962	0.48997
Inflammatory bowel disease	54877	155	28	2	1	0.32962	0.48997
Viral carcinogenesis	54877	155	28	13	3	0.42768	0.5923
Alcoholism	54877	155	28	8	2	0.44126	0.5923
Thyroid hormone signaling pathway	54877	155	28	3	1	0.4523	0.5923
Pancreatic cancer	54877	155	28	3	1	0.4523	0.5923
Lipid and atherosclerosis	54877	155	28	3	1	0.4523	0.5923
Pathways in cancer	54877	155	28	9	2	0.50808	0.63387
Pyrimidine metabolism	54877	155	28	4	1	0.55319	0.63387
Nucleotide metabolism	54877	155	28	4	1	0.55319	0.63387
Biosynthesis of cofactors	54877	155	28	4	1	0.55319	0.63387
Tuberculosis	54877	155	28	4	1	0.55319	0.63387
PD-L1 expression and PD-1 checkpoint pathway in cancer	54877	155	28	4	1	0.55319	0.63387
Systemic lupus erythematosus	54877	155	28	10	2	0.56988	0.63966
Protein processing in endoplasmic reticulum	54877	155	28	6	1	0.70398	0.77438
Neutrophil extracellular trap formation	54877	155	28	13	2	0.72234	0.779
Human immunodeficiency virus 1 infection	54877	155	28	7	1	0.75961	0.80343
Alzheimer disease	54877	155	28	8	1	0.80509	0.83547
Metabolic pathways	54877	155	28	24	2	0.95985	0.97762
Ribosome biogenesis in eukaryotes	54877	155	28	18	1	0.97816	0.97816
Protein processing in endoplasmic reticulum	54900	155	11	6	3	0.004803	0.13449
DNA replication	54900	155	11	4	2	0.025524	0.16559
Metabolic pathways	54900	155	11	24	4	0.069202	0.16559
Glycine, serine and threonine metabolism	54900	155	11	1	1	0.070968	0.16559
Glyoxylate and dicarboxylate metabolism	54900	155	11	1	1	0.070968	0.16559
Carbon metabolism	54900	155	11	1	1	0.070968	0.16559
Biosynthesis of nucleotide sugars	54900	155	11	1	1	0.070968	0.16559
Protein export	54900	155	11	1	1	0.070968	0.16559
Estrogen signaling pathway	54900	155	11	1	1	0.070968	0.16559
Thyroid hormone synthesis	54900	155	11	1	1	0.070968	0.16559
Oxytocin signaling pathway	54900	155	11	1	1	0.070968	0.16559
Pancreatic secretion	54900	155	11	1	1	0.070968	0.16559
Glutathione metabolism	54900	155	11	2	1	0.13733	0.1831
Amino sugar and nucleotide sugar metabolism	54900	155	11	2	1	0.13733	0.1831
Nicotinate and nicotinamide metabolism	54900	155	11	2	1	0.13733	0.1831
Calcium signaling pathway	54900	155	11	2	1	0.13733	0.1831
IL-17 signaling pathway	54900	155	11	2	1	0.13733	0.1831
Th17 cell differentiation	54900	155	11	2	1	0.13733	0.1831
Salivary secretion	54900	155	11	2	1	0.13733	0.1831
Salmonella infection	54900	155	11	2	1	0.13733	0.1831
Fluid shear stress and atherosclerosis	54900	155	11	2	1	0.13733	0.1831
PI3K-Akt signaling pathway	54900	155	11	3	1	0.19935	0.23257
Prostate cancer	54900	155	11	3	1	0.19935	0.23257
Lipid and atherosclerosis	54900	155	11	3	1	0.19935	0.23257
Cell cycle	54900	155	11	14	2	0.25994	0.29113
Hematopoietic cell lineage	54900	155	11	5	1	0.3114	0.32293
Chemical carcinogenesis - receptor activation	54900	155	11	5	1	0.3114	0.32293
Pathways in cancer	54900	155	11	9	1	0.49386	0.49386
Protein processing in endoplasmic reticulum	54979	155	16	6	4	0.0010348	0.036218
Intestinal immune network for IgA production	54979	155	16	2	2	0.010054	0.17595
Cytokine-cytokine receptor interaction	54979	155	16	3	2	0.028323	0.25806
Chemical carcinogenesis - receptor activation	54979	155	16	5	2	0.0833	0.25806
Glycine, serine and threonine metabolism	54979	155	16	1	1	0.10323	0.25806
Glyoxylate and dicarboxylate metabolism	54979	155	16	1	1	0.10323	0.25806
Carbon metabolism	54979	155	16	1	1	0.10323	0.25806
Biosynthesis of nucleotide sugars	54979	155	16	1	1	0.10323	0.25806
Protein export	54979	155	16	1	1	0.10323	0.25806
Estrogen signaling pathway	54979	155	16	1	1	0.10323	0.25806
Thyroid hormone synthesis	54979	155	16	1	1	0.10323	0.25806
Oxytocin signaling pathway	54979	155	16	1	1	0.10323	0.25806
Pancreatic secretion	54979	155	16	1	1	0.10323	0.25806
Primary immunodeficiency	54979	155	16	1	1	0.10323	0.25806
Glutathione metabolism	54979	155	16	2	1	0.1964	0.29887
Amino sugar and nucleotide sugar metabolism	54979	155	16	2	1	0.1964	0.29887
Nicotinate and nicotinamide metabolism	54979	155	16	2	1	0.1964	0.29887
Calcium signaling pathway	54979	155	16	2	1	0.1964	0.29887
IL-17 signaling pathway	54979	155	16	2	1	0.1964	0.29887
Th17 cell differentiation	54979	155	16	2	1	0.1964	0.29887
Salivary secretion	54979	155	16	2	1	0.1964	0.29887
Salmonella infection	54979	155	16	2	1	0.1964	0.29887
Fluid shear stress and atherosclerosis	54979	155	16	2	1	0.1964	0.29887
Metabolic pathways	54979	155	16	24	4	0.21862	0.31882
PI3K-Akt signaling pathway	54979	155	16	3	1	0.28043	0.36353
Prostate cancer	54979	155	16	3	1	0.28043	0.36353
Lipid and atherosclerosis	54979	155	16	3	1	0.28043	0.36353
Hematopoietic cell lineage	54979	155	16	5	1	0.4244	0.52825
Cell cycle	54979	155	16	14	2	0.43769	0.52825
Parkinson disease	54979	155	16	6	1	0.4858	0.55692
Oocyte meiosis	54979	155	16	7	1	0.54101	0.55692
Cellular senescence	54979	155	16	7	1	0.54101	0.55692
Progesterone-mediated oocyte maturation	54979	155	16	7	1	0.54101	0.55692
Pathways of neurodegeneration - multiple diseases	54979	155	16	7	1	0.54101	0.55692
Pathways in cancer	54979	155	16	9	1	0.63519	0.63519
Influenza A	55008	155	23	10	10	6.9765e-10	3.4185e-08
Measles	55008	155	23	9	9	7.2755e-09	1.7825e-07
Hepatitis C	55008	155	23	12	10	3.8826e-08	6.3416e-07
Coronavirus disease - COVID-19	55008	155	23	11	9	3.339e-07	4.0903e-06
Herpes simplex virus 1 infection	55008	155	23	9	8	5.835e-07	5.7183e-06
Epstein-Barr virus infection	55008	155	23	11	7	0.00014587	0.0011912
Necroptosis	55008	155	23	4	4	0.00038284	0.0026798
NOD-like receptor signaling pathway	55008	155	23	15	7	0.0018928	0.011594
Human papillomavirus infection	55008	155	23	10	5	0.0071494	0.038925
Kaposi sarcoma-associated herpesvirus infection	55008	155	23	4	3	0.01049	0.0514
Hepatitis B	55008	155	23	8	4	0.017524	0.069247
Chemokine signaling pathway	55008	155	23	2	2	0.021198	0.069247
RIG-I-like receptor signaling pathway	55008	155	23	2	2	0.021198	0.069247
Cytosolic DNA-sensing pathway	55008	155	23	2	2	0.021198	0.069247
C-type lectin receptor signaling pathway	55008	155	23	2	2	0.021198	0.069247
JAK-STAT signaling pathway	55008	155	23	3	2	0.057775	0.17694
Osteoclast differentiation	55008	155	23	4	2	0.10506	0.2693
Glycolysis / Gluconeogenesis	55008	155	23	1	1	0.14839	0.2693
Galactose metabolism	55008	155	23	1	1	0.14839	0.2693
NF-kappa B signaling pathway	55008	155	23	1	1	0.14839	0.2693
Toll-like receptor signaling pathway	55008	155	23	1	1	0.14839	0.2693
Th1 and Th2 cell differentiation	55008	155	23	1	1	0.14839	0.2693
Prolactin signaling pathway	55008	155	23	1	1	0.14839	0.2693
AGE-RAGE signaling pathway in diabetic complications	55008	155	23	1	1	0.14839	0.2693
Growth hormone synthesis, secretion and action	55008	155	23	1	1	0.14839	0.2693
Pertussis	55008	155	23	1	1	0.14839	0.2693
Toxoplasmosis	55008	155	23	1	1	0.14839	0.2693
Viral life cycle - HIV-1	55008	155	23	5	2	0.15934	0.27885
Lysosome	55008	155	23	2	1	0.27558	0.38581
Notch signaling pathway	55008	155	23	2	1	0.27558	0.38581
Cell adhesion molecules	55008	155	23	2	1	0.27558	0.38581
Complement and coagulation cascades	55008	155	23	2	1	0.27558	0.38581
Th17 cell differentiation	55008	155	23	2	1	0.27558	0.38581
Leishmaniasis	55008	155	23	2	1	0.27558	0.38581
Inflammatory bowel disease	55008	155	23	2	1	0.27558	0.38581
Thyroid hormone signaling pathway	55008	155	23	3	1	0.38448	0.50917
Pancreatic cancer	55008	155	23	3	1	0.38448	0.50917
Pathways in cancer	55008	155	23	9	2	0.39705	0.51199
Pyrimidine metabolism	55008	155	23	4	1	0.47761	0.54426
Nucleotide metabolism	55008	155	23	4	1	0.47761	0.54426
Biosynthesis of cofactors	55008	155	23	4	1	0.47761	0.54426
Tuberculosis	55008	155	23	4	1	0.47761	0.54426
PD-L1 expression and PD-1 checkpoint pathway in cancer	55008	155	23	4	1	0.47761	0.54426
Protein processing in endoplasmic reticulum	55008	155	23	6	1	0.62508	0.69611
Human immunodeficiency virus 1 infection	55008	155	23	7	1	0.68296	0.74366
Alzheimer disease	55008	155	23	8	1	0.73223	0.76338
Transcriptional misregulation in cancer	55008	155	23	8	1	0.73223	0.76338
Viral carcinogenesis	55008	155	23	13	1	0.8871	0.90558
Metabolic pathways	55008	155	23	24	2	0.90944	0.90944
Cell cycle	55165	155	22	14	11	9.5413e-09	3.5303e-07
Oocyte meiosis	55165	155	22	7	6	2.7155e-05	0.00050237
p53 signaling pathway	55165	155	22	4	4	0.00031626	0.0039005
Progesterone-mediated oocyte maturation	55165	155	22	7	5	0.00064903	0.0060035
Cellular senescence	55165	155	22	7	4	0.0081921	0.048477
Human T-cell leukemia virus 1 infection	55165	155	22	7	4	0.0081921	0.048477
DNA replication	55165	155	22	4	3	0.0091714	0.048477
Glutathione metabolism	55165	155	22	2	2	0.019355	0.07957
One carbon pool by folate	55165	155	22	2	2	0.019355	0.07957
Antifolate resistance	55165	155	22	3	2	0.053004	0.19612
Human immunodeficiency virus 1 infection	55165	155	22	7	3	0.059803	0.20115
Pyrimidine metabolism	55165	155	22	4	2	0.096837	0.22394
Nucleotide metabolism	55165	155	22	4	2	0.096837	0.22394
FoxO signaling pathway	55165	155	22	4	2	0.096837	0.22394
Ubiquitin mediated proteolysis	55165	155	22	4	2	0.096837	0.22394
MicroRNAs in cancer	55165	155	22	4	2	0.096837	0.22394
Purine metabolism	55165	155	22	1	1	0.14194	0.26258
Base excision repair	55165	155	22	1	1	0.14194	0.26258
Non-homologous end-joining	55165	155	22	1	1	0.14194	0.26258
Fanconi anemia pathway	55165	155	22	1	1	0.14194	0.26258
Folate biosynthesis	55165	155	22	2	1	0.26452	0.40501
Platinum drug resistance	55165	155	22	2	1	0.26452	0.40501
MAPK signaling pathway	55165	155	22	2	1	0.26452	0.40501
ECM-receptor interaction	55165	155	22	2	1	0.26452	0.40501
Viral carcinogenesis	55165	155	22	13	3	0.27366	0.40501
Drug metabolism - other enzymes	55165	155	22	3	1	0.37027	0.47242
AMPK signaling pathway	55165	155	22	3	1	0.37027	0.47242
Gap junction	55165	155	22	3	1	0.37027	0.47242
Acute myeloid leukemia	55165	155	22	3	1	0.37027	0.47242
Metabolic pathways	55165	155	22	24	4	0.45485	0.55072
Biosynthesis of cofactors	55165	155	22	4	1	0.46142	0.55072
Chemical carcinogenesis - receptor activation	55165	155	22	5	1	0.53989	0.62424
Hepatitis B	55165	155	22	8	1	0.71509	0.77818
Transcriptional misregulation in cancer	55165	155	22	8	1	0.71509	0.77818
Pathways in cancer	55165	155	22	9	1	0.75773	0.80103
Human papillomavirus infection	55165	155	22	10	1	0.79423	0.8163
Epstein-Barr virus infection	55165	155	22	11	1	0.82545	0.82545
Alzheimer disease	55196	155	21	8	4	0.012408	0.26979
RNA degradation	55196	155	21	2	2	0.017595	0.26979
Protein digestion and absorption	55196	155	21	2	2	0.017595	0.26979
Pathways of neurodegeneration - multiple diseases	55196	155	21	7	3	0.052765	0.3666
Mucin type O-glycan biosynthesis	55196	155	21	1	1	0.13548	0.3666
Glycerolipid metabolism	55196	155	21	1	1	0.13548	0.3666
Glycerophospholipid metabolism	55196	155	21	1	1	0.13548	0.3666
Arachidonic acid metabolism	55196	155	21	1	1	0.13548	0.3666
Sphingolipid metabolism	55196	155	21	1	1	0.13548	0.3666
ABC transporters	55196	155	21	1	1	0.13548	0.3666
mTOR signaling pathway	55196	155	21	1	1	0.13548	0.3666
Glutamatergic synapse	55196	155	21	1	1	0.13548	0.3666
Serotonergic synapse	55196	155	21	1	1	0.13548	0.3666
GABAergic synapse	55196	155	21	1	1	0.13548	0.3666
Fat digestion and absorption	55196	155	21	1	1	0.13548	0.3666
Epithelial cell signaling in Helicobacter pylori infection	55196	155	21	1	1	0.13548	0.3666
Pathogenic Escherichia coli infection	55196	155	21	1	1	0.13548	0.3666
Parkinson disease	55196	155	21	6	2	0.18749	0.47914
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	55196	155	21	2	1	0.25337	0.48563
Notch signaling pathway	55196	155	21	2	1	0.25337	0.48563
Renin-angiotensin system	55196	155	21	2	1	0.25337	0.48563
Alcoholic liver disease	55196	155	21	2	1	0.25337	0.48563
Cholesterol metabolism	55196	155	21	2	1	0.25337	0.48563
Salmonella infection	55196	155	21	2	1	0.25337	0.48563
Alcoholism	55196	155	21	8	2	0.29618	0.54497
Gap junction	55196	155	21	3	1	0.35585	0.58461
Thyroid hormone signaling pathway	55196	155	21	3	1	0.35585	0.58461
Lipid and atherosclerosis	55196	155	21	3	1	0.35585	0.58461
Systemic lupus erythematosus	55196	155	21	10	2	0.40408	0.60185
Metabolic pathways	55196	155	21	24	4	0.41485	0.60185
Ubiquitin mediated proteolysis	55196	155	21	4	1	0.44485	0.60185
Amyotrophic lateral sclerosis	55196	155	21	4	1	0.44485	0.60185
Huntington disease	55196	155	21	4	1	0.44485	0.60185
Prion disease	55196	155	21	4	1	0.44485	0.60185
Viral life cycle - HIV-1	55196	155	21	5	1	0.52205	0.64904
Phagosome	55196	155	21	5	1	0.52205	0.64904
Hematopoietic cell lineage	55196	155	21	5	1	0.52205	0.64904
Neutrophil extracellular trap formation	55196	155	21	13	2	0.55134	0.6503
Viral carcinogenesis	55196	155	21	13	2	0.55134	0.6503
Protein processing in endoplasmic reticulum	55196	155	21	6	1	0.58896	0.67731
Oocyte meiosis	55196	155	21	7	1	0.6469	0.69203
Progesterone-mediated oocyte maturation	55196	155	21	7	1	0.6469	0.69203
Human immunodeficiency virus 1 infection	55196	155	21	7	1	0.6469	0.69203
Coronavirus disease - COVID-19	55196	155	21	11	1	0.80984	0.84666
NOD-like receptor signaling pathway	55196	155	21	15	1	0.89951	0.9195
Ribosome biogenesis in eukaryotes	55196	155	21	18	1	0.93852	0.93852
ABC transporters	55350	155	2	1	1	0.012903	0.051613
Fat digestion and absorption	55350	155	2	1	1	0.012903	0.051613
Cholesterol metabolism	55350	155	2	2	1	0.025723	0.068594
Lipid and atherosclerosis	55350	155	2	3	1	0.038458	0.076917
Alcoholism	55350	155	2	8	1	0.10088	0.16121
Systemic lupus erythematosus	55350	155	2	10	1	0.12526	0.16121
Neutrophil extracellular trap formation	55350	155	2	13	1	0.16121	0.16121
Viral carcinogenesis	55350	155	2	13	1	0.16121	0.16121
Cell cycle	55355	155	29	14	12	1.4419e-08	6.2002e-07
Oocyte meiosis	55355	155	29	7	6	0.00016522	0.0035521
DNA replication	55355	155	29	4	4	0.0010268	0.011039
p53 signaling pathway	55355	155	29	4	4	0.0010268	0.011039
Cellular senescence	55355	155	29	7	5	0.0026811	0.019215
Progesterone-mediated oocyte maturation	55355	155	29	7	5	0.0026811	0.019215
Antifolate resistance	55355	155	29	3	3	0.0060031	0.036876
Pyrimidine metabolism	55355	155	29	4	3	0.020932	0.10001
Nucleotide metabolism	55355	155	29	4	3	0.020932	0.10001
Human T-cell leukemia virus 1 infection	55355	155	29	7	4	0.023479	0.10096
Glutathione metabolism	55355	155	29	2	2	0.034018	0.10448
One carbon pool by folate	55355	155	29	2	2	0.034018	0.10448
Folate biosynthesis	55355	155	29	2	2	0.034018	0.10448
Platinum drug resistance	55355	155	29	2	2	0.034018	0.10448
Drug metabolism - other enzymes	55355	155	29	3	2	0.090047	0.25813
Human immunodeficiency virus 1 infection	55355	155	29	7	3	0.12187	0.30943
Biosynthesis of cofactors	55355	155	29	4	2	0.15916	0.30943
FoxO signaling pathway	55355	155	29	4	2	0.15916	0.30943
Ubiquitin mediated proteolysis	55355	155	29	4	2	0.15916	0.30943
MicroRNAs in cancer	55355	155	29	4	2	0.15916	0.30943
Purine metabolism	55355	155	29	1	1	0.1871	0.30943
Base excision repair	55355	155	29	1	1	0.1871	0.30943
Non-homologous end-joining	55355	155	29	1	1	0.1871	0.30943
Fanconi anemia pathway	55355	155	29	1	1	0.1871	0.30943
Hippo signaling pathway	55355	155	29	1	1	0.1871	0.30943
Carbohydrate digestion and absorption	55355	155	29	1	1	0.1871	0.30943
Chemical carcinogenesis - receptor activation	55355	155	29	5	2	0.23484	0.374
MAPK signaling pathway	55355	155	29	2	1	0.34018	0.45711
Apoptosis	55355	155	29	2	1	0.34018	0.45711
Apoptosis - multiple species	55355	155	29	2	1	0.34018	0.45711
ECM-receptor interaction	55355	155	29	2	1	0.34018	0.45711
Colorectal cancer	55355	155	29	2	1	0.34018	0.45711
Viral carcinogenesis	55355	155	29	13	3	0.4532	0.54069
Hepatitis B	55355	155	29	8	2	0.46131	0.54069
AMPK signaling pathway	55355	155	29	3	1	0.46524	0.54069
Gap junction	55355	155	29	3	1	0.46524	0.54069
Acute myeloid leukemia	55355	155	29	3	1	0.46524	0.54069
Metabolic pathways	55355	155	29	24	5	0.48092	0.54419
Pathways in cancer	55355	155	29	9	2	0.52913	0.5834
Protein processing in endoplasmic reticulum	55355	155	29	6	1	0.71797	0.77182
Transcriptional misregulation in cancer	55355	155	29	8	1	0.81737	0.85724
Human papillomavirus infection	55355	155	29	10	1	0.88252	0.90353
Epstein-Barr virus infection	55355	155	29	11	1	0.90601	0.90601
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	55454	155	13	2	2	0.0065354	0.15685
Mucin type O-glycan biosynthesis	55454	155	13	1	1	0.083871	0.22366
Sphingolipid metabolism	55454	155	13	1	1	0.083871	0.22366
Pantothenate and CoA biosynthesis	55454	155	13	1	1	0.083871	0.22366
Viral protein interaction with cytokine and cytokine receptor	55454	155	13	1	1	0.083871	0.22366
TNF signaling pathway	55454	155	13	1	1	0.083871	0.22366
Glutamatergic synapse	55454	155	13	1	1	0.083871	0.22366
GABAergic synapse	55454	155	13	1	1	0.083871	0.22366
Epithelial cell signaling in Helicobacter pylori infection	55454	155	13	1	1	0.083871	0.22366
Metabolic pathways	55454	155	13	24	4	0.11991	0.28779
Notch signaling pathway	55454	155	13	2	1	0.16121	0.29761
Protein digestion and absorption	55454	155	13	2	1	0.16121	0.29761
Inflammatory bowel disease	55454	155	13	2	1	0.16121	0.29761
Cytokine-cytokine receptor interaction	55454	155	13	3	1	0.23248	0.37196
Thyroid hormone signaling pathway	55454	155	13	3	1	0.23248	0.37196
Ubiquitin mediated proteolysis	55454	155	13	4	1	0.29812	0.44718
Protein processing in endoplasmic reticulum	55454	155	13	6	1	0.41414	0.53172
Parkinson disease	55454	155	13	6	1	0.41414	0.53172
Oocyte meiosis	55454	155	13	7	1	0.46525	0.53172
Progesterone-mediated oocyte maturation	55454	155	13	7	1	0.46525	0.53172
Pathways of neurodegeneration - multiple diseases	55454	155	13	7	1	0.46525	0.53172
Alzheimer disease	55454	155	13	8	1	0.51223	0.55879
Coronavirus disease - COVID-19	55454	155	13	11	1	0.63127	0.65871
NOD-like receptor signaling pathway	55454	155	13	15	1	0.74851	0.74851
Protein processing in endoplasmic reticulum	55507	155	24	6	4	0.0055078	0.29191
Glutathione metabolism	55507	155	24	2	2	0.023125	0.39078
Intestinal immune network for IgA production	55507	155	24	2	2	0.023125	0.39078
Cell cycle	55507	155	24	14	5	0.044272	0.39078
Cytokine-cytokine receptor interaction	55507	155	24	3	2	0.062725	0.39078
Oocyte meiosis	55507	155	24	7	3	0.075286	0.39078
p53 signaling pathway	55507	155	24	4	2	0.11353	0.39078
Purine metabolism	55507	155	24	1	1	0.15484	0.39078
Glycine, serine and threonine metabolism	55507	155	24	1	1	0.15484	0.39078
Glyoxylate and dicarboxylate metabolism	55507	155	24	1	1	0.15484	0.39078
Carbon metabolism	55507	155	24	1	1	0.15484	0.39078
Biosynthesis of nucleotide sugars	55507	155	24	1	1	0.15484	0.39078
Protein export	55507	155	24	1	1	0.15484	0.39078
Base excision repair	55507	155	24	1	1	0.15484	0.39078
Non-homologous end-joining	55507	155	24	1	1	0.15484	0.39078
Fanconi anemia pathway	55507	155	24	1	1	0.15484	0.39078
Estrogen signaling pathway	55507	155	24	1	1	0.15484	0.39078
Thyroid hormone synthesis	55507	155	24	1	1	0.15484	0.39078
Oxytocin signaling pathway	55507	155	24	1	1	0.15484	0.39078
Pancreatic secretion	55507	155	24	1	1	0.15484	0.39078
Primary immunodeficiency	55507	155	24	1	1	0.15484	0.39078
Chemical carcinogenesis - receptor activation	55507	155	24	5	2	0.1714	0.41291
Amino sugar and nucleotide sugar metabolism	55507	155	24	2	1	0.28655	0.47114
Nicotinate and nicotinamide metabolism	55507	155	24	2	1	0.28655	0.47114
Folate biosynthesis	55507	155	24	2	1	0.28655	0.47114
Calcium signaling pathway	55507	155	24	2	1	0.28655	0.47114
IL-17 signaling pathway	55507	155	24	2	1	0.28655	0.47114
Th17 cell differentiation	55507	155	24	2	1	0.28655	0.47114
Salivary secretion	55507	155	24	2	1	0.28655	0.47114
Salmonella infection	55507	155	24	2	1	0.28655	0.47114
Fluid shear stress and atherosclerosis	55507	155	24	2	1	0.28655	0.47114
Cellular senescence	55507	155	24	7	2	0.29626	0.47114
Progesterone-mediated oocyte maturation	55507	155	24	7	2	0.29626	0.47114
Metabolic pathways	55507	155	24	24	5	0.30224	0.47114
Drug metabolism - other enzymes	55507	155	24	3	1	0.39847	0.5415
Antifolate resistance	55507	155	24	3	1	0.39847	0.5415
PI3K-Akt signaling pathway	55507	155	24	3	1	0.39847	0.5415
Prostate cancer	55507	155	24	3	1	0.39847	0.5415
Lipid and atherosclerosis	55507	155	24	3	1	0.39847	0.5415
Pyrimidine metabolism	55507	155	24	4	1	0.49344	0.58117
Nucleotide metabolism	55507	155	24	4	1	0.49344	0.58117
Biosynthesis of cofactors	55507	155	24	4	1	0.49344	0.58117
DNA replication	55507	155	24	4	1	0.49344	0.58117
FoxO signaling pathway	55507	155	24	4	1	0.49344	0.58117
Ubiquitin mediated proteolysis	55507	155	24	4	1	0.49344	0.58117
Viral life cycle - HIV-1	55507	155	24	5	1	0.57396	0.64723
Hematopoietic cell lineage	55507	155	24	5	1	0.57396	0.64723
Parkinson disease	55507	155	24	6	1	0.64212	0.70901
Pathways of neurodegeneration - multiple diseases	55507	155	24	7	1	0.69977	0.72721
Human T-cell leukemia virus 1 infection	55507	155	24	7	1	0.69977	0.72721
Human immunodeficiency virus 1 infection	55507	155	24	7	1	0.69977	0.72721
Pathways in cancer	55507	155	24	9	1	0.78952	0.80471
Viral carcinogenesis	55507	155	24	13	1	0.89822	0.89822
Influenza A	55601	155	31	10	10	2.7046e-08	1.5416e-06
Measles	55601	155	31	9	9	1.7949e-07	5.1154e-06
Hepatitis C	55601	155	31	12	10	1.3449e-06	2.5553e-05
Coronavirus disease - COVID-19	55601	155	31	11	9	7.3705e-06	0.00010133
Herpes simplex virus 1 infection	55601	155	31	9	8	8.8885e-06	0.00010133
NOD-like receptor signaling pathway	55601	155	31	15	9	0.0003707	0.0035217
Epstein-Barr virus infection	55601	155	31	11	7	0.0012617	0.0096925
Necroptosis	55601	155	31	4	4	0.0013604	0.0096925
Kaposi sarcoma-associated herpesvirus infection	55601	155	31	4	3	0.025458	0.14805
Human papillomavirus infection	55601	155	31	10	5	0.028076	0.14805
RNA degradation	55601	155	31	2	2	0.038961	0.14805
Chemokine signaling pathway	55601	155	31	2	2	0.038961	0.14805
RIG-I-like receptor signaling pathway	55601	155	31	2	2	0.038961	0.14805
Cytosolic DNA-sensing pathway	55601	155	31	2	2	0.038961	0.14805
C-type lectin receptor signaling pathway	55601	155	31	2	2	0.038961	0.14805
Hepatitis B	55601	155	31	8	4	0.051452	0.1833
JAK-STAT signaling pathway	55601	155	31	3	2	0.10211	0.34238
Osteoclast differentiation	55601	155	31	4	2	0.17877	0.38
PD-L1 expression and PD-1 checkpoint pathway in cancer	55601	155	31	4	2	0.17877	0.38
Glycolysis / Gluconeogenesis	55601	155	31	1	1	0.2	0.38
Galactose metabolism	55601	155	31	1	1	0.2	0.38
NF-kappa B signaling pathway	55601	155	31	1	1	0.2	0.38
Signaling pathways regulating pluripotency of stem cells	55601	155	31	1	1	0.2	0.38
Toll-like receptor signaling pathway	55601	155	31	1	1	0.2	0.38
Th1 and Th2 cell differentiation	55601	155	31	1	1	0.2	0.38
Prolactin signaling pathway	55601	155	31	1	1	0.2	0.38
AGE-RAGE signaling pathway in diabetic complications	55601	155	31	1	1	0.2	0.38
Growth hormone synthesis, secretion and action	55601	155	31	1	1	0.2	0.38
Pertussis	55601	155	31	1	1	0.2	0.38
Toxoplasmosis	55601	155	31	1	1	0.2	0.38
Viral life cycle - HIV-1	55601	155	31	5	2	0.26135	0.48054
Lysosome	55601	155	31	2	1	0.36104	0.51448
Apoptosis	55601	155	31	2	1	0.36104	0.51448
Apoptosis - multiple species	55601	155	31	2	1	0.36104	0.51448
Notch signaling pathway	55601	155	31	2	1	0.36104	0.51448
Cell adhesion molecules	55601	155	31	2	1	0.36104	0.51448
Complement and coagulation cascades	55601	155	31	2	1	0.36104	0.51448
Th17 cell differentiation	55601	155	31	2	1	0.36104	0.51448
Leishmaniasis	55601	155	31	2	1	0.36104	0.51448
Inflammatory bowel disease	55601	155	31	2	1	0.36104	0.51448
Thyroid hormone signaling pathway	55601	155	31	3	1	0.4905	0.66568
Pancreatic cancer	55601	155	31	3	1	0.4905	0.66568
Pathways in cancer	55601	155	31	9	2	0.56983	0.72088
Pyrimidine metabolism	55601	155	31	4	1	0.59441	0.72088
Nucleotide metabolism	55601	155	31	4	1	0.59441	0.72088
Biosynthesis of cofactors	55601	155	31	4	1	0.59441	0.72088
Tuberculosis	55601	155	31	4	1	0.59441	0.72088
Protein processing in endoplasmic reticulum	55601	155	31	6	1	0.74429	0.88385
Viral carcinogenesis	55601	155	31	13	2	0.77891	0.9033
Human immunodeficiency virus 1 infection	55601	155	31	7	1	0.79749	0.9033
Alzheimer disease	55601	155	31	8	1	0.83991	0.9033
Alcoholism	55601	155	31	8	1	0.83991	0.9033
Transcriptional misregulation in cancer	55601	155	31	8	1	0.83991	0.9033
Systemic lupus erythematosus	55601	155	31	10	1	0.90049	0.95052
Neutrophil extracellular trap formation	55601	155	31	13	1	0.95192	0.98625
Metabolic pathways	55601	155	31	24	2	0.97612	0.98625
Ribosome biogenesis in eukaryotes	55601	155	31	18	1	0.98625	0.98625
Rap1 signaling pathway	5577	155	12	2	2	0.00553	0.11429
Focal adhesion	5577	155	12	2	2	0.00553	0.11429
Regulation of actin cytoskeleton	5577	155	12	2	2	0.00553	0.11429
Pathways of neurodegeneration - multiple diseases	5577	155	12	7	3	0.010542	0.14054
PI3K-Akt signaling pathway	5577	155	12	3	2	0.015867	0.14054
Gap junction	5577	155	12	3	2	0.015867	0.14054
Thyroid hormone signaling pathway	5577	155	12	3	2	0.015867	0.14054
Phagosome	5577	155	12	5	2	0.048387	0.2
Parkinson disease	5577	155	12	6	2	0.069428	0.2
EGFR tyrosine kinase inhibitor resistance	5577	155	12	1	1	0.077419	0.2
ErbB signaling pathway	5577	155	12	1	1	0.077419	0.2
Ras signaling pathway	5577	155	12	1	1	0.077419	0.2
Phospholipase D signaling pathway	5577	155	12	1	1	0.077419	0.2
Axon guidance	5577	155	12	1	1	0.077419	0.2
Platelet activation	5577	155	12	1	1	0.077419	0.2
Serotonergic synapse	5577	155	12	1	1	0.077419	0.2
Insulin signaling pathway	5577	155	12	1	1	0.077419	0.2
Pathogenic Escherichia coli infection	5577	155	12	1	1	0.077419	0.2
Proteoglycans in cancer	5577	155	12	1	1	0.077419	0.2
Endometrial cancer	5577	155	12	1	1	0.077419	0.2
Choline metabolism in cancer	5577	155	12	1	1	0.077419	0.2
Hypertrophic cardiomyopathy	5577	155	12	1	1	0.077419	0.2
Arrhythmogenic right ventricular cardiomyopathy	5577	155	12	1	1	0.077419	0.2
Dilated cardiomyopathy	5577	155	12	1	1	0.077419	0.2
Alzheimer disease	5577	155	12	8	2	0.11861	0.23143
MAPK signaling pathway	5577	155	12	2	1	0.14931	0.23143
Calcium signaling pathway	5577	155	12	2	1	0.14931	0.23143
HIF-1 signaling pathway	5577	155	12	2	1	0.14931	0.23143
ECM-receptor interaction	5577	155	12	2	1	0.14931	0.23143
Complement and coagulation cascades	5577	155	12	2	1	0.14931	0.23143
Salmonella infection	5577	155	12	2	1	0.14931	0.23143
Human cytomegalovirus infection	5577	155	12	2	1	0.14931	0.23143
Colorectal cancer	5577	155	12	2	1	0.14931	0.23143
Glioma	5577	155	12	2	1	0.14931	0.23143
Melanoma	5577	155	12	2	1	0.14931	0.23143
Bladder cancer	5577	155	12	2	1	0.14931	0.23143
Non-small cell lung cancer	5577	155	12	2	1	0.14931	0.23143
Breast cancer	5577	155	12	2	1	0.14931	0.23143
Gastric cancer	5577	155	12	2	1	0.14931	0.23143
Fluid shear stress and atherosclerosis	5577	155	12	2	1	0.14931	0.23143
Human papillomavirus infection	5577	155	12	10	2	0.1745	0.26387
JAK-STAT signaling pathway	5577	155	12	3	1	0.21603	0.30441
Pancreatic cancer	5577	155	12	3	1	0.21603	0.30441
Prostate cancer	5577	155	12	3	1	0.21603	0.30441
FoxO signaling pathway	5577	155	12	4	1	0.27792	0.32512
Ubiquitin mediated proteolysis	5577	155	12	4	1	0.27792	0.32512
Osteoclast differentiation	5577	155	12	4	1	0.27792	0.32512
Amyotrophic lateral sclerosis	5577	155	12	4	1	0.27792	0.32512
Huntington disease	5577	155	12	4	1	0.27792	0.32512
Prion disease	5577	155	12	4	1	0.27792	0.32512
MicroRNAs in cancer	5577	155	12	4	1	0.27792	0.32512
Chemical carcinogenesis - reactive oxygen species	5577	155	12	4	1	0.27792	0.32512
PD-L1 expression and PD-1 checkpoint pathway in cancer	5577	155	12	4	1	0.27792	0.32512
Hematopoietic cell lineage	5577	155	12	5	1	0.33531	0.37798
Chemical carcinogenesis - receptor activation	5577	155	12	5	1	0.33531	0.37798
Protein processing in endoplasmic reticulum	5577	155	12	6	1	0.38848	0.4301
Herpes simplex virus 1 infection	5577	155	12	9	1	0.5255	0.56174
Pathways in cancer	5577	155	12	9	1	0.5255	0.56174
Coronavirus disease - COVID-19	5577	155	12	11	1	0.60054	0.63108
Hepatitis C	5577	155	12	12	1	0.63383	0.65496
Neutrophil extracellular trap formation	5577	155	12	13	1	0.66456	0.67545
NOD-like receptor signaling pathway	5577	155	12	15	1	0.71904	0.71904
Cell cycle	55789	155	26	14	12	2.8017e-09	1.2047e-07
Oocyte meiosis	55789	155	26	7	6	8.1668e-05	0.0017559
DNA replication	55789	155	26	4	4	0.00064635	0.0069482
p53 signaling pathway	55789	155	26	4	4	0.00064635	0.0069482
Progesterone-mediated oocyte maturation	55789	155	26	7	5	0.0015427	0.013267
Antifolate resistance	55789	155	26	3	3	0.0042715	0.030612
Cellular senescence	55789	155	26	7	4	0.015599	0.083846
Human T-cell leukemia virus 1 infection	55789	155	26	7	4	0.015599	0.083846
Glutathione metabolism	55789	155	26	2	2	0.027231	0.097577
One carbon pool by folate	55789	155	26	2	2	0.027231	0.097577
Folate biosynthesis	55789	155	26	2	2	0.027231	0.097577
Platinum drug resistance	55789	155	26	2	2	0.027231	0.097577
Human immunodeficiency virus 1 infection	55789	155	26	7	3	0.092605	0.28852
Pyrimidine metabolism	55789	155	26	4	2	0.13115	0.28852
Nucleotide metabolism	55789	155	26	4	2	0.13115	0.28852
Biosynthesis of cofactors	55789	155	26	4	2	0.13115	0.28852
FoxO signaling pathway	55789	155	26	4	2	0.13115	0.28852
Ubiquitin mediated proteolysis	55789	155	26	4	2	0.13115	0.28852
MicroRNAs in cancer	55789	155	26	4	2	0.13115	0.28852
Purine metabolism	55789	155	26	1	1	0.16774	0.28852
Biosynthesis of nucleotide sugars	55789	155	26	1	1	0.16774	0.28852
Base excision repair	55789	155	26	1	1	0.16774	0.28852
Non-homologous end-joining	55789	155	26	1	1	0.16774	0.28852
Fanconi anemia pathway	55789	155	26	1	1	0.16774	0.28852
Hippo signaling pathway	55789	155	26	1	1	0.16774	0.28852
Chemical carcinogenesis - receptor activation	55789	155	26	5	2	0.1962	0.32448
Amino sugar and nucleotide sugar metabolism	55789	155	26	2	1	0.30825	0.41422
MAPK signaling pathway	55789	155	26	2	1	0.30825	0.41422
Apoptosis	55789	155	26	2	1	0.30825	0.41422
Apoptosis - multiple species	55789	155	26	2	1	0.30825	0.41422
ECM-receptor interaction	55789	155	26	2	1	0.30825	0.41422
Colorectal cancer	55789	155	26	2	1	0.30825	0.41422
Metabolic pathways	55789	155	26	24	5	0.37315	0.46948
Viral carcinogenesis	55789	155	26	13	3	0.37612	0.46948
Hepatitis B	55789	155	26	8	2	0.40046	0.46948
Drug metabolism - other enzymes	55789	155	26	3	1	0.4258	0.46948
AMPK signaling pathway	55789	155	26	3	1	0.4258	0.46948
Gap junction	55789	155	26	3	1	0.4258	0.46948
Acute myeloid leukemia	55789	155	26	3	1	0.4258	0.46948
Pathways in cancer	55789	155	26	9	2	0.46472	0.49958
Transcriptional misregulation in cancer	55789	155	26	8	1	0.77835	0.81632
Human papillomavirus infection	55789	155	26	10	1	0.85004	0.87028
Epstein-Barr virus infection	55789	155	26	11	1	0.87693	0.87693
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	55790	155	4	2	2	0.00050272	0.0045245
Glutamatergic synapse	55790	155	4	1	1	0.025806	0.058065
GABAergic synapse	55790	155	4	1	1	0.025806	0.058065
Epithelial cell signaling in Helicobacter pylori infection	55790	155	4	1	1	0.025806	0.058065
Notch signaling pathway	55790	155	4	2	1	0.05111	0.076665
Protein digestion and absorption	55790	155	4	2	1	0.05111	0.076665
Metabolic pathways	55790	155	4	24	2	0.11353	0.14596
Alzheimer disease	55790	155	4	8	1	0.19274	0.21683
Coronavirus disease - COVID-19	55790	155	4	11	1	0.25729	0.25729
Influenza A	5610	155	28	10	10	8.0025e-09	4.4814e-07
Measles	5610	155	28	9	9	6.1493e-08	1.7218e-06
Hepatitis C	5610	155	28	12	10	4.1541e-07	7.7542e-06
Coronavirus disease - COVID-19	5610	155	28	11	9	2.6346e-06	3.6884e-05
Herpes simplex virus 1 infection	5610	155	28	9	8	3.5758e-06	4.0049e-05
Epstein-Barr virus infection	5610	155	28	11	7	0.00061664	0.0057554
Necroptosis	5610	155	28	4	4	0.00088521	0.0070817
NOD-like receptor signaling pathway	5610	155	28	15	7	0.0069988	0.048992
Human papillomavirus infection	5610	155	28	10	5	0.017867	0.10569
Kaposi sarcoma-associated herpesvirus infection	5610	155	28	4	3	0.018873	0.10569
RNA degradation	5610	155	28	2	2	0.031672	0.11824
Chemokine signaling pathway	5610	155	28	2	2	0.031672	0.11824
RIG-I-like receptor signaling pathway	5610	155	28	2	2	0.031672	0.11824
Cytosolic DNA-sensing pathway	5610	155	28	2	2	0.031672	0.11824
C-type lectin receptor signaling pathway	5610	155	28	2	2	0.031672	0.11824
Hepatitis B	5610	155	28	8	4	0.035996	0.12598
JAK-STAT signaling pathway	5610	155	28	3	2	0.08425	0.27753
Osteoclast differentiation	5610	155	28	4	2	0.14963	0.30655
Tuberculosis	5610	155	28	4	2	0.14963	0.30655
Alcoholism	5610	155	28	8	3	0.15711	0.30655
Glycolysis / Gluconeogenesis	5610	155	28	1	1	0.18065	0.30655
Galactose metabolism	5610	155	28	1	1	0.18065	0.30655
ABC transporters	5610	155	28	1	1	0.18065	0.30655
NF-kappa B signaling pathway	5610	155	28	1	1	0.18065	0.30655
Signaling pathways regulating pluripotency of stem cells	5610	155	28	1	1	0.18065	0.30655
Toll-like receptor signaling pathway	5610	155	28	1	1	0.18065	0.30655
Th1 and Th2 cell differentiation	5610	155	28	1	1	0.18065	0.30655
Neurotrophin signaling pathway	5610	155	28	1	1	0.18065	0.30655
Prolactin signaling pathway	5610	155	28	1	1	0.18065	0.30655
AGE-RAGE signaling pathway in diabetic complications	5610	155	28	1	1	0.18065	0.30655
Growth hormone synthesis, secretion and action	5610	155	28	1	1	0.18065	0.30655
Fat digestion and absorption	5610	155	28	1	1	0.18065	0.30655
Toxoplasmosis	5610	155	28	1	1	0.18065	0.30655
Viral carcinogenesis	5610	155	28	13	4	0.18758	0.30896
Viral life cycle - HIV-1	5610	155	28	5	2	0.22179	0.35486
Systemic lupus erythematosus	5610	155	28	10	3	0.26092	0.40587
Lysosome	5610	155	28	2	1	0.32962	0.43949
Notch signaling pathway	5610	155	28	2	1	0.32962	0.43949
Th17 cell differentiation	5610	155	28	2	1	0.32962	0.43949
Cholesterol metabolism	5610	155	28	2	1	0.32962	0.43949
Leishmaniasis	5610	155	28	2	1	0.32962	0.43949
Inflammatory bowel disease	5610	155	28	2	1	0.32962	0.43949
Neutrophil extracellular trap formation	5610	155	28	13	3	0.42768	0.55063
Thyroid hormone signaling pathway	5610	155	28	3	1	0.4523	0.55063
Pancreatic cancer	5610	155	28	3	1	0.4523	0.55063
Lipid and atherosclerosis	5610	155	28	3	1	0.4523	0.55063
Pathways in cancer	5610	155	28	9	2	0.50808	0.60538
Pyrimidine metabolism	5610	155	28	4	1	0.55319	0.60743
Nucleotide metabolism	5610	155	28	4	1	0.55319	0.60743
Biosynthesis of cofactors	5610	155	28	4	1	0.55319	0.60743
PD-L1 expression and PD-1 checkpoint pathway in cancer	5610	155	28	4	1	0.55319	0.60743
Protein processing in endoplasmic reticulum	5610	155	28	6	1	0.70398	0.75814
Human immunodeficiency virus 1 infection	5610	155	28	7	1	0.75961	0.80261
Alzheimer disease	5610	155	28	8	1	0.80509	0.83491
Metabolic pathways	5610	155	28	24	2	0.95985	0.9773
Ribosome biogenesis in eukaryotes	5610	155	28	18	1	0.97816	0.97816
RNA degradation	57162	155	17	2	2	0.011395	0.24822
Parkinson disease	57162	155	17	6	3	0.018025	0.24822
Pathways of neurodegeneration - multiple diseases	57162	155	17	7	3	0.029364	0.24822
Alzheimer disease	57162	155	17	8	3	0.043737	0.24822
Amyotrophic lateral sclerosis	57162	155	17	4	2	0.059742	0.24822
Huntington disease	57162	155	17	4	2	0.059742	0.24822
Prion disease	57162	155	17	4	2	0.059742	0.24822
Mucin type O-glycan biosynthesis	57162	155	17	1	1	0.10968	0.24822
Glycerolipid metabolism	57162	155	17	1	1	0.10968	0.24822
Glycerophospholipid metabolism	57162	155	17	1	1	0.10968	0.24822
Sphingolipid metabolism	57162	155	17	1	1	0.10968	0.24822
ABC transporters	57162	155	17	1	1	0.10968	0.24822
mTOR signaling pathway	57162	155	17	1	1	0.10968	0.24822
Glutamatergic synapse	57162	155	17	1	1	0.10968	0.24822
GABAergic synapse	57162	155	17	1	1	0.10968	0.24822
Insulin signaling pathway	57162	155	17	1	1	0.10968	0.24822
Fat digestion and absorption	57162	155	17	1	1	0.10968	0.24822
Epithelial cell signaling in Helicobacter pylori infection	57162	155	17	1	1	0.10968	0.24822
Pathogenic Escherichia coli infection	57162	155	17	1	1	0.10968	0.24822
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	57162	155	17	2	1	0.20796	0.3312
Notch signaling pathway	57162	155	17	2	1	0.20796	0.3312
Retrograde endocannabinoid signaling	57162	155	17	2	1	0.20796	0.3312
Non-alcoholic fatty liver disease	57162	155	17	2	1	0.20796	0.3312
Alcoholic liver disease	57162	155	17	2	1	0.20796	0.3312
Protein digestion and absorption	57162	155	17	2	1	0.20796	0.3312
Cholesterol metabolism	57162	155	17	2	1	0.20796	0.3312
Salmonella infection	57162	155	17	2	1	0.20796	0.3312
Metabolic pathways	57162	155	17	24	4	0.25592	0.37431
Oxidative phosphorylation	57162	155	17	3	1	0.29596	0.37431
Gap junction	57162	155	17	3	1	0.29596	0.37431
Thermogenesis	57162	155	17	3	1	0.29596	0.37431
Thyroid hormone signaling pathway	57162	155	17	3	1	0.29596	0.37431
Diabetic cardiomyopathy	57162	155	17	3	1	0.29596	0.37431
Lipid and atherosclerosis	57162	155	17	3	1	0.29596	0.37431
Ubiquitin mediated proteolysis	57162	155	17	4	1	0.37471	0.44756
Chemical carcinogenesis - reactive oxygen species	57162	155	17	4	1	0.37471	0.44756
Phagosome	57162	155	17	5	1	0.4451	0.51728
Protein processing in endoplasmic reticulum	57162	155	17	6	1	0.50799	0.57483
Oocyte meiosis	57162	155	17	7	1	0.56413	0.60644
Progesterone-mediated oocyte maturation	57162	155	17	7	1	0.56413	0.60644
Coronavirus disease - COVID-19	57162	155	17	11	1	0.73388	0.76968
NOD-like receptor signaling pathway	57162	155	17	15	1	0.83991	0.8599
Ribosome biogenesis in eukaryotes	57162	155	17	18	1	0.89176	0.89176
Influenza A	57674	155	29	10	10	1.2214e-08	6.9622e-07
Measles	57674	155	29	9	9	8.9165e-08	2.5412e-06
Hepatitis C	57674	155	29	12	10	6.2509e-07	1.1877e-05
Coronavirus disease - COVID-19	57674	155	29	11	9	3.7669e-06	5.3678e-05
Herpes simplex virus 1 infection	57674	155	29	9	8	4.9041e-06	5.5906e-05
NOD-like receptor signaling pathway	57674	155	29	15	9	0.00020063	0.001906
Epstein-Barr virus infection	57674	155	29	11	7	0.00079109	0.0064417
Necroptosis	57674	155	29	4	4	0.0010268	0.0073163
Human papillomavirus infection	57674	155	29	10	5	0.020916	0.11931
Kaposi sarcoma-associated herpesvirus infection	57674	155	29	4	3	0.020932	0.11931
RNA degradation	57674	155	29	2	2	0.034018	0.12927
Chemokine signaling pathway	57674	155	29	2	2	0.034018	0.12927
RIG-I-like receptor signaling pathway	57674	155	29	2	2	0.034018	0.12927
Cytosolic DNA-sensing pathway	57674	155	29	2	2	0.034018	0.12927
C-type lectin receptor signaling pathway	57674	155	29	2	2	0.034018	0.12927
Hepatitis B	57674	155	29	8	4	0.040764	0.14522
JAK-STAT signaling pathway	57674	155	29	3	2	0.090047	0.30192
Osteoclast differentiation	57674	155	29	4	2	0.15916	0.34402
Glycolysis / Gluconeogenesis	57674	155	29	1	1	0.1871	0.34402
Galactose metabolism	57674	155	29	1	1	0.1871	0.34402
ABC transporters	57674	155	29	1	1	0.1871	0.34402
NF-kappa B signaling pathway	57674	155	29	1	1	0.1871	0.34402
Signaling pathways regulating pluripotency of stem cells	57674	155	29	1	1	0.1871	0.34402
Toll-like receptor signaling pathway	57674	155	29	1	1	0.1871	0.34402
Th1 and Th2 cell differentiation	57674	155	29	1	1	0.1871	0.34402
Prolactin signaling pathway	57674	155	29	1	1	0.1871	0.34402
AGE-RAGE signaling pathway in diabetic complications	57674	155	29	1	1	0.1871	0.34402
Growth hormone synthesis, secretion and action	57674	155	29	1	1	0.1871	0.34402
Fat digestion and absorption	57674	155	29	1	1	0.1871	0.34402
Pertussis	57674	155	29	1	1	0.1871	0.34402
Toxoplasmosis	57674	155	29	1	1	0.1871	0.34402
Viral life cycle - HIV-1	57674	155	29	5	2	0.23484	0.4183
Lysosome	57674	155	29	2	1	0.34018	0.49718
Notch signaling pathway	57674	155	29	2	1	0.34018	0.49718
Complement and coagulation cascades	57674	155	29	2	1	0.34018	0.49718
Th17 cell differentiation	57674	155	29	2	1	0.34018	0.49718
Cholesterol metabolism	57674	155	29	2	1	0.34018	0.49718
Leishmaniasis	57674	155	29	2	1	0.34018	0.49718
Inflammatory bowel disease	57674	155	29	2	1	0.34018	0.49718
Viral carcinogenesis	57674	155	29	13	3	0.4532	0.6027
Alcoholism	57674	155	29	8	2	0.46131	0.6027
Thyroid hormone signaling pathway	57674	155	29	3	1	0.46524	0.6027
Pancreatic cancer	57674	155	29	3	1	0.46524	0.6027
Lipid and atherosclerosis	57674	155	29	3	1	0.46524	0.6027
Pathways in cancer	57674	155	29	9	2	0.52913	0.64668
Pyrimidine metabolism	57674	155	29	4	1	0.56727	0.64668
Nucleotide metabolism	57674	155	29	4	1	0.56727	0.64668
Biosynthesis of cofactors	57674	155	29	4	1	0.56727	0.64668
Tuberculosis	57674	155	29	4	1	0.56727	0.64668
PD-L1 expression and PD-1 checkpoint pathway in cancer	57674	155	29	4	1	0.56727	0.64668
Systemic lupus erythematosus	57674	155	29	10	2	0.59132	0.66089
Protein processing in endoplasmic reticulum	57674	155	29	6	1	0.71797	0.787
Neutrophil extracellular trap formation	57674	155	29	13	2	0.74228	0.7983
Human immunodeficiency virus 1 infection	57674	155	29	7	1	0.77286	0.8158
Alzheimer disease	57674	155	29	8	1	0.81737	0.84709
Metabolic pathways	57674	155	29	24	2	0.96614	0.98126
Ribosome biogenesis in eukaryotes	57674	155	29	18	1	0.98126	0.98126
Phagosome	5806	155	5	5	2	0.0080534	0.080534
PPAR signaling pathway	5806	155	5	2	1	0.063678	0.13468
IL-17 signaling pathway	5806	155	5	2	1	0.063678	0.13468
Amoebiasis	5806	155	5	2	1	0.063678	0.13468
Drug metabolism - other enzymes	5806	155	5	3	1	0.094277	0.13468
Acute myeloid leukemia	5806	155	5	3	1	0.094277	0.13468
Lipid and atherosclerosis	5806	155	5	3	1	0.094277	0.13468
Hematopoietic cell lineage	5806	155	5	5	1	0.15307	0.19134
Transcriptional misregulation in cancer	5806	155	5	8	1	0.23551	0.26168
Neutrophil extracellular trap formation	5806	155	5	13	1	0.35855	0.35855
Transcriptional misregulation in cancer	6037	155	8	8	4	0.00019433	0.002915
Staphylococcus aureus infection	6037	155	8	6	3	0.0017067	0.0128
NOD-like receptor signaling pathway	6037	155	8	15	3	0.030834	0.15417
Asthma	6037	155	8	1	1	0.051613	0.18487
Lysosome	6037	155	8	2	1	0.10088	0.18487
Renin-angiotensin system	6037	155	8	2	1	0.10088	0.18487
IL-17 signaling pathway	6037	155	8	2	1	0.10088	0.18487
Amoebiasis	6037	155	8	2	1	0.10088	0.18487
Neutrophil extracellular trap formation	6037	155	8	13	2	0.13646	0.18487
Drug metabolism - other enzymes	6037	155	8	3	1	0.14789	0.18487
Neuroactive ligand-receptor interaction	6037	155	8	3	1	0.14789	0.18487
Acute myeloid leukemia	6037	155	8	3	1	0.14789	0.18487
Phagosome	6037	155	8	5	1	0.23551	0.25233
Hematopoietic cell lineage	6037	155	8	5	1	0.23551	0.25233
Systemic lupus erythematosus	6037	155	8	10	1	0.42098	0.42098
Protein processing in endoplasmic reticulum	608	155	16	6	4	0.0010348	0.035183
Glutathione metabolism	608	155	16	2	2	0.010054	0.11395
Intestinal immune network for IgA production	608	155	16	2	2	0.010054	0.11395
Cytokine-cytokine receptor interaction	608	155	16	3	2	0.028323	0.24075
Chemical carcinogenesis - receptor activation	608	155	16	5	2	0.0833	0.25069
Purine metabolism	608	155	16	1	1	0.10323	0.25069
Glycine, serine and threonine metabolism	608	155	16	1	1	0.10323	0.25069
Glyoxylate and dicarboxylate metabolism	608	155	16	1	1	0.10323	0.25069
Carbon metabolism	608	155	16	1	1	0.10323	0.25069
Biosynthesis of nucleotide sugars	608	155	16	1	1	0.10323	0.25069
Protein export	608	155	16	1	1	0.10323	0.25069
Estrogen signaling pathway	608	155	16	1	1	0.10323	0.25069
Thyroid hormone synthesis	608	155	16	1	1	0.10323	0.25069
Primary immunodeficiency	608	155	16	1	1	0.10323	0.25069
Amino sugar and nucleotide sugar metabolism	608	155	16	2	1	0.1964	0.35145
IL-17 signaling pathway	608	155	16	2	1	0.1964	0.35145
Th17 cell differentiation	608	155	16	2	1	0.1964	0.35145
Salmonella infection	608	155	16	2	1	0.1964	0.35145
Fluid shear stress and atherosclerosis	608	155	16	2	1	0.1964	0.35145
Metabolic pathways	608	155	16	24	4	0.21862	0.37165
Drug metabolism - other enzymes	608	155	16	3	1	0.28043	0.39728
PI3K-Akt signaling pathway	608	155	16	3	1	0.28043	0.39728
Prostate cancer	608	155	16	3	1	0.28043	0.39728
Lipid and atherosclerosis	608	155	16	3	1	0.28043	0.39728
Pyrimidine metabolism	608	155	16	4	1	0.35618	0.44852
Nucleotide metabolism	608	155	16	4	1	0.35618	0.44852
p53 signaling pathway	608	155	16	4	1	0.35618	0.44852
Cell cycle	608	155	16	14	2	0.43769	0.53148
Parkinson disease	608	155	16	6	1	0.4858	0.55741
Oocyte meiosis	608	155	16	7	1	0.54101	0.55741
Cellular senescence	608	155	16	7	1	0.54101	0.55741
Progesterone-mediated oocyte maturation	608	155	16	7	1	0.54101	0.55741
Pathways of neurodegeneration - multiple diseases	608	155	16	7	1	0.54101	0.55741
Pathways in cancer	608	155	16	9	1	0.63519	0.63519
Cell cycle	6241	155	37	14	12	4.5658e-07	3.0591e-05
Oocyte meiosis	6241	155	37	7	6	0.00076569	0.025651
DNA replication	6241	155	37	4	4	0.0028554	0.047828
p53 signaling pathway	6241	155	37	4	4	0.0028554	0.047828
Cellular senescence	6241	155	37	7	5	0.0088606	0.098943
Progesterone-mediated oocyte maturation	6241	155	37	7	5	0.0088606	0.098943
Antifolate resistance	6241	155	37	3	3	0.012765	0.12218
Pyrimidine metabolism	6241	155	37	4	3	0.042495	0.26936
Nucleotide metabolism	6241	155	37	4	3	0.042495	0.26936
Glutathione metabolism	6241	155	37	2	2	0.055802	0.26936
One carbon pool by folate	6241	155	37	2	2	0.055802	0.26936
Folate biosynthesis	6241	155	37	2	2	0.055802	0.26936
Platinum drug resistance	6241	155	37	2	2	0.055802	0.26936
Human T-cell leukemia virus 1 infection	6241	155	37	7	4	0.056285	0.26936
Chemical carcinogenesis - receptor activation	6241	155	37	5	3	0.088566	0.39559
Drug metabolism - other enzymes	6241	155	37	3	2	0.14188	0.43687
Protein processing in endoplasmic reticulum	6241	155	37	6	3	0.14795	0.43687
Metabolic pathways	6241	155	37	24	8	0.17673	0.43687
Human immunodeficiency virus 1 infection	6241	155	37	7	3	0.21669	0.43687
Purine metabolism	6241	155	37	1	1	0.23871	0.43687
Glycine, serine and threonine metabolism	6241	155	37	1	1	0.23871	0.43687
Glyoxylate and dicarboxylate metabolism	6241	155	37	1	1	0.23871	0.43687
Carbon metabolism	6241	155	37	1	1	0.23871	0.43687
Biosynthesis of nucleotide sugars	6241	155	37	1	1	0.23871	0.43687
Protein export	6241	155	37	1	1	0.23871	0.43687
Base excision repair	6241	155	37	1	1	0.23871	0.43687
Non-homologous end-joining	6241	155	37	1	1	0.23871	0.43687
Fanconi anemia pathway	6241	155	37	1	1	0.23871	0.43687
Hippo signaling pathway	6241	155	37	1	1	0.23871	0.43687
Estrogen signaling pathway	6241	155	37	1	1	0.23871	0.43687
Thyroid hormone synthesis	6241	155	37	1	1	0.23871	0.43687
Oxytocin signaling pathway	6241	155	37	1	1	0.23871	0.43687
Pancreatic secretion	6241	155	37	1	1	0.23871	0.43687
Biosynthesis of cofactors	6241	155	37	4	2	0.24126	0.43687
FoxO signaling pathway	6241	155	37	4	2	0.24126	0.43687
Ubiquitin mediated proteolysis	6241	155	37	4	2	0.24126	0.43687
MicroRNAs in cancer	6241	155	37	4	2	0.24126	0.43687
Pathways in cancer	6241	155	37	9	3	0.36681	0.54324
Amino sugar and nucleotide sugar metabolism	6241	155	37	2	1	0.42162	0.54324
Nicotinate and nicotinamide metabolism	6241	155	37	2	1	0.42162	0.54324
MAPK signaling pathway	6241	155	37	2	1	0.42162	0.54324
Calcium signaling pathway	6241	155	37	2	1	0.42162	0.54324
Apoptosis	6241	155	37	2	1	0.42162	0.54324
Apoptosis - multiple species	6241	155	37	2	1	0.42162	0.54324
ECM-receptor interaction	6241	155	37	2	1	0.42162	0.54324
IL-17 signaling pathway	6241	155	37	2	1	0.42162	0.54324
Th17 cell differentiation	6241	155	37	2	1	0.42162	0.54324
Intestinal immune network for IgA production	6241	155	37	2	1	0.42162	0.54324
Salivary secretion	6241	155	37	2	1	0.42162	0.54324
Salmonella infection	6241	155	37	2	1	0.42162	0.54324
Colorectal cancer	6241	155	37	2	1	0.42162	0.54324
Fluid shear stress and atherosclerosis	6241	155	37	2	1	0.42162	0.54324
Cytokine-cytokine receptor interaction	6241	155	37	3	1	0.56149	0.63762
PI3K-Akt signaling pathway	6241	155	37	3	1	0.56149	0.63762
AMPK signaling pathway	6241	155	37	3	1	0.56149	0.63762
Gap junction	6241	155	37	3	1	0.56149	0.63762
Prostate cancer	6241	155	37	3	1	0.56149	0.63762
Acute myeloid leukemia	6241	155	37	3	1	0.56149	0.63762
Lipid and atherosclerosis	6241	155	37	3	1	0.56149	0.63762
Hepatitis B	6241	155	37	8	2	0.60995	0.68112
Viral carcinogenesis	6241	155	37	13	3	0.64166	0.70477
Hematopoietic cell lineage	6241	155	37	5	1	0.74953	0.80997
Parkinson disease	6241	155	37	6	1	0.81131	0.86282
Pathways of neurodegeneration - multiple diseases	6241	155	37	7	1	0.85817	0.89839
Transcriptional misregulation in cancer	6241	155	37	8	1	0.89362	0.92112
Human papillomavirus infection	6241	155	37	10	1	0.94057	0.95482
Epstein-Barr virus infection	6241	155	37	11	1	0.95574	0.95574
Biosynthesis of unsaturated fatty acids	6319	155	5	1	1	0.032258	0.11144
Fatty acid metabolism	6319	155	5	1	1	0.032258	0.11144
Carbohydrate digestion and absorption	6319	155	5	1	1	0.032258	0.11144
One carbon pool by folate	6319	155	5	2	1	0.063678	0.11144
Folate biosynthesis	6319	155	5	2	1	0.063678	0.11144
Platinum drug resistance	6319	155	5	2	1	0.063678	0.11144
PPAR signaling pathway	6319	155	5	2	1	0.063678	0.11144
Alcoholic liver disease	6319	155	5	2	1	0.063678	0.11144
Antifolate resistance	6319	155	5	3	1	0.094277	0.13199
AMPK signaling pathway	6319	155	5	3	1	0.094277	0.13199
Biosynthesis of cofactors	6319	155	5	4	1	0.12407	0.14475
DNA replication	6319	155	5	4	1	0.12407	0.14475
Metabolic pathways	6319	155	5	24	2	0.1714	0.18458
Cell cycle	6319	155	5	14	1	0.38113	0.38113
DNA replication	64105	155	3	4	2	0.001495	0.0044851
Cell cycle	64105	155	3	14	2	0.021678	0.032517
Platinum drug resistance	64105	155	3	2	1	0.038458	0.038458
Influenza A	64108	155	27	10	10	5.1445e-09	2.6237e-07
Measles	64108	155	27	9	9	4.1727e-08	1.064e-06
Hepatitis C	64108	155	27	12	10	2.7084e-07	4.6043e-06
Coronavirus disease - COVID-19	64108	155	27	11	9	1.8128e-06	2.3114e-05
Herpes simplex virus 1 infection	64108	155	27	9	8	2.5717e-06	2.6232e-05
NOD-like receptor signaling pathway	64108	155	27	15	9	0.00010217	0.00086849
Epstein-Barr virus infection	64108	155	27	11	7	0.00047513	0.0034616
Necroptosis	64108	155	27	4	4	0.00075875	0.0048371
Human papillomavirus infection	64108	155	27	10	5	0.015146	0.085829
Kaposi sarcoma-associated herpesvirus infection	64108	155	27	4	3	0.016946	0.086422
Chemokine signaling pathway	64108	155	27	2	2	0.029409	0.10713
RIG-I-like receptor signaling pathway	64108	155	27	2	2	0.029409	0.10713
Cytosolic DNA-sensing pathway	64108	155	27	2	2	0.029409	0.10713
C-type lectin receptor signaling pathway	64108	155	27	2	2	0.029409	0.10713
Hepatitis B	64108	155	27	8	4	0.0316	0.10744
JAK-STAT signaling pathway	64108	155	27	3	2	0.078617	0.25059
Osteoclast differentiation	64108	155	27	4	2	0.14029	0.31728
PD-L1 expression and PD-1 checkpoint pathway in cancer	64108	155	27	4	2	0.14029	0.31728
Glycolysis / Gluconeogenesis	64108	155	27	1	1	0.17419	0.31728
Galactose metabolism	64108	155	27	1	1	0.17419	0.31728
NF-kappa B signaling pathway	64108	155	27	1	1	0.17419	0.31728
Toll-like receptor signaling pathway	64108	155	27	1	1	0.17419	0.31728
Th1 and Th2 cell differentiation	64108	155	27	1	1	0.17419	0.31728
Prolactin signaling pathway	64108	155	27	1	1	0.17419	0.31728
AGE-RAGE signaling pathway in diabetic complications	64108	155	27	1	1	0.17419	0.31728
Growth hormone synthesis, secretion and action	64108	155	27	1	1	0.17419	0.31728
Pertussis	64108	155	27	1	1	0.17419	0.31728
Toxoplasmosis	64108	155	27	1	1	0.17419	0.31728
Viral life cycle - HIV-1	64108	155	27	5	2	0.2089	0.36738
Lysosome	64108	155	27	2	1	0.31898	0.4281
Apoptosis	64108	155	27	2	1	0.31898	0.4281
Apoptosis - multiple species	64108	155	27	2	1	0.31898	0.4281
Notch signaling pathway	64108	155	27	2	1	0.31898	0.4281
Cell adhesion molecules	64108	155	27	2	1	0.31898	0.4281
Complement and coagulation cascades	64108	155	27	2	1	0.31898	0.4281
Th17 cell differentiation	64108	155	27	2	1	0.31898	0.4281
Leishmaniasis	64108	155	27	2	1	0.31898	0.4281
Inflammatory bowel disease	64108	155	27	2	1	0.31898	0.4281
Thyroid hormone signaling pathway	64108	155	27	3	1	0.43916	0.55993
Pancreatic cancer	64108	155	27	3	1	0.43916	0.55993
Pathways in cancer	64108	155	27	9	2	0.4866	0.60529
Pyrimidine metabolism	64108	155	27	4	1	0.53878	0.61062
Nucleotide metabolism	64108	155	27	4	1	0.53878	0.61062
Biosynthesis of cofactors	64108	155	27	4	1	0.53878	0.61062
Tuberculosis	64108	155	27	4	1	0.53878	0.61062
Protein processing in endoplasmic reticulum	64108	155	27	6	1	0.68943	0.76436
Human immunodeficiency virus 1 infection	64108	155	27	7	1	0.7457	0.80917
Alzheimer disease	64108	155	27	8	1	0.7921	0.82443
Transcriptional misregulation in cancer	64108	155	27	8	1	0.7921	0.82443
Viral carcinogenesis	64108	155	27	13	1	0.9258	0.94432
Metabolic pathways	64108	155	27	24	2	0.9525	0.9525
Influenza A	64135	155	30	10	10	1.8322e-08	9.8936e-07
Measles	64135	155	30	9	9	1.2738e-07	3.4392e-06
Hepatitis C	64135	155	30	12	10	9.2431e-07	1.6638e-05
Coronavirus disease - COVID-19	64135	155	30	11	9	5.3057e-06	7.1627e-05
Herpes simplex virus 1 infection	64135	155	30	9	8	6.641e-06	7.1723e-05
NOD-like receptor signaling pathway	64135	155	30	15	9	0.00027463	0.0024717
Epstein-Barr virus infection	64135	155	30	11	7	0.0010041	0.0077456
Necroptosis	64135	155	30	4	4	0.0011848	0.0079976
Kaposi sarcoma-associated herpesvirus infection	64135	155	30	4	3	0.023126	0.13121
Human papillomavirus infection	64135	155	30	10	5	0.024313	0.13121
RNA degradation	64135	155	30	2	2	0.036447	0.13121
Chemokine signaling pathway	64135	155	30	2	2	0.036447	0.13121
RIG-I-like receptor signaling pathway	64135	155	30	2	2	0.036447	0.13121
Cytosolic DNA-sensing pathway	64135	155	30	2	2	0.036447	0.13121
C-type lectin receptor signaling pathway	64135	155	30	2	2	0.036447	0.13121
Hepatitis B	64135	155	30	8	4	0.045913	0.15496
JAK-STAT signaling pathway	64135	155	30	3	2	0.096002	0.30495
Osteoclast differentiation	64135	155	30	4	2	0.16888	0.34839
PD-L1 expression and PD-1 checkpoint pathway in cancer	64135	155	30	4	2	0.16888	0.34839
Glycolysis / Gluconeogenesis	64135	155	30	1	1	0.19355	0.34839
Galactose metabolism	64135	155	30	1	1	0.19355	0.34839
NF-kappa B signaling pathway	64135	155	30	1	1	0.19355	0.34839
Signaling pathways regulating pluripotency of stem cells	64135	155	30	1	1	0.19355	0.34839
Toll-like receptor signaling pathway	64135	155	30	1	1	0.19355	0.34839
Th1 and Th2 cell differentiation	64135	155	30	1	1	0.19355	0.34839
Prolactin signaling pathway	64135	155	30	1	1	0.19355	0.34839
AGE-RAGE signaling pathway in diabetic complications	64135	155	30	1	1	0.19355	0.34839
Growth hormone synthesis, secretion and action	64135	155	30	1	1	0.19355	0.34839
Pertussis	64135	155	30	1	1	0.19355	0.34839
Toxoplasmosis	64135	155	30	1	1	0.19355	0.34839
Viral life cycle - HIV-1	64135	155	30	5	2	0.24803	0.43205
Lysosome	64135	155	30	2	1	0.35065	0.47338
Apoptosis	64135	155	30	2	1	0.35065	0.47338
Apoptosis - multiple species	64135	155	30	2	1	0.35065	0.47338
Notch signaling pathway	64135	155	30	2	1	0.35065	0.47338
Cell adhesion molecules	64135	155	30	2	1	0.35065	0.47338
Complement and coagulation cascades	64135	155	30	2	1	0.35065	0.47338
Th17 cell differentiation	64135	155	30	2	1	0.35065	0.47338
Leishmaniasis	64135	155	30	2	1	0.35065	0.47338
Inflammatory bowel disease	64135	155	30	2	1	0.35065	0.47338
Thyroid hormone signaling pathway	64135	155	30	3	1	0.47797	0.61454
Pancreatic cancer	64135	155	30	3	1	0.47797	0.61454
Pathways in cancer	64135	155	30	9	2	0.54972	0.66754
Pyrimidine metabolism	64135	155	30	4	1	0.581	0.66754
Nucleotide metabolism	64135	155	30	4	1	0.581	0.66754
Biosynthesis of cofactors	64135	155	30	4	1	0.581	0.66754
Tuberculosis	64135	155	30	4	1	0.581	0.66754
Protein processing in endoplasmic reticulum	64135	155	30	6	1	0.7314	0.82282
Human immunodeficiency virus 1 infection	64135	155	30	7	1	0.78548	0.86563
Alzheimer disease	64135	155	30	8	1	0.82896	0.87773
Transcriptional misregulation in cancer	64135	155	30	8	1	0.82896	0.87773
Viral carcinogenesis	64135	155	30	13	1	0.94634	0.98273
Metabolic pathways	64135	155	30	24	2	0.97153	0.98393
Ribosome biogenesis in eukaryotes	64135	155	30	18	1	0.98393	0.98393
Cell cycle	64151	155	31	14	12	3.8078e-08	1.8658e-06
Oocyte meiosis	64151	155	31	7	6	0.00025269	0.0061909
DNA replication	64151	155	31	4	4	0.0013604	0.016664
p53 signaling pathway	64151	155	31	4	4	0.0013604	0.016664
Cellular senescence	64151	155	31	7	5	0.0037385	0.030531
Progesterone-mediated oocyte maturation	64151	155	31	7	5	0.0037385	0.030531
Antifolate resistance	64151	155	31	3	3	0.0073848	0.051693
Pyrimidine metabolism	64151	155	31	4	3	0.025458	0.13636
Nucleotide metabolism	64151	155	31	4	3	0.025458	0.13636
Human T-cell leukemia virus 1 infection	64151	155	31	7	4	0.02999	0.13636
Glutathione metabolism	64151	155	31	2	2	0.038961	0.13636
One carbon pool by folate	64151	155	31	2	2	0.038961	0.13636
Folate biosynthesis	64151	155	31	2	2	0.038961	0.13636
Platinum drug resistance	64151	155	31	2	2	0.038961	0.13636
Drug metabolism - other enzymes	64151	155	31	3	2	0.10211	0.32667
Human immunodeficiency virus 1 infection	64151	155	31	7	3	0.14343	0.32667
Metabolic pathways	64151	155	31	24	7	0.1712	0.32667
Biosynthesis of cofactors	64151	155	31	4	2	0.17877	0.32667
FoxO signaling pathway	64151	155	31	4	2	0.17877	0.32667
Ubiquitin mediated proteolysis	64151	155	31	4	2	0.17877	0.32667
MicroRNAs in cancer	64151	155	31	4	2	0.17877	0.32667
Purine metabolism	64151	155	31	1	1	0.2	0.32667
Glycine, serine and threonine metabolism	64151	155	31	1	1	0.2	0.32667
Glyoxylate and dicarboxylate metabolism	64151	155	31	1	1	0.2	0.32667
Carbon metabolism	64151	155	31	1	1	0.2	0.32667
Biosynthesis of nucleotide sugars	64151	155	31	1	1	0.2	0.32667
Base excision repair	64151	155	31	1	1	0.2	0.32667
Non-homologous end-joining	64151	155	31	1	1	0.2	0.32667
Fanconi anemia pathway	64151	155	31	1	1	0.2	0.32667
Hippo signaling pathway	64151	155	31	1	1	0.2	0.32667
Chemical carcinogenesis - receptor activation	64151	155	31	5	2	0.26135	0.4131
Amino sugar and nucleotide sugar metabolism	64151	155	31	2	1	0.36104	0.47813
MAPK signaling pathway	64151	155	31	2	1	0.36104	0.47813
Apoptosis	64151	155	31	2	1	0.36104	0.47813
Apoptosis - multiple species	64151	155	31	2	1	0.36104	0.47813
ECM-receptor interaction	64151	155	31	2	1	0.36104	0.47813
Colorectal cancer	64151	155	31	2	1	0.36104	0.47813
AMPK signaling pathway	64151	155	31	3	1	0.4905	0.5872
Gap junction	64151	155	31	3	1	0.4905	0.5872
Acute myeloid leukemia	64151	155	31	3	1	0.4905	0.5872
Hepatitis B	64151	155	31	8	2	0.50057	0.5872
Viral carcinogenesis	64151	155	31	13	3	0.50332	0.5872
Pathways in cancer	64151	155	31	9	2	0.56983	0.64934
Protein processing in endoplasmic reticulum	64151	155	31	6	1	0.74429	0.81045
Parkinson disease	64151	155	31	6	1	0.74429	0.81045
Pathways of neurodegeneration - multiple diseases	64151	155	31	7	1	0.79749	0.8495
Transcriptional misregulation in cancer	64151	155	31	8	1	0.83991	0.87565
Human papillomavirus infection	64151	155	31	10	1	0.90049	0.91925
Epstein-Barr virus infection	64151	155	31	11	1	0.92177	0.92177
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	64407	155	18	2	2	0.012819	0.28203
RNA degradation	64407	155	18	2	2	0.012819	0.28203
Mucin type O-glycan biosynthesis	64407	155	18	1	1	0.11613	0.35303
Glycerolipid metabolism	64407	155	18	1	1	0.11613	0.35303
Glycerophospholipid metabolism	64407	155	18	1	1	0.11613	0.35303
Sphingolipid metabolism	64407	155	18	1	1	0.11613	0.35303
ABC transporters	64407	155	18	1	1	0.11613	0.35303
Viral protein interaction with cytokine and cytokine receptor	64407	155	18	1	1	0.11613	0.35303
mTOR signaling pathway	64407	155	18	1	1	0.11613	0.35303
TNF signaling pathway	64407	155	18	1	1	0.11613	0.35303
Glutamatergic synapse	64407	155	18	1	1	0.11613	0.35303
GABAergic synapse	64407	155	18	1	1	0.11613	0.35303
Fat digestion and absorption	64407	155	18	1	1	0.11613	0.35303
Epithelial cell signaling in Helicobacter pylori infection	64407	155	18	1	1	0.11613	0.35303
Metabolic pathways	64407	155	18	24	5	0.12035	0.35303
Parkinson disease	64407	155	18	6	2	0.14433	0.39691
Pathways of neurodegeneration - multiple diseases	64407	155	18	7	2	0.18826	0.43888
Notch signaling pathway	64407	155	18	2	1	0.21944	0.43888
Alcoholic liver disease	64407	155	18	2	1	0.21944	0.43888
Protein digestion and absorption	64407	155	18	2	1	0.21944	0.43888
Cholesterol metabolism	64407	155	18	2	1	0.21944	0.43888
Inflammatory bowel disease	64407	155	18	2	1	0.21944	0.43888
Alzheimer disease	64407	155	18	8	2	0.23398	0.44761
Oxidative phosphorylation	64407	155	18	3	1	0.31127	0.47227
Cytokine-cytokine receptor interaction	64407	155	18	3	1	0.31127	0.47227
Thermogenesis	64407	155	18	3	1	0.31127	0.47227
Thyroid hormone signaling pathway	64407	155	18	3	1	0.31127	0.47227
Diabetic cardiomyopathy	64407	155	18	3	1	0.31127	0.47227
Lipid and atherosclerosis	64407	155	18	3	1	0.31127	0.47227
Ubiquitin mediated proteolysis	64407	155	18	4	1	0.39283	0.50837
Amyotrophic lateral sclerosis	64407	155	18	4	1	0.39283	0.50837
Huntington disease	64407	155	18	4	1	0.39283	0.50837
Prion disease	64407	155	18	4	1	0.39283	0.50837
Chemical carcinogenesis - reactive oxygen species	64407	155	18	4	1	0.39283	0.50837
Protein processing in endoplasmic reticulum	64407	155	18	6	1	0.52938	0.66551
Oocyte meiosis	64407	155	18	7	1	0.58624	0.69715
Progesterone-mediated oocyte maturation	64407	155	18	7	1	0.58624	0.69715
Alcoholism	64407	155	18	8	1	0.63656	0.73707
Systemic lupus erythematosus	64407	155	18	10	1	0.72038	0.81274
Coronavirus disease - COVID-19	64407	155	18	11	1	0.75509	0.8306
Neutrophil extracellular trap formation	64407	155	18	13	1	0.81268	0.85138
Viral carcinogenesis	64407	155	18	13	1	0.81268	0.85138
NOD-like receptor signaling pathway	64407	155	18	15	1	0.85731	0.87724
Ribosome biogenesis in eukaryotes	64407	155	18	18	1	0.90587	0.90587
PPAR signaling pathway	6518	155	16	2	2	0.010054	0.3393
Staphylococcus aureus infection	6518	155	16	6	3	0.01508	0.3393
Drug metabolism - other enzymes	6518	155	16	3	2	0.028323	0.36824
Transcriptional misregulation in cancer	6518	155	16	8	3	0.036973	0.36824
Pyrimidine metabolism	6518	155	16	4	2	0.053203	0.36824
Nucleotide metabolism	6518	155	16	4	2	0.053203	0.36824
Phagosome	6518	155	16	5	2	0.0833	0.36824
Biosynthesis of unsaturated fatty acids	6518	155	16	1	1	0.10323	0.36824
Fatty acid metabolism	6518	155	16	1	1	0.10323	0.36824
Hippo signaling pathway	6518	155	16	1	1	0.10323	0.36824
Carbohydrate digestion and absorption	6518	155	16	1	1	0.10323	0.36824
Neutrophil extracellular trap formation	6518	155	16	13	3	0.13551	0.36824
Cell cycle	6518	155	16	14	3	0.16141	0.36824
NOD-like receptor signaling pathway	6518	155	16	15	3	0.18884	0.36824
One carbon pool by folate	6518	155	16	2	1	0.1964	0.36824
Platinum drug resistance	6518	155	16	2	1	0.1964	0.36824
Lysosome	6518	155	16	2	1	0.1964	0.36824
Apoptosis	6518	155	16	2	1	0.1964	0.36824
Apoptosis - multiple species	6518	155	16	2	1	0.1964	0.36824
Renin-angiotensin system	6518	155	16	2	1	0.1964	0.36824
Alcoholic liver disease	6518	155	16	2	1	0.1964	0.36824
Salivary secretion	6518	155	16	2	1	0.1964	0.36824
Amoebiasis	6518	155	16	2	1	0.1964	0.36824
Colorectal cancer	6518	155	16	2	1	0.1964	0.36824
Antifolate resistance	6518	155	16	3	1	0.28043	0.42065
Neuroactive ligand-receptor interaction	6518	155	16	3	1	0.28043	0.42065
AMPK signaling pathway	6518	155	16	3	1	0.28043	0.42065
Gap junction	6518	155	16	3	1	0.28043	0.42065
Acute myeloid leukemia	6518	155	16	3	1	0.28043	0.42065
Lipid and atherosclerosis	6518	155	16	3	1	0.28043	0.42065
DNA replication	6518	155	16	4	1	0.35618	0.47141
p53 signaling pathway	6518	155	16	4	1	0.35618	0.47141
Tuberculosis	6518	155	16	4	1	0.35618	0.47141
MicroRNAs in cancer	6518	155	16	4	1	0.35618	0.47141
Hematopoietic cell lineage	6518	155	16	5	1	0.4244	0.5305
Chemical carcinogenesis - receptor activation	6518	155	16	5	1	0.4244	0.5305
Metabolic pathways	6518	155	16	24	3	0.46555	0.5662
Oocyte meiosis	6518	155	16	7	1	0.54101	0.59379
Cellular senescence	6518	155	16	7	1	0.54101	0.59379
Progesterone-mediated oocyte maturation	6518	155	16	7	1	0.54101	0.59379
Human immunodeficiency virus 1 infection	6518	155	16	7	1	0.54101	0.59379
Hepatitis B	6518	155	16	8	1	0.59063	0.63282
Pathways in cancer	6518	155	16	9	1	0.63519	0.66473
Systemic lupus erythematosus	6518	155	16	10	1	0.67517	0.69051
Viral carcinogenesis	6518	155	16	13	1	0.77186	0.77186
Protein processing in endoplasmic reticulum	65244	155	22	6	4	0.0038818	0.17856
DNA replication	65244	155	22	4	3	0.0091714	0.21094
Glutathione metabolism	65244	155	22	2	2	0.019355	0.22258
Intestinal immune network for IgA production	65244	155	22	2	2	0.019355	0.22258
Cell cycle	65244	155	22	14	5	0.030626	0.28176
Cytokine-cytokine receptor interaction	65244	155	22	3	2	0.053004	0.32318
p53 signaling pathway	65244	155	22	4	2	0.096837	0.32318
Purine metabolism	65244	155	22	1	1	0.14194	0.32318
Glycine, serine and threonine metabolism	65244	155	22	1	1	0.14194	0.32318
Glyoxylate and dicarboxylate metabolism	65244	155	22	1	1	0.14194	0.32318
Carbon metabolism	65244	155	22	1	1	0.14194	0.32318
Biosynthesis of nucleotide sugars	65244	155	22	1	1	0.14194	0.32318
Protein export	65244	155	22	1	1	0.14194	0.32318
Base excision repair	65244	155	22	1	1	0.14194	0.32318
Non-homologous end-joining	65244	155	22	1	1	0.14194	0.32318
Estrogen signaling pathway	65244	155	22	1	1	0.14194	0.32318
Thyroid hormone synthesis	65244	155	22	1	1	0.14194	0.32318
Oxytocin signaling pathway	65244	155	22	1	1	0.14194	0.32318
Pancreatic secretion	65244	155	22	1	1	0.14194	0.32318
Primary immunodeficiency	65244	155	22	1	1	0.14194	0.32318
Chemical carcinogenesis - receptor activation	65244	155	22	5	2	0.14754	0.32318
Metabolic pathways	65244	155	22	24	5	0.23488	0.36872
Oocyte meiosis	65244	155	22	7	2	0.25954	0.36872
Cellular senescence	65244	155	22	7	2	0.25954	0.36872
Progesterone-mediated oocyte maturation	65244	155	22	7	2	0.25954	0.36872
Amino sugar and nucleotide sugar metabolism	65244	155	22	2	1	0.26452	0.36872
Nicotinate and nicotinamide metabolism	65244	155	22	2	1	0.26452	0.36872
Calcium signaling pathway	65244	155	22	2	1	0.26452	0.36872
IL-17 signaling pathway	65244	155	22	2	1	0.26452	0.36872
Th17 cell differentiation	65244	155	22	2	1	0.26452	0.36872
Salivary secretion	65244	155	22	2	1	0.26452	0.36872
Salmonella infection	65244	155	22	2	1	0.26452	0.36872
Fluid shear stress and atherosclerosis	65244	155	22	2	1	0.26452	0.36872
Drug metabolism - other enzymes	65244	155	22	3	1	0.37027	0.46034
PI3K-Akt signaling pathway	65244	155	22	3	1	0.37027	0.46034
Prostate cancer	65244	155	22	3	1	0.37027	0.46034
Lipid and atherosclerosis	65244	155	22	3	1	0.37027	0.46034
Pyrimidine metabolism	65244	155	22	4	1	0.46142	0.53063
Nucleotide metabolism	65244	155	22	4	1	0.46142	0.53063
FoxO signaling pathway	65244	155	22	4	1	0.46142	0.53063
Viral life cycle - HIV-1	65244	155	22	5	1	0.53989	0.5913
Hematopoietic cell lineage	65244	155	22	5	1	0.53989	0.5913
Parkinson disease	65244	155	22	6	1	0.60737	0.64974
Pathways of neurodegeneration - multiple diseases	65244	155	22	7	1	0.66534	0.68013
Human immunodeficiency virus 1 infection	65244	155	22	7	1	0.66534	0.68013
Pathways in cancer	65244	155	22	9	1	0.75773	0.75773
Influenza A	6614	155	18	10	8	2.5267e-07	7.8329e-06
Hepatitis C	6614	155	18	12	8	2.4492e-06	2.7831e-05
Measles	6614	155	18	9	7	2.6933e-06	2.7831e-05
Coronavirus disease - COVID-19	6614	155	18	11	7	2.1545e-05	0.00016698
Herpes simplex virus 1 infection	6614	155	18	9	6	7.1981e-05	0.00044628
Epstein-Barr virus infection	6614	155	18	11	5	0.0035999	0.018599
RIG-I-like receptor signaling pathway	6614	155	18	2	2	0.012819	0.049675
Cytosolic DNA-sensing pathway	6614	155	18	2	2	0.012819	0.049675
NOD-like receptor signaling pathway	6614	155	18	15	5	0.017204	0.05926
Hepatitis B	6614	155	18	8	3	0.051125	0.15849
Necroptosis	6614	155	18	4	2	0.066589	0.18766
Human papillomavirus infection	6614	155	18	10	3	0.093987	0.225
Glycolysis / Gluconeogenesis	6614	155	18	1	1	0.11613	0.225
Galactose metabolism	6614	155	18	1	1	0.11613	0.225
NF-kappa B signaling pathway	6614	155	18	1	1	0.11613	0.225
Pertussis	6614	155	18	1	1	0.11613	0.225
Chemokine signaling pathway	6614	155	18	2	1	0.21944	0.32393
Lysosome	6614	155	18	2	1	0.21944	0.32393
Cell adhesion molecules	6614	155	18	2	1	0.21944	0.32393
Complement and coagulation cascades	6614	155	18	2	1	0.21944	0.32393
C-type lectin receptor signaling pathway	6614	155	18	2	1	0.21944	0.32393
JAK-STAT signaling pathway	6614	155	18	3	1	0.31127	0.43861
Pyrimidine metabolism	6614	155	18	4	1	0.39283	0.45103
Nucleotide metabolism	6614	155	18	4	1	0.39283	0.45103
Biosynthesis of cofactors	6614	155	18	4	1	0.39283	0.45103
Osteoclast differentiation	6614	155	18	4	1	0.39283	0.45103
Kaposi sarcoma-associated herpesvirus infection	6614	155	18	4	1	0.39283	0.45103
Viral life cycle - HIV-1	6614	155	18	5	1	0.46521	0.51505
Transcriptional misregulation in cancer	6614	155	18	8	1	0.63656	0.68046
Pathways in cancer	6614	155	18	9	1	0.68106	0.70376
Metabolic pathways	6614	155	18	24	2	0.80965	0.80965
DNA replication	6675	155	18	4	3	0.0049655	0.1752
Glutathione metabolism	6675	155	18	2	2	0.012819	0.1752
Intestinal immune network for IgA production	6675	155	18	2	2	0.012819	0.1752
Protein processing in endoplasmic reticulum	6675	155	18	6	3	0.02129	0.21822
Cytokine-cytokine receptor interaction	6675	155	18	3	2	0.035777	0.23497
Cell cycle	6675	155	18	14	4	0.060872	0.23497
Chemical carcinogenesis - receptor activation	6675	155	18	5	2	0.10332	0.23497
Purine metabolism	6675	155	18	1	1	0.11613	0.23497
Glycine, serine and threonine metabolism	6675	155	18	1	1	0.11613	0.23497
Glyoxylate and dicarboxylate metabolism	6675	155	18	1	1	0.11613	0.23497
Carbon metabolism	6675	155	18	1	1	0.11613	0.23497
Biosynthesis of nucleotide sugars	6675	155	18	1	1	0.11613	0.23497
Protein export	6675	155	18	1	1	0.11613	0.23497
Base excision repair	6675	155	18	1	1	0.11613	0.23497
Non-homologous end-joining	6675	155	18	1	1	0.11613	0.23497
Estrogen signaling pathway	6675	155	18	1	1	0.11613	0.23497
Thyroid hormone synthesis	6675	155	18	1	1	0.11613	0.23497
Oxytocin signaling pathway	6675	155	18	1	1	0.11613	0.23497
Pancreatic secretion	6675	155	18	1	1	0.11613	0.23497
Primary immunodeficiency	6675	155	18	1	1	0.11613	0.23497
Metabolic pathways	6675	155	18	24	5	0.12035	0.23497
Amino sugar and nucleotide sugar metabolism	6675	155	18	2	1	0.21944	0.31024
Nicotinate and nicotinamide metabolism	6675	155	18	2	1	0.21944	0.31024
Calcium signaling pathway	6675	155	18	2	1	0.21944	0.31024
IL-17 signaling pathway	6675	155	18	2	1	0.21944	0.31024
Th17 cell differentiation	6675	155	18	2	1	0.21944	0.31024
Salivary secretion	6675	155	18	2	1	0.21944	0.31024
Salmonella infection	6675	155	18	2	1	0.21944	0.31024
Fluid shear stress and atherosclerosis	6675	155	18	2	1	0.21944	0.31024
Drug metabolism - other enzymes	6675	155	18	3	1	0.31127	0.38673
PI3K-Akt signaling pathway	6675	155	18	3	1	0.31127	0.38673
Prostate cancer	6675	155	18	3	1	0.31127	0.38673
Lipid and atherosclerosis	6675	155	18	3	1	0.31127	0.38673
Pyrimidine metabolism	6675	155	18	4	1	0.39283	0.44739
Nucleotide metabolism	6675	155	18	4	1	0.39283	0.44739
p53 signaling pathway	6675	155	18	4	1	0.39283	0.44739
Viral life cycle - HIV-1	6675	155	18	5	1	0.46521	0.50193
Hematopoietic cell lineage	6675	155	18	5	1	0.46521	0.50193
Oocyte meiosis	6675	155	18	7	1	0.58624	0.60089
Progesterone-mediated oocyte maturation	6675	155	18	7	1	0.58624	0.60089
Pathways in cancer	6675	155	18	9	1	0.68106	0.68106
Rap1 signaling pathway	6678	155	6	2	2	0.0012568	0.024298
Focal adhesion	6678	155	6	2	2	0.0012568	0.024298
Regulation of actin cytoskeleton	6678	155	6	2	2	0.0012568	0.024298
PI3K-Akt signaling pathway	6678	155	6	3	2	0.0037047	0.042975
Gap junction	6678	155	6	3	2	0.0037047	0.042975
Phagosome	6678	155	6	5	2	0.011921	0.11226
EGFR tyrosine kinase inhibitor resistance	6678	155	6	1	1	0.03871	0.11226
ErbB signaling pathway	6678	155	6	1	1	0.03871	0.11226
Ras signaling pathway	6678	155	6	1	1	0.03871	0.11226
Phospholipase D signaling pathway	6678	155	6	1	1	0.03871	0.11226
Axon guidance	6678	155	6	1	1	0.03871	0.11226
Platelet activation	6678	155	6	1	1	0.03871	0.11226
Insulin signaling pathway	6678	155	6	1	1	0.03871	0.11226
Pathogenic Escherichia coli infection	6678	155	6	1	1	0.03871	0.11226
Proteoglycans in cancer	6678	155	6	1	1	0.03871	0.11226
Endometrial cancer	6678	155	6	1	1	0.03871	0.11226
Choline metabolism in cancer	6678	155	6	1	1	0.03871	0.11226
Hypertrophic cardiomyopathy	6678	155	6	1	1	0.03871	0.11226
Arrhythmogenic right ventricular cardiomyopathy	6678	155	6	1	1	0.03871	0.11226
Dilated cardiomyopathy	6678	155	6	1	1	0.03871	0.11226
Human papillomavirus infection	6678	155	6	10	2	0.04907	0.12271
MAPK signaling pathway	6678	155	6	2	1	0.076163	0.12271
Calcium signaling pathway	6678	155	6	2	1	0.076163	0.12271
HIF-1 signaling pathway	6678	155	6	2	1	0.076163	0.12271
ECM-receptor interaction	6678	155	6	2	1	0.076163	0.12271
Complement and coagulation cascades	6678	155	6	2	1	0.076163	0.12271
Salmonella infection	6678	155	6	2	1	0.076163	0.12271
Human cytomegalovirus infection	6678	155	6	2	1	0.076163	0.12271
Colorectal cancer	6678	155	6	2	1	0.076163	0.12271
Glioma	6678	155	6	2	1	0.076163	0.12271
Melanoma	6678	155	6	2	1	0.076163	0.12271
Bladder cancer	6678	155	6	2	1	0.076163	0.12271
Non-small cell lung cancer	6678	155	6	2	1	0.076163	0.12271
Breast cancer	6678	155	6	2	1	0.076163	0.12271
Gastric cancer	6678	155	6	2	1	0.076163	0.12271
Fluid shear stress and atherosclerosis	6678	155	6	2	1	0.076163	0.12271
JAK-STAT signaling pathway	6678	155	6	3	1	0.11239	0.16297
Thyroid hormone signaling pathway	6678	155	6	3	1	0.11239	0.16297
Pancreatic cancer	6678	155	6	3	1	0.11239	0.16297
Prostate cancer	6678	155	6	3	1	0.11239	0.16297
FoxO signaling pathway	6678	155	6	4	1	0.14743	0.17814
Osteoclast differentiation	6678	155	6	4	1	0.14743	0.17814
Amyotrophic lateral sclerosis	6678	155	6	4	1	0.14743	0.17814
Huntington disease	6678	155	6	4	1	0.14743	0.17814
Prion disease	6678	155	6	4	1	0.14743	0.17814
MicroRNAs in cancer	6678	155	6	4	1	0.14743	0.17814
Chemical carcinogenesis - reactive oxygen species	6678	155	6	4	1	0.14743	0.17814
PD-L1 expression and PD-1 checkpoint pathway in cancer	6678	155	6	4	1	0.14743	0.17814
Hematopoietic cell lineage	6678	155	6	5	1	0.18131	0.21031
Chemical carcinogenesis - receptor activation	6678	155	6	5	1	0.18131	0.21031
Parkinson disease	6678	155	6	6	1	0.21405	0.24343
Pathways of neurodegeneration - multiple diseases	6678	155	6	7	1	0.2457	0.27405
Alzheimer disease	6678	155	6	8	1	0.27628	0.30235
Herpes simplex virus 1 infection	6678	155	6	9	1	0.30582	0.3225
Pathways in cancer	6678	155	6	9	1	0.30582	0.3225
Coronavirus disease - COVID-19	6678	155	6	11	1	0.36189	0.37482
Hepatitis C	6678	155	6	12	1	0.38848	0.3953
Neutrophil extracellular trap formation	6678	155	6	13	1	0.41414	0.41414
Staphylococcus aureus infection	671	155	13	6	4	0.00042045	0.0092498
Transcriptional misregulation in cancer	671	155	13	8	4	0.0017779	0.019557
Amoebiasis	671	155	13	2	2	0.0065354	0.047926
NOD-like receptor signaling pathway	671	155	13	15	4	0.024428	0.13435
Phagosome	671	155	13	5	2	0.056413	0.23065
Neutrophil extracellular trap formation	671	155	13	13	3	0.08073	0.23065
Carbohydrate digestion and absorption	671	155	13	1	1	0.083871	0.23065
Asthma	671	155	13	1	1	0.083871	0.23065
Amino sugar and nucleotide sugar metabolism	671	155	13	2	1	0.16121	0.25332
PPAR signaling pathway	671	155	13	2	1	0.16121	0.25332
Lysosome	671	155	13	2	1	0.16121	0.25332
Renin-angiotensin system	671	155	13	2	1	0.16121	0.25332
IL-17 signaling pathway	671	155	13	2	1	0.16121	0.25332
Salivary secretion	671	155	13	2	1	0.16121	0.25332
Drug metabolism - other enzymes	671	155	13	3	1	0.23248	0.28414
Neuroactive ligand-receptor interaction	671	155	13	3	1	0.23248	0.28414
Acute myeloid leukemia	671	155	13	3	1	0.23248	0.28414
Lipid and atherosclerosis	671	155	13	3	1	0.23248	0.28414
Tuberculosis	671	155	13	4	1	0.29812	0.34519
Hematopoietic cell lineage	671	155	13	5	1	0.35855	0.3944
Systemic lupus erythematosus	671	155	13	10	1	0.59495	0.62328
Metabolic pathways	671	155	13	24	1	0.89822	0.89822
Influenza A	6772	155	29	10	10	1.2214e-08	6.7179e-07
Measles	6772	155	29	9	9	8.9165e-08	2.452e-06
Hepatitis C	6772	155	29	12	10	6.2509e-07	1.146e-05
Coronavirus disease - COVID-19	6772	155	29	11	9	3.7669e-06	5.1794e-05
Herpes simplex virus 1 infection	6772	155	29	9	8	4.9041e-06	5.3945e-05
NOD-like receptor signaling pathway	6772	155	29	15	9	0.00020063	0.0018391
Epstein-Barr virus infection	6772	155	29	11	7	0.00079109	0.0062157
Necroptosis	6772	155	29	4	4	0.0010268	0.0070596
Human papillomavirus infection	6772	155	29	10	5	0.020916	0.10466
Kaposi sarcoma-associated herpesvirus infection	6772	155	29	4	3	0.020932	0.10466
PD-L1 expression and PD-1 checkpoint pathway in cancer	6772	155	29	4	3	0.020932	0.10466
RNA degradation	6772	155	29	2	2	0.034018	0.11694
Chemokine signaling pathway	6772	155	29	2	2	0.034018	0.11694
RIG-I-like receptor signaling pathway	6772	155	29	2	2	0.034018	0.11694
Cytosolic DNA-sensing pathway	6772	155	29	2	2	0.034018	0.11694
C-type lectin receptor signaling pathway	6772	155	29	2	2	0.034018	0.11694
Hepatitis B	6772	155	29	8	4	0.040764	0.13188
JAK-STAT signaling pathway	6772	155	29	3	2	0.090047	0.27514
Osteoclast differentiation	6772	155	29	4	2	0.15916	0.32157
Glycolysis / Gluconeogenesis	6772	155	29	1	1	0.1871	0.32157
Galactose metabolism	6772	155	29	1	1	0.1871	0.32157
ABC transporters	6772	155	29	1	1	0.1871	0.32157
NF-kappa B signaling pathway	6772	155	29	1	1	0.1871	0.32157
Signaling pathways regulating pluripotency of stem cells	6772	155	29	1	1	0.1871	0.32157
Toll-like receptor signaling pathway	6772	155	29	1	1	0.1871	0.32157
Th1 and Th2 cell differentiation	6772	155	29	1	1	0.1871	0.32157
Prolactin signaling pathway	6772	155	29	1	1	0.1871	0.32157
AGE-RAGE signaling pathway in diabetic complications	6772	155	29	1	1	0.1871	0.32157
Growth hormone synthesis, secretion and action	6772	155	29	1	1	0.1871	0.32157
Fat digestion and absorption	6772	155	29	1	1	0.1871	0.32157
Pertussis	6772	155	29	1	1	0.1871	0.32157
Toxoplasmosis	6772	155	29	1	1	0.1871	0.32157
Viral life cycle - HIV-1	6772	155	29	5	2	0.23484	0.39139
Lysosome	6772	155	29	2	1	0.34018	0.45633
Notch signaling pathway	6772	155	29	2	1	0.34018	0.45633
Cell adhesion molecules	6772	155	29	2	1	0.34018	0.45633
Complement and coagulation cascades	6772	155	29	2	1	0.34018	0.45633
Th17 cell differentiation	6772	155	29	2	1	0.34018	0.45633
Cholesterol metabolism	6772	155	29	2	1	0.34018	0.45633
Leishmaniasis	6772	155	29	2	1	0.34018	0.45633
Inflammatory bowel disease	6772	155	29	2	1	0.34018	0.45633
Thyroid hormone signaling pathway	6772	155	29	3	1	0.46524	0.58155
Pancreatic cancer	6772	155	29	3	1	0.46524	0.58155
Lipid and atherosclerosis	6772	155	29	3	1	0.46524	0.58155
Pathways in cancer	6772	155	29	9	2	0.52913	0.63673
Pyrimidine metabolism	6772	155	29	4	1	0.56727	0.63673
Nucleotide metabolism	6772	155	29	4	1	0.56727	0.63673
Biosynthesis of cofactors	6772	155	29	4	1	0.56727	0.63673
Tuberculosis	6772	155	29	4	1	0.56727	0.63673
Protein processing in endoplasmic reticulum	6772	155	29	6	1	0.71797	0.78977
Human immunodeficiency virus 1 infection	6772	155	29	7	1	0.77286	0.83348
Alzheimer disease	6772	155	29	8	1	0.81737	0.86452
Viral carcinogenesis	6772	155	29	13	1	0.94016	0.97564
Metabolic pathways	6772	155	29	24	2	0.96614	0.98126
Ribosome biogenesis in eukaryotes	6772	155	29	18	1	0.98126	0.98126
Influenza A	6773	155	30	10	10	1.8322e-08	9.8936e-07
Measles	6773	155	30	9	9	1.2738e-07	3.4392e-06
Hepatitis C	6773	155	30	12	10	9.2431e-07	1.6638e-05
Coronavirus disease - COVID-19	6773	155	30	11	9	5.3057e-06	7.1627e-05
Herpes simplex virus 1 infection	6773	155	30	9	8	6.641e-06	7.1723e-05
NOD-like receptor signaling pathway	6773	155	30	15	9	0.00027463	0.0024717
Epstein-Barr virus infection	6773	155	30	11	7	0.0010041	0.0077456
Necroptosis	6773	155	30	4	4	0.0011848	0.0079976
Kaposi sarcoma-associated herpesvirus infection	6773	155	30	4	3	0.023126	0.13121
Human papillomavirus infection	6773	155	30	10	5	0.024313	0.13121
RNA degradation	6773	155	30	2	2	0.036447	0.13121
Chemokine signaling pathway	6773	155	30	2	2	0.036447	0.13121
RIG-I-like receptor signaling pathway	6773	155	30	2	2	0.036447	0.13121
Cytosolic DNA-sensing pathway	6773	155	30	2	2	0.036447	0.13121
C-type lectin receptor signaling pathway	6773	155	30	2	2	0.036447	0.13121
Hepatitis B	6773	155	30	8	4	0.045913	0.15496
JAK-STAT signaling pathway	6773	155	30	3	2	0.096002	0.30495
Osteoclast differentiation	6773	155	30	4	2	0.16888	0.34839
PD-L1 expression and PD-1 checkpoint pathway in cancer	6773	155	30	4	2	0.16888	0.34839
Glycolysis / Gluconeogenesis	6773	155	30	1	1	0.19355	0.34839
Galactose metabolism	6773	155	30	1	1	0.19355	0.34839
NF-kappa B signaling pathway	6773	155	30	1	1	0.19355	0.34839
Signaling pathways regulating pluripotency of stem cells	6773	155	30	1	1	0.19355	0.34839
Toll-like receptor signaling pathway	6773	155	30	1	1	0.19355	0.34839
Th1 and Th2 cell differentiation	6773	155	30	1	1	0.19355	0.34839
Prolactin signaling pathway	6773	155	30	1	1	0.19355	0.34839
AGE-RAGE signaling pathway in diabetic complications	6773	155	30	1	1	0.19355	0.34839
Growth hormone synthesis, secretion and action	6773	155	30	1	1	0.19355	0.34839
Pertussis	6773	155	30	1	1	0.19355	0.34839
Toxoplasmosis	6773	155	30	1	1	0.19355	0.34839
Viral life cycle - HIV-1	6773	155	30	5	2	0.24803	0.43205
Lysosome	6773	155	30	2	1	0.35065	0.47338
Apoptosis	6773	155	30	2	1	0.35065	0.47338
Apoptosis - multiple species	6773	155	30	2	1	0.35065	0.47338
Notch signaling pathway	6773	155	30	2	1	0.35065	0.47338
Cell adhesion molecules	6773	155	30	2	1	0.35065	0.47338
Complement and coagulation cascades	6773	155	30	2	1	0.35065	0.47338
Th17 cell differentiation	6773	155	30	2	1	0.35065	0.47338
Leishmaniasis	6773	155	30	2	1	0.35065	0.47338
Inflammatory bowel disease	6773	155	30	2	1	0.35065	0.47338
Thyroid hormone signaling pathway	6773	155	30	3	1	0.47797	0.61454
Pancreatic cancer	6773	155	30	3	1	0.47797	0.61454
Pathways in cancer	6773	155	30	9	2	0.54972	0.66754
Pyrimidine metabolism	6773	155	30	4	1	0.581	0.66754
Nucleotide metabolism	6773	155	30	4	1	0.581	0.66754
Biosynthesis of cofactors	6773	155	30	4	1	0.581	0.66754
Tuberculosis	6773	155	30	4	1	0.581	0.66754
Protein processing in endoplasmic reticulum	6773	155	30	6	1	0.7314	0.82282
Human immunodeficiency virus 1 infection	6773	155	30	7	1	0.78548	0.86563
Alzheimer disease	6773	155	30	8	1	0.82896	0.87773
Transcriptional misregulation in cancer	6773	155	30	8	1	0.82896	0.87773
Viral carcinogenesis	6773	155	30	13	1	0.94634	0.98273
Metabolic pathways	6773	155	30	24	2	0.97153	0.98393
Ribosome biogenesis in eukaryotes	6773	155	30	18	1	0.98393	0.98393
Salmonella infection	6782	155	21	2	2	0.017595	0.46621
Protein processing in endoplasmic reticulum	6782	155	21	6	3	0.033074	0.46621
Pathways of neurodegeneration - multiple diseases	6782	155	21	7	3	0.052765	0.46621
Biosynthesis of nucleotide sugars	6782	155	21	1	1	0.13548	0.46621
Signaling pathways regulating pluripotency of stem cells	6782	155	21	1	1	0.13548	0.46621
Serotonergic synapse	6782	155	21	1	1	0.13548	0.46621
Insulin signaling pathway	6782	155	21	1	1	0.13548	0.46621
Estrogen signaling pathway	6782	155	21	1	1	0.13548	0.46621
Thyroid hormone synthesis	6782	155	21	1	1	0.13548	0.46621
Oxytocin signaling pathway	6782	155	21	1	1	0.13548	0.46621
Pancreatic secretion	6782	155	21	1	1	0.13548	0.46621
Pathogenic Escherichia coli infection	6782	155	21	1	1	0.13548	0.46621
Parkinson disease	6782	155	21	6	2	0.18749	0.46621
Oocyte meiosis	6782	155	21	7	2	0.24138	0.46621
Progesterone-mediated oocyte maturation	6782	155	21	7	2	0.24138	0.46621
Glutathione metabolism	6782	155	21	2	1	0.25337	0.46621
Amino sugar and nucleotide sugar metabolism	6782	155	21	2	1	0.25337	0.46621
Nicotinate and nicotinamide metabolism	6782	155	21	2	1	0.25337	0.46621
RNA degradation	6782	155	21	2	1	0.25337	0.46621
Calcium signaling pathway	6782	155	21	2	1	0.25337	0.46621
Complement and coagulation cascades	6782	155	21	2	1	0.25337	0.46621
IL-17 signaling pathway	6782	155	21	2	1	0.25337	0.46621
Th17 cell differentiation	6782	155	21	2	1	0.25337	0.46621
Salivary secretion	6782	155	21	2	1	0.25337	0.46621
Fluid shear stress and atherosclerosis	6782	155	21	2	1	0.25337	0.46621
Alzheimer disease	6782	155	21	8	2	0.29618	0.52401
PI3K-Akt signaling pathway	6782	155	21	3	1	0.35585	0.52804
Gap junction	6782	155	21	3	1	0.35585	0.52804
Thyroid hormone signaling pathway	6782	155	21	3	1	0.35585	0.52804
Prostate cancer	6782	155	21	3	1	0.35585	0.52804
Lipid and atherosclerosis	6782	155	21	3	1	0.35585	0.52804
DNA replication	6782	155	21	4	1	0.44485	0.56841
Ubiquitin mediated proteolysis	6782	155	21	4	1	0.44485	0.56841
Amyotrophic lateral sclerosis	6782	155	21	4	1	0.44485	0.56841
Huntington disease	6782	155	21	4	1	0.44485	0.56841
Prion disease	6782	155	21	4	1	0.44485	0.56841
Viral life cycle - HIV-1	6782	155	21	5	1	0.52205	0.60036
Phagosome	6782	155	21	5	1	0.52205	0.60036
Hematopoietic cell lineage	6782	155	21	5	1	0.52205	0.60036
Chemical carcinogenesis - receptor activation	6782	155	21	5	1	0.52205	0.60036
Cell cycle	6782	155	21	14	2	0.59502	0.66758
Metabolic pathways	6782	155	21	24	3	0.67005	0.73387
Pathways in cancer	6782	155	21	9	1	0.74028	0.79193
Coronavirus disease - COVID-19	6782	155	21	11	1	0.80984	0.84666
NOD-like receptor signaling pathway	6782	155	21	15	1	0.89951	0.9195
Ribosome biogenesis in eukaryotes	6782	155	21	18	1	0.93852	0.93852
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	6868	155	17	2	2	0.011395	0.21081
RNA degradation	6868	155	17	2	2	0.011395	0.21081
Pathways of neurodegeneration - multiple diseases	6868	155	17	7	3	0.029364	0.25363
Alzheimer disease	6868	155	17	8	3	0.043737	0.25363
Mucin type O-glycan biosynthesis	6868	155	17	1	1	0.10968	0.25363
Glycerolipid metabolism	6868	155	17	1	1	0.10968	0.25363
Glycerophospholipid metabolism	6868	155	17	1	1	0.10968	0.25363
Sphingolipid metabolism	6868	155	17	1	1	0.10968	0.25363
ABC transporters	6868	155	17	1	1	0.10968	0.25363
mTOR signaling pathway	6868	155	17	1	1	0.10968	0.25363
Glutamatergic synapse	6868	155	17	1	1	0.10968	0.25363
Serotonergic synapse	6868	155	17	1	1	0.10968	0.25363
GABAergic synapse	6868	155	17	1	1	0.10968	0.25363
Fat digestion and absorption	6868	155	17	1	1	0.10968	0.25363
Epithelial cell signaling in Helicobacter pylori infection	6868	155	17	1	1	0.10968	0.25363
Pathogenic Escherichia coli infection	6868	155	17	1	1	0.10968	0.25363
Parkinson disease	6868	155	17	6	2	0.13066	0.28438
Notch signaling pathway	6868	155	17	2	1	0.20796	0.34975
Alcoholic liver disease	6868	155	17	2	1	0.20796	0.34975
Protein digestion and absorption	6868	155	17	2	1	0.20796	0.34975
Cholesterol metabolism	6868	155	17	2	1	0.20796	0.34975
Salmonella infection	6868	155	17	2	1	0.20796	0.34975
Metabolic pathways	6868	155	17	24	4	0.25592	0.4117
Gap junction	6868	155	17	3	1	0.29596	0.42118
Thyroid hormone signaling pathway	6868	155	17	3	1	0.29596	0.42118
Lipid and atherosclerosis	6868	155	17	3	1	0.29596	0.42118
Ubiquitin mediated proteolysis	6868	155	17	4	1	0.37471	0.46214
Amyotrophic lateral sclerosis	6868	155	17	4	1	0.37471	0.46214
Huntington disease	6868	155	17	4	1	0.37471	0.46214
Prion disease	6868	155	17	4	1	0.37471	0.46214
Phagosome	6868	155	17	5	1	0.4451	0.53125
Protein processing in endoplasmic reticulum	6868	155	17	6	1	0.50799	0.58736
Oocyte meiosis	6868	155	17	7	1	0.56413	0.6139
Progesterone-mediated oocyte maturation	6868	155	17	7	1	0.56413	0.6139
Coronavirus disease - COVID-19	6868	155	17	11	1	0.73388	0.77582
NOD-like receptor signaling pathway	6868	155	17	15	1	0.83991	0.86324
Ribosome biogenesis in eukaryotes	6868	155	17	18	1	0.89176	0.89176
Oxidative phosphorylation	6923	155	11	3	3	0.00027108	0.0028011
Thermogenesis	6923	155	11	3	3	0.00027108	0.0028011
Diabetic cardiomyopathy	6923	155	11	3	3	0.00027108	0.0028011
Amyotrophic lateral sclerosis	6923	155	11	4	3	0.0010415	0.0046124
Huntington disease	6923	155	11	4	3	0.0010415	0.0046124
Prion disease	6923	155	11	4	3	0.0010415	0.0046124
Chemical carcinogenesis - reactive oxygen species	6923	155	11	4	3	0.0010415	0.0046124
Retrograde endocannabinoid signaling	6923	155	11	2	2	0.0046083	0.014889
Non-alcoholic fatty liver disease	6923	155	11	2	2	0.0046083	0.014889
Parkinson disease	6923	155	11	6	3	0.004803	0.014889
Pathways of neurodegeneration - multiple diseases	6923	155	11	7	3	0.0080711	0.022746
Alzheimer disease	6923	155	11	8	3	0.012399	0.031674
Neuroactive ligand-receptor interaction	6923	155	11	3	2	0.013283	0.031674
Metabolic pathways	6923	155	11	24	5	0.014342	0.031758
Mucin type O-glycan biosynthesis	6923	155	11	1	1	0.070968	0.12222
Sphingolipid metabolism	6923	155	11	1	1	0.070968	0.12222
Sphingolipid signaling pathway	6923	155	11	1	1	0.070968	0.12222
Renal cell carcinoma	6923	155	11	1	1	0.070968	0.12222
Nicotinate and nicotinamide metabolism	6923	155	11	2	1	0.13733	0.20272
HIF-1 signaling pathway	6923	155	11	2	1	0.13733	0.20272
Cholesterol metabolism	6923	155	11	2	1	0.13733	0.20272
Biosynthesis of cofactors	6923	155	11	4	1	0.25729	0.33233
FoxO signaling pathway	6923	155	11	4	1	0.25729	0.33233
Ubiquitin mediated proteolysis	6923	155	11	4	1	0.25729	0.33233
Hematopoietic cell lineage	6923	155	11	5	1	0.3114	0.38613
Oocyte meiosis	6923	155	11	7	1	0.409	0.43721
Progesterone-mediated oocyte maturation	6923	155	11	7	1	0.409	0.43721
Human T-cell leukemia virus 1 infection	6923	155	11	7	1	0.409	0.43721
Human immunodeficiency virus 1 infection	6923	155	11	7	1	0.409	0.43721
Pathways in cancer	6923	155	11	9	1	0.49386	0.51033
NOD-like receptor signaling pathway	6923	155	11	15	1	0.68637	0.68637
Cell cycle	6941	155	34	14	12	1.4148e-07	8.6305e-06
Oocyte meiosis	6941	155	34	7	6	0.00045226	0.013794
DNA replication	6941	155	34	4	4	0.002005	0.030576
p53 signaling pathway	6941	155	34	4	4	0.002005	0.030576
Cellular senescence	6941	155	34	7	5	0.0058869	0.05985
Progesterone-mediated oocyte maturation	6941	155	34	7	5	0.0058869	0.05985
Pyrimidine metabolism	6941	155	34	4	3	0.033309	0.23894
Nucleotide metabolism	6941	155	34	4	3	0.033309	0.23894
Human T-cell leukemia virus 1 infection	6941	155	34	7	4	0.041816	0.23894
Glutathione metabolism	6941	155	34	2	2	0.047005	0.23894
One carbon pool by folate	6941	155	34	2	2	0.047005	0.23894
Platinum drug resistance	6941	155	34	2	2	0.047005	0.23894
Chemical carcinogenesis - receptor activation	6941	155	34	5	3	0.070625	0.3314
Protein processing in endoplasmic reticulum	6941	155	34	6	3	0.11997	0.41815
Drug metabolism - other enzymes	6941	155	34	3	2	0.12135	0.41815
Antifolate resistance	6941	155	34	3	2	0.12135	0.41815
Human immunodeficiency virus 1 infection	6941	155	34	7	3	0.17858	0.41815
FoxO signaling pathway	6941	155	34	4	2	0.20939	0.41815
Ubiquitin mediated proteolysis	6941	155	34	4	2	0.20939	0.41815
MicroRNAs in cancer	6941	155	34	4	2	0.20939	0.41815
Purine metabolism	6941	155	34	1	1	0.21935	0.41815
Biosynthesis of nucleotide sugars	6941	155	34	1	1	0.21935	0.41815
Protein export	6941	155	34	1	1	0.21935	0.41815
Base excision repair	6941	155	34	1	1	0.21935	0.41815
Non-homologous end-joining	6941	155	34	1	1	0.21935	0.41815
Fanconi anemia pathway	6941	155	34	1	1	0.21935	0.41815
Hippo signaling pathway	6941	155	34	1	1	0.21935	0.41815
Estrogen signaling pathway	6941	155	34	1	1	0.21935	0.41815
Thyroid hormone synthesis	6941	155	34	1	1	0.21935	0.41815
Oxytocin signaling pathway	6941	155	34	1	1	0.21935	0.41815
Pancreatic secretion	6941	155	34	1	1	0.21935	0.41815
Carbohydrate digestion and absorption	6941	155	34	1	1	0.21935	0.41815
Metabolic pathways	6941	155	34	24	7	0.24766	0.4578
Pathways in cancer	6941	155	34	9	3	0.3117	0.49779
Amino sugar and nucleotide sugar metabolism	6941	155	34	2	1	0.39171	0.49779
Nicotinate and nicotinamide metabolism	6941	155	34	2	1	0.39171	0.49779
Folate biosynthesis	6941	155	34	2	1	0.39171	0.49779
MAPK signaling pathway	6941	155	34	2	1	0.39171	0.49779
Calcium signaling pathway	6941	155	34	2	1	0.39171	0.49779
Apoptosis	6941	155	34	2	1	0.39171	0.49779
Apoptosis - multiple species	6941	155	34	2	1	0.39171	0.49779
ECM-receptor interaction	6941	155	34	2	1	0.39171	0.49779
IL-17 signaling pathway	6941	155	34	2	1	0.39171	0.49779
Th17 cell differentiation	6941	155	34	2	1	0.39171	0.49779
Salivary secretion	6941	155	34	2	1	0.39171	0.49779
Salmonella infection	6941	155	34	2	1	0.39171	0.49779
Colorectal cancer	6941	155	34	2	1	0.39171	0.49779
Fluid shear stress and atherosclerosis	6941	155	34	2	1	0.39171	0.49779
PI3K-Akt signaling pathway	6941	155	34	3	1	0.52688	0.59518
AMPK signaling pathway	6941	155	34	3	1	0.52688	0.59518
Gap junction	6941	155	34	3	1	0.52688	0.59518
Prostate cancer	6941	155	34	3	1	0.52688	0.59518
Acute myeloid leukemia	6941	155	34	3	1	0.52688	0.59518
Lipid and atherosclerosis	6941	155	34	3	1	0.52688	0.59518
Hepatitis B	6941	155	34	8	2	0.55698	0.61774
Viral carcinogenesis	6941	155	34	13	3	0.57513	0.62648
Biosynthesis of cofactors	6941	155	34	4	1	0.63271	0.67711
Hematopoietic cell lineage	6941	155	34	5	1	0.71541	0.75242
Transcriptional misregulation in cancer	6941	155	34	8	1	0.86916	0.89862
Human papillomavirus infection	6941	155	34	10	1	0.92284	0.93823
Epstein-Barr virus infection	6941	155	34	11	1	0.94094	0.94094
Transcriptional misregulation in cancer	6947	155	11	8	4	0.00085782	0.016299
Amoebiasis	6947	155	11	2	2	0.0046083	0.030419
Staphylococcus aureus infection	6947	155	11	6	3	0.004803	0.030419
Phagosome	6947	155	11	5	2	0.040873	0.19415
Asthma	6947	155	11	1	1	0.070968	0.2372
NOD-like receptor signaling pathway	6947	155	11	15	3	0.075591	0.2372
Amino sugar and nucleotide sugar metabolism	6947	155	11	2	1	0.13733	0.2372
PPAR signaling pathway	6947	155	11	2	1	0.13733	0.2372
Lysosome	6947	155	11	2	1	0.13733	0.2372
Renin-angiotensin system	6947	155	11	2	1	0.13733	0.2372
IL-17 signaling pathway	6947	155	11	2	1	0.13733	0.2372
Drug metabolism - other enzymes	6947	155	11	3	1	0.19935	0.25251
Neuroactive ligand-receptor interaction	6947	155	11	3	1	0.19935	0.25251
Acute myeloid leukemia	6947	155	11	3	1	0.19935	0.25251
Lipid and atherosclerosis	6947	155	11	3	1	0.19935	0.25251
Neutrophil extracellular trap formation	6947	155	11	13	2	0.23181	0.27527
Hematopoietic cell lineage	6947	155	11	5	1	0.3114	0.34803
Systemic lupus erythematosus	6947	155	11	10	1	0.532	0.56155
Metabolic pathways	6947	155	11	24	1	0.85323	0.85323
Cell cycle	699	155	38	14	12	6.5706e-07	4.468e-05
Oocyte meiosis	699	155	38	7	6	0.00090289	0.030698
DNA replication	699	155	38	4	4	0.0031913	0.054252
p53 signaling pathway	699	155	38	4	4	0.0031913	0.054252
Cellular senescence	699	155	38	7	5	0.010066	0.11408
Progesterone-mediated oocyte maturation	699	155	38	7	5	0.010066	0.11408
Antifolate resistance	699	155	38	3	3	0.013859	0.13463
Protein processing in endoplasmic reticulum	699	155	38	6	4	0.032205	0.27374
Glutathione metabolism	699	155	38	2	2	0.058902	0.32286
One carbon pool by folate	699	155	38	2	2	0.058902	0.32286
Folate biosynthesis	699	155	38	2	2	0.058902	0.32286
Platinum drug resistance	699	155	38	2	2	0.058902	0.32286
Human T-cell leukemia virus 1 infection	699	155	38	7	4	0.061723	0.32286
Chemical carcinogenesis - receptor activation	699	155	38	5	3	0.095036	0.4616
Human immunodeficiency virus 1 infection	699	155	38	7	3	0.22997	0.48982
Purine metabolism	699	155	38	1	1	0.24516	0.48982
Glycine, serine and threonine metabolism	699	155	38	1	1	0.24516	0.48982
Glyoxylate and dicarboxylate metabolism	699	155	38	1	1	0.24516	0.48982
Carbon metabolism	699	155	38	1	1	0.24516	0.48982
Biosynthesis of nucleotide sugars	699	155	38	1	1	0.24516	0.48982
Protein export	699	155	38	1	1	0.24516	0.48982
Base excision repair	699	155	38	1	1	0.24516	0.48982
Non-homologous end-joining	699	155	38	1	1	0.24516	0.48982
Fanconi anemia pathway	699	155	38	1	1	0.24516	0.48982
Hippo signaling pathway	699	155	38	1	1	0.24516	0.48982
Estrogen signaling pathway	699	155	38	1	1	0.24516	0.48982
Thyroid hormone synthesis	699	155	38	1	1	0.24516	0.48982
Oxytocin signaling pathway	699	155	38	1	1	0.24516	0.48982
Pancreatic secretion	699	155	38	1	1	0.24516	0.48982
Pyrimidine metabolism	699	155	38	4	2	0.25211	0.48982
Nucleotide metabolism	699	155	38	4	2	0.25211	0.48982
Biosynthesis of cofactors	699	155	38	4	2	0.25211	0.48982
FoxO signaling pathway	699	155	38	4	2	0.25211	0.48982
Ubiquitin mediated proteolysis	699	155	38	4	2	0.25211	0.48982
MicroRNAs in cancer	699	155	38	4	2	0.25211	0.48982
Metabolic pathways	699	155	38	24	7	0.36512	0.57523
Pathways in cancer	699	155	38	9	3	0.38535	0.57523
Amino sugar and nucleotide sugar metabolism	699	155	38	2	1	0.43142	0.57523
Nicotinate and nicotinamide metabolism	699	155	38	2	1	0.43142	0.57523
MAPK signaling pathway	699	155	38	2	1	0.43142	0.57523
Calcium signaling pathway	699	155	38	2	1	0.43142	0.57523
Apoptosis	699	155	38	2	1	0.43142	0.57523
Apoptosis - multiple species	699	155	38	2	1	0.43142	0.57523
ECM-receptor interaction	699	155	38	2	1	0.43142	0.57523
IL-17 signaling pathway	699	155	38	2	1	0.43142	0.57523
Th17 cell differentiation	699	155	38	2	1	0.43142	0.57523
Intestinal immune network for IgA production	699	155	38	2	1	0.43142	0.57523
Salivary secretion	699	155	38	2	1	0.43142	0.57523
Salmonella infection	699	155	38	2	1	0.43142	0.57523
Colorectal cancer	699	155	38	2	1	0.43142	0.57523
Fluid shear stress and atherosclerosis	699	155	38	2	1	0.43142	0.57523
Drug metabolism - other enzymes	699	155	38	3	1	0.57264	0.65999
Cytokine-cytokine receptor interaction	699	155	38	3	1	0.57264	0.65999
PI3K-Akt signaling pathway	699	155	38	3	1	0.57264	0.65999
AMPK signaling pathway	699	155	38	3	1	0.57264	0.65999
Gap junction	699	155	38	3	1	0.57264	0.65999
Prostate cancer	699	155	38	3	1	0.57264	0.65999
Acute myeloid leukemia	699	155	38	3	1	0.57264	0.65999
Lipid and atherosclerosis	699	155	38	3	1	0.57264	0.65999
Hepatitis B	699	155	38	8	2	0.62678	0.71035
Viral carcinogenesis	699	155	38	13	3	0.66248	0.7385
Viral life cycle - HIV-1	699	155	38	5	1	0.76014	0.82047
Hematopoietic cell lineage	699	155	38	5	1	0.76014	0.82047
Parkinson disease	699	155	38	6	1	0.8209	0.87221
Pathways of neurodegeneration - multiple diseases	699	155	38	7	1	0.86658	0.90657
Transcriptional misregulation in cancer	699	155	38	8	1	0.90084	0.92813
Human papillomavirus infection	699	155	38	10	1	0.94561	0.95972
Epstein-Barr virus infection	699	155	38	11	1	0.95986	0.95986
Neuroactive ligand-receptor interaction	706	155	5	3	2	0.0024808	0.034731
Sphingolipid signaling pathway	706	155	5	1	1	0.032258	0.1129
Signaling pathways regulating pluripotency of stem cells	706	155	5	1	1	0.032258	0.1129
Renal cell carcinoma	706	155	5	1	1	0.032258	0.1129
Nicotinate and nicotinamide metabolism	706	155	5	2	1	0.063678	0.12736
HIF-1 signaling pathway	706	155	5	2	1	0.063678	0.12736
Cholesterol metabolism	706	155	5	2	1	0.063678	0.12736
Biosynthesis of cofactors	706	155	5	4	1	0.12407	0.1737
FoxO signaling pathway	706	155	5	4	1	0.12407	0.1737
Ubiquitin mediated proteolysis	706	155	5	4	1	0.12407	0.1737
Human T-cell leukemia virus 1 infection	706	155	5	7	1	0.20878	0.24358
Human immunodeficiency virus 1 infection	706	155	5	7	1	0.20878	0.24358
Pathways in cancer	706	155	5	9	1	0.26151	0.28163
Metabolic pathways	706	155	5	24	1	0.57396	0.57396
Cell cycle	7083	155	17	14	6	0.001251	0.028288
Oocyte meiosis	7083	155	17	7	4	0.0029058	0.028288
Pyrimidine metabolism	7083	155	17	4	3	0.00416	0.028288
Nucleotide metabolism	7083	155	17	4	3	0.00416	0.028288
p53 signaling pathway	7083	155	17	4	3	0.00416	0.028288
Cellular senescence	7083	155	17	7	3	0.029364	0.13579
Human T-cell leukemia virus 1 infection	7083	155	17	7	3	0.029364	0.13579
Drug metabolism - other enzymes	7083	155	17	3	2	0.031951	0.13579
DNA replication	7083	155	17	4	2	0.059742	0.18466
FoxO signaling pathway	7083	155	17	4	2	0.059742	0.18466
MicroRNAs in cancer	7083	155	17	4	2	0.059742	0.18466
Purine metabolism	7083	155	17	1	1	0.10968	0.21935
Base excision repair	7083	155	17	1	1	0.10968	0.21935
Non-homologous end-joining	7083	155	17	1	1	0.10968	0.21935
Fanconi anemia pathway	7083	155	17	1	1	0.10968	0.21935
Hippo signaling pathway	7083	155	17	1	1	0.10968	0.21935
Carbohydrate digestion and absorption	7083	155	17	1	1	0.10968	0.21935
Progesterone-mediated oocyte maturation	7083	155	17	7	2	0.17118	0.27195
Human immunodeficiency virus 1 infection	7083	155	17	7	2	0.17118	0.27195
Glutathione metabolism	7083	155	17	2	1	0.20796	0.27195
One carbon pool by folate	7083	155	17	2	1	0.20796	0.27195
Platinum drug resistance	7083	155	17	2	1	0.20796	0.27195
MAPK signaling pathway	7083	155	17	2	1	0.20796	0.27195
Apoptosis	7083	155	17	2	1	0.20796	0.27195
Apoptosis - multiple species	7083	155	17	2	1	0.20796	0.27195
Colorectal cancer	7083	155	17	2	1	0.20796	0.27195
Antifolate resistance	7083	155	17	3	1	0.29596	0.3727
Ubiquitin mediated proteolysis	7083	155	17	4	1	0.37471	0.455
Chemical carcinogenesis - receptor activation	7083	155	17	5	1	0.4451	0.52184
Protein processing in endoplasmic reticulum	7083	155	17	6	1	0.50799	0.55986
Metabolic pathways	7083	155	17	24	3	0.51046	0.55986
Hepatitis B	7083	155	17	8	1	0.61419	0.65258
Pathways in cancer	7083	155	17	9	1	0.65881	0.67877
Viral carcinogenesis	7083	155	17	13	1	0.7932	0.7932
Influenza A	710	155	24	10	9	1.0564e-07	4.8597e-06
Measles	710	155	24	9	8	8.6943e-07	1.9997e-05
Hepatitis C	710	155	24	12	9	1.9112e-06	2.9305e-05
Coronavirus disease - COVID-19	710	155	24	11	8	1.2985e-05	0.00014932
Herpes simplex virus 1 infection	710	155	24	9	7	2.7108e-05	0.00024758
NOD-like receptor signaling pathway	710	155	24	15	9	3.2293e-05	0.00024758
Epstein-Barr virus infection	710	155	24	11	6	0.0020536	0.013495
Necroptosis	710	155	24	4	3	0.011923	0.068555
Hepatitis B	710	155	24	8	4	0.020541	0.081828
Chemokine signaling pathway	710	155	24	2	2	0.023125	0.081828
RIG-I-like receptor signaling pathway	710	155	24	2	2	0.023125	0.081828
Cytosolic DNA-sensing pathway	710	155	24	2	2	0.023125	0.081828
C-type lectin receptor signaling pathway	710	155	24	2	2	0.023125	0.081828
Human papillomavirus infection	710	155	24	10	4	0.049253	0.16183
JAK-STAT signaling pathway	710	155	24	3	2	0.062725	0.19236
Osteoclast differentiation	710	155	24	4	2	0.11353	0.25438
Kaposi sarcoma-associated herpesvirus infection	710	155	24	4	2	0.11353	0.25438
PD-L1 expression and PD-1 checkpoint pathway in cancer	710	155	24	4	2	0.11353	0.25438
Glycolysis / Gluconeogenesis	710	155	24	1	1	0.15484	0.25438
Galactose metabolism	710	155	24	1	1	0.15484	0.25438
NF-kappa B signaling pathway	710	155	24	1	1	0.15484	0.25438
Toll-like receptor signaling pathway	710	155	24	1	1	0.15484	0.25438
Th1 and Th2 cell differentiation	710	155	24	1	1	0.15484	0.25438
Prolactin signaling pathway	710	155	24	1	1	0.15484	0.25438
AGE-RAGE signaling pathway in diabetic complications	710	155	24	1	1	0.15484	0.25438
Growth hormone synthesis, secretion and action	710	155	24	1	1	0.15484	0.25438
Pertussis	710	155	24	1	1	0.15484	0.25438
Toxoplasmosis	710	155	24	1	1	0.15484	0.25438
Apoptosis	710	155	24	2	1	0.28655	0.36615
Apoptosis - multiple species	710	155	24	2	1	0.28655	0.36615
Notch signaling pathway	710	155	24	2	1	0.28655	0.36615
Cell adhesion molecules	710	155	24	2	1	0.28655	0.36615
Complement and coagulation cascades	710	155	24	2	1	0.28655	0.36615
Th17 cell differentiation	710	155	24	2	1	0.28655	0.36615
Leishmaniasis	710	155	24	2	1	0.28655	0.36615
Inflammatory bowel disease	710	155	24	2	1	0.28655	0.36615
Thyroid hormone signaling pathway	710	155	24	3	1	0.39847	0.48235
Pancreatic cancer	710	155	24	3	1	0.39847	0.48235
Pathways in cancer	710	155	24	9	2	0.41991	0.49527
Pyrimidine metabolism	710	155	24	4	1	0.49344	0.52787
Nucleotide metabolism	710	155	24	4	1	0.49344	0.52787
Biosynthesis of cofactors	710	155	24	4	1	0.49344	0.52787
Tuberculosis	710	155	24	4	1	0.49344	0.52787
Viral life cycle - HIV-1	710	155	24	5	1	0.57396	0.60005
Transcriptional misregulation in cancer	710	155	24	8	1	0.74845	0.76509
Metabolic pathways	710	155	24	24	2	0.92262	0.92262
Cell cycle	7153	155	22	14	11	9.5413e-09	3.9119e-07
DNA replication	7153	155	22	4	4	0.00031626	0.0043222
p53 signaling pathway	7153	155	22	4	4	0.00031626	0.0043222
Oocyte meiosis	7153	155	22	7	5	0.00064903	0.005322
Progesterone-mediated oocyte maturation	7153	155	22	7	5	0.00064903	0.005322
Cellular senescence	7153	155	22	7	4	0.0081921	0.055979
One carbon pool by folate	7153	155	22	2	2	0.019355	0.11336
Antifolate resistance	7153	155	22	3	2	0.053004	0.2229
AMPK signaling pathway	7153	155	22	3	2	0.053004	0.2229
Human T-cell leukemia virus 1 infection	7153	155	22	7	3	0.059803	0.2229
Human immunodeficiency virus 1 infection	7153	155	22	7	3	0.059803	0.2229
Pyrimidine metabolism	7153	155	22	4	2	0.096837	0.26469
Nucleotide metabolism	7153	155	22	4	2	0.096837	0.26469
FoxO signaling pathway	7153	155	22	4	2	0.096837	0.26469
MicroRNAs in cancer	7153	155	22	4	2	0.096837	0.26469
Purine metabolism	7153	155	22	1	1	0.14194	0.27711
Biosynthesis of unsaturated fatty acids	7153	155	22	1	1	0.14194	0.27711
Fatty acid metabolism	7153	155	22	1	1	0.14194	0.27711
Base excision repair	7153	155	22	1	1	0.14194	0.27711
Non-homologous end-joining	7153	155	22	1	1	0.14194	0.27711
Fanconi anemia pathway	7153	155	22	1	1	0.14194	0.27711
Glutathione metabolism	7153	155	22	2	1	0.26452	0.38733
Folate biosynthesis	7153	155	22	2	1	0.26452	0.38733
Platinum drug resistance	7153	155	22	2	1	0.26452	0.38733
PPAR signaling pathway	7153	155	22	2	1	0.26452	0.38733
MAPK signaling pathway	7153	155	22	2	1	0.26452	0.38733
ECM-receptor interaction	7153	155	22	2	1	0.26452	0.38733
Alcoholic liver disease	7153	155	22	2	1	0.26452	0.38733
Drug metabolism - other enzymes	7153	155	22	3	1	0.37027	0.48971
Gap junction	7153	155	22	3	1	0.37027	0.48971
Acute myeloid leukemia	7153	155	22	3	1	0.37027	0.48971
Metabolic pathways	7153	155	22	24	4	0.45485	0.55641
Biosynthesis of cofactors	7153	155	22	4	1	0.46142	0.55641
Ubiquitin mediated proteolysis	7153	155	22	4	1	0.46142	0.55641
Chemical carcinogenesis - receptor activation	7153	155	22	5	1	0.53989	0.63244
Viral carcinogenesis	7153	155	22	13	2	0.57911	0.65955
Hepatitis B	7153	155	22	8	1	0.71509	0.77154
Transcriptional misregulation in cancer	7153	155	22	8	1	0.71509	0.77154
Pathways in cancer	7153	155	22	9	1	0.75773	0.79659
Human papillomavirus infection	7153	155	22	10	1	0.79423	0.81409
Epstein-Barr virus infection	7153	155	22	11	1	0.82545	0.82545
Protein processing in endoplasmic reticulum	7184	155	20	6	4	0.0026315	0.11316
DNA replication	7184	155	20	4	3	0.0068632	0.14756
Glutathione metabolism	7184	155	20	2	2	0.01592	0.17114
Intestinal immune network for IgA production	7184	155	20	2	2	0.01592	0.17114
Cytokine-cytokine receptor interaction	7184	155	20	3	2	0.044013	0.27742
Cell cycle	7184	155	20	14	4	0.086042	0.27742
Chemical carcinogenesis - receptor activation	7184	155	20	5	2	0.12479	0.27742
Purine metabolism	7184	155	20	1	1	0.12903	0.27742
Glycine, serine and threonine metabolism	7184	155	20	1	1	0.12903	0.27742
Glyoxylate and dicarboxylate metabolism	7184	155	20	1	1	0.12903	0.27742
Carbon metabolism	7184	155	20	1	1	0.12903	0.27742
Biosynthesis of nucleotide sugars	7184	155	20	1	1	0.12903	0.27742
Protein export	7184	155	20	1	1	0.12903	0.27742
Base excision repair	7184	155	20	1	1	0.12903	0.27742
Non-homologous end-joining	7184	155	20	1	1	0.12903	0.27742
Estrogen signaling pathway	7184	155	20	1	1	0.12903	0.27742
Thyroid hormone synthesis	7184	155	20	1	1	0.12903	0.27742
Oxytocin signaling pathway	7184	155	20	1	1	0.12903	0.27742
Pancreatic secretion	7184	155	20	1	1	0.12903	0.27742
Primary immunodeficiency	7184	155	20	1	1	0.12903	0.27742
Metabolic pathways	7184	155	20	24	5	0.17353	0.35531
Amino sugar and nucleotide sugar metabolism	7184	155	20	2	1	0.24214	0.35904
Nicotinate and nicotinamide metabolism	7184	155	20	2	1	0.24214	0.35904
Calcium signaling pathway	7184	155	20	2	1	0.24214	0.35904
IL-17 signaling pathway	7184	155	20	2	1	0.24214	0.35904
Th17 cell differentiation	7184	155	20	2	1	0.24214	0.35904
Salivary secretion	7184	155	20	2	1	0.24214	0.35904
Salmonella infection	7184	155	20	2	1	0.24214	0.35904
Fluid shear stress and atherosclerosis	7184	155	20	2	1	0.24214	0.35904
Drug metabolism - other enzymes	7184	155	20	3	1	0.34121	0.44461
PI3K-Akt signaling pathway	7184	155	20	3	1	0.34121	0.44461
Prostate cancer	7184	155	20	3	1	0.34121	0.44461
Lipid and atherosclerosis	7184	155	20	3	1	0.34121	0.44461
Pyrimidine metabolism	7184	155	20	4	1	0.42789	0.5111
Nucleotide metabolism	7184	155	20	4	1	0.42789	0.5111
p53 signaling pathway	7184	155	20	4	1	0.42789	0.5111
Viral life cycle - HIV-1	7184	155	20	5	1	0.50367	0.56994
Hematopoietic cell lineage	7184	155	20	5	1	0.50367	0.56994
Parkinson disease	7184	155	20	6	1	0.56985	0.62829
Oocyte meiosis	7184	155	20	7	1	0.62759	0.64253
Progesterone-mediated oocyte maturation	7184	155	20	7	1	0.62759	0.64253
Pathways of neurodegeneration - multiple diseases	7184	155	20	7	1	0.62759	0.64253
Pathways in cancer	7184	155	20	9	1	0.72173	0.72173
Staphylococcus aureus infection	728358	155	13	6	5	1.0563e-05	0.00023239
Transcriptional misregulation in cancer	728358	155	13	8	5	8.9968e-05	0.00098964
NOD-like receptor signaling pathway	728358	155	13	15	5	0.0034794	0.025516
Phagosome	728358	155	13	5	2	0.056413	0.25332
Neutrophil extracellular trap formation	728358	155	13	13	3	0.08073	0.25332
Carbohydrate digestion and absorption	728358	155	13	1	1	0.083871	0.25332
Asthma	728358	155	13	1	1	0.083871	0.25332
Amino sugar and nucleotide sugar metabolism	728358	155	13	2	1	0.16121	0.25332
PPAR signaling pathway	728358	155	13	2	1	0.16121	0.25332
Lysosome	728358	155	13	2	1	0.16121	0.25332
Renin-angiotensin system	728358	155	13	2	1	0.16121	0.25332
IL-17 signaling pathway	728358	155	13	2	1	0.16121	0.25332
Salivary secretion	728358	155	13	2	1	0.16121	0.25332
Amoebiasis	728358	155	13	2	1	0.16121	0.25332
Drug metabolism - other enzymes	728358	155	13	3	1	0.23248	0.28414
Neuroactive ligand-receptor interaction	728358	155	13	3	1	0.23248	0.28414
Acute myeloid leukemia	728358	155	13	3	1	0.23248	0.28414
Lipid and atherosclerosis	728358	155	13	3	1	0.23248	0.28414
Tuberculosis	728358	155	13	4	1	0.29812	0.34519
Hematopoietic cell lineage	728358	155	13	5	1	0.35855	0.3944
Systemic lupus erythematosus	728358	155	13	10	1	0.59495	0.62328
Metabolic pathways	728358	155	13	24	1	0.89822	0.89822
Cell cycle	7298	155	25	14	12	1.5302e-09	6.1206e-08
Oocyte meiosis	7298	155	25	7	6	6.323e-05	0.0012646
DNA replication	7298	155	25	4	4	0.00054691	0.0054691
p53 signaling pathway	7298	155	25	4	4	0.00054691	0.0054691
Cellular senescence	7298	155	25	7	5	0.0012617	0.0084114
Progesterone-mediated oocyte maturation	7298	155	25	7	5	0.0012617	0.0084114
Human T-cell leukemia virus 1 infection	7298	155	25	7	4	0.013437	0.059884
Pyrimidine metabolism	7298	155	25	4	3	0.013474	0.059884
Nucleotide metabolism	7298	155	25	4	3	0.013474	0.059884
Platinum drug resistance	7298	155	25	2	2	0.025136	0.10054
Drug metabolism - other enzymes	7298	155	25	3	2	0.067851	0.24673
Human immunodeficiency virus 1 infection	7298	155	25	7	3	0.08372	0.27907
FoxO signaling pathway	7298	155	25	4	2	0.12223	0.30722
Ubiquitin mediated proteolysis	7298	155	25	4	2	0.12223	0.30722
MicroRNAs in cancer	7298	155	25	4	2	0.12223	0.30722
Purine metabolism	7298	155	25	1	1	0.16129	0.30722
Base excision repair	7298	155	25	1	1	0.16129	0.30722
Non-homologous end-joining	7298	155	25	1	1	0.16129	0.30722
Fanconi anemia pathway	7298	155	25	1	1	0.16129	0.30722
Hippo signaling pathway	7298	155	25	1	1	0.16129	0.30722
Carbohydrate digestion and absorption	7298	155	25	1	1	0.16129	0.30722
Chemical carcinogenesis - receptor activation	7298	155	25	5	2	0.18369	0.33398
Glutathione metabolism	7298	155	25	2	1	0.29744	0.41027
One carbon pool by folate	7298	155	25	2	1	0.29744	0.41027
MAPK signaling pathway	7298	155	25	2	1	0.29744	0.41027
Apoptosis	7298	155	25	2	1	0.29744	0.41027
Apoptosis - multiple species	7298	155	25	2	1	0.29744	0.41027
ECM-receptor interaction	7298	155	25	2	1	0.29744	0.41027
Colorectal cancer	7298	155	25	2	1	0.29744	0.41027
Viral carcinogenesis	7298	155	25	13	3	0.35026	0.46702
Hepatitis B	7298	155	25	8	2	0.37978	0.47113
Antifolate resistance	7298	155	25	3	1	0.41224	0.47113
AMPK signaling pathway	7298	155	25	3	1	0.41224	0.47113
Gap junction	7298	155	25	3	1	0.41224	0.47113
Acute myeloid leukemia	7298	155	25	3	1	0.41224	0.47113
Pathways in cancer	7298	155	25	9	2	0.44248	0.49164
Transcriptional misregulation in cancer	7298	155	25	8	1	0.76382	0.82575
Metabolic pathways	7298	155	25	24	3	0.79105	0.83269
Human papillomavirus infection	7298	155	25	10	1	0.83755	0.85902
Epstein-Barr virus infection	7298	155	25	11	1	0.86556	0.86556
RNA degradation	734	155	17	2	2	0.011395	0.2393
Protein digestion and absorption	734	155	17	2	2	0.011395	0.2393
Mucin type O-glycan biosynthesis	734	155	17	1	1	0.10968	0.3071
Glycerolipid metabolism	734	155	17	1	1	0.10968	0.3071
Glycerophospholipid metabolism	734	155	17	1	1	0.10968	0.3071
Arachidonic acid metabolism	734	155	17	1	1	0.10968	0.3071
Sphingolipid metabolism	734	155	17	1	1	0.10968	0.3071
ABC transporters	734	155	17	1	1	0.10968	0.3071
mTOR signaling pathway	734	155	17	1	1	0.10968	0.3071
Natural killer cell mediated cytotoxicity	734	155	17	1	1	0.10968	0.3071
Fc gamma R-mediated phagocytosis	734	155	17	1	1	0.10968	0.3071
Glutamatergic synapse	734	155	17	1	1	0.10968	0.3071
GABAergic synapse	734	155	17	1	1	0.10968	0.3071
Fat digestion and absorption	734	155	17	1	1	0.10968	0.3071
Epithelial cell signaling in Helicobacter pylori infection	734	155	17	1	1	0.10968	0.3071
Notch signaling pathway	734	155	17	2	1	0.20796	0.42732
Renin-angiotensin system	734	155	17	2	1	0.20796	0.42732
Alcoholic liver disease	734	155	17	2	1	0.20796	0.42732
Cholesterol metabolism	734	155	17	2	1	0.20796	0.42732
Leishmaniasis	734	155	17	2	1	0.20796	0.42732
Alzheimer disease	734	155	17	8	2	0.21366	0.42732
Thyroid hormone signaling pathway	734	155	17	3	1	0.29596	0.52721
Lipid and atherosclerosis	734	155	17	3	1	0.29596	0.52721
Systemic lupus erythematosus	734	155	17	10	2	0.30126	0.52721
Ubiquitin mediated proteolysis	734	155	17	4	1	0.37471	0.58287
Osteoclast differentiation	734	155	17	4	1	0.37471	0.58287
Tuberculosis	734	155	17	4	1	0.37471	0.58287
Neutrophil extracellular trap formation	734	155	17	13	2	0.43048	0.62314
Phagosome	734	155	17	5	1	0.4451	0.62314
Hematopoietic cell lineage	734	155	17	5	1	0.4451	0.62314
Protein processing in endoplasmic reticulum	734	155	17	6	1	0.50799	0.63057
Parkinson disease	734	155	17	6	1	0.50799	0.63057
Staphylococcus aureus infection	734	155	17	6	1	0.50799	0.63057
Metabolic pathways	734	155	17	24	3	0.51046	0.63057
Oocyte meiosis	734	155	17	7	1	0.56413	0.64036
Progesterone-mediated oocyte maturation	734	155	17	7	1	0.56413	0.64036
Pathways of neurodegeneration - multiple diseases	734	155	17	7	1	0.56413	0.64036
Alcoholism	734	155	17	8	1	0.61419	0.67884
Coronavirus disease - COVID-19	734	155	17	11	1	0.73388	0.79033
Viral carcinogenesis	734	155	17	13	1	0.7932	0.83286
NOD-like receptor signaling pathway	734	155	17	15	1	0.83991	0.86039
Ribosome biogenesis in eukaryotes	734	155	17	18	1	0.89176	0.89176
Glutathione metabolism	7345	155	16	2	2	0.010054	0.18599
Intestinal immune network for IgA production	7345	155	16	2	2	0.010054	0.18599
Protein processing in endoplasmic reticulum	7345	155	16	6	3	0.01508	0.18599
Cytokine-cytokine receptor interaction	7345	155	16	3	2	0.028323	0.26199
p53 signaling pathway	7345	155	16	4	2	0.053203	0.27281
Chemical carcinogenesis - receptor activation	7345	155	16	5	2	0.0833	0.27281
Purine metabolism	7345	155	16	1	1	0.10323	0.27281
Glycine, serine and threonine metabolism	7345	155	16	1	1	0.10323	0.27281
Glyoxylate and dicarboxylate metabolism	7345	155	16	1	1	0.10323	0.27281
Carbon metabolism	7345	155	16	1	1	0.10323	0.27281
Protein export	7345	155	16	1	1	0.10323	0.27281
Estrogen signaling pathway	7345	155	16	1	1	0.10323	0.27281
Thyroid hormone synthesis	7345	155	16	1	1	0.10323	0.27281
Primary immunodeficiency	7345	155	16	1	1	0.10323	0.27281
Oocyte meiosis	7345	155	16	7	2	0.1545	0.3303
Cellular senescence	7345	155	16	7	2	0.1545	0.3303
Progesterone-mediated oocyte maturation	7345	155	16	7	2	0.1545	0.3303
Cell cycle	7345	155	16	14	3	0.16141	0.3303
Folate biosynthesis	7345	155	16	2	1	0.1964	0.3303
IL-17 signaling pathway	7345	155	16	2	1	0.1964	0.3303
Salmonella infection	7345	155	16	2	1	0.1964	0.3303
Fluid shear stress and atherosclerosis	7345	155	16	2	1	0.1964	0.3303
Drug metabolism - other enzymes	7345	155	16	3	1	0.28043	0.3843
Antifolate resistance	7345	155	16	3	1	0.28043	0.3843
PI3K-Akt signaling pathway	7345	155	16	3	1	0.28043	0.3843
Prostate cancer	7345	155	16	3	1	0.28043	0.3843
Lipid and atherosclerosis	7345	155	16	3	1	0.28043	0.3843
Pyrimidine metabolism	7345	155	16	4	1	0.35618	0.41183
Nucleotide metabolism	7345	155	16	4	1	0.35618	0.41183
Biosynthesis of cofactors	7345	155	16	4	1	0.35618	0.41183
FoxO signaling pathway	7345	155	16	4	1	0.35618	0.41183
Ubiquitin mediated proteolysis	7345	155	16	4	1	0.35618	0.41183
Metabolic pathways	7345	155	16	24	3	0.46555	0.52198
Parkinson disease	7345	155	16	6	1	0.4858	0.52866
Pathways of neurodegeneration - multiple diseases	7345	155	16	7	1	0.54101	0.55604
Human immunodeficiency virus 1 infection	7345	155	16	7	1	0.54101	0.55604
Pathways in cancer	7345	155	16	9	1	0.63519	0.63519
Protein digestion and absorption	79056	155	15	2	2	0.0087977	0.25161
Tuberculosis	79056	155	15	4	2	0.046983	0.25161
Mucin type O-glycan biosynthesis	79056	155	15	1	1	0.096774	0.25161
Glycerolipid metabolism	79056	155	15	1	1	0.096774	0.25161
Glycerophospholipid metabolism	79056	155	15	1	1	0.096774	0.25161
Sphingolipid metabolism	79056	155	15	1	1	0.096774	0.25161
ABC transporters	79056	155	15	1	1	0.096774	0.25161
mTOR signaling pathway	79056	155	15	1	1	0.096774	0.25161
Natural killer cell mediated cytotoxicity	79056	155	15	1	1	0.096774	0.25161
Fc gamma R-mediated phagocytosis	79056	155	15	1	1	0.096774	0.25161
Neurotrophin signaling pathway	79056	155	15	1	1	0.096774	0.25161
Glutamatergic synapse	79056	155	15	1	1	0.096774	0.25161
GABAergic synapse	79056	155	15	1	1	0.096774	0.25161
Fat digestion and absorption	79056	155	15	1	1	0.096774	0.25161
Epithelial cell signaling in Helicobacter pylori infection	79056	155	15	1	1	0.096774	0.25161
Alzheimer disease	79056	155	15	8	2	0.17408	0.32751
RNA degradation	79056	155	15	2	1	0.18475	0.32751
Notch signaling pathway	79056	155	15	2	1	0.18475	0.32751
Renin-angiotensin system	79056	155	15	2	1	0.18475	0.32751
Alcoholic liver disease	79056	155	15	2	1	0.18475	0.32751
Cholesterol metabolism	79056	155	15	2	1	0.18475	0.32751
Leishmaniasis	79056	155	15	2	1	0.18475	0.32751
Thyroid hormone signaling pathway	79056	155	15	3	1	0.26468	0.4301
Lipid and atherosclerosis	79056	155	15	3	1	0.26468	0.4301
Ubiquitin mediated proteolysis	79056	155	15	4	1	0.33724	0.50586
Osteoclast differentiation	79056	155	15	4	1	0.33724	0.50586
Phagosome	79056	155	15	5	1	0.40308	0.56143
Hematopoietic cell lineage	79056	155	15	5	1	0.40308	0.56143
Protein processing in endoplasmic reticulum	79056	155	15	6	1	0.46277	0.5822
Parkinson disease	79056	155	15	6	1	0.46277	0.5822
Staphylococcus aureus infection	79056	155	15	6	1	0.46277	0.5822
Oocyte meiosis	79056	155	15	7	1	0.51685	0.59286
Progesterone-mediated oocyte maturation	79056	155	15	7	1	0.51685	0.59286
Pathways of neurodegeneration - multiple diseases	79056	155	15	7	1	0.51685	0.59286
Systemic lupus erythematosus	79056	155	15	10	1	0.65018	0.72449
Coronavirus disease - COVID-19	79056	155	15	11	1	0.68637	0.74357
Metabolic pathways	79056	155	15	24	2	0.71388	0.75247
Neutrophil extracellular trap formation	79056	155	15	13	1	0.74851	0.76821
NOD-like receptor signaling pathway	79056	155	15	15	1	0.799	0.799
Protein digestion and absorption	79598	155	12	2	2	0.00553	0.13825
Mucin type O-glycan biosynthesis	79598	155	12	1	1	0.077419	0.21505
Glycerolipid metabolism	79598	155	12	1	1	0.077419	0.21505
Glycerophospholipid metabolism	79598	155	12	1	1	0.077419	0.21505
Sphingolipid metabolism	79598	155	12	1	1	0.077419	0.21505
mTOR signaling pathway	79598	155	12	1	1	0.077419	0.21505
Glutamatergic synapse	79598	155	12	1	1	0.077419	0.21505
GABAergic synapse	79598	155	12	1	1	0.077419	0.21505
Epithelial cell signaling in Helicobacter pylori infection	79598	155	12	1	1	0.077419	0.21505
Alzheimer disease	79598	155	12	8	2	0.11861	0.26662
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	79598	155	12	2	1	0.14931	0.26662
Notch signaling pathway	79598	155	12	2	1	0.14931	0.26662
Renin-angiotensin system	79598	155	12	2	1	0.14931	0.26662
Alcoholic liver disease	79598	155	12	2	1	0.14931	0.26662
Thyroid hormone signaling pathway	79598	155	12	3	1	0.21603	0.36005
Metabolic pathways	79598	155	12	24	3	0.27728	0.40871
Ubiquitin mediated proteolysis	79598	155	12	4	1	0.27792	0.40871
Hematopoietic cell lineage	79598	155	12	5	1	0.33531	0.4657
Protein processing in endoplasmic reticulum	79598	155	12	6	1	0.38848	0.47579
Parkinson disease	79598	155	12	6	1	0.38848	0.47579
Oocyte meiosis	79598	155	12	7	1	0.43773	0.47579
Progesterone-mediated oocyte maturation	79598	155	12	7	1	0.43773	0.47579
Pathways of neurodegeneration - multiple diseases	79598	155	12	7	1	0.43773	0.47579
Coronavirus disease - COVID-19	79598	155	12	11	1	0.60054	0.62556
NOD-like receptor signaling pathway	79598	155	12	15	1	0.71904	0.71904
Cell cycle	79682	155	16	14	10	4.1872e-09	1.298e-07
p53 signaling pathway	79682	155	16	4	4	7.8686e-05	0.0011959
Progesterone-mediated oocyte maturation	79682	155	16	7	5	0.00011573	0.0011959
Oocyte meiosis	79682	155	16	7	4	0.0022602	0.014013
Cellular senescence	79682	155	16	7	4	0.0022602	0.014013
DNA replication	79682	155	16	4	3	0.003444	0.017794
Human immunodeficiency virus 1 infection	79682	155	16	7	3	0.024695	0.10936
Pyrimidine metabolism	79682	155	16	4	2	0.053203	0.16493
Nucleotide metabolism	79682	155	16	4	2	0.053203	0.16493
FoxO signaling pathway	79682	155	16	4	2	0.053203	0.16493
Purine metabolism	79682	155	16	1	1	0.10323	0.29091
Human T-cell leukemia virus 1 infection	79682	155	16	7	2	0.1545	0.38052
Glutathione metabolism	79682	155	16	2	1	0.1964	0.38052
One carbon pool by folate	79682	155	16	2	1	0.1964	0.38052
Platinum drug resistance	79682	155	16	2	1	0.1964	0.38052
ECM-receptor interaction	79682	155	16	2	1	0.1964	0.38052
Drug metabolism - other enzymes	79682	155	16	3	1	0.28043	0.41397
Antifolate resistance	79682	155	16	3	1	0.28043	0.41397
AMPK signaling pathway	79682	155	16	3	1	0.28043	0.41397
Gap junction	79682	155	16	3	1	0.28043	0.41397
Acute myeloid leukemia	79682	155	16	3	1	0.28043	0.41397
Ubiquitin mediated proteolysis	79682	155	16	4	1	0.35618	0.48007
MicroRNAs in cancer	79682	155	16	4	1	0.35618	0.48007
Viral carcinogenesis	79682	155	16	13	2	0.39822	0.51437
Chemical carcinogenesis - receptor activation	79682	155	16	5	1	0.4244	0.52625
Hepatitis B	79682	155	16	8	1	0.59063	0.67813
Transcriptional misregulation in cancer	79682	155	16	8	1	0.59063	0.67813
Pathways in cancer	79682	155	16	9	1	0.63519	0.70325
Human papillomavirus infection	79682	155	16	10	1	0.67517	0.72173
Epstein-Barr virus infection	79682	155	16	11	1	0.71101	0.73471
Metabolic pathways	79682	155	16	24	2	0.74935	0.74935
Cell cycle	79801	155	35	14	12	2.1206e-07	1.336e-05
Oocyte meiosis	79801	155	35	7	6	0.00054209	0.017076
DNA replication	79801	155	35	4	4	0.0022637	0.035654
p53 signaling pathway	79801	155	35	4	4	0.0022637	0.035654
Cellular senescence	79801	155	35	7	5	0.0067777	0.071166
Progesterone-mediated oocyte maturation	79801	155	35	7	5	0.0067777	0.071166
Antifolate resistance	79801	155	35	3	3	0.010753	0.096774
Human T-cell leukemia virus 1 infection	79801	155	35	7	4	0.046337	0.28552
Glutathione metabolism	79801	155	35	2	2	0.049853	0.28552
One carbon pool by folate	79801	155	35	2	2	0.049853	0.28552
Folate biosynthesis	79801	155	35	2	2	0.049853	0.28552
Protein processing in endoplasmic reticulum	79801	155	35	6	3	0.12899	0.4589
Human immunodeficiency virus 1 infection	79801	155	35	7	3	0.19098	0.4589
Pyrimidine metabolism	79801	155	35	4	2	0.21989	0.4589
Nucleotide metabolism	79801	155	35	4	2	0.21989	0.4589
Biosynthesis of cofactors	79801	155	35	4	2	0.21989	0.4589
FoxO signaling pathway	79801	155	35	4	2	0.21989	0.4589
Ubiquitin mediated proteolysis	79801	155	35	4	2	0.21989	0.4589
Purine metabolism	79801	155	35	1	1	0.22581	0.4589
Glycine, serine and threonine metabolism	79801	155	35	1	1	0.22581	0.4589
Glyoxylate and dicarboxylate metabolism	79801	155	35	1	1	0.22581	0.4589
Carbon metabolism	79801	155	35	1	1	0.22581	0.4589
Biosynthesis of nucleotide sugars	79801	155	35	1	1	0.22581	0.4589
Protein export	79801	155	35	1	1	0.22581	0.4589
Base excision repair	79801	155	35	1	1	0.22581	0.4589
Non-homologous end-joining	79801	155	35	1	1	0.22581	0.4589
Fanconi anemia pathway	79801	155	35	1	1	0.22581	0.4589
Estrogen signaling pathway	79801	155	35	1	1	0.22581	0.4589
Thyroid hormone synthesis	79801	155	35	1	1	0.22581	0.4589
Oxytocin signaling pathway	79801	155	35	1	1	0.22581	0.4589
Pancreatic secretion	79801	155	35	1	1	0.22581	0.4589
Metabolic pathways	79801	155	35	24	7	0.2757	0.54278
Chemical carcinogenesis - receptor activation	79801	155	35	5	2	0.31558	0.57525
Amino sugar and nucleotide sugar metabolism	79801	155	35	2	1	0.40176	0.57525
Nicotinate and nicotinamide metabolism	79801	155	35	2	1	0.40176	0.57525
Platinum drug resistance	79801	155	35	2	1	0.40176	0.57525
Calcium signaling pathway	79801	155	35	2	1	0.40176	0.57525
ECM-receptor interaction	79801	155	35	2	1	0.40176	0.57525
IL-17 signaling pathway	79801	155	35	2	1	0.40176	0.57525
Th17 cell differentiation	79801	155	35	2	1	0.40176	0.57525
Intestinal immune network for IgA production	79801	155	35	2	1	0.40176	0.57525
Salivary secretion	79801	155	35	2	1	0.40176	0.57525
Salmonella infection	79801	155	35	2	1	0.40176	0.57525
Fluid shear stress and atherosclerosis	79801	155	35	2	1	0.40176	0.57525
Drug metabolism - other enzymes	79801	155	35	3	1	0.53861	0.65255
Cytokine-cytokine receptor interaction	79801	155	35	3	1	0.53861	0.65255
PI3K-Akt signaling pathway	79801	155	35	3	1	0.53861	0.65255
AMPK signaling pathway	79801	155	35	3	1	0.53861	0.65255
Gap junction	79801	155	35	3	1	0.53861	0.65255
Prostate cancer	79801	155	35	3	1	0.53861	0.65255
Acute myeloid leukemia	79801	155	35	3	1	0.53861	0.65255
Lipid and atherosclerosis	79801	155	35	3	1	0.53861	0.65255
Viral carcinogenesis	79801	155	35	13	3	0.59795	0.71077
MicroRNAs in cancer	79801	155	35	4	1	0.64485	0.7389
Pathways in cancer	79801	155	35	9	2	0.64507	0.7389
Viral life cycle - HIV-1	79801	155	35	5	1	0.72717	0.80372
Hematopoietic cell lineage	79801	155	35	5	1	0.72717	0.80372
Parkinson disease	79801	155	35	6	1	0.79083	0.85901
Pathways of neurodegeneration - multiple diseases	79801	155	35	7	1	0.83997	0.89691
Hepatitis B	79801	155	35	8	1	0.87781	0.90659
Transcriptional misregulation in cancer	79801	155	35	8	1	0.87781	0.90659
Human papillomavirus infection	79801	155	35	10	1	0.92922	0.94421
Epstein-Barr virus infection	79801	155	35	11	1	0.94631	0.94631
Renin-angiotensin system	79971	155	1	2	1	0.012903	0.025806
Protein digestion and absorption	79971	155	1	2	1	0.012903	0.025806
Hematopoietic cell lineage	79971	155	1	5	1	0.032258	0.043011
Alzheimer disease	79971	155	1	8	1	0.051613	0.051613
RNA degradation	80267	155	20	2	2	0.01592	0.33397
Pathways of neurodegeneration - multiple diseases	80267	155	20	7	3	0.046201	0.33397
Alzheimer disease	80267	155	20	8	3	0.067754	0.33397
Mucin type O-glycan biosynthesis	80267	155	20	1	1	0.12903	0.33397
Glycerolipid metabolism	80267	155	20	1	1	0.12903	0.33397
Glycerophospholipid metabolism	80267	155	20	1	1	0.12903	0.33397
Sphingolipid metabolism	80267	155	20	1	1	0.12903	0.33397
ABC transporters	80267	155	20	1	1	0.12903	0.33397
mTOR signaling pathway	80267	155	20	1	1	0.12903	0.33397
Signaling pathways regulating pluripotency of stem cells	80267	155	20	1	1	0.12903	0.33397
Glutamatergic synapse	80267	155	20	1	1	0.12903	0.33397
Serotonergic synapse	80267	155	20	1	1	0.12903	0.33397
GABAergic synapse	80267	155	20	1	1	0.12903	0.33397
Insulin signaling pathway	80267	155	20	1	1	0.12903	0.33397
Fat digestion and absorption	80267	155	20	1	1	0.12903	0.33397
Epithelial cell signaling in Helicobacter pylori infection	80267	155	20	1	1	0.12903	0.33397
Pathogenic Escherichia coli infection	80267	155	20	1	1	0.12903	0.33397
Parkinson disease	80267	155	20	6	2	0.17278	0.42236
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	80267	155	20	2	1	0.24214	0.42618
Notch signaling pathway	80267	155	20	2	1	0.24214	0.42618
Complement and coagulation cascades	80267	155	20	2	1	0.24214	0.42618
Alcoholic liver disease	80267	155	20	2	1	0.24214	0.42618
Protein digestion and absorption	80267	155	20	2	1	0.24214	0.42618
Cholesterol metabolism	80267	155	20	2	1	0.24214	0.42618
Salmonella infection	80267	155	20	2	1	0.24214	0.42618
Gap junction	80267	155	20	3	1	0.34121	0.53619
Thyroid hormone signaling pathway	80267	155	20	3	1	0.34121	0.53619
Lipid and atherosclerosis	80267	155	20	3	1	0.34121	0.53619
Ubiquitin mediated proteolysis	80267	155	20	4	1	0.42789	0.57148
Amyotrophic lateral sclerosis	80267	155	20	4	1	0.42789	0.57148
Huntington disease	80267	155	20	4	1	0.42789	0.57148
Prion disease	80267	155	20	4	1	0.42789	0.57148
Coronavirus disease - COVID-19	80267	155	20	11	2	0.42861	0.57148
Phagosome	80267	155	20	5	1	0.50367	0.65181
Protein processing in endoplasmic reticulum	80267	155	20	6	1	0.56985	0.71638
Oocyte meiosis	80267	155	20	7	1	0.62759	0.73364
Progesterone-mediated oocyte maturation	80267	155	20	7	1	0.62759	0.73364
Metabolic pathways	80267	155	20	24	3	0.6336	0.73364
Alcoholism	80267	155	20	8	1	0.67791	0.76482
Systemic lupus erythematosus	80267	155	20	10	1	0.75985	0.83584
Neutrophil extracellular trap formation	80267	155	20	13	1	0.84666	0.88698
Viral carcinogenesis	80267	155	20	13	1	0.84666	0.88698
NOD-like receptor signaling pathway	80267	155	20	15	1	0.88695	0.90757
Ribosome biogenesis in eukaryotes	80267	155	20	18	1	0.92906	0.92906
Pathways of neurodegeneration - multiple diseases	80315	155	22	7	6	2.7155e-05	0.0013578
Alzheimer disease	80315	155	22	8	6	9.8587e-05	0.0024647
Parkinson disease	80315	155	22	6	5	0.00020483	0.0026355
Amyotrophic lateral sclerosis	80315	155	22	4	4	0.00031626	0.0026355
Huntington disease	80315	155	22	4	4	0.00031626	0.0026355
Prion disease	80315	155	22	4	4	0.00031626	0.0026355
Oxidative phosphorylation	80315	155	22	3	3	0.00253	0.014056
Thermogenesis	80315	155	22	3	3	0.00253	0.014056
Diabetic cardiomyopathy	80315	155	22	3	3	0.00253	0.014056
Chemical carcinogenesis - reactive oxygen species	80315	155	22	4	3	0.0091714	0.045857
RNA degradation	80315	155	22	2	2	0.019355	0.074442
Retrograde endocannabinoid signaling	80315	155	22	2	2	0.019355	0.074442
Non-alcoholic fatty liver disease	80315	155	22	2	2	0.019355	0.074442
Metabolic pathways	80315	155	22	24	7	0.030923	0.11044
Ubiquitin mediated proteolysis	80315	155	22	4	2	0.096837	0.25346
Mucin type O-glycan biosynthesis	80315	155	22	1	1	0.14194	0.25346
Glycerolipid metabolism	80315	155	22	1	1	0.14194	0.25346
Glycerophospholipid metabolism	80315	155	22	1	1	0.14194	0.25346
Sphingolipid metabolism	80315	155	22	1	1	0.14194	0.25346
ABC transporters	80315	155	22	1	1	0.14194	0.25346
mTOR signaling pathway	80315	155	22	1	1	0.14194	0.25346
Glutamatergic synapse	80315	155	22	1	1	0.14194	0.25346
Serotonergic synapse	80315	155	22	1	1	0.14194	0.25346
GABAergic synapse	80315	155	22	1	1	0.14194	0.25346
Fat digestion and absorption	80315	155	22	1	1	0.14194	0.25346
Epithelial cell signaling in Helicobacter pylori infection	80315	155	22	1	1	0.14194	0.25346
Pathogenic Escherichia coli infection	80315	155	22	1	1	0.14194	0.25346
Renal cell carcinoma	80315	155	22	1	1	0.14194	0.25346
Human immunodeficiency virus 1 infection	80315	155	22	7	2	0.25954	0.35745
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	80315	155	22	2	1	0.26452	0.35745
Nicotinate and nicotinamide metabolism	80315	155	22	2	1	0.26452	0.35745
HIF-1 signaling pathway	80315	155	22	2	1	0.26452	0.35745
Notch signaling pathway	80315	155	22	2	1	0.26452	0.35745
Alcoholic liver disease	80315	155	22	2	1	0.26452	0.35745
Protein digestion and absorption	80315	155	22	2	1	0.26452	0.35745
Cholesterol metabolism	80315	155	22	2	1	0.26452	0.35745
Salmonella infection	80315	155	22	2	1	0.26452	0.35745
Gap junction	80315	155	22	3	1	0.37027	0.46284
Thyroid hormone signaling pathway	80315	155	22	3	1	0.37027	0.46284
Lipid and atherosclerosis	80315	155	22	3	1	0.37027	0.46284
Biosynthesis of cofactors	80315	155	22	4	1	0.46142	0.5627
Viral life cycle - HIV-1	80315	155	22	5	1	0.53989	0.62777
Phagosome	80315	155	22	5	1	0.53989	0.62777
Protein processing in endoplasmic reticulum	80315	155	22	6	1	0.60737	0.69019
Oocyte meiosis	80315	155	22	7	1	0.66534	0.7232
Progesterone-mediated oocyte maturation	80315	155	22	7	1	0.66534	0.7232
Pathways in cancer	80315	155	22	9	1	0.75773	0.80609
Coronavirus disease - COVID-19	80315	155	22	11	1	0.82545	0.85985
NOD-like receptor signaling pathway	80315	155	22	15	1	0.91076	0.92934
Ribosome biogenesis in eukaryotes	80315	155	22	18	1	0.94678	0.94678
Influenza A	80830	155	30	10	10	1.8322e-08	9.8936e-07
Measles	80830	155	30	9	9	1.2738e-07	3.4392e-06
Hepatitis C	80830	155	30	12	10	9.2431e-07	1.6638e-05
Coronavirus disease - COVID-19	80830	155	30	11	9	5.3057e-06	7.1627e-05
Herpes simplex virus 1 infection	80830	155	30	9	8	6.641e-06	7.1723e-05
NOD-like receptor signaling pathway	80830	155	30	15	9	0.00027463	0.0024717
Epstein-Barr virus infection	80830	155	30	11	7	0.0010041	0.0077456
Necroptosis	80830	155	30	4	4	0.0011848	0.0079976
Kaposi sarcoma-associated herpesvirus infection	80830	155	30	4	3	0.023126	0.11936
PD-L1 expression and PD-1 checkpoint pathway in cancer	80830	155	30	4	3	0.023126	0.11936
Human papillomavirus infection	80830	155	30	10	5	0.024313	0.11936
RNA degradation	80830	155	30	2	2	0.036447	0.12301
Chemokine signaling pathway	80830	155	30	2	2	0.036447	0.12301
RIG-I-like receptor signaling pathway	80830	155	30	2	2	0.036447	0.12301
Cytosolic DNA-sensing pathway	80830	155	30	2	2	0.036447	0.12301
C-type lectin receptor signaling pathway	80830	155	30	2	2	0.036447	0.12301
Hepatitis B	80830	155	30	8	4	0.045913	0.14584
JAK-STAT signaling pathway	80830	155	30	3	2	0.096002	0.28801
Osteoclast differentiation	80830	155	30	4	2	0.16888	0.34839
Glycolysis / Gluconeogenesis	80830	155	30	1	1	0.19355	0.34839
Galactose metabolism	80830	155	30	1	1	0.19355	0.34839
NF-kappa B signaling pathway	80830	155	30	1	1	0.19355	0.34839
Signaling pathways regulating pluripotency of stem cells	80830	155	30	1	1	0.19355	0.34839
Toll-like receptor signaling pathway	80830	155	30	1	1	0.19355	0.34839
Th1 and Th2 cell differentiation	80830	155	30	1	1	0.19355	0.34839
Prolactin signaling pathway	80830	155	30	1	1	0.19355	0.34839
AGE-RAGE signaling pathway in diabetic complications	80830	155	30	1	1	0.19355	0.34839
Growth hormone synthesis, secretion and action	80830	155	30	1	1	0.19355	0.34839
Pertussis	80830	155	30	1	1	0.19355	0.34839
Toxoplasmosis	80830	155	30	1	1	0.19355	0.34839
Viral life cycle - HIV-1	80830	155	30	5	2	0.24803	0.43205
Lysosome	80830	155	30	2	1	0.35065	0.47338
Apoptosis	80830	155	30	2	1	0.35065	0.47338
Apoptosis - multiple species	80830	155	30	2	1	0.35065	0.47338
Notch signaling pathway	80830	155	30	2	1	0.35065	0.47338
Cell adhesion molecules	80830	155	30	2	1	0.35065	0.47338
Complement and coagulation cascades	80830	155	30	2	1	0.35065	0.47338
Th17 cell differentiation	80830	155	30	2	1	0.35065	0.47338
Leishmaniasis	80830	155	30	2	1	0.35065	0.47338
Inflammatory bowel disease	80830	155	30	2	1	0.35065	0.47338
Thyroid hormone signaling pathway	80830	155	30	3	1	0.47797	0.61454
Pancreatic cancer	80830	155	30	3	1	0.47797	0.61454
Pathways in cancer	80830	155	30	9	2	0.54972	0.66754
Pyrimidine metabolism	80830	155	30	4	1	0.581	0.66754
Nucleotide metabolism	80830	155	30	4	1	0.581	0.66754
Biosynthesis of cofactors	80830	155	30	4	1	0.581	0.66754
Tuberculosis	80830	155	30	4	1	0.581	0.66754
Protein processing in endoplasmic reticulum	80830	155	30	6	1	0.7314	0.82282
Human immunodeficiency virus 1 infection	80830	155	30	7	1	0.78548	0.86563
Alzheimer disease	80830	155	30	8	1	0.82896	0.87773
Transcriptional misregulation in cancer	80830	155	30	8	1	0.82896	0.87773
Viral carcinogenesis	80830	155	30	13	1	0.94634	0.98273
Metabolic pathways	80830	155	30	24	2	0.97153	0.98393
Ribosome biogenesis in eukaryotes	80830	155	30	18	1	0.98393	0.98393
RNA degradation	81027	155	18	2	2	0.012819	0.23716
Rap1 signaling pathway	81027	155	18	2	2	0.012819	0.23716
Focal adhesion	81027	155	18	2	2	0.012819	0.23716
Regulation of actin cytoskeleton	81027	155	18	2	2	0.012819	0.23716
Pathways of neurodegeneration - multiple diseases	81027	155	18	7	3	0.034502	0.28645
PI3K-Akt signaling pathway	81027	155	18	3	2	0.035777	0.28645
Gap junction	81027	155	18	3	2	0.035777	0.28645
Thyroid hormone signaling pathway	81027	155	18	3	2	0.035777	0.28645
Alzheimer disease	81027	155	18	8	3	0.051125	0.28645
Phagosome	81027	155	18	5	2	0.10332	0.28645
Glycerolipid metabolism	81027	155	18	1	1	0.11613	0.28645
Glycerophospholipid metabolism	81027	155	18	1	1	0.11613	0.28645
EGFR tyrosine kinase inhibitor resistance	81027	155	18	1	1	0.11613	0.28645
ErbB signaling pathway	81027	155	18	1	1	0.11613	0.28645
Ras signaling pathway	81027	155	18	1	1	0.11613	0.28645
Phospholipase D signaling pathway	81027	155	18	1	1	0.11613	0.28645
mTOR signaling pathway	81027	155	18	1	1	0.11613	0.28645
Axon guidance	81027	155	18	1	1	0.11613	0.28645
Signaling pathways regulating pluripotency of stem cells	81027	155	18	1	1	0.11613	0.28645
Platelet activation	81027	155	18	1	1	0.11613	0.28645
Serotonergic synapse	81027	155	18	1	1	0.11613	0.28645
Insulin signaling pathway	81027	155	18	1	1	0.11613	0.28645
Epithelial cell signaling in Helicobacter pylori infection	81027	155	18	1	1	0.11613	0.28645
Pathogenic Escherichia coli infection	81027	155	18	1	1	0.11613	0.28645
Proteoglycans in cancer	81027	155	18	1	1	0.11613	0.28645
Endometrial cancer	81027	155	18	1	1	0.11613	0.28645
Choline metabolism in cancer	81027	155	18	1	1	0.11613	0.28645
Hypertrophic cardiomyopathy	81027	155	18	1	1	0.11613	0.28645
Arrhythmogenic right ventricular cardiomyopathy	81027	155	18	1	1	0.11613	0.28645
Dilated cardiomyopathy	81027	155	18	1	1	0.11613	0.28645
Parkinson disease	81027	155	18	6	2	0.14433	0.3383
MAPK signaling pathway	81027	155	18	2	1	0.21944	0.3383
Calcium signaling pathway	81027	155	18	2	1	0.21944	0.3383
HIF-1 signaling pathway	81027	155	18	2	1	0.21944	0.3383
Notch signaling pathway	81027	155	18	2	1	0.21944	0.3383
ECM-receptor interaction	81027	155	18	2	1	0.21944	0.3383
Complement and coagulation cascades	81027	155	18	2	1	0.21944	0.3383
Alcoholic liver disease	81027	155	18	2	1	0.21944	0.3383
Salmonella infection	81027	155	18	2	1	0.21944	0.3383
Human cytomegalovirus infection	81027	155	18	2	1	0.21944	0.3383
Colorectal cancer	81027	155	18	2	1	0.21944	0.3383
Glioma	81027	155	18	2	1	0.21944	0.3383
Melanoma	81027	155	18	2	1	0.21944	0.3383
Bladder cancer	81027	155	18	2	1	0.21944	0.3383
Non-small cell lung cancer	81027	155	18	2	1	0.21944	0.3383
Breast cancer	81027	155	18	2	1	0.21944	0.3383
Gastric cancer	81027	155	18	2	1	0.21944	0.3383
Fluid shear stress and atherosclerosis	81027	155	18	2	1	0.21944	0.3383
JAK-STAT signaling pathway	81027	155	18	3	1	0.31127	0.45165
Pancreatic cancer	81027	155	18	3	1	0.31127	0.45165
Prostate cancer	81027	155	18	3	1	0.31127	0.45165
Human papillomavirus infection	81027	155	18	10	2	0.32717	0.46559
Coronavirus disease - COVID-19	81027	155	18	11	2	0.37327	0.46886
FoxO signaling pathway	81027	155	18	4	1	0.39283	0.46886
Ubiquitin mediated proteolysis	81027	155	18	4	1	0.39283	0.46886
Osteoclast differentiation	81027	155	18	4	1	0.39283	0.46886
Amyotrophic lateral sclerosis	81027	155	18	4	1	0.39283	0.46886
Huntington disease	81027	155	18	4	1	0.39283	0.46886
Prion disease	81027	155	18	4	1	0.39283	0.46886
MicroRNAs in cancer	81027	155	18	4	1	0.39283	0.46886
Chemical carcinogenesis - reactive oxygen species	81027	155	18	4	1	0.39283	0.46886
PD-L1 expression and PD-1 checkpoint pathway in cancer	81027	155	18	4	1	0.39283	0.46886
Hematopoietic cell lineage	81027	155	18	5	1	0.46521	0.5379
Chemical carcinogenesis - receptor activation	81027	155	18	5	1	0.46521	0.5379
Protein processing in endoplasmic reticulum	81027	155	18	6	1	0.52938	0.60268
Oocyte meiosis	81027	155	18	7	1	0.58624	0.64748
Progesterone-mediated oocyte maturation	81027	155	18	7	1	0.58624	0.64748
Herpes simplex virus 1 infection	81027	155	18	9	1	0.68106	0.73041
Pathways in cancer	81027	155	18	9	1	0.68106	0.73041
Hepatitis C	81027	155	18	12	1	0.78571	0.8306
Neutrophil extracellular trap formation	81027	155	18	13	1	0.81268	0.84702
NOD-like receptor signaling pathway	81027	155	18	15	1	0.85731	0.88112
Ribosome biogenesis in eukaryotes	81027	155	18	18	1	0.90587	0.91828
Metabolic pathways	81027	155	18	24	1	0.96026	0.96026
Influenza A	81030	155	28	10	10	8.0025e-09	4.3214e-07
Measles	81030	155	28	9	9	6.1493e-08	1.6603e-06
Hepatitis C	81030	155	28	12	10	4.1541e-07	7.4773e-06
Coronavirus disease - COVID-19	81030	155	28	11	9	2.6346e-06	3.5567e-05
Herpes simplex virus 1 infection	81030	155	28	9	8	3.5758e-06	3.8619e-05
NOD-like receptor signaling pathway	81030	155	28	15	9	0.00014436	0.0012992
Epstein-Barr virus infection	81030	155	28	11	7	0.00061664	0.004757
Necroptosis	81030	155	28	4	4	0.00088521	0.0059752
Human papillomavirus infection	81030	155	28	10	5	0.017867	0.10191
Kaposi sarcoma-associated herpesvirus infection	81030	155	28	4	3	0.018873	0.10191
Chemokine signaling pathway	81030	155	28	2	2	0.031672	0.12216
RIG-I-like receptor signaling pathway	81030	155	28	2	2	0.031672	0.12216
Cytosolic DNA-sensing pathway	81030	155	28	2	2	0.031672	0.12216
C-type lectin receptor signaling pathway	81030	155	28	2	2	0.031672	0.12216
Hepatitis B	81030	155	28	8	4	0.035996	0.12958
JAK-STAT signaling pathway	81030	155	28	3	2	0.08425	0.28435
Osteoclast differentiation	81030	155	28	4	2	0.14963	0.34839
PD-L1 expression and PD-1 checkpoint pathway in cancer	81030	155	28	4	2	0.14963	0.34839
Glycolysis / Gluconeogenesis	81030	155	28	1	1	0.18065	0.34839
Galactose metabolism	81030	155	28	1	1	0.18065	0.34839
NF-kappa B signaling pathway	81030	155	28	1	1	0.18065	0.34839
Toll-like receptor signaling pathway	81030	155	28	1	1	0.18065	0.34839
Th1 and Th2 cell differentiation	81030	155	28	1	1	0.18065	0.34839
Prolactin signaling pathway	81030	155	28	1	1	0.18065	0.34839
AGE-RAGE signaling pathway in diabetic complications	81030	155	28	1	1	0.18065	0.34839
Growth hormone synthesis, secretion and action	81030	155	28	1	1	0.18065	0.34839
Pertussis	81030	155	28	1	1	0.18065	0.34839
Toxoplasmosis	81030	155	28	1	1	0.18065	0.34839
Viral life cycle - HIV-1	81030	155	28	5	2	0.22179	0.41299
Lysosome	81030	155	28	2	1	0.32962	0.46841
Apoptosis	81030	155	28	2	1	0.32962	0.46841
Apoptosis - multiple species	81030	155	28	2	1	0.32962	0.46841
Notch signaling pathway	81030	155	28	2	1	0.32962	0.46841
Cell adhesion molecules	81030	155	28	2	1	0.32962	0.46841
Complement and coagulation cascades	81030	155	28	2	1	0.32962	0.46841
Th17 cell differentiation	81030	155	28	2	1	0.32962	0.46841
Leishmaniasis	81030	155	28	2	1	0.32962	0.46841
Inflammatory bowel disease	81030	155	28	2	1	0.32962	0.46841
Thyroid hormone signaling pathway	81030	155	28	3	1	0.4523	0.61061
Pancreatic cancer	81030	155	28	3	1	0.4523	0.61061
Pathways in cancer	81030	155	28	9	2	0.50808	0.66383
Pyrimidine metabolism	81030	155	28	4	1	0.55319	0.66383
Nucleotide metabolism	81030	155	28	4	1	0.55319	0.66383
Biosynthesis of cofactors	81030	155	28	4	1	0.55319	0.66383
Tuberculosis	81030	155	28	4	1	0.55319	0.66383
Protein processing in endoplasmic reticulum	81030	155	28	6	1	0.70398	0.82642
Viral carcinogenesis	81030	155	28	13	2	0.72234	0.82993
Human immunodeficiency virus 1 infection	81030	155	28	7	1	0.75961	0.85245
Alzheimer disease	81030	155	28	8	1	0.80509	0.85245
Alcoholism	81030	155	28	8	1	0.80509	0.85245
Transcriptional misregulation in cancer	81030	155	28	8	1	0.80509	0.85245
Systemic lupus erythematosus	81030	155	28	10	1	0.87248	0.90603
Neutrophil extracellular trap formation	81030	155	28	13	1	0.93334	0.95095
Metabolic pathways	81030	155	28	24	2	0.95985	0.95985
Protein processing in endoplasmic reticulum	81567	155	23	6	4	0.0046442	0.22757
Glutathione metabolism	81567	155	23	2	2	0.021198	0.34624
Intestinal immune network for IgA production	81567	155	23	2	2	0.021198	0.34624
Cell cycle	81567	155	23	14	5	0.037039	0.36355
Cytokine-cytokine receptor interaction	81567	155	23	3	2	0.057775	0.36355
DNA replication	81567	155	23	4	2	0.10506	0.36355
p53 signaling pathway	81567	155	23	4	2	0.10506	0.36355
Purine metabolism	81567	155	23	1	1	0.14839	0.36355
Glycine, serine and threonine metabolism	81567	155	23	1	1	0.14839	0.36355
Glyoxylate and dicarboxylate metabolism	81567	155	23	1	1	0.14839	0.36355
Carbon metabolism	81567	155	23	1	1	0.14839	0.36355
Biosynthesis of nucleotide sugars	81567	155	23	1	1	0.14839	0.36355
Protein export	81567	155	23	1	1	0.14839	0.36355
Base excision repair	81567	155	23	1	1	0.14839	0.36355
Non-homologous end-joining	81567	155	23	1	1	0.14839	0.36355
Estrogen signaling pathway	81567	155	23	1	1	0.14839	0.36355
Thyroid hormone synthesis	81567	155	23	1	1	0.14839	0.36355
Oxytocin signaling pathway	81567	155	23	1	1	0.14839	0.36355
Pancreatic secretion	81567	155	23	1	1	0.14839	0.36355
Primary immunodeficiency	81567	155	23	1	1	0.14839	0.36355
Chemical carcinogenesis - receptor activation	81567	155	23	5	2	0.15934	0.37179
Metabolic pathways	81567	155	23	24	5	0.26796	0.40042
Amino sugar and nucleotide sugar metabolism	81567	155	23	2	1	0.27558	0.40042
Nicotinate and nicotinamide metabolism	81567	155	23	2	1	0.27558	0.40042
Folate biosynthesis	81567	155	23	2	1	0.27558	0.40042
Calcium signaling pathway	81567	155	23	2	1	0.27558	0.40042
IL-17 signaling pathway	81567	155	23	2	1	0.27558	0.40042
Th17 cell differentiation	81567	155	23	2	1	0.27558	0.40042
Salivary secretion	81567	155	23	2	1	0.27558	0.40042
Salmonella infection	81567	155	23	2	1	0.27558	0.40042
Fluid shear stress and atherosclerosis	81567	155	23	2	1	0.27558	0.40042
Oocyte meiosis	81567	155	23	7	2	0.27784	0.40042
Cellular senescence	81567	155	23	7	2	0.27784	0.40042
Progesterone-mediated oocyte maturation	81567	155	23	7	2	0.27784	0.40042
Drug metabolism - other enzymes	81567	155	23	3	1	0.38448	0.48306
Antifolate resistance	81567	155	23	3	1	0.38448	0.48306
PI3K-Akt signaling pathway	81567	155	23	3	1	0.38448	0.48306
Prostate cancer	81567	155	23	3	1	0.38448	0.48306
Lipid and atherosclerosis	81567	155	23	3	1	0.38448	0.48306
Pyrimidine metabolism	81567	155	23	4	1	0.47761	0.54426
Nucleotide metabolism	81567	155	23	4	1	0.47761	0.54426
Biosynthesis of cofactors	81567	155	23	4	1	0.47761	0.54426
FoxO signaling pathway	81567	155	23	4	1	0.47761	0.54426
Viral life cycle - HIV-1	81567	155	23	5	1	0.55718	0.60671
Hematopoietic cell lineage	81567	155	23	5	1	0.55718	0.60671
Parkinson disease	81567	155	23	6	1	0.62508	0.66585
Pathways of neurodegeneration - multiple diseases	81567	155	23	7	1	0.68296	0.69718
Human immunodeficiency virus 1 infection	81567	155	23	7	1	0.68296	0.69718
Pathways in cancer	81567	155	23	9	1	0.77412	0.77412
Protein processing in endoplasmic reticulum	81618	155	23	6	4	0.0046442	0.18476
Cell cycle	81618	155	23	14	6	0.0075412	0.18476
Glutathione metabolism	81618	155	23	2	2	0.021198	0.25968
Intestinal immune network for IgA production	81618	155	23	2	2	0.021198	0.25968
Cytokine-cytokine receptor interaction	81618	155	23	3	2	0.057775	0.3305
Oocyte meiosis	81618	155	23	7	3	0.067311	0.3305
DNA replication	81618	155	23	4	2	0.10506	0.3305
p53 signaling pathway	81618	155	23	4	2	0.10506	0.3305
Purine metabolism	81618	155	23	1	1	0.14839	0.3305
Glycine, serine and threonine metabolism	81618	155	23	1	1	0.14839	0.3305
Glyoxylate and dicarboxylate metabolism	81618	155	23	1	1	0.14839	0.3305
Carbon metabolism	81618	155	23	1	1	0.14839	0.3305
Biosynthesis of nucleotide sugars	81618	155	23	1	1	0.14839	0.3305
Protein export	81618	155	23	1	1	0.14839	0.3305
Base excision repair	81618	155	23	1	1	0.14839	0.3305
Non-homologous end-joining	81618	155	23	1	1	0.14839	0.3305
Fanconi anemia pathway	81618	155	23	1	1	0.14839	0.3305
Estrogen signaling pathway	81618	155	23	1	1	0.14839	0.3305
Thyroid hormone synthesis	81618	155	23	1	1	0.14839	0.3305
Oxytocin signaling pathway	81618	155	23	1	1	0.14839	0.3305
Pancreatic secretion	81618	155	23	1	1	0.14839	0.3305
Primary immunodeficiency	81618	155	23	1	1	0.14839	0.3305
Chemical carcinogenesis - receptor activation	81618	155	23	5	2	0.15934	0.33946
Metabolic pathways	81618	155	23	24	5	0.26796	0.40042
Amino sugar and nucleotide sugar metabolism	81618	155	23	2	1	0.27558	0.40042
Nicotinate and nicotinamide metabolism	81618	155	23	2	1	0.27558	0.40042
Calcium signaling pathway	81618	155	23	2	1	0.27558	0.40042
IL-17 signaling pathway	81618	155	23	2	1	0.27558	0.40042
Th17 cell differentiation	81618	155	23	2	1	0.27558	0.40042
Salivary secretion	81618	155	23	2	1	0.27558	0.40042
Salmonella infection	81618	155	23	2	1	0.27558	0.40042
Fluid shear stress and atherosclerosis	81618	155	23	2	1	0.27558	0.40042
Cellular senescence	81618	155	23	7	2	0.27784	0.40042
Progesterone-mediated oocyte maturation	81618	155	23	7	2	0.27784	0.40042
Drug metabolism - other enzymes	81618	155	23	3	1	0.38448	0.49577
PI3K-Akt signaling pathway	81618	155	23	3	1	0.38448	0.49577
Prostate cancer	81618	155	23	3	1	0.38448	0.49577
Lipid and atherosclerosis	81618	155	23	3	1	0.38448	0.49577
Pyrimidine metabolism	81618	155	23	4	1	0.47761	0.55722
Nucleotide metabolism	81618	155	23	4	1	0.47761	0.55722
FoxO signaling pathway	81618	155	23	4	1	0.47761	0.55722
Ubiquitin mediated proteolysis	81618	155	23	4	1	0.47761	0.55722
Hematopoietic cell lineage	81618	155	23	5	1	0.55718	0.63493
Parkinson disease	81618	155	23	6	1	0.62508	0.69611
Pathways of neurodegeneration - multiple diseases	81618	155	23	7	1	0.68296	0.71202
Human T-cell leukemia virus 1 infection	81618	155	23	7	1	0.68296	0.71202
Human immunodeficiency virus 1 infection	81618	155	23	7	1	0.68296	0.71202
Pathways in cancer	81618	155	23	9	1	0.77412	0.79025
Viral carcinogenesis	81618	155	23	13	1	0.8871	0.8871
Staphylococcus aureus infection	820	155	9	6	4	7.7431e-05	0.0013938
Transcriptional misregulation in cancer	820	155	9	8	4	0.00034225	0.0030802
NOD-like receptor signaling pathway	820	155	9	15	4	0.0054976	0.032986
Phagosome	820	155	9	5	2	0.027484	0.10475
Neutrophil extracellular trap formation	820	155	9	13	3	0.029097	0.10475
Carbohydrate digestion and absorption	820	155	9	1	1	0.058065	0.16967
PPAR signaling pathway	820	155	9	2	1	0.11311	0.16967
Lysosome	820	155	9	2	1	0.11311	0.16967
Renin-angiotensin system	820	155	9	2	1	0.11311	0.16967
IL-17 signaling pathway	820	155	9	2	1	0.11311	0.16967
Salivary secretion	820	155	9	2	1	0.11311	0.16967
Amoebiasis	820	155	9	2	1	0.11311	0.16967
Drug metabolism - other enzymes	820	155	9	3	1	0.16528	0.18594
Neuroactive ligand-receptor interaction	820	155	9	3	1	0.16528	0.18594
Acute myeloid leukemia	820	155	9	3	1	0.16528	0.18594
Lipid and atherosclerosis	820	155	9	3	1	0.16528	0.18594
Tuberculosis	820	155	9	4	1	0.21471	0.22734
Systemic lupus erythematosus	820	155	9	10	1	0.46037	0.46037
Cell cycle	8318	155	27	14	12	4.9715e-09	2.0383e-07
Oocyte meiosis	8318	155	27	7	6	0.00010432	0.0021386
DNA replication	8318	155	27	4	4	0.00075875	0.0077772
p53 signaling pathway	8318	155	27	4	4	0.00075875	0.0077772
Cellular senescence	8318	155	27	7	5	0.0018696	0.012775
Progesterone-mediated oocyte maturation	8318	155	27	7	5	0.0018696	0.012775
Pyrimidine metabolism	8318	155	27	4	3	0.016946	0.081941
Nucleotide metabolism	8318	155	27	4	3	0.016946	0.081941
Human T-cell leukemia virus 1 infection	8318	155	27	7	4	0.017987	0.081941
Platinum drug resistance	8318	155	27	2	2	0.029409	0.12058
Drug metabolism - other enzymes	8318	155	27	3	2	0.078617	0.29303
Human immunodeficiency virus 1 infection	8318	155	27	7	3	0.10193	0.34009
FoxO signaling pathway	8318	155	27	4	2	0.14029	0.34009
Ubiquitin mediated proteolysis	8318	155	27	4	2	0.14029	0.34009
MicroRNAs in cancer	8318	155	27	4	2	0.14029	0.34009
Purine metabolism	8318	155	27	1	1	0.17419	0.34009
Base excision repair	8318	155	27	1	1	0.17419	0.34009
Non-homologous end-joining	8318	155	27	1	1	0.17419	0.34009
Fanconi anemia pathway	8318	155	27	1	1	0.17419	0.34009
Hippo signaling pathway	8318	155	27	1	1	0.17419	0.34009
Carbohydrate digestion and absorption	8318	155	27	1	1	0.17419	0.34009
Chemical carcinogenesis - receptor activation	8318	155	27	5	2	0.2089	0.38932
Protein processing in endoplasmic reticulum	8318	155	27	6	2	0.28038	0.43594
Glutathione metabolism	8318	155	27	2	1	0.31898	0.43594
One carbon pool by folate	8318	155	27	2	1	0.31898	0.43594
MAPK signaling pathway	8318	155	27	2	1	0.31898	0.43594
Apoptosis	8318	155	27	2	1	0.31898	0.43594
Apoptosis - multiple species	8318	155	27	2	1	0.31898	0.43594
ECM-receptor interaction	8318	155	27	2	1	0.31898	0.43594
Colorectal cancer	8318	155	27	2	1	0.31898	0.43594
Viral carcinogenesis	8318	155	27	13	3	0.40196	0.50015
Hepatitis B	8318	155	27	8	2	0.42096	0.50015
Antifolate resistance	8318	155	27	3	1	0.43916	0.50015
AMPK signaling pathway	8318	155	27	3	1	0.43916	0.50015
Gap junction	8318	155	27	3	1	0.43916	0.50015
Acute myeloid leukemia	8318	155	27	3	1	0.43916	0.50015
Pathways in cancer	8318	155	27	9	2	0.4866	0.53921
Transcriptional misregulation in cancer	8318	155	27	8	1	0.7921	0.85463
Metabolic pathways	8318	155	27	24	3	0.8372	0.88014
Human papillomavirus infection	8318	155	27	10	1	0.86167	0.88321
Epstein-Barr virus infection	8318	155	27	11	1	0.88743	0.88743
Alcoholism	8339	155	8	8	8	1.4542e-13	5.8167e-13
Systemic lupus erythematosus	8339	155	8	10	8	6.5438e-12	1.3088e-11
Neutrophil extracellular trap formation	8339	155	8	13	8	1.8715e-10	1.8715e-10
Viral carcinogenesis	8339	155	8	13	8	1.8715e-10	1.8715e-10
Alcoholism	8343	155	11	8	5	3.344e-05	0.00040575
Viral carcinogenesis	8343	155	11	13	6	3.6887e-05	0.00040575
Systemic lupus erythematosus	8343	155	11	10	5	0.00014045	0.00103
Neutrophil extracellular trap formation	8343	155	11	13	5	0.00064602	0.0035531
RNA degradation	8343	155	11	2	2	0.0046083	0.020276
Protein processing in endoplasmic reticulum	8343	155	11	6	2	0.058908	0.17348
ABC transporters	8343	155	11	1	1	0.070968	0.17348
Signaling pathways regulating pluripotency of stem cells	8343	155	11	1	1	0.070968	0.17348
Fat digestion and absorption	8343	155	11	1	1	0.070968	0.17348
Cholesterol metabolism	8343	155	11	2	1	0.13733	0.30212
Lipid and atherosclerosis	8343	155	11	3	1	0.19935	0.3987
Necroptosis	8343	155	11	4	1	0.25729	0.43542
Kaposi sarcoma-associated herpesvirus infection	8343	155	11	4	1	0.25729	0.43542
Alzheimer disease	8343	155	11	8	1	0.45293	0.62425
Measles	8343	155	11	9	1	0.49386	0.62425
Herpes simplex virus 1 infection	8343	155	11	9	1	0.49386	0.62425
Influenza A	8343	155	11	10	1	0.532	0.62425
Human papillomavirus infection	8343	155	11	10	1	0.532	0.62425
Epstein-Barr virus infection	8343	155	11	11	1	0.5675	0.62425
Coronavirus disease - COVID-19	8343	155	11	11	1	0.5675	0.62425
Hepatitis C	8343	155	11	12	1	0.60054	0.62914
Ribosome biogenesis in eukaryotes	8343	155	11	18	1	0.75509	0.75509
Alcoholism	8345	155	5	8	5	8.0169e-08	3.2067e-07
Systemic lupus erythematosus	8345	155	5	10	5	3.6076e-07	7.2152e-07
Neutrophil extracellular trap formation	8345	155	5	13	5	1.8424e-06	1.8424e-06
Viral carcinogenesis	8345	155	5	13	5	1.8424e-06	1.8424e-06
Alcoholism	8347	155	12	8	5	5.6339e-05	0.00091945
Viral carcinogenesis	8347	155	12	13	6	7.0727e-05	0.00091945
Systemic lupus erythematosus	8347	155	12	10	5	0.00023389	0.002027
Neutrophil extracellular trap formation	8347	155	12	13	5	0.0010569	0.0068701
RNA degradation	8347	155	12	2	2	0.00553	0.028756
ABC transporters	8347	155	12	1	1	0.077419	0.28756
Fat digestion and absorption	8347	155	12	1	1	0.077419	0.28756
Notch signaling pathway	8347	155	12	2	1	0.14931	0.43134
Cholesterol metabolism	8347	155	12	2	1	0.14931	0.43134
Lipid and atherosclerosis	8347	155	12	3	1	0.21603	0.56168
Necroptosis	8347	155	12	4	1	0.27792	0.60216
Kaposi sarcoma-associated herpesvirus infection	8347	155	12	4	1	0.27792	0.60216
Viral life cycle - HIV-1	8347	155	12	5	1	0.33531	0.65059
Protein processing in endoplasmic reticulum	8347	155	12	6	1	0.38848	0.65059
Parkinson disease	8347	155	12	6	1	0.38848	0.65059
Pathways of neurodegeneration - multiple diseases	8347	155	12	7	1	0.43773	0.65059
Human immunodeficiency virus 1 infection	8347	155	12	7	1	0.43773	0.65059
Alzheimer disease	8347	155	12	8	1	0.48332	0.65059
Measles	8347	155	12	9	1	0.5255	0.65059
Herpes simplex virus 1 infection	8347	155	12	9	1	0.5255	0.65059
Influenza A	8347	155	12	10	1	0.5645	0.65059
Human papillomavirus infection	8347	155	12	10	1	0.5645	0.65059
Epstein-Barr virus infection	8347	155	12	11	1	0.60054	0.65059
Coronavirus disease - COVID-19	8347	155	12	11	1	0.60054	0.65059
Hepatitis C	8347	155	12	12	1	0.63383	0.65918
Ribosome biogenesis in eukaryotes	8347	155	12	18	1	0.78571	0.78571
Alcoholism	8348	155	5	8	5	8.0169e-08	3.2067e-07
Systemic lupus erythematosus	8348	155	5	10	5	3.6076e-07	7.2152e-07
Neutrophil extracellular trap formation	8348	155	5	13	5	1.8424e-06	1.8424e-06
Viral carcinogenesis	8348	155	5	13	5	1.8424e-06	1.8424e-06
Cell cycle	83540	155	23	14	12	4.0917e-10	1.5958e-08
Oocyte meiosis	83540	155	23	7	6	3.6507e-05	0.00071188
DNA replication	83540	155	23	4	4	0.00038284	0.0037326
p53 signaling pathway	83540	155	23	4	4	0.00038284	0.0037326
Cellular senescence	83540	155	23	7	5	0.00081917	0.0053246
Progesterone-mediated oocyte maturation	83540	155	23	7	5	0.00081917	0.0053246
Human T-cell leukemia virus 1 infection	83540	155	23	7	4	0.0097443	0.05429
Platinum drug resistance	83540	155	23	2	2	0.021198	0.10334
Human immunodeficiency virus 1 infection	83540	155	23	7	3	0.067311	0.29168
Pyrimidine metabolism	83540	155	23	4	2	0.10506	0.29267
Nucleotide metabolism	83540	155	23	4	2	0.10506	0.29267
FoxO signaling pathway	83540	155	23	4	2	0.10506	0.29267
Ubiquitin mediated proteolysis	83540	155	23	4	2	0.10506	0.29267
MicroRNAs in cancer	83540	155	23	4	2	0.10506	0.29267
Purine metabolism	83540	155	23	1	1	0.14839	0.30458
Base excision repair	83540	155	23	1	1	0.14839	0.30458
Non-homologous end-joining	83540	155	23	1	1	0.14839	0.30458
Fanconi anemia pathway	83540	155	23	1	1	0.14839	0.30458
Hippo signaling pathway	83540	155	23	1	1	0.14839	0.30458
Chemical carcinogenesis - receptor activation	83540	155	23	5	2	0.15934	0.31071
Glutathione metabolism	83540	155	23	2	1	0.27558	0.39805
One carbon pool by folate	83540	155	23	2	1	0.27558	0.39805
MAPK signaling pathway	83540	155	23	2	1	0.27558	0.39805
Apoptosis	83540	155	23	2	1	0.27558	0.39805
Apoptosis - multiple species	83540	155	23	2	1	0.27558	0.39805
ECM-receptor interaction	83540	155	23	2	1	0.27558	0.39805
Colorectal cancer	83540	155	23	2	1	0.27558	0.39805
Viral carcinogenesis	83540	155	23	13	3	0.29892	0.41636
Hepatitis B	83540	155	23	8	2	0.33806	0.44102
Drug metabolism - other enzymes	83540	155	23	3	1	0.38448	0.44102
Antifolate resistance	83540	155	23	3	1	0.38448	0.44102
AMPK signaling pathway	83540	155	23	3	1	0.38448	0.44102
Gap junction	83540	155	23	3	1	0.38448	0.44102
Acute myeloid leukemia	83540	155	23	3	1	0.38448	0.44102
Pathways in cancer	83540	155	23	9	2	0.39705	0.44243
Transcriptional misregulation in cancer	83540	155	23	8	1	0.73223	0.79324
Human papillomavirus infection	83540	155	23	10	1	0.80971	0.85347
Epstein-Barr virus infection	83540	155	23	11	1	0.83989	0.86199
Metabolic pathways	83540	155	23	24	2	0.90944	0.90944
Alcoholism	8365	155	8	8	8	1.4542e-13	5.8167e-13
Systemic lupus erythematosus	8365	155	8	10	8	6.5438e-12	1.3088e-11
Neutrophil extracellular trap formation	8365	155	8	13	8	1.8715e-10	1.8715e-10
Viral carcinogenesis	8365	155	8	13	8	1.8715e-10	1.8715e-10
Influenza A	83666	155	34	10	10	7.9962e-08	4.8777e-06
Measles	83666	155	34	9	9	4.6698e-07	1.4243e-05
Hepatitis C	83666	155	34	12	10	3.8056e-06	7.738e-05
Coronavirus disease - COVID-19	83666	155	34	11	9	1.8363e-05	0.00024432
Herpes simplex virus 1 infection	83666	155	34	9	8	2.0026e-05	0.00024432
NOD-like receptor signaling pathway	83666	155	34	15	9	0.00084635	0.0086046
Necroptosis	83666	155	34	4	4	0.002005	0.017472
Epstein-Barr virus infection	83666	155	34	11	7	0.0023745	0.018105
Kaposi sarcoma-associated herpesvirus infection	83666	155	34	4	3	0.033309	0.17921
PD-L1 expression and PD-1 checkpoint pathway in cancer	83666	155	34	4	3	0.033309	0.17921
Human papillomavirus infection	83666	155	34	10	5	0.041728	0.17921
RNA degradation	83666	155	34	2	2	0.047005	0.17921
Chemokine signaling pathway	83666	155	34	2	2	0.047005	0.17921
RIG-I-like receptor signaling pathway	83666	155	34	2	2	0.047005	0.17921
Cytosolic DNA-sensing pathway	83666	155	34	2	2	0.047005	0.17921
C-type lectin receptor signaling pathway	83666	155	34	2	2	0.047005	0.17921
Hepatitis B	83666	155	34	8	4	0.070462	0.23934
Viral life cycle - HIV-1	83666	155	34	5	3	0.070625	0.23934
JAK-STAT signaling pathway	83666	155	34	3	2	0.12135	0.3896
Osteoclast differentiation	83666	155	34	4	2	0.20939	0.39355
Tuberculosis	83666	155	34	4	2	0.20939	0.39355
Mucin type O-glycan biosynthesis	83666	155	34	1	1	0.21935	0.39355
Sphingolipid metabolism	83666	155	34	1	1	0.21935	0.39355
ABC transporters	83666	155	34	1	1	0.21935	0.39355
NF-kappa B signaling pathway	83666	155	34	1	1	0.21935	0.39355
Signaling pathways regulating pluripotency of stem cells	83666	155	34	1	1	0.21935	0.39355
Toll-like receptor signaling pathway	83666	155	34	1	1	0.21935	0.39355
Th1 and Th2 cell differentiation	83666	155	34	1	1	0.21935	0.39355
Neurotrophin signaling pathway	83666	155	34	1	1	0.21935	0.39355
Prolactin signaling pathway	83666	155	34	1	1	0.21935	0.39355
AGE-RAGE signaling pathway in diabetic complications	83666	155	34	1	1	0.21935	0.39355
Growth hormone synthesis, secretion and action	83666	155	34	1	1	0.21935	0.39355
Fat digestion and absorption	83666	155	34	1	1	0.21935	0.39355
Toxoplasmosis	83666	155	34	1	1	0.21935	0.39355
Lysosome	83666	155	34	2	1	0.39171	0.58278
Notch signaling pathway	83666	155	34	2	1	0.39171	0.58278
Cell adhesion molecules	83666	155	34	2	1	0.39171	0.58278
Th17 cell differentiation	83666	155	34	2	1	0.39171	0.58278
Cholesterol metabolism	83666	155	34	2	1	0.39171	0.58278
Leishmaniasis	83666	155	34	2	1	0.39171	0.58278
Inflammatory bowel disease	83666	155	34	2	1	0.39171	0.58278
Human immunodeficiency virus 1 infection	83666	155	34	7	2	0.4786	0.69511
Thyroid hormone signaling pathway	83666	155	34	3	1	0.52688	0.71422
Pancreatic cancer	83666	155	34	3	1	0.52688	0.71422
Lipid and atherosclerosis	83666	155	34	3	1	0.52688	0.71422
Alcoholism	83666	155	34	8	2	0.55698	0.73861
Viral carcinogenesis	83666	155	34	13	3	0.57513	0.74645
Pathways in cancer	83666	155	34	9	2	0.62706	0.75677
Pyrimidine metabolism	83666	155	34	4	1	0.63271	0.75677
Nucleotide metabolism	83666	155	34	4	1	0.63271	0.75677
Biosynthesis of cofactors	83666	155	34	4	1	0.63271	0.75677
Systemic lupus erythematosus	83666	155	34	10	2	0.68862	0.80781
Protein processing in endoplasmic reticulum	83666	155	34	6	1	0.77992	0.87308
Parkinson disease	83666	155	34	6	1	0.77992	0.87308
Neutrophil extracellular trap formation	83666	155	34	13	2	0.82615	0.87308
Oocyte meiosis	83666	155	34	7	1	0.83014	0.87308
Progesterone-mediated oocyte maturation	83666	155	34	7	1	0.83014	0.87308
Pathways of neurodegeneration - multiple diseases	83666	155	34	7	1	0.83014	0.87308
Alzheimer disease	83666	155	34	8	1	0.86916	0.89862
Metabolic pathways	83666	155	34	24	2	0.98612	0.99144
Ribosome biogenesis in eukaryotes	83666	155	34	18	1	0.99144	0.99144
Cell cycle	84057	155	20	14	9	2.0989e-06	8.1857e-05
p53 signaling pathway	84057	155	20	4	4	0.00020947	0.0040846
Oocyte meiosis	84057	155	20	7	5	0.00039155	0.0050901
Cellular senescence	84057	155	20	7	4	0.0056182	0.02974
Progesterone-mediated oocyte maturation	84057	155	20	7	4	0.0056182	0.02974
Human T-cell leukemia virus 1 infection	84057	155	20	7	4	0.0056182	0.02974
Pyrimidine metabolism	84057	155	20	4	3	0.0068632	0.02974
Nucleotide metabolism	84057	155	20	4	3	0.0068632	0.02974
DNA replication	84057	155	20	4	3	0.0068632	0.02974
Platinum drug resistance	84057	155	20	2	2	0.01592	0.062086
Drug metabolism - other enzymes	84057	155	20	3	2	0.044013	0.15015
Human immunodeficiency virus 1 infection	84057	155	20	7	3	0.046201	0.15015
FoxO signaling pathway	84057	155	20	4	2	0.081163	0.21102
Ubiquitin mediated proteolysis	84057	155	20	4	2	0.081163	0.21102
MicroRNAs in cancer	84057	155	20	4	2	0.081163	0.21102
Purine metabolism	84057	155	20	1	1	0.12903	0.25161
Base excision repair	84057	155	20	1	1	0.12903	0.25161
Non-homologous end-joining	84057	155	20	1	1	0.12903	0.25161
Fanconi anemia pathway	84057	155	20	1	1	0.12903	0.25161
Hippo signaling pathway	84057	155	20	1	1	0.12903	0.25161
Viral carcinogenesis	84057	155	20	13	3	0.22454	0.33727
Glutathione metabolism	84057	155	20	2	1	0.24214	0.33727
One carbon pool by folate	84057	155	20	2	1	0.24214	0.33727
MAPK signaling pathway	84057	155	20	2	1	0.24214	0.33727
Apoptosis	84057	155	20	2	1	0.24214	0.33727
Apoptosis - multiple species	84057	155	20	2	1	0.24214	0.33727
ECM-receptor interaction	84057	155	20	2	1	0.24214	0.33727
Colorectal cancer	84057	155	20	2	1	0.24214	0.33727
Hepatitis B	84057	155	20	8	2	0.2753	0.37023
Pathways in cancer	84057	155	20	9	2	0.32734	0.39139
Antifolate resistance	84057	155	20	3	1	0.34121	0.39139
AMPK signaling pathway	84057	155	20	3	1	0.34121	0.39139
Gap junction	84057	155	20	3	1	0.34121	0.39139
Acute myeloid leukemia	84057	155	20	3	1	0.34121	0.39139
Chemical carcinogenesis - receptor activation	84057	155	20	5	1	0.50367	0.56123
Metabolic pathways	84057	155	20	24	3	0.6336	0.6864
Transcriptional misregulation in cancer	84057	155	20	8	1	0.67791	0.71456
Human papillomavirus infection	84057	155	20	10	1	0.75985	0.77985
Epstein-Barr virus infection	84057	155	20	11	1	0.79298	0.79298
Rap1 signaling pathway	84174	155	7	2	2	0.0017595	0.035777
Focal adhesion	84174	155	7	2	2	0.0017595	0.035777
Regulation of actin cytoskeleton	84174	155	7	2	2	0.0017595	0.035777
PI3K-Akt signaling pathway	84174	155	7	3	2	0.0051636	0.062996
Gap junction	84174	155	7	3	2	0.0051636	0.062996
Phagosome	84174	155	7	5	2	0.016468	0.13774
EGFR tyrosine kinase inhibitor resistance	84174	155	7	1	1	0.045161	0.13774
ErbB signaling pathway	84174	155	7	1	1	0.045161	0.13774
Ras signaling pathway	84174	155	7	1	1	0.045161	0.13774
Phospholipase D signaling pathway	84174	155	7	1	1	0.045161	0.13774
Axon guidance	84174	155	7	1	1	0.045161	0.13774
Platelet activation	84174	155	7	1	1	0.045161	0.13774
Insulin signaling pathway	84174	155	7	1	1	0.045161	0.13774
Pathogenic Escherichia coli infection	84174	155	7	1	1	0.045161	0.13774
Proteoglycans in cancer	84174	155	7	1	1	0.045161	0.13774
Endometrial cancer	84174	155	7	1	1	0.045161	0.13774
Choline metabolism in cancer	84174	155	7	1	1	0.045161	0.13774
Hypertrophic cardiomyopathy	84174	155	7	1	1	0.045161	0.13774
Arrhythmogenic right ventricular cardiomyopathy	84174	155	7	1	1	0.045161	0.13774
Dilated cardiomyopathy	84174	155	7	1	1	0.045161	0.13774
Human papillomavirus infection	84174	155	7	10	2	0.066302	0.15007
MAPK signaling pathway	84174	155	7	2	1	0.088563	0.15007
Calcium signaling pathway	84174	155	7	2	1	0.088563	0.15007
HIF-1 signaling pathway	84174	155	7	2	1	0.088563	0.15007
ECM-receptor interaction	84174	155	7	2	1	0.088563	0.15007
Complement and coagulation cascades	84174	155	7	2	1	0.088563	0.15007
Salmonella infection	84174	155	7	2	1	0.088563	0.15007
Human cytomegalovirus infection	84174	155	7	2	1	0.088563	0.15007
Colorectal cancer	84174	155	7	2	1	0.088563	0.15007
Glioma	84174	155	7	2	1	0.088563	0.15007
Melanoma	84174	155	7	2	1	0.088563	0.15007
Bladder cancer	84174	155	7	2	1	0.088563	0.15007
Non-small cell lung cancer	84174	155	7	2	1	0.088563	0.15007
Breast cancer	84174	155	7	2	1	0.088563	0.15007
Gastric cancer	84174	155	7	2	1	0.088563	0.15007
Fluid shear stress and atherosclerosis	84174	155	7	2	1	0.088563	0.15007
Neutrophil extracellular trap formation	84174	155	7	13	2	0.10745	0.17714
JAK-STAT signaling pathway	84174	155	7	3	1	0.13026	0.19381
Thyroid hormone signaling pathway	84174	155	7	3	1	0.13026	0.19381
Pancreatic cancer	84174	155	7	3	1	0.13026	0.19381
Prostate cancer	84174	155	7	3	1	0.13026	0.19381
FoxO signaling pathway	84174	155	7	4	1	0.17032	0.21203
Osteoclast differentiation	84174	155	7	4	1	0.17032	0.21203
Amyotrophic lateral sclerosis	84174	155	7	4	1	0.17032	0.21203
Huntington disease	84174	155	7	4	1	0.17032	0.21203
Prion disease	84174	155	7	4	1	0.17032	0.21203
MicroRNAs in cancer	84174	155	7	4	1	0.17032	0.21203
Chemical carcinogenesis - reactive oxygen species	84174	155	7	4	1	0.17032	0.21203
PD-L1 expression and PD-1 checkpoint pathway in cancer	84174	155	7	4	1	0.17032	0.21203
Hematopoietic cell lineage	84174	155	7	5	1	0.20878	0.24972
Chemical carcinogenesis - receptor activation	84174	155	7	5	1	0.20878	0.24972
Parkinson disease	84174	155	7	6	1	0.2457	0.28823
Pathways of neurodegeneration - multiple diseases	84174	155	7	7	1	0.28114	0.32358
Alzheimer disease	84174	155	7	8	1	0.31514	0.34952
Alcoholism	84174	155	7	8	1	0.31514	0.34952
Herpes simplex virus 1 infection	84174	155	7	9	1	0.34775	0.37216
Pathways in cancer	84174	155	7	9	1	0.34775	0.37216
Systemic lupus erythematosus	84174	155	7	10	1	0.37902	0.39863
Coronavirus disease - COVID-19	84174	155	7	11	1	0.409	0.42287
Hepatitis C	84174	155	7	12	1	0.43773	0.44503
Viral carcinogenesis	84174	155	7	13	1	0.46525	0.46525
Measles	84333	155	25	9	7	3.7156e-05	0.0011332
Herpes simplex virus 1 infection	84333	155	25	9	7	3.7156e-05	0.0011332
Influenza A	84333	155	25	10	7	0.00011057	0.0022482
Coronavirus disease - COVID-19	84333	155	25	11	7	0.00027131	0.0041374
NOD-like receptor signaling pathway	84333	155	25	15	8	0.00046839	0.0057144
Epstein-Barr virus infection	84333	155	25	11	6	0.0026164	0.026601
Hepatitis C	84333	155	25	12	6	0.0046522	0.04054
Necroptosis	84333	155	25	4	3	0.013474	0.091323
Kaposi sarcoma-associated herpesvirus infection	84333	155	25	4	3	0.013474	0.091323
Hepatitis B	84333	155	25	8	4	0.023884	0.10222
RNA degradation	84333	155	25	2	2	0.025136	0.10222
Chemokine signaling pathway	84333	155	25	2	2	0.025136	0.10222
RIG-I-like receptor signaling pathway	84333	155	25	2	2	0.025136	0.10222
C-type lectin receptor signaling pathway	84333	155	25	2	2	0.025136	0.10222
Cholesterol metabolism	84333	155	25	2	2	0.025136	0.10222
JAK-STAT signaling pathway	84333	155	25	3	2	0.067851	0.24347
Thyroid hormone signaling pathway	84333	155	25	3	2	0.067851	0.24347
Osteoclast differentiation	84333	155	25	4	2	0.12223	0.33927
ABC transporters	84333	155	25	1	1	0.16129	0.33927
NF-kappa B signaling pathway	84333	155	25	1	1	0.16129	0.33927
Signaling pathways regulating pluripotency of stem cells	84333	155	25	1	1	0.16129	0.33927
Toll-like receptor signaling pathway	84333	155	25	1	1	0.16129	0.33927
Th1 and Th2 cell differentiation	84333	155	25	1	1	0.16129	0.33927
Prolactin signaling pathway	84333	155	25	1	1	0.16129	0.33927
AGE-RAGE signaling pathway in diabetic complications	84333	155	25	1	1	0.16129	0.33927
Growth hormone synthesis, secretion and action	84333	155	25	1	1	0.16129	0.33927
Fat digestion and absorption	84333	155	25	1	1	0.16129	0.33927
Pathogenic Escherichia coli infection	84333	155	25	1	1	0.16129	0.33927
Toxoplasmosis	84333	155	25	1	1	0.16129	0.33927
Human papillomavirus infection	84333	155	25	10	3	0.20477	0.41637
Protein processing in endoplasmic reticulum	84333	155	25	6	2	0.24873	0.46523
Parkinson disease	84333	155	25	6	2	0.24873	0.46523
Lysosome	84333	155	25	2	1	0.29744	0.46523
Notch signaling pathway	84333	155	25	2	1	0.29744	0.46523
Cytosolic DNA-sensing pathway	84333	155	25	2	1	0.29744	0.46523
Th17 cell differentiation	84333	155	25	2	1	0.29744	0.46523
Salmonella infection	84333	155	25	2	1	0.29744	0.46523
Leishmaniasis	84333	155	25	2	1	0.29744	0.46523
Inflammatory bowel disease	84333	155	25	2	1	0.29744	0.46523
Pathways of neurodegeneration - multiple diseases	84333	155	25	7	2	0.31474	0.47998
Alzheimer disease	84333	155	25	8	2	0.37978	0.55882
Neuroactive ligand-receptor interaction	84333	155	25	3	1	0.41224	0.55882
Gap junction	84333	155	25	3	1	0.41224	0.55882
Pancreatic cancer	84333	155	25	3	1	0.41224	0.55882
Lipid and atherosclerosis	84333	155	25	3	1	0.41224	0.55882
Pathways in cancer	84333	155	25	9	2	0.44248	0.58676
Ubiquitin mediated proteolysis	84333	155	25	4	1	0.50891	0.59699
Amyotrophic lateral sclerosis	84333	155	25	4	1	0.50891	0.59699
Huntington disease	84333	155	25	4	1	0.50891	0.59699
Prion disease	84333	155	25	4	1	0.50891	0.59699
Tuberculosis	84333	155	25	4	1	0.50891	0.59699
PD-L1 expression and PD-1 checkpoint pathway in cancer	84333	155	25	4	1	0.50891	0.59699
Viral life cycle - HIV-1	84333	155	25	5	1	0.59022	0.66673
Phagosome	84333	155	25	5	1	0.59022	0.66673
Viral carcinogenesis	84333	155	25	13	2	0.65582	0.72736
Human T-cell leukemia virus 1 infection	84333	155	25	7	1	0.71581	0.76604
Human immunodeficiency virus 1 infection	84333	155	25	7	1	0.71581	0.76604
Alcoholism	84333	155	25	8	1	0.76382	0.80332
Systemic lupus erythematosus	84333	155	25	10	1	0.83755	0.86594
Neutrophil extracellular trap formation	84333	155	25	13	1	0.90832	0.92346
Ribosome biogenesis in eukaryotes	84333	155	25	18	1	0.96572	0.96572
Viral protein interaction with cytokine and cytokine receptor	8460	155	2	1	1	0.012903	0.032258
TNF signaling pathway	8460	155	2	1	1	0.012903	0.032258
Inflammatory bowel disease	8460	155	2	2	1	0.025723	0.042871
Cytokine-cytokine receptor interaction	8460	155	2	3	1	0.038458	0.048073
Epstein-Barr virus infection	8460	155	2	11	1	0.13733	0.13733
Influenza A	85363	155	29	10	10	1.2214e-08	6.84e-07
Measles	85363	155	29	9	9	8.9165e-08	2.4966e-06
Hepatitis C	85363	155	29	12	10	6.2509e-07	1.1668e-05
Coronavirus disease - COVID-19	85363	155	29	11	9	3.7669e-06	5.2736e-05
Herpes simplex virus 1 infection	85363	155	29	9	8	4.9041e-06	5.4925e-05
NOD-like receptor signaling pathway	85363	155	29	15	9	0.00020063	0.0018725
Epstein-Barr virus infection	85363	155	29	11	7	0.00079109	0.0063287
Necroptosis	85363	155	29	4	4	0.0010268	0.0071879
Human papillomavirus infection	85363	155	29	10	5	0.020916	0.11722
Kaposi sarcoma-associated herpesvirus infection	85363	155	29	4	3	0.020932	0.11722
RNA degradation	85363	155	29	2	2	0.034018	0.127
Chemokine signaling pathway	85363	155	29	2	2	0.034018	0.127
RIG-I-like receptor signaling pathway	85363	155	29	2	2	0.034018	0.127
Cytosolic DNA-sensing pathway	85363	155	29	2	2	0.034018	0.127
C-type lectin receptor signaling pathway	85363	155	29	2	2	0.034018	0.127
Hepatitis B	85363	155	29	8	4	0.040764	0.14267
JAK-STAT signaling pathway	85363	155	29	3	2	0.090047	0.29662
Osteoclast differentiation	85363	155	29	4	2	0.15916	0.32742
Tuberculosis	85363	155	29	4	2	0.15916	0.32742
Glycolysis / Gluconeogenesis	85363	155	29	1	1	0.1871	0.32742
Galactose metabolism	85363	155	29	1	1	0.1871	0.32742
ABC transporters	85363	155	29	1	1	0.1871	0.32742
NF-kappa B signaling pathway	85363	155	29	1	1	0.1871	0.32742
Signaling pathways regulating pluripotency of stem cells	85363	155	29	1	1	0.1871	0.32742
Toll-like receptor signaling pathway	85363	155	29	1	1	0.1871	0.32742
Th1 and Th2 cell differentiation	85363	155	29	1	1	0.1871	0.32742
Neurotrophin signaling pathway	85363	155	29	1	1	0.1871	0.32742
Prolactin signaling pathway	85363	155	29	1	1	0.1871	0.32742
AGE-RAGE signaling pathway in diabetic complications	85363	155	29	1	1	0.1871	0.32742
Growth hormone synthesis, secretion and action	85363	155	29	1	1	0.1871	0.32742
Fat digestion and absorption	85363	155	29	1	1	0.1871	0.32742
Toxoplasmosis	85363	155	29	1	1	0.1871	0.32742
Viral life cycle - HIV-1	85363	155	29	5	2	0.23484	0.39851
Lysosome	85363	155	29	2	1	0.34018	0.48846
Notch signaling pathway	85363	155	29	2	1	0.34018	0.48846
Th17 cell differentiation	85363	155	29	2	1	0.34018	0.48846
Cholesterol metabolism	85363	155	29	2	1	0.34018	0.48846
Leishmaniasis	85363	155	29	2	1	0.34018	0.48846
Inflammatory bowel disease	85363	155	29	2	1	0.34018	0.48846
Viral carcinogenesis	85363	155	29	13	3	0.4532	0.59212
Alcoholism	85363	155	29	8	2	0.46131	0.59212
Thyroid hormone signaling pathway	85363	155	29	3	1	0.46524	0.59212
Pancreatic cancer	85363	155	29	3	1	0.46524	0.59212
Lipid and atherosclerosis	85363	155	29	3	1	0.46524	0.59212
Pathways in cancer	85363	155	29	9	2	0.52913	0.64831
Pyrimidine metabolism	85363	155	29	4	1	0.56727	0.64831
Nucleotide metabolism	85363	155	29	4	1	0.56727	0.64831
Biosynthesis of cofactors	85363	155	29	4	1	0.56727	0.64831
PD-L1 expression and PD-1 checkpoint pathway in cancer	85363	155	29	4	1	0.56727	0.64831
Systemic lupus erythematosus	85363	155	29	10	2	0.59132	0.66228
Protein processing in endoplasmic reticulum	85363	155	29	6	1	0.71797	0.78836
Neutrophil extracellular trap formation	85363	155	29	13	2	0.74228	0.79938
Human immunodeficiency virus 1 infection	85363	155	29	7	1	0.77286	0.81661
Alzheimer disease	85363	155	29	8	1	0.81737	0.84764
Metabolic pathways	85363	155	29	24	2	0.96614	0.98126
Ribosome biogenesis in eukaryotes	85363	155	29	18	1	0.98126	0.98126
Influenza A	8638	155	25	10	10	1.9933e-09	1.0564e-07
Measles	8638	155	25	9	9	1.8189e-08	4.82e-07
Hepatitis C	8638	155	25	12	10	1.0792e-07	1.9065e-06
Coronavirus disease - COVID-19	8638	155	25	11	9	8.1233e-07	1.0763e-05
Herpes simplex virus 1 infection	8638	155	25	9	8	1.27e-06	1.3462e-05
Epstein-Barr virus infection	8638	155	25	11	7	0.00027131	0.0023965
Necroptosis	8638	155	25	4	4	0.00054691	0.0041409
NOD-like receptor signaling pathway	8638	155	25	15	7	0.0033382	0.022116
Human papillomavirus infection	8638	155	25	10	5	0.010611	0.062488
Kaposi sarcoma-associated herpesvirus infection	8638	155	25	4	3	0.013474	0.071411
Hepatitis B	8638	155	25	8	4	0.023884	0.088814
Chemokine signaling pathway	8638	155	25	2	2	0.025136	0.088814
RIG-I-like receptor signaling pathway	8638	155	25	2	2	0.025136	0.088814
Cytosolic DNA-sensing pathway	8638	155	25	2	2	0.025136	0.088814
C-type lectin receptor signaling pathway	8638	155	25	2	2	0.025136	0.088814
JAK-STAT signaling pathway	8638	155	25	3	2	0.067851	0.22476
Osteoclast differentiation	8638	155	25	4	2	0.12223	0.3053
PD-L1 expression and PD-1 checkpoint pathway in cancer	8638	155	25	4	2	0.12223	0.3053
Glycolysis / Gluconeogenesis	8638	155	25	1	1	0.16129	0.3053
Galactose metabolism	8638	155	25	1	1	0.16129	0.3053
NF-kappa B signaling pathway	8638	155	25	1	1	0.16129	0.3053
Toll-like receptor signaling pathway	8638	155	25	1	1	0.16129	0.3053
Th1 and Th2 cell differentiation	8638	155	25	1	1	0.16129	0.3053
Prolactin signaling pathway	8638	155	25	1	1	0.16129	0.3053
AGE-RAGE signaling pathway in diabetic complications	8638	155	25	1	1	0.16129	0.3053
Growth hormone synthesis, secretion and action	8638	155	25	1	1	0.16129	0.3053
Pertussis	8638	155	25	1	1	0.16129	0.3053
Toxoplasmosis	8638	155	25	1	1	0.16129	0.3053
Viral life cycle - HIV-1	8638	155	25	5	2	0.18369	0.33571
Apoptosis	8638	155	25	2	1	0.29744	0.42607
Apoptosis - multiple species	8638	155	25	2	1	0.29744	0.42607
Notch signaling pathway	8638	155	25	2	1	0.29744	0.42607
Cell adhesion molecules	8638	155	25	2	1	0.29744	0.42607
Complement and coagulation cascades	8638	155	25	2	1	0.29744	0.42607
Th17 cell differentiation	8638	155	25	2	1	0.29744	0.42607
Leishmaniasis	8638	155	25	2	1	0.29744	0.42607
Inflammatory bowel disease	8638	155	25	2	1	0.29744	0.42607
Thyroid hormone signaling pathway	8638	155	25	3	1	0.41224	0.56023
Pancreatic cancer	8638	155	25	3	1	0.41224	0.56023
Pathways in cancer	8638	155	25	9	2	0.44248	0.58628
Pyrimidine metabolism	8638	155	25	4	1	0.50891	0.61301
Nucleotide metabolism	8638	155	25	4	1	0.50891	0.61301
Biosynthesis of cofactors	8638	155	25	4	1	0.50891	0.61301
Tuberculosis	8638	155	25	4	1	0.50891	0.61301
Viral carcinogenesis	8638	155	25	13	2	0.65582	0.75872
Protein processing in endoplasmic reticulum	8638	155	25	6	1	0.65851	0.75872
Human immunodeficiency virus 1 infection	8638	155	25	7	1	0.71581	0.80719
Alzheimer disease	8638	155	25	8	1	0.76382	0.80964
Alcoholism	8638	155	25	8	1	0.76382	0.80964
Transcriptional misregulation in cancer	8638	155	25	8	1	0.76382	0.80964
Systemic lupus erythematosus	8638	155	25	10	1	0.83755	0.87039
Neutrophil extracellular trap formation	8638	155	25	13	1	0.90832	0.92579
Metabolic pathways	8638	155	25	24	2	0.93406	0.93406
Neuroactive ligand-receptor interaction	8698	155	6	3	2	0.0037047	0.096322
Glycosphingolipid biosynthesis - lacto and neolacto series	8698	155	6	1	1	0.03871	0.19166
Sphingolipid signaling pathway	8698	155	6	1	1	0.03871	0.19166
Renal cell carcinoma	8698	155	6	1	1	0.03871	0.19166
Metabolic pathways	8698	155	6	24	3	0.047944	0.19166
Nicotinate and nicotinamide metabolism	8698	155	6	2	1	0.076163	0.19166
HIF-1 signaling pathway	8698	155	6	2	1	0.076163	0.19166
Retrograde endocannabinoid signaling	8698	155	6	2	1	0.076163	0.19166
Non-alcoholic fatty liver disease	8698	155	6	2	1	0.076163	0.19166
Cholesterol metabolism	8698	155	6	2	1	0.076163	0.19166
Oxidative phosphorylation	8698	155	6	3	1	0.11239	0.19166
Thermogenesis	8698	155	6	3	1	0.11239	0.19166
Diabetic cardiomyopathy	8698	155	6	3	1	0.11239	0.19166
Biosynthesis of cofactors	8698	155	6	4	1	0.14743	0.19166
FoxO signaling pathway	8698	155	6	4	1	0.14743	0.19166
Ubiquitin mediated proteolysis	8698	155	6	4	1	0.14743	0.19166
Amyotrophic lateral sclerosis	8698	155	6	4	1	0.14743	0.19166
Huntington disease	8698	155	6	4	1	0.14743	0.19166
Prion disease	8698	155	6	4	1	0.14743	0.19166
Chemical carcinogenesis - reactive oxygen species	8698	155	6	4	1	0.14743	0.19166
Parkinson disease	8698	155	6	6	1	0.21405	0.26502
Pathways of neurodegeneration - multiple diseases	8698	155	6	7	1	0.2457	0.26618
Human T-cell leukemia virus 1 infection	8698	155	6	7	1	0.2457	0.26618
Human immunodeficiency virus 1 infection	8698	155	6	7	1	0.2457	0.26618
Alzheimer disease	8698	155	6	8	1	0.27628	0.28733
Pathways in cancer	8698	155	6	9	1	0.30582	0.30582
Metabolic pathways	8809	155	5	24	3	0.026726	0.053763
Mucin type O-glycan biosynthesis	8809	155	5	1	1	0.032258	0.053763
Sphingolipid metabolism	8809	155	5	1	1	0.032258	0.053763
Pantothenate and CoA biosynthesis	8809	155	5	1	1	0.032258	0.053763
Viral protein interaction with cytokine and cytokine receptor	8809	155	5	1	1	0.032258	0.053763
TNF signaling pathway	8809	155	5	1	1	0.032258	0.053763
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	8809	155	5	2	1	0.063678	0.079598
Inflammatory bowel disease	8809	155	5	2	1	0.063678	0.079598
Cytokine-cytokine receptor interaction	8809	155	5	3	1	0.094277	0.10475
Epstein-Barr virus infection	8809	155	5	11	1	0.3114	0.3114
Viral protein interaction with cytokine and cytokine receptor	8819	155	2	1	1	0.012903	0.032258
TNF signaling pathway	8819	155	2	1	1	0.012903	0.032258
Inflammatory bowel disease	8819	155	2	2	1	0.025723	0.042871
Cytokine-cytokine receptor interaction	8819	155	2	3	1	0.038458	0.048073
Epstein-Barr virus infection	8819	155	2	11	1	0.13733	0.13733
p53 signaling pathway	8836	155	13	4	3	0.0017867	0.051815
Glutathione metabolism	8836	155	13	2	2	0.0065354	0.094763
Oocyte meiosis	8836	155	13	7	3	0.013425	0.09733
Progesterone-mediated oocyte maturation	8836	155	13	7	3	0.013425	0.09733
Cell cycle	8836	155	13	14	4	0.018842	0.10928
Purine metabolism	8836	155	13	1	1	0.083871	0.27025
Glycine, serine and threonine metabolism	8836	155	13	1	1	0.083871	0.27025
Glyoxylate and dicarboxylate metabolism	8836	155	13	1	1	0.083871	0.27025
Carbon metabolism	8836	155	13	1	1	0.083871	0.27025
Cellular senescence	8836	155	13	7	2	0.10745	0.28327
Human immunodeficiency virus 1 infection	8836	155	13	7	2	0.10745	0.28327
Folate biosynthesis	8836	155	13	2	1	0.16121	0.35961
ECM-receptor interaction	8836	155	13	2	1	0.16121	0.35961
Drug metabolism - other enzymes	8836	155	13	3	1	0.23248	0.41169
Antifolate resistance	8836	155	13	3	1	0.23248	0.41169
Gap junction	8836	155	13	3	1	0.23248	0.41169
Pyrimidine metabolism	8836	155	13	4	1	0.29812	0.41169
Nucleotide metabolism	8836	155	13	4	1	0.29812	0.41169
Biosynthesis of cofactors	8836	155	13	4	1	0.29812	0.41169
FoxO signaling pathway	8836	155	13	4	1	0.29812	0.41169
Ubiquitin mediated proteolysis	8836	155	13	4	1	0.29812	0.41169
Metabolic pathways	8836	155	13	24	3	0.32449	0.42774
Viral life cycle - HIV-1	8836	155	13	5	1	0.35855	0.43324
Chemical carcinogenesis - receptor activation	8836	155	13	5	1	0.35855	0.43324
Protein processing in endoplasmic reticulum	8836	155	13	6	1	0.41414	0.46192
Parkinson disease	8836	155	13	6	1	0.41414	0.46192
Pathways of neurodegeneration - multiple diseases	8836	155	13	7	1	0.46525	0.48187
Human T-cell leukemia virus 1 infection	8836	155	13	7	1	0.46525	0.48187
Viral carcinogenesis	8836	155	13	13	1	0.69505	0.69505
Metabolic pathways	8876	155	4	24	3	0.011923	0.03871
Mucin type O-glycan biosynthesis	8876	155	4	1	1	0.025806	0.03871
Sphingolipid metabolism	8876	155	4	1	1	0.025806	0.03871
Pantothenate and CoA biosynthesis	8876	155	4	1	1	0.025806	0.03871
Viral protein interaction with cytokine and cytokine receptor	8876	155	4	1	1	0.025806	0.03871
TNF signaling pathway	8876	155	4	1	1	0.025806	0.03871
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	8876	155	4	2	1	0.05111	0.057499
Inflammatory bowel disease	8876	155	4	2	1	0.05111	0.057499
Cytokine-cytokine receptor interaction	8876	155	4	3	1	0.075918	0.075918
Cell cycle	890	155	25	14	12	1.5302e-09	6.2736e-08
Oocyte meiosis	890	155	25	7	6	6.323e-05	0.0012962
DNA replication	890	155	25	4	4	0.00054691	0.0056058
p53 signaling pathway	890	155	25	4	4	0.00054691	0.0056058
Cellular senescence	890	155	25	7	5	0.0012617	0.0086217
Progesterone-mediated oocyte maturation	890	155	25	7	5	0.0012617	0.0086217
Human T-cell leukemia virus 1 infection	890	155	25	7	4	0.013437	0.078701
Glutathione metabolism	890	155	25	2	2	0.025136	0.10306
One carbon pool by folate	890	155	25	2	2	0.025136	0.10306
Platinum drug resistance	890	155	25	2	2	0.025136	0.10306
Antifolate resistance	890	155	25	3	2	0.067851	0.2529
Human immunodeficiency virus 1 infection	890	155	25	7	3	0.08372	0.28604
Pyrimidine metabolism	890	155	25	4	2	0.12223	0.29479
Nucleotide metabolism	890	155	25	4	2	0.12223	0.29479
FoxO signaling pathway	890	155	25	4	2	0.12223	0.29479
Ubiquitin mediated proteolysis	890	155	25	4	2	0.12223	0.29479
MicroRNAs in cancer	890	155	25	4	2	0.12223	0.29479
Purine metabolism	890	155	25	1	1	0.16129	0.30059
Base excision repair	890	155	25	1	1	0.16129	0.30059
Non-homologous end-joining	890	155	25	1	1	0.16129	0.30059
Fanconi anemia pathway	890	155	25	1	1	0.16129	0.30059
Hippo signaling pathway	890	155	25	1	1	0.16129	0.30059
Chemical carcinogenesis - receptor activation	890	155	25	5	2	0.18369	0.32744
Folate biosynthesis	890	155	25	2	1	0.29744	0.42052
MAPK signaling pathway	890	155	25	2	1	0.29744	0.42052
Apoptosis	890	155	25	2	1	0.29744	0.42052
Apoptosis - multiple species	890	155	25	2	1	0.29744	0.42052
ECM-receptor interaction	890	155	25	2	1	0.29744	0.42052
Colorectal cancer	890	155	25	2	1	0.29744	0.42052
Viral carcinogenesis	890	155	25	13	3	0.35026	0.47869
Hepatitis B	890	155	25	8	2	0.37978	0.48291
Drug metabolism - other enzymes	890	155	25	3	1	0.41224	0.48291
AMPK signaling pathway	890	155	25	3	1	0.41224	0.48291
Gap junction	890	155	25	3	1	0.41224	0.48291
Acute myeloid leukemia	890	155	25	3	1	0.41224	0.48291
Pathways in cancer	890	155	25	9	2	0.44248	0.50393
Biosynthesis of cofactors	890	155	25	4	1	0.50891	0.56393
Metabolic pathways	890	155	25	24	4	0.56976	0.61474
Transcriptional misregulation in cancer	890	155	25	8	1	0.76382	0.80299
Human papillomavirus infection	890	155	25	10	1	0.83755	0.85849
Epstein-Barr virus infection	890	155	25	11	1	0.86556	0.86556
AMPK signaling pathway	8900	155	1	3	1	0.019355	0.085161
Acute myeloid leukemia	8900	155	1	3	1	0.019355	0.085161
Cellular senescence	8900	155	1	7	1	0.045161	0.085161
Progesterone-mediated oocyte maturation	8900	155	1	7	1	0.045161	0.085161
Human T-cell leukemia virus 1 infection	8900	155	1	7	1	0.045161	0.085161
Hepatitis B	8900	155	1	8	1	0.051613	0.085161
Transcriptional misregulation in cancer	8900	155	1	8	1	0.051613	0.085161
Pathways in cancer	8900	155	1	9	1	0.058065	0.085161
Human papillomavirus infection	8900	155	1	10	1	0.064516	0.085161
Epstein-Barr virus infection	8900	155	1	11	1	0.070968	0.085161
Viral carcinogenesis	8900	155	1	13	1	0.083871	0.090323
Cell cycle	8900	155	1	14	1	0.090323	0.090323
Cell cycle	891	155	29	14	12	1.4419e-08	6.6328e-07
Oocyte meiosis	891	155	29	7	6	0.00016522	0.0038
DNA replication	891	155	29	4	4	0.0010268	0.011809
p53 signaling pathway	891	155	29	4	4	0.0010268	0.011809
Cellular senescence	891	155	29	7	5	0.0026811	0.020555
Progesterone-mediated oocyte maturation	891	155	29	7	5	0.0026811	0.020555
Pyrimidine metabolism	891	155	29	4	3	0.020932	0.12
Nucleotide metabolism	891	155	29	4	3	0.020932	0.12
Human T-cell leukemia virus 1 infection	891	155	29	7	4	0.023479	0.12
Glutathione metabolism	891	155	29	2	2	0.034018	0.14226
Platinum drug resistance	891	155	29	2	2	0.034018	0.14226
Drug metabolism - other enzymes	891	155	29	3	2	0.090047	0.34426
Human immunodeficiency virus 1 infection	891	155	29	7	3	0.12187	0.34426
FoxO signaling pathway	891	155	29	4	2	0.15916	0.34426
Ubiquitin mediated proteolysis	891	155	29	4	2	0.15916	0.34426
MicroRNAs in cancer	891	155	29	4	2	0.15916	0.34426
Purine metabolism	891	155	29	1	1	0.1871	0.34426
Glycine, serine and threonine metabolism	891	155	29	1	1	0.1871	0.34426
Glyoxylate and dicarboxylate metabolism	891	155	29	1	1	0.1871	0.34426
Carbon metabolism	891	155	29	1	1	0.1871	0.34426
Protein export	891	155	29	1	1	0.1871	0.34426
Base excision repair	891	155	29	1	1	0.1871	0.34426
Non-homologous end-joining	891	155	29	1	1	0.1871	0.34426
Fanconi anemia pathway	891	155	29	1	1	0.1871	0.34426
Hippo signaling pathway	891	155	29	1	1	0.1871	0.34426
Chemical carcinogenesis - receptor activation	891	155	29	5	2	0.23484	0.41548
One carbon pool by folate	891	155	29	2	1	0.34018	0.489
MAPK signaling pathway	891	155	29	2	1	0.34018	0.489
Apoptosis	891	155	29	2	1	0.34018	0.489
Apoptosis - multiple species	891	155	29	2	1	0.34018	0.489
ECM-receptor interaction	891	155	29	2	1	0.34018	0.489
Colorectal cancer	891	155	29	2	1	0.34018	0.489
Viral carcinogenesis	891	155	29	13	3	0.4532	0.56319
Hepatitis B	891	155	29	8	2	0.46131	0.56319
Antifolate resistance	891	155	29	3	1	0.46524	0.56319
AMPK signaling pathway	891	155	29	3	1	0.46524	0.56319
Gap junction	891	155	29	3	1	0.46524	0.56319
Acute myeloid leukemia	891	155	29	3	1	0.46524	0.56319
Metabolic pathways	891	155	29	24	5	0.48092	0.56723
Pathways in cancer	891	155	29	9	2	0.52913	0.6085
Protein processing in endoplasmic reticulum	891	155	29	6	1	0.71797	0.78635
Parkinson disease	891	155	29	6	1	0.71797	0.78635
Pathways of neurodegeneration - multiple diseases	891	155	29	7	1	0.77286	0.82678
Transcriptional misregulation in cancer	891	155	29	8	1	0.81737	0.85452
Human papillomavirus infection	891	155	29	10	1	0.88252	0.90213
Epstein-Barr virus infection	891	155	29	11	1	0.90601	0.90601
RNA degradation	8916	155	20	2	2	0.01592	0.31879
Pathways of neurodegeneration - multiple diseases	8916	155	20	7	3	0.046201	0.31879
Alzheimer disease	8916	155	20	8	3	0.067754	0.31879
Mucin type O-glycan biosynthesis	8916	155	20	1	1	0.12903	0.31879
Glycerolipid metabolism	8916	155	20	1	1	0.12903	0.31879
Glycerophospholipid metabolism	8916	155	20	1	1	0.12903	0.31879
Sphingolipid metabolism	8916	155	20	1	1	0.12903	0.31879
ABC transporters	8916	155	20	1	1	0.12903	0.31879
mTOR signaling pathway	8916	155	20	1	1	0.12903	0.31879
Signaling pathways regulating pluripotency of stem cells	8916	155	20	1	1	0.12903	0.31879
Glutamatergic synapse	8916	155	20	1	1	0.12903	0.31879
Serotonergic synapse	8916	155	20	1	1	0.12903	0.31879
GABAergic synapse	8916	155	20	1	1	0.12903	0.31879
Insulin signaling pathway	8916	155	20	1	1	0.12903	0.31879
Fat digestion and absorption	8916	155	20	1	1	0.12903	0.31879
Epithelial cell signaling in Helicobacter pylori infection	8916	155	20	1	1	0.12903	0.31879
Pathogenic Escherichia coli infection	8916	155	20	1	1	0.12903	0.31879
Parkinson disease	8916	155	20	6	2	0.17278	0.40316
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	8916	155	20	2	1	0.24214	0.4068
Notch signaling pathway	8916	155	20	2	1	0.24214	0.4068
Complement and coagulation cascades	8916	155	20	2	1	0.24214	0.4068
Alcoholic liver disease	8916	155	20	2	1	0.24214	0.4068
Protein digestion and absorption	8916	155	20	2	1	0.24214	0.4068
Cholesterol metabolism	8916	155	20	2	1	0.24214	0.4068
Salmonella infection	8916	155	20	2	1	0.24214	0.4068
Gap junction	8916	155	20	3	1	0.34121	0.51182
Thyroid hormone signaling pathway	8916	155	20	3	1	0.34121	0.51182
Lipid and atherosclerosis	8916	155	20	3	1	0.34121	0.51182
Ubiquitin mediated proteolysis	8916	155	20	4	1	0.42789	0.54551
Amyotrophic lateral sclerosis	8916	155	20	4	1	0.42789	0.54551
Huntington disease	8916	155	20	4	1	0.42789	0.54551
Prion disease	8916	155	20	4	1	0.42789	0.54551
Coronavirus disease - COVID-19	8916	155	20	11	2	0.42861	0.54551
Viral life cycle - HIV-1	8916	155	20	5	1	0.50367	0.6044
Phagosome	8916	155	20	5	1	0.50367	0.6044
Protein processing in endoplasmic reticulum	8916	155	20	6	1	0.56985	0.66482
Oocyte meiosis	8916	155	20	7	1	0.62759	0.66528
Progesterone-mediated oocyte maturation	8916	155	20	7	1	0.62759	0.66528
Human immunodeficiency virus 1 infection	8916	155	20	7	1	0.62759	0.66528
Metabolic pathways	8916	155	20	24	3	0.6336	0.66528
NOD-like receptor signaling pathway	8916	155	20	15	1	0.88695	0.90858
Ribosome biogenesis in eukaryotes	8916	155	20	18	1	0.92906	0.92906
Pathways of neurodegeneration - multiple diseases	8926	155	5	7	2	0.016468	0.12903
Alzheimer disease	8926	155	5	8	2	0.021665	0.12903
Serotonergic synapse	8926	155	5	1	1	0.032258	0.12903
Pathogenic Escherichia coli infection	8926	155	5	1	1	0.032258	0.12903
Complement and coagulation cascades	8926	155	5	2	1	0.063678	0.16981
Salmonella infection	8926	155	5	2	1	0.063678	0.16981
Gap junction	8926	155	5	3	1	0.094277	0.18047
DNA replication	8926	155	5	4	1	0.12407	0.18047
Amyotrophic lateral sclerosis	8926	155	5	4	1	0.12407	0.18047
Huntington disease	8926	155	5	4	1	0.12407	0.18047
Prion disease	8926	155	5	4	1	0.12407	0.18047
Phagosome	8926	155	5	5	1	0.15307	0.2041
Protein processing in endoplasmic reticulum	8926	155	5	6	1	0.18131	0.20721
Parkinson disease	8926	155	5	6	1	0.18131	0.20721
Coronavirus disease - COVID-19	8926	155	5	11	1	0.3114	0.33216
Cell cycle	8926	155	5	14	1	0.38113	0.38113
Alcoholism	8970	155	6	8	5	4.73e-07	1.6555e-05
Systemic lupus erythematosus	8970	155	6	10	5	2.1044e-06	3.6828e-05
Neutrophil extracellular trap formation	8970	155	6	13	5	1.0563e-05	9.243e-05
Viral carcinogenesis	8970	155	6	13	5	1.0563e-05	9.243e-05
EGFR tyrosine kinase inhibitor resistance	8970	155	6	1	1	0.03871	0.1159
ErbB signaling pathway	8970	155	6	1	1	0.03871	0.1159
Ras signaling pathway	8970	155	6	1	1	0.03871	0.1159
Phospholipase D signaling pathway	8970	155	6	1	1	0.03871	0.1159
Endometrial cancer	8970	155	6	1	1	0.03871	0.1159
Choline metabolism in cancer	8970	155	6	1	1	0.03871	0.1159
MAPK signaling pathway	8970	155	6	2	1	0.076163	0.1159
Rap1 signaling pathway	8970	155	6	2	1	0.076163	0.1159
Calcium signaling pathway	8970	155	6	2	1	0.076163	0.1159
HIF-1 signaling pathway	8970	155	6	2	1	0.076163	0.1159
Focal adhesion	8970	155	6	2	1	0.076163	0.1159
Regulation of actin cytoskeleton	8970	155	6	2	1	0.076163	0.1159
Colorectal cancer	8970	155	6	2	1	0.076163	0.1159
Glioma	8970	155	6	2	1	0.076163	0.1159
Melanoma	8970	155	6	2	1	0.076163	0.1159
Bladder cancer	8970	155	6	2	1	0.076163	0.1159
Non-small cell lung cancer	8970	155	6	2	1	0.076163	0.1159
Breast cancer	8970	155	6	2	1	0.076163	0.1159
Gastric cancer	8970	155	6	2	1	0.076163	0.1159
PI3K-Akt signaling pathway	8970	155	6	3	1	0.11239	0.14049
Gap junction	8970	155	6	3	1	0.11239	0.14049
JAK-STAT signaling pathway	8970	155	6	3	1	0.11239	0.14049
Pancreatic cancer	8970	155	6	3	1	0.11239	0.14049
Prostate cancer	8970	155	6	3	1	0.11239	0.14049
FoxO signaling pathway	8970	155	6	4	1	0.14743	0.16645
Chemical carcinogenesis - reactive oxygen species	8970	155	6	4	1	0.14743	0.16645
PD-L1 expression and PD-1 checkpoint pathway in cancer	8970	155	6	4	1	0.14743	0.16645
Chemical carcinogenesis - receptor activation	8970	155	6	5	1	0.18131	0.1983
Pathways in cancer	8970	155	6	9	1	0.30582	0.32436
Human papillomavirus infection	8970	155	6	10	1	0.33435	0.34418
Hepatitis C	8970	155	6	12	1	0.38848	0.38848
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	90355	155	4	2	2	0.00050272	0.0035191
Viral protein interaction with cytokine and cytokine receptor	90355	155	4	1	1	0.025806	0.060215
TNF signaling pathway	90355	155	4	1	1	0.025806	0.060215
Inflammatory bowel disease	90355	155	4	2	1	0.05111	0.089443
Cytokine-cytokine receptor interaction	90355	155	4	3	1	0.075918	0.10628
Metabolic pathways	90355	155	4	24	2	0.11353	0.13245
Epstein-Barr virus infection	90355	155	4	11	1	0.25729	0.25729
Cell cycle	9055	155	22	14	10	2.8788e-07	1.2667e-05
p53 signaling pathway	9055	155	22	4	4	0.00031626	0.0069576
Oocyte meiosis	9055	155	22	7	5	0.00064903	0.0071393
Progesterone-mediated oocyte maturation	9055	155	22	7	5	0.00064903	0.0071393
Cellular senescence	9055	155	22	7	4	0.0081921	0.067257
DNA replication	9055	155	22	4	3	0.0091714	0.067257
One carbon pool by folate	9055	155	22	2	2	0.019355	0.10645
Platinum drug resistance	9055	155	22	2	2	0.019355	0.10645
Antifolate resistance	9055	155	22	3	2	0.053004	0.21928
AMPK signaling pathway	9055	155	22	3	2	0.053004	0.21928
Human T-cell leukemia virus 1 infection	9055	155	22	7	3	0.059803	0.21928
Human immunodeficiency virus 1 infection	9055	155	22	7	3	0.059803	0.21928
Pyrimidine metabolism	9055	155	22	4	2	0.096837	0.2663
Nucleotide metabolism	9055	155	22	4	2	0.096837	0.2663
FoxO signaling pathway	9055	155	22	4	2	0.096837	0.2663
MicroRNAs in cancer	9055	155	22	4	2	0.096837	0.2663
Purine metabolism	9055	155	22	1	1	0.14194	0.28387
Biosynthesis of unsaturated fatty acids	9055	155	22	1	1	0.14194	0.28387
Fatty acid metabolism	9055	155	22	1	1	0.14194	0.28387
Fanconi anemia pathway	9055	155	22	1	1	0.14194	0.28387
Hippo signaling pathway	9055	155	22	1	1	0.14194	0.28387
Carbohydrate digestion and absorption	9055	155	22	1	1	0.14194	0.28387
Glutathione metabolism	9055	155	22	2	1	0.26452	0.37544
Folate biosynthesis	9055	155	22	2	1	0.26452	0.37544
PPAR signaling pathway	9055	155	22	2	1	0.26452	0.37544
MAPK signaling pathway	9055	155	22	2	1	0.26452	0.37544
Apoptosis	9055	155	22	2	1	0.26452	0.37544
Apoptosis - multiple species	9055	155	22	2	1	0.26452	0.37544
ECM-receptor interaction	9055	155	22	2	1	0.26452	0.37544
Alcoholic liver disease	9055	155	22	2	1	0.26452	0.37544
Colorectal cancer	9055	155	22	2	1	0.26452	0.37544
Hepatitis B	9055	155	22	8	2	0.31712	0.43603
Drug metabolism - other enzymes	9055	155	22	3	1	0.37027	0.45707
Gap junction	9055	155	22	3	1	0.37027	0.45707
Acute myeloid leukemia	9055	155	22	3	1	0.37027	0.45707
Pathways in cancer	9055	155	22	9	2	0.37397	0.45707
Metabolic pathways	9055	155	22	24	4	0.45485	0.52057
Biosynthesis of cofactors	9055	155	22	4	1	0.46142	0.52057
Ubiquitin mediated proteolysis	9055	155	22	4	1	0.46142	0.52057
Chemical carcinogenesis - receptor activation	9055	155	22	5	1	0.53989	0.59387
Viral carcinogenesis	9055	155	22	13	2	0.57911	0.62149
Transcriptional misregulation in cancer	9055	155	22	8	1	0.71509	0.74914
Human papillomavirus infection	9055	155	22	10	1	0.79423	0.81271
Epstein-Barr virus infection	9055	155	22	11	1	0.82545	0.82545
Protein processing in endoplasmic reticulum	90701	155	21	6	4	0.0032132	0.15102
Glutathione metabolism	90701	155	21	2	2	0.017595	0.27566
Intestinal immune network for IgA production	90701	155	21	2	2	0.017595	0.27566
Cytokine-cytokine receptor interaction	90701	155	21	3	2	0.048416	0.29058
Oocyte meiosis	90701	155	21	7	3	0.052765	0.29058
p53 signaling pathway	90701	155	21	4	2	0.088868	0.29058
Cell cycle	90701	155	21	14	4	0.10041	0.29058
Purine metabolism	90701	155	21	1	1	0.13548	0.29058
Glycine, serine and threonine metabolism	90701	155	21	1	1	0.13548	0.29058
Glyoxylate and dicarboxylate metabolism	90701	155	21	1	1	0.13548	0.29058
Carbon metabolism	90701	155	21	1	1	0.13548	0.29058
Biosynthesis of nucleotide sugars	90701	155	21	1	1	0.13548	0.29058
Protein export	90701	155	21	1	1	0.13548	0.29058
Base excision repair	90701	155	21	1	1	0.13548	0.29058
Non-homologous end-joining	90701	155	21	1	1	0.13548	0.29058
Fanconi anemia pathway	90701	155	21	1	1	0.13548	0.29058
Estrogen signaling pathway	90701	155	21	1	1	0.13548	0.29058
Thyroid hormone synthesis	90701	155	21	1	1	0.13548	0.29058
Oxytocin signaling pathway	90701	155	21	1	1	0.13548	0.29058
Pancreatic secretion	90701	155	21	1	1	0.13548	0.29058
Primary immunodeficiency	90701	155	21	1	1	0.13548	0.29058
Chemical carcinogenesis - receptor activation	90701	155	21	5	2	0.13602	0.29058
Metabolic pathways	90701	155	21	24	5	0.20331	0.36086
Cellular senescence	90701	155	21	7	2	0.24138	0.36086
Progesterone-mediated oocyte maturation	90701	155	21	7	2	0.24138	0.36086
Amino sugar and nucleotide sugar metabolism	90701	155	21	2	1	0.25337	0.36086
Nicotinate and nicotinamide metabolism	90701	155	21	2	1	0.25337	0.36086
Calcium signaling pathway	90701	155	21	2	1	0.25337	0.36086
IL-17 signaling pathway	90701	155	21	2	1	0.25337	0.36086
Th17 cell differentiation	90701	155	21	2	1	0.25337	0.36086
Salivary secretion	90701	155	21	2	1	0.25337	0.36086
Salmonella infection	90701	155	21	2	1	0.25337	0.36086
Fluid shear stress and atherosclerosis	90701	155	21	2	1	0.25337	0.36086
Drug metabolism - other enzymes	90701	155	21	3	1	0.35585	0.45203
PI3K-Akt signaling pathway	90701	155	21	3	1	0.35585	0.45203
Prostate cancer	90701	155	21	3	1	0.35585	0.45203
Lipid and atherosclerosis	90701	155	21	3	1	0.35585	0.45203
Pyrimidine metabolism	90701	155	21	4	1	0.44485	0.50994
Nucleotide metabolism	90701	155	21	4	1	0.44485	0.50994
DNA replication	90701	155	21	4	1	0.44485	0.50994
FoxO signaling pathway	90701	155	21	4	1	0.44485	0.50994
Hematopoietic cell lineage	90701	155	21	5	1	0.52205	0.5842
Parkinson disease	90701	155	21	6	1	0.58896	0.64375
Pathways of neurodegeneration - multiple diseases	90701	155	21	7	1	0.6469	0.66096
Human T-cell leukemia virus 1 infection	90701	155	21	7	1	0.6469	0.66096
Human immunodeficiency virus 1 infection	90701	155	21	7	1	0.6469	0.66096
Pathways in cancer	90701	155	21	9	1	0.74028	0.74028
Cell cycle	91319	155	17	14	5	0.0094447	0.19941
Intestinal immune network for IgA production	91319	155	17	2	2	0.011395	0.19941
Protein processing in endoplasmic reticulum	91319	155	17	6	3	0.018025	0.21029
Cytokine-cytokine receptor interaction	91319	155	17	3	2	0.031951	0.25591
DNA replication	91319	155	17	4	2	0.059742	0.25591
Chemical carcinogenesis - receptor activation	91319	155	17	5	2	0.093115	0.25591
Glycine, serine and threonine metabolism	91319	155	17	1	1	0.10968	0.25591
Glyoxylate and dicarboxylate metabolism	91319	155	17	1	1	0.10968	0.25591
Carbon metabolism	91319	155	17	1	1	0.10968	0.25591
Protein export	91319	155	17	1	1	0.10968	0.25591
Base excision repair	91319	155	17	1	1	0.10968	0.25591
Non-homologous end-joining	91319	155	17	1	1	0.10968	0.25591
Estrogen signaling pathway	91319	155	17	1	1	0.10968	0.25591
Thyroid hormone synthesis	91319	155	17	1	1	0.10968	0.25591
Primary immunodeficiency	91319	155	17	1	1	0.10968	0.25591
Oocyte meiosis	91319	155	17	7	2	0.17118	0.36393
IL-17 signaling pathway	91319	155	17	2	1	0.20796	0.36393
Th17 cell differentiation	91319	155	17	2	1	0.20796	0.36393
Salmonella infection	91319	155	17	2	1	0.20796	0.36393
Fluid shear stress and atherosclerosis	91319	155	17	2	1	0.20796	0.36393
Drug metabolism - other enzymes	91319	155	17	3	1	0.29596	0.43161
PI3K-Akt signaling pathway	91319	155	17	3	1	0.29596	0.43161
Prostate cancer	91319	155	17	3	1	0.29596	0.43161
Lipid and atherosclerosis	91319	155	17	3	1	0.29596	0.43161
Pyrimidine metabolism	91319	155	17	4	1	0.37471	0.48573
Nucleotide metabolism	91319	155	17	4	1	0.37471	0.48573
Ubiquitin mediated proteolysis	91319	155	17	4	1	0.37471	0.48573
Parkinson disease	91319	155	17	6	1	0.50799	0.61701
Cellular senescence	91319	155	17	7	1	0.56413	0.61701
Progesterone-mediated oocyte maturation	91319	155	17	7	1	0.56413	0.61701
Pathways of neurodegeneration - multiple diseases	91319	155	17	7	1	0.56413	0.61701
Human T-cell leukemia virus 1 infection	91319	155	17	7	1	0.56413	0.61701
Pathways in cancer	91319	155	17	9	1	0.65881	0.69874
Metabolic pathways	91319	155	17	24	2	0.78121	0.7932
Viral carcinogenesis	91319	155	17	13	1	0.7932	0.7932
Cell cycle	9133	155	24	14	11	3.2386e-08	1.3278e-06
Oocyte meiosis	9133	155	24	7	6	4.8365e-05	0.00099149
p53 signaling pathway	9133	155	24	4	4	0.0004594	0.0062785
Cellular senescence	9133	155	24	7	5	0.001022	0.0083805
Progesterone-mediated oocyte maturation	9133	155	24	7	5	0.001022	0.0083805
Human T-cell leukemia virus 1 infection	9133	155	24	7	4	0.011489	0.054314
Pyrimidine metabolism	9133	155	24	4	3	0.011923	0.054314
Nucleotide metabolism	9133	155	24	4	3	0.011923	0.054314
DNA replication	9133	155	24	4	3	0.011923	0.054314
Platinum drug resistance	9133	155	24	2	2	0.023125	0.094814
Drug metabolism - other enzymes	9133	155	24	3	2	0.062725	0.21431
Antifolate resistance	9133	155	24	3	2	0.062725	0.21431
Human immunodeficiency virus 1 infection	9133	155	24	7	3	0.075286	0.23744
FoxO signaling pathway	9133	155	24	4	2	0.11353	0.29092
Ubiquitin mediated proteolysis	9133	155	24	4	2	0.11353	0.29092
MicroRNAs in cancer	9133	155	24	4	2	0.11353	0.29092
Purine metabolism	9133	155	24	1	1	0.15484	0.3023
Base excision repair	9133	155	24	1	1	0.15484	0.3023
Non-homologous end-joining	9133	155	24	1	1	0.15484	0.3023
Fanconi anemia pathway	9133	155	24	1	1	0.15484	0.3023
Hippo signaling pathway	9133	155	24	1	1	0.15484	0.3023
Chemical carcinogenesis - receptor activation	9133	155	24	5	2	0.1714	0.31942
Glutathione metabolism	9133	155	24	2	1	0.28655	0.39162
One carbon pool by folate	9133	155	24	2	1	0.28655	0.39162
Folate biosynthesis	9133	155	24	2	1	0.28655	0.39162
MAPK signaling pathway	9133	155	24	2	1	0.28655	0.39162
Apoptosis	9133	155	24	2	1	0.28655	0.39162
Apoptosis - multiple species	9133	155	24	2	1	0.28655	0.39162
ECM-receptor interaction	9133	155	24	2	1	0.28655	0.39162
Colorectal cancer	9133	155	24	2	1	0.28655	0.39162
Viral carcinogenesis	9133	155	24	13	3	0.32449	0.42917
Hepatitis B	9133	155	24	8	2	0.35896	0.45992
AMPK signaling pathway	9133	155	24	3	1	0.39847	0.46677
Gap junction	9133	155	24	3	1	0.39847	0.46677
Acute myeloid leukemia	9133	155	24	3	1	0.39847	0.46677
Pathways in cancer	9133	155	24	9	2	0.41991	0.47823
Biosynthesis of cofactors	9133	155	24	4	1	0.49344	0.54679
Transcriptional misregulation in cancer	9133	155	24	8	1	0.74845	0.8037
Metabolic pathways	9133	155	24	24	3	0.7645	0.8037
Human papillomavirus infection	9133	155	24	10	1	0.82412	0.84473
Epstein-Barr virus infection	9133	155	24	11	1	0.85323	0.85323
Influenza A	91543	155	27	10	10	5.1445e-09	2.6237e-07
Measles	91543	155	27	9	9	4.1727e-08	1.064e-06
Hepatitis C	91543	155	27	12	10	2.7084e-07	4.6043e-06
Coronavirus disease - COVID-19	91543	155	27	11	9	1.8128e-06	2.3114e-05
Herpes simplex virus 1 infection	91543	155	27	9	8	2.5717e-06	2.6232e-05
NOD-like receptor signaling pathway	91543	155	27	15	9	0.00010217	0.00086849
Epstein-Barr virus infection	91543	155	27	11	7	0.00047513	0.0034616
Necroptosis	91543	155	27	4	4	0.00075875	0.0048371
Human papillomavirus infection	91543	155	27	10	5	0.015146	0.085829
Kaposi sarcoma-associated herpesvirus infection	91543	155	27	4	3	0.016946	0.086422
Chemokine signaling pathway	91543	155	27	2	2	0.029409	0.10713
RIG-I-like receptor signaling pathway	91543	155	27	2	2	0.029409	0.10713
Cytosolic DNA-sensing pathway	91543	155	27	2	2	0.029409	0.10713
C-type lectin receptor signaling pathway	91543	155	27	2	2	0.029409	0.10713
Hepatitis B	91543	155	27	8	4	0.0316	0.10744
JAK-STAT signaling pathway	91543	155	27	3	2	0.078617	0.25059
Osteoclast differentiation	91543	155	27	4	2	0.14029	0.31728
PD-L1 expression and PD-1 checkpoint pathway in cancer	91543	155	27	4	2	0.14029	0.31728
Glycolysis / Gluconeogenesis	91543	155	27	1	1	0.17419	0.31728
Galactose metabolism	91543	155	27	1	1	0.17419	0.31728
NF-kappa B signaling pathway	91543	155	27	1	1	0.17419	0.31728
Toll-like receptor signaling pathway	91543	155	27	1	1	0.17419	0.31728
Th1 and Th2 cell differentiation	91543	155	27	1	1	0.17419	0.31728
Prolactin signaling pathway	91543	155	27	1	1	0.17419	0.31728
AGE-RAGE signaling pathway in diabetic complications	91543	155	27	1	1	0.17419	0.31728
Growth hormone synthesis, secretion and action	91543	155	27	1	1	0.17419	0.31728
Pertussis	91543	155	27	1	1	0.17419	0.31728
Toxoplasmosis	91543	155	27	1	1	0.17419	0.31728
Viral life cycle - HIV-1	91543	155	27	5	2	0.2089	0.36738
Lysosome	91543	155	27	2	1	0.31898	0.4281
Apoptosis	91543	155	27	2	1	0.31898	0.4281
Apoptosis - multiple species	91543	155	27	2	1	0.31898	0.4281
Notch signaling pathway	91543	155	27	2	1	0.31898	0.4281
Cell adhesion molecules	91543	155	27	2	1	0.31898	0.4281
Complement and coagulation cascades	91543	155	27	2	1	0.31898	0.4281
Th17 cell differentiation	91543	155	27	2	1	0.31898	0.4281
Leishmaniasis	91543	155	27	2	1	0.31898	0.4281
Inflammatory bowel disease	91543	155	27	2	1	0.31898	0.4281
Thyroid hormone signaling pathway	91543	155	27	3	1	0.43916	0.55993
Pancreatic cancer	91543	155	27	3	1	0.43916	0.55993
Pathways in cancer	91543	155	27	9	2	0.4866	0.60529
Pyrimidine metabolism	91543	155	27	4	1	0.53878	0.61062
Nucleotide metabolism	91543	155	27	4	1	0.53878	0.61062
Biosynthesis of cofactors	91543	155	27	4	1	0.53878	0.61062
Tuberculosis	91543	155	27	4	1	0.53878	0.61062
Protein processing in endoplasmic reticulum	91543	155	27	6	1	0.68943	0.76436
Human immunodeficiency virus 1 infection	91543	155	27	7	1	0.7457	0.80917
Alzheimer disease	91543	155	27	8	1	0.7921	0.82443
Transcriptional misregulation in cancer	91543	155	27	8	1	0.7921	0.82443
Viral carcinogenesis	91543	155	27	13	1	0.9258	0.94432
Metabolic pathways	91543	155	27	24	2	0.9525	0.9525
Cell cycle	9212	155	21	14	9	3.552e-06	0.00014208
p53 signaling pathway	9212	155	21	4	4	0.00025875	0.0050769
Oocyte meiosis	9212	155	21	7	5	0.00050769	0.0050769
Cellular senescence	9212	155	21	7	5	0.00050769	0.0050769
Progesterone-mediated oocyte maturation	9212	155	21	7	4	0.0068206	0.039819
Human T-cell leukemia virus 1 infection	9212	155	21	7	4	0.0068206	0.039819
Pyrimidine metabolism	9212	155	21	4	3	0.0079639	0.039819
Nucleotide metabolism	9212	155	21	4	3	0.0079639	0.039819
Drug metabolism - other enzymes	9212	155	21	3	2	0.048416	0.21106
Human immunodeficiency virus 1 infection	9212	155	21	7	3	0.052765	0.21106
DNA replication	9212	155	21	4	2	0.088868	0.25391
FoxO signaling pathway	9212	155	21	4	2	0.088868	0.25391
Ubiquitin mediated proteolysis	9212	155	21	4	2	0.088868	0.25391
MicroRNAs in cancer	9212	155	21	4	2	0.088868	0.25391
Purine metabolism	9212	155	21	1	1	0.13548	0.25908
Base excision repair	9212	155	21	1	1	0.13548	0.25908
Non-homologous end-joining	9212	155	21	1	1	0.13548	0.25908
Fanconi anemia pathway	9212	155	21	1	1	0.13548	0.25908
Hippo signaling pathway	9212	155	21	1	1	0.13548	0.25908
Carbohydrate digestion and absorption	9212	155	21	1	1	0.13548	0.25908
Chemical carcinogenesis - receptor activation	9212	155	21	5	2	0.13602	0.25908
Viral carcinogenesis	9212	155	21	13	3	0.24882	0.34948
Glutathione metabolism	9212	155	21	2	1	0.25337	0.34948
One carbon pool by folate	9212	155	21	2	1	0.25337	0.34948
Platinum drug resistance	9212	155	21	2	1	0.25337	0.34948
MAPK signaling pathway	9212	155	21	2	1	0.25337	0.34948
Apoptosis	9212	155	21	2	1	0.25337	0.34948
Apoptosis - multiple species	9212	155	21	2	1	0.25337	0.34948
Colorectal cancer	9212	155	21	2	1	0.25337	0.34948
Hepatitis B	9212	155	21	8	2	0.29618	0.3949
Pathways in cancer	9212	155	21	9	2	0.35071	0.40669
Antifolate resistance	9212	155	21	3	1	0.35585	0.40669
AMPK signaling pathway	9212	155	21	3	1	0.35585	0.40669
Gap junction	9212	155	21	3	1	0.35585	0.40669
Acute myeloid leukemia	9212	155	21	3	1	0.35585	0.40669
Protein processing in endoplasmic reticulum	9212	155	21	6	1	0.58896	0.65441
Metabolic pathways	9212	155	21	24	3	0.67005	0.72438
Transcriptional misregulation in cancer	9212	155	21	8	1	0.697	0.73368
Human papillomavirus infection	9212	155	21	10	1	0.77764	0.79758
Epstein-Barr virus infection	9212	155	21	11	1	0.80984	0.80984
Cell cycle	9232	155	24	14	11	3.2386e-08	1.2955e-06
Oocyte meiosis	9232	155	24	7	6	4.8365e-05	0.00096731
p53 signaling pathway	9232	155	24	4	4	0.0004594	0.0061254
Cellular senescence	9232	155	24	7	5	0.001022	0.0081761
Progesterone-mediated oocyte maturation	9232	155	24	7	5	0.001022	0.0081761
Human T-cell leukemia virus 1 infection	9232	155	24	7	4	0.011489	0.052989
Pyrimidine metabolism	9232	155	24	4	3	0.011923	0.052989
Nucleotide metabolism	9232	155	24	4	3	0.011923	0.052989
DNA replication	9232	155	24	4	3	0.011923	0.052989
Platinum drug resistance	9232	155	24	2	2	0.023125	0.092501
Drug metabolism - other enzymes	9232	155	24	3	2	0.062725	0.22809
Human immunodeficiency virus 1 infection	9232	155	24	7	3	0.075286	0.25095
FoxO signaling pathway	9232	155	24	4	2	0.11353	0.29493
Ubiquitin mediated proteolysis	9232	155	24	4	2	0.11353	0.29493
MicroRNAs in cancer	9232	155	24	4	2	0.11353	0.29493
Purine metabolism	9232	155	24	1	1	0.15484	0.29493
Protein export	9232	155	24	1	1	0.15484	0.29493
Base excision repair	9232	155	24	1	1	0.15484	0.29493
Non-homologous end-joining	9232	155	24	1	1	0.15484	0.29493
Fanconi anemia pathway	9232	155	24	1	1	0.15484	0.29493
Hippo signaling pathway	9232	155	24	1	1	0.15484	0.29493
Chemical carcinogenesis - receptor activation	9232	155	24	5	2	0.1714	0.31163
Glutathione metabolism	9232	155	24	2	1	0.28655	0.39524
One carbon pool by folate	9232	155	24	2	1	0.28655	0.39524
MAPK signaling pathway	9232	155	24	2	1	0.28655	0.39524
Apoptosis	9232	155	24	2	1	0.28655	0.39524
Apoptosis - multiple species	9232	155	24	2	1	0.28655	0.39524
ECM-receptor interaction	9232	155	24	2	1	0.28655	0.39524
Colorectal cancer	9232	155	24	2	1	0.28655	0.39524
Viral carcinogenesis	9232	155	24	13	3	0.32449	0.43266
Hepatitis B	9232	155	24	8	2	0.35896	0.45539
Antifolate resistance	9232	155	24	3	1	0.39847	0.45539
AMPK signaling pathway	9232	155	24	3	1	0.39847	0.45539
Gap junction	9232	155	24	3	1	0.39847	0.45539
Acute myeloid leukemia	9232	155	24	3	1	0.39847	0.45539
Pathways in cancer	9232	155	24	9	2	0.41991	0.46656
Transcriptional misregulation in cancer	9232	155	24	8	1	0.74845	0.80473
Metabolic pathways	9232	155	24	24	3	0.7645	0.80473
Human papillomavirus infection	9232	155	24	10	1	0.82412	0.84525
Epstein-Barr virus infection	9232	155	24	11	1	0.85323	0.85323
Oxidative phosphorylation	924	155	6	3	3	3.2858e-05	0.00023
Thermogenesis	924	155	6	3	3	3.2858e-05	0.00023
Diabetic cardiomyopathy	924	155	6	3	3	3.2858e-05	0.00023
Amyotrophic lateral sclerosis	924	155	6	4	3	0.00012949	0.00038846
Huntington disease	924	155	6	4	3	0.00012949	0.00038846
Prion disease	924	155	6	4	3	0.00012949	0.00038846
Chemical carcinogenesis - reactive oxygen species	924	155	6	4	3	0.00012949	0.00038846
Parkinson disease	924	155	6	6	3	0.00062828	0.0016492
Pathways of neurodegeneration - multiple diseases	924	155	6	7	3	0.001083	0.0023994
Retrograde endocannabinoid signaling	924	155	6	2	2	0.0012568	0.0023994
Non-alcoholic fatty liver disease	924	155	6	2	2	0.0012568	0.0023994
Alzheimer disease	924	155	6	8	3	0.0017067	0.0029868
Metabolic pathways	924	155	6	24	4	0.0055078	0.0088972
Mucin type O-glycan biosynthesis	924	155	6	1	1	0.03871	0.050806
Sphingolipid metabolism	924	155	6	1	1	0.03871	0.050806
Renal cell carcinoma	924	155	6	1	1	0.03871	0.050806
HIF-1 signaling pathway	924	155	6	2	1	0.076163	0.094083
Ubiquitin mediated proteolysis	924	155	6	4	1	0.14743	0.172
Hematopoietic cell lineage	924	155	6	5	1	0.18131	0.20039
Human immunodeficiency virus 1 infection	924	155	6	7	1	0.2457	0.25799
Pathways in cancer	924	155	6	9	1	0.30582	0.30582
Alzheimer disease	92906	155	24	8	4	0.020541	0.3871
RNA degradation	92906	155	24	2	2	0.023125	0.3871
Notch signaling pathway	92906	155	24	2	2	0.023125	0.3871
Thyroid hormone signaling pathway	92906	155	24	3	2	0.062725	0.3871
Pathways of neurodegeneration - multiple diseases	92906	155	24	7	3	0.075286	0.3871
Necroptosis	92906	155	24	4	2	0.11353	0.3871
Tuberculosis	92906	155	24	4	2	0.11353	0.3871
Kaposi sarcoma-associated herpesvirus infection	92906	155	24	4	2	0.11353	0.3871
Mucin type O-glycan biosynthesis	92906	155	24	1	1	0.15484	0.3871
Glycerolipid metabolism	92906	155	24	1	1	0.15484	0.3871
Glycerophospholipid metabolism	92906	155	24	1	1	0.15484	0.3871
Sphingolipid metabolism	92906	155	24	1	1	0.15484	0.3871
ABC transporters	92906	155	24	1	1	0.15484	0.3871
mTOR signaling pathway	92906	155	24	1	1	0.15484	0.3871
Signaling pathways regulating pluripotency of stem cells	92906	155	24	1	1	0.15484	0.3871
Toll-like receptor signaling pathway	92906	155	24	1	1	0.15484	0.3871
Th1 and Th2 cell differentiation	92906	155	24	1	1	0.15484	0.3871
Neurotrophin signaling pathway	92906	155	24	1	1	0.15484	0.3871
Glutamatergic synapse	92906	155	24	1	1	0.15484	0.3871
Serotonergic synapse	92906	155	24	1	1	0.15484	0.3871
GABAergic synapse	92906	155	24	1	1	0.15484	0.3871
Prolactin signaling pathway	92906	155	24	1	1	0.15484	0.3871
AGE-RAGE signaling pathway in diabetic complications	92906	155	24	1	1	0.15484	0.3871
Growth hormone synthesis, secretion and action	92906	155	24	1	1	0.15484	0.3871
Fat digestion and absorption	92906	155	24	1	1	0.15484	0.3871
Epithelial cell signaling in Helicobacter pylori infection	92906	155	24	1	1	0.15484	0.3871
Pathogenic Escherichia coli infection	92906	155	24	1	1	0.15484	0.3871
Toxoplasmosis	92906	155	24	1	1	0.15484	0.3871
Viral life cycle - HIV-1	92906	155	24	5	2	0.1714	0.41372
Coronavirus disease - COVID-19	92906	155	24	11	3	0.23117	0.48924
Protein processing in endoplasmic reticulum	92906	155	24	6	2	0.23312	0.48924
Parkinson disease	92906	155	24	6	2	0.23312	0.48924
Chemokine signaling pathway	92906	155	24	2	1	0.28655	0.48924
C-type lectin receptor signaling pathway	92906	155	24	2	1	0.28655	0.48924
Th17 cell differentiation	92906	155	24	2	1	0.28655	0.48924
Alcoholic liver disease	92906	155	24	2	1	0.28655	0.48924
Protein digestion and absorption	92906	155	24	2	1	0.28655	0.48924
Cholesterol metabolism	92906	155	24	2	1	0.28655	0.48924
Salmonella infection	92906	155	24	2	1	0.28655	0.48924
Leishmaniasis	92906	155	24	2	1	0.28655	0.48924
Inflammatory bowel disease	92906	155	24	2	1	0.28655	0.48924
Human immunodeficiency virus 1 infection	92906	155	24	7	2	0.29626	0.49376
Viral carcinogenesis	92906	155	24	13	3	0.32449	0.52825
Alcoholism	92906	155	24	8	2	0.35896	0.57108
Gap junction	92906	155	24	3	1	0.39847	0.5811
JAK-STAT signaling pathway	92906	155	24	3	1	0.39847	0.5811
Pancreatic cancer	92906	155	24	3	1	0.39847	0.5811
Lipid and atherosclerosis	92906	155	24	3	1	0.39847	0.5811
Measles	92906	155	24	9	2	0.41991	0.58544
Herpes simplex virus 1 infection	92906	155	24	9	2	0.41991	0.58544
Influenza A	92906	155	24	10	2	0.47813	0.58544
Human papillomavirus infection	92906	155	24	10	2	0.47813	0.58544
Systemic lupus erythematosus	92906	155	24	10	2	0.47813	0.58544
Ubiquitin mediated proteolysis	92906	155	24	4	1	0.49344	0.58544
Osteoclast differentiation	92906	155	24	4	1	0.49344	0.58544
Amyotrophic lateral sclerosis	92906	155	24	4	1	0.49344	0.58544
Huntington disease	92906	155	24	4	1	0.49344	0.58544
Prion disease	92906	155	24	4	1	0.49344	0.58544
PD-L1 expression and PD-1 checkpoint pathway in cancer	92906	155	24	4	1	0.49344	0.58544
Epstein-Barr virus infection	92906	155	24	11	2	0.53301	0.62185
Phagosome	92906	155	24	5	1	0.57396	0.65864
Hepatitis C	92906	155	24	12	2	0.58416	0.65954
Neutrophil extracellular trap formation	92906	155	24	13	2	0.63137	0.70152
Oocyte meiosis	92906	155	24	7	1	0.69977	0.7536
Progesterone-mediated oocyte maturation	92906	155	24	7	1	0.69977	0.7536
NOD-like receptor signaling pathway	92906	155	24	15	2	0.71388	0.75714
Hepatitis B	92906	155	24	8	1	0.74845	0.78197
Pathways in cancer	92906	155	24	9	1	0.78952	0.81274
Metabolic pathways	92906	155	24	24	2	0.92262	0.93599
Ribosome biogenesis in eukaryotes	92906	155	24	18	1	0.96026	0.96026
Oxidative phosphorylation	93100	155	9	3	3	0.000138	0.001288
Thermogenesis	93100	155	9	3	3	0.000138	0.001288
Diabetic cardiomyopathy	93100	155	9	3	3	0.000138	0.001288
Amyotrophic lateral sclerosis	93100	155	9	4	3	0.00053567	0.0021427
Huntington disease	93100	155	9	4	3	0.00053567	0.0021427
Prion disease	93100	155	9	4	3	0.00053567	0.0021427
Chemical carcinogenesis - reactive oxygen species	93100	155	9	4	3	0.00053567	0.0021427
Parkinson disease	93100	155	9	6	3	0.0025214	0.0084457
Retrograde endocannabinoid signaling	93100	155	9	2	2	0.0030163	0.0084457
Non-alcoholic fatty liver disease	93100	155	9	2	2	0.0030163	0.0084457
Pathways of neurodegeneration - multiple diseases	93100	155	9	7	3	0.0042805	0.010896
Alzheimer disease	93100	155	9	8	3	0.0066434	0.015501
Neuroactive ligand-receptor interaction	93100	155	9	3	2	0.008773	0.018896
Metabolic pathways	93100	155	9	24	4	0.033054	0.066108
Sphingolipid signaling pathway	93100	155	9	1	1	0.058065	0.10161
Renal cell carcinoma	93100	155	9	1	1	0.058065	0.10161
Nicotinate and nicotinamide metabolism	93100	155	9	2	1	0.11311	0.16669
HIF-1 signaling pathway	93100	155	9	2	1	0.11311	0.16669
Cholesterol metabolism	93100	155	9	2	1	0.11311	0.16669
Biosynthesis of cofactors	93100	155	9	4	1	0.21471	0.27326
FoxO signaling pathway	93100	155	9	4	1	0.21471	0.27326
Ubiquitin mediated proteolysis	93100	155	9	4	1	0.21471	0.27326
Oocyte meiosis	93100	155	9	7	1	0.34775	0.3745
Progesterone-mediated oocyte maturation	93100	155	9	7	1	0.34775	0.3745
Human T-cell leukemia virus 1 infection	93100	155	9	7	1	0.34775	0.3745
Human immunodeficiency virus 1 infection	93100	155	9	7	1	0.34775	0.3745
Pathways in cancer	93100	155	9	9	1	0.42492	0.44066
NOD-like receptor signaling pathway	93100	155	9	15	1	0.61013	0.61013
Staphylococcus aureus infection	932	155	13	6	4	0.00042045	0.0092498
Transcriptional misregulation in cancer	932	155	13	8	4	0.0017779	0.019557
Amoebiasis	932	155	13	2	2	0.0065354	0.047926
NOD-like receptor signaling pathway	932	155	13	15	4	0.024428	0.13435
Phagosome	932	155	13	5	2	0.056413	0.23065
Neutrophil extracellular trap formation	932	155	13	13	3	0.08073	0.23065
Carbohydrate digestion and absorption	932	155	13	1	1	0.083871	0.23065
Asthma	932	155	13	1	1	0.083871	0.23065
Amino sugar and nucleotide sugar metabolism	932	155	13	2	1	0.16121	0.25332
PPAR signaling pathway	932	155	13	2	1	0.16121	0.25332
Lysosome	932	155	13	2	1	0.16121	0.25332
Renin-angiotensin system	932	155	13	2	1	0.16121	0.25332
IL-17 signaling pathway	932	155	13	2	1	0.16121	0.25332
Salivary secretion	932	155	13	2	1	0.16121	0.25332
Drug metabolism - other enzymes	932	155	13	3	1	0.23248	0.28414
Neuroactive ligand-receptor interaction	932	155	13	3	1	0.23248	0.28414
Acute myeloid leukemia	932	155	13	3	1	0.23248	0.28414
Lipid and atherosclerosis	932	155	13	3	1	0.23248	0.28414
Tuberculosis	932	155	13	4	1	0.29812	0.34519
Hematopoietic cell lineage	932	155	13	5	1	0.35855	0.3944
Systemic lupus erythematosus	932	155	13	10	1	0.59495	0.62328
Metabolic pathways	932	155	13	24	1	0.89822	0.89822
Oxidative phosphorylation	9334	155	20	3	3	0.0018729	0.027469
Thermogenesis	9334	155	20	3	3	0.0018729	0.027469
Diabetic cardiomyopathy	9334	155	20	3	3	0.0018729	0.027469
Parkinson disease	9334	155	20	6	4	0.0026315	0.028947
Pathways of neurodegeneration - multiple diseases	9334	155	20	7	4	0.0056182	0.033553
Amyotrophic lateral sclerosis	9334	155	20	4	3	0.0068632	0.033553
Huntington disease	9334	155	20	4	3	0.0068632	0.033553
Prion disease	9334	155	20	4	3	0.0068632	0.033553
Chemical carcinogenesis - reactive oxygen species	9334	155	20	4	3	0.0068632	0.033553
Alzheimer disease	9334	155	20	8	4	0.01028	0.045231
RNA degradation	9334	155	20	2	2	0.01592	0.053882
Retrograde endocannabinoid signaling	9334	155	20	2	2	0.01592	0.053882
Non-alcoholic fatty liver disease	9334	155	20	2	2	0.01592	0.053882
Metabolic pathways	9334	155	20	24	6	0.06261	0.19677
Ubiquitin mediated proteolysis	9334	155	20	4	2	0.081163	0.21836
Mucin type O-glycan biosynthesis	9334	155	20	1	1	0.12903	0.21836
Sphingolipid metabolism	9334	155	20	1	1	0.12903	0.21836
Pantothenate and CoA biosynthesis	9334	155	20	1	1	0.12903	0.21836
ABC transporters	9334	155	20	1	1	0.12903	0.21836
Viral protein interaction with cytokine and cytokine receptor	9334	155	20	1	1	0.12903	0.21836
TNF signaling pathway	9334	155	20	1	1	0.12903	0.21836
Glutamatergic synapse	9334	155	20	1	1	0.12903	0.21836
GABAergic synapse	9334	155	20	1	1	0.12903	0.21836
Fat digestion and absorption	9334	155	20	1	1	0.12903	0.21836
Epithelial cell signaling in Helicobacter pylori infection	9334	155	20	1	1	0.12903	0.21836
Renal cell carcinoma	9334	155	20	1	1	0.12903	0.21836
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	9334	155	20	2	1	0.24214	0.33295
HIF-1 signaling pathway	9334	155	20	2	1	0.24214	0.33295
Notch signaling pathway	9334	155	20	2	1	0.24214	0.33295
Protein digestion and absorption	9334	155	20	2	1	0.24214	0.33295
Cholesterol metabolism	9334	155	20	2	1	0.24214	0.33295
Inflammatory bowel disease	9334	155	20	2	1	0.24214	0.33295
Cytokine-cytokine receptor interaction	9334	155	20	3	1	0.34121	0.42895
Thyroid hormone signaling pathway	9334	155	20	3	1	0.34121	0.42895
Lipid and atherosclerosis	9334	155	20	3	1	0.34121	0.42895
Hematopoietic cell lineage	9334	155	20	5	1	0.50367	0.6156
Protein processing in endoplasmic reticulum	9334	155	20	6	1	0.56985	0.67766
Oocyte meiosis	9334	155	20	7	1	0.62759	0.69034
Progesterone-mediated oocyte maturation	9334	155	20	7	1	0.62759	0.69034
Human immunodeficiency virus 1 infection	9334	155	20	7	1	0.62759	0.69034
Pathways in cancer	9334	155	20	9	1	0.72173	0.77454
Coronavirus disease - COVID-19	9334	155	20	11	1	0.79298	0.83074
NOD-like receptor signaling pathway	9334	155	20	15	1	0.88695	0.90757
Ribosome biogenesis in eukaryotes	9334	155	20	18	1	0.92906	0.92906
Influenza A	9381	155	15	10	7	1.7949e-06	5.0259e-05
Hepatitis C	9381	155	15	12	7	1.0733e-05	0.00015026
Measles	9381	155	15	9	6	2.051e-05	0.00019142
Coronavirus disease - COVID-19	9381	155	15	11	6	0.00010124	0.00070869
Herpes simplex virus 1 infection	9381	155	15	9	5	0.00043036	0.00241
Epstein-Barr virus infection	9381	155	15	11	4	0.012745	0.059477
NOD-like receptor signaling pathway	9381	155	15	15	4	0.041229	0.16444
Necroptosis	9381	155	15	4	2	0.046983	0.16444
Human papillomavirus infection	9381	155	15	10	3	0.058451	0.18185
Pertussis	9381	155	15	1	1	0.096774	0.27097
Hepatitis B	9381	155	15	8	2	0.17408	0.3043
Chemokine signaling pathway	9381	155	15	2	1	0.18475	0.3043
Cell adhesion molecules	9381	155	15	2	1	0.18475	0.3043
Complement and coagulation cascades	9381	155	15	2	1	0.18475	0.3043
RIG-I-like receptor signaling pathway	9381	155	15	2	1	0.18475	0.3043
Cytosolic DNA-sensing pathway	9381	155	15	2	1	0.18475	0.3043
C-type lectin receptor signaling pathway	9381	155	15	2	1	0.18475	0.3043
JAK-STAT signaling pathway	9381	155	15	3	1	0.26468	0.39345
Pyrimidine metabolism	9381	155	15	4	1	0.33724	0.39345
Nucleotide metabolism	9381	155	15	4	1	0.33724	0.39345
Biosynthesis of cofactors	9381	155	15	4	1	0.33724	0.39345
Osteoclast differentiation	9381	155	15	4	1	0.33724	0.39345
Kaposi sarcoma-associated herpesvirus infection	9381	155	15	4	1	0.33724	0.39345
PD-L1 expression and PD-1 checkpoint pathway in cancer	9381	155	15	4	1	0.33724	0.39345
Viral life cycle - HIV-1	9381	155	15	5	1	0.40308	0.45145
Transcriptional misregulation in cancer	9381	155	15	8	1	0.56582	0.60935
Pathways in cancer	9381	155	15	9	1	0.61013	0.63272
Metabolic pathways	9381	155	15	24	1	0.92982	0.92982
Influenza A	94240	155	28	10	10	8.0025e-09	4.3214e-07
Measles	94240	155	28	9	9	6.1493e-08	1.6603e-06
Hepatitis C	94240	155	28	12	10	4.1541e-07	7.4773e-06
Coronavirus disease - COVID-19	94240	155	28	11	9	2.6346e-06	3.5567e-05
Herpes simplex virus 1 infection	94240	155	28	9	8	3.5758e-06	3.8619e-05
NOD-like receptor signaling pathway	94240	155	28	15	9	0.00014436	0.0012992
Epstein-Barr virus infection	94240	155	28	11	7	0.00061664	0.004757
Necroptosis	94240	155	28	4	4	0.00088521	0.0059752
Human papillomavirus infection	94240	155	28	10	5	0.017867	0.10191
Kaposi sarcoma-associated herpesvirus infection	94240	155	28	4	3	0.018873	0.10191
Chemokine signaling pathway	94240	155	28	2	2	0.031672	0.12216
RIG-I-like receptor signaling pathway	94240	155	28	2	2	0.031672	0.12216
Cytosolic DNA-sensing pathway	94240	155	28	2	2	0.031672	0.12216
C-type lectin receptor signaling pathway	94240	155	28	2	2	0.031672	0.12216
Hepatitis B	94240	155	28	8	4	0.035996	0.12958
JAK-STAT signaling pathway	94240	155	28	3	2	0.08425	0.28435
Osteoclast differentiation	94240	155	28	4	2	0.14963	0.34839
PD-L1 expression and PD-1 checkpoint pathway in cancer	94240	155	28	4	2	0.14963	0.34839
Glycolysis / Gluconeogenesis	94240	155	28	1	1	0.18065	0.34839
Galactose metabolism	94240	155	28	1	1	0.18065	0.34839
NF-kappa B signaling pathway	94240	155	28	1	1	0.18065	0.34839
Toll-like receptor signaling pathway	94240	155	28	1	1	0.18065	0.34839
Th1 and Th2 cell differentiation	94240	155	28	1	1	0.18065	0.34839
Prolactin signaling pathway	94240	155	28	1	1	0.18065	0.34839
AGE-RAGE signaling pathway in diabetic complications	94240	155	28	1	1	0.18065	0.34839
Growth hormone synthesis, secretion and action	94240	155	28	1	1	0.18065	0.34839
Pertussis	94240	155	28	1	1	0.18065	0.34839
Toxoplasmosis	94240	155	28	1	1	0.18065	0.34839
Viral life cycle - HIV-1	94240	155	28	5	2	0.22179	0.41299
Lysosome	94240	155	28	2	1	0.32962	0.46841
Apoptosis	94240	155	28	2	1	0.32962	0.46841
Apoptosis - multiple species	94240	155	28	2	1	0.32962	0.46841
Notch signaling pathway	94240	155	28	2	1	0.32962	0.46841
Cell adhesion molecules	94240	155	28	2	1	0.32962	0.46841
Complement and coagulation cascades	94240	155	28	2	1	0.32962	0.46841
Th17 cell differentiation	94240	155	28	2	1	0.32962	0.46841
Leishmaniasis	94240	155	28	2	1	0.32962	0.46841
Inflammatory bowel disease	94240	155	28	2	1	0.32962	0.46841
Thyroid hormone signaling pathway	94240	155	28	3	1	0.4523	0.61061
Pancreatic cancer	94240	155	28	3	1	0.4523	0.61061
Pathways in cancer	94240	155	28	9	2	0.50808	0.66383
Pyrimidine metabolism	94240	155	28	4	1	0.55319	0.66383
Nucleotide metabolism	94240	155	28	4	1	0.55319	0.66383
Biosynthesis of cofactors	94240	155	28	4	1	0.55319	0.66383
Tuberculosis	94240	155	28	4	1	0.55319	0.66383
Protein processing in endoplasmic reticulum	94240	155	28	6	1	0.70398	0.82642
Viral carcinogenesis	94240	155	28	13	2	0.72234	0.82993
Human immunodeficiency virus 1 infection	94240	155	28	7	1	0.75961	0.85245
Alzheimer disease	94240	155	28	8	1	0.80509	0.85245
Alcoholism	94240	155	28	8	1	0.80509	0.85245
Transcriptional misregulation in cancer	94240	155	28	8	1	0.80509	0.85245
Systemic lupus erythematosus	94240	155	28	10	1	0.87248	0.90603
Neutrophil extracellular trap formation	94240	155	28	13	1	0.93334	0.95095
Metabolic pathways	94240	155	28	24	2	0.95985	0.95985
DNA replication	952	155	15	4	3	0.002813	0.10408
Glutathione metabolism	952	155	15	2	2	0.0087977	0.15351
Protein processing in endoplasmic reticulum	952	155	15	6	3	0.012447	0.15351
Cell cycle	952	155	15	14	4	0.032158	0.19892
Metabolic pathways	952	155	15	24	5	0.059292	0.19892
Chemical carcinogenesis - receptor activation	952	155	15	5	2	0.073894	0.19892
Purine metabolism	952	155	15	1	1	0.096774	0.19892
Glycine, serine and threonine metabolism	952	155	15	1	1	0.096774	0.19892
Glyoxylate and dicarboxylate metabolism	952	155	15	1	1	0.096774	0.19892
Carbon metabolism	952	155	15	1	1	0.096774	0.19892
Biosynthesis of nucleotide sugars	952	155	15	1	1	0.096774	0.19892
Protein export	952	155	15	1	1	0.096774	0.19892
Base excision repair	952	155	15	1	1	0.096774	0.19892
Non-homologous end-joining	952	155	15	1	1	0.096774	0.19892
Estrogen signaling pathway	952	155	15	1	1	0.096774	0.19892
Thyroid hormone synthesis	952	155	15	1	1	0.096774	0.19892
Oxytocin signaling pathway	952	155	15	1	1	0.096774	0.19892
Pancreatic secretion	952	155	15	1	1	0.096774	0.19892
Amino sugar and nucleotide sugar metabolism	952	155	15	2	1	0.18475	0.26291
Nicotinate and nicotinamide metabolism	952	155	15	2	1	0.18475	0.26291
Calcium signaling pathway	952	155	15	2	1	0.18475	0.26291
IL-17 signaling pathway	952	155	15	2	1	0.18475	0.26291
Th17 cell differentiation	952	155	15	2	1	0.18475	0.26291
Salivary secretion	952	155	15	2	1	0.18475	0.26291
Salmonella infection	952	155	15	2	1	0.18475	0.26291
Fluid shear stress and atherosclerosis	952	155	15	2	1	0.18475	0.26291
Drug metabolism - other enzymes	952	155	15	3	1	0.26468	0.32644
PI3K-Akt signaling pathway	952	155	15	3	1	0.26468	0.32644
Prostate cancer	952	155	15	3	1	0.26468	0.32644
Lipid and atherosclerosis	952	155	15	3	1	0.26468	0.32644
Pyrimidine metabolism	952	155	15	4	1	0.33724	0.37812
Nucleotide metabolism	952	155	15	4	1	0.33724	0.37812
p53 signaling pathway	952	155	15	4	1	0.33724	0.37812
Hematopoietic cell lineage	952	155	15	5	1	0.40308	0.43864
Oocyte meiosis	952	155	15	7	1	0.51685	0.53121
Progesterone-mediated oocyte maturation	952	155	15	7	1	0.51685	0.53121
Pathways in cancer	952	155	15	9	1	0.61013	0.61013
Viral life cycle - HIV-1	9582	155	1	5	1	0.032258	0.045161
Human immunodeficiency virus 1 infection	9582	155	1	7	1	0.045161	0.045161
RNA degradation	9663	155	15	2	2	0.0087977	0.15836
Protein digestion and absorption	9663	155	15	2	2	0.0087977	0.15836
Alzheimer disease	9663	155	15	8	3	0.030834	0.26799
Glycerolipid metabolism	9663	155	15	1	1	0.096774	0.26799
Glycerophospholipid metabolism	9663	155	15	1	1	0.096774	0.26799
Arachidonic acid metabolism	9663	155	15	1	1	0.096774	0.26799
ABC transporters	9663	155	15	1	1	0.096774	0.26799
mTOR signaling pathway	9663	155	15	1	1	0.096774	0.26799
Glutamatergic synapse	9663	155	15	1	1	0.096774	0.26799
GABAergic synapse	9663	155	15	1	1	0.096774	0.26799
Fat digestion and absorption	9663	155	15	1	1	0.096774	0.26799
Epithelial cell signaling in Helicobacter pylori infection	9663	155	15	1	1	0.096774	0.26799
Pathogenic Escherichia coli infection	9663	155	15	1	1	0.096774	0.26799
Parkinson disease	9663	155	15	6	2	0.10462	0.26902
Pathways of neurodegeneration - multiple diseases	9663	155	15	7	2	0.13827	0.33185
Notch signaling pathway	9663	155	15	2	1	0.18475	0.33255
Renin-angiotensin system	9663	155	15	2	1	0.18475	0.33255
Alcoholic liver disease	9663	155	15	2	1	0.18475	0.33255
Cholesterol metabolism	9663	155	15	2	1	0.18475	0.33255
Salmonella infection	9663	155	15	2	1	0.18475	0.33255
Gap junction	9663	155	15	3	1	0.26468	0.41428
Thyroid hormone signaling pathway	9663	155	15	3	1	0.26468	0.41428
Lipid and atherosclerosis	9663	155	15	3	1	0.26468	0.41428
Ubiquitin mediated proteolysis	9663	155	15	4	1	0.33724	0.44966
Amyotrophic lateral sclerosis	9663	155	15	4	1	0.33724	0.44966
Huntington disease	9663	155	15	4	1	0.33724	0.44966
Prion disease	9663	155	15	4	1	0.33724	0.44966
Phagosome	9663	155	15	5	1	0.40308	0.50037
Hematopoietic cell lineage	9663	155	15	5	1	0.40308	0.50037
Protein processing in endoplasmic reticulum	9663	155	15	6	1	0.46277	0.55533
Oocyte meiosis	9663	155	15	7	1	0.51685	0.58146
Progesterone-mediated oocyte maturation	9663	155	15	7	1	0.51685	0.58146
Coronavirus disease - COVID-19	9663	155	15	11	1	0.68637	0.74877
Metabolic pathways	9663	155	15	24	2	0.71388	0.75587
NOD-like receptor signaling pathway	9663	155	15	15	1	0.799	0.82183
Ribosome biogenesis in eukaryotes	9663	155	15	18	1	0.85731	0.85731
Protein processing in endoplasmic reticulum	9697	155	17	6	4	0.0013379	0.058869
Salmonella infection	9697	155	17	2	2	0.011395	0.25069
Cell cycle	9697	155	17	14	4	0.050098	0.30161
DNA replication	9697	155	17	4	2	0.059742	0.30161
Chemical carcinogenesis - receptor activation	9697	155	17	5	2	0.093115	0.30161
Metabolic pathways	9697	155	17	24	5	0.097372	0.30161
Glycine, serine and threonine metabolism	9697	155	17	1	1	0.10968	0.30161
Glyoxylate and dicarboxylate metabolism	9697	155	17	1	1	0.10968	0.30161
Carbon metabolism	9697	155	17	1	1	0.10968	0.30161
Biosynthesis of nucleotide sugars	9697	155	17	1	1	0.10968	0.30161
Protein export	9697	155	17	1	1	0.10968	0.30161
Estrogen signaling pathway	9697	155	17	1	1	0.10968	0.30161
Thyroid hormone synthesis	9697	155	17	1	1	0.10968	0.30161
Oxytocin signaling pathway	9697	155	17	1	1	0.10968	0.30161
Pancreatic secretion	9697	155	17	1	1	0.10968	0.30161
Pathogenic Escherichia coli infection	9697	155	17	1	1	0.10968	0.30161
Glutathione metabolism	9697	155	17	2	1	0.20796	0.35193
Amino sugar and nucleotide sugar metabolism	9697	155	17	2	1	0.20796	0.35193
One carbon pool by folate	9697	155	17	2	1	0.20796	0.35193
Nicotinate and nicotinamide metabolism	9697	155	17	2	1	0.20796	0.35193
Folate biosynthesis	9697	155	17	2	1	0.20796	0.35193
Calcium signaling pathway	9697	155	17	2	1	0.20796	0.35193
IL-17 signaling pathway	9697	155	17	2	1	0.20796	0.35193
Th17 cell differentiation	9697	155	17	2	1	0.20796	0.35193
Salivary secretion	9697	155	17	2	1	0.20796	0.35193
Fluid shear stress and atherosclerosis	9697	155	17	2	1	0.20796	0.35193
Antifolate resistance	9697	155	17	3	1	0.29596	0.42008
PI3K-Akt signaling pathway	9697	155	17	3	1	0.29596	0.42008
Gap junction	9697	155	17	3	1	0.29596	0.42008
Prostate cancer	9697	155	17	3	1	0.29596	0.42008
Lipid and atherosclerosis	9697	155	17	3	1	0.29596	0.42008
Biosynthesis of cofactors	9697	155	17	4	1	0.37471	0.47106
Amyotrophic lateral sclerosis	9697	155	17	4	1	0.37471	0.47106
Huntington disease	9697	155	17	4	1	0.37471	0.47106
Prion disease	9697	155	17	4	1	0.37471	0.47106
Viral life cycle - HIV-1	9697	155	17	5	1	0.4451	0.51538
Phagosome	9697	155	17	5	1	0.4451	0.51538
Hematopoietic cell lineage	9697	155	17	5	1	0.4451	0.51538
Parkinson disease	9697	155	17	6	1	0.50799	0.57312
Oocyte meiosis	9697	155	17	7	1	0.56413	0.59099
Progesterone-mediated oocyte maturation	9697	155	17	7	1	0.56413	0.59099
Pathways of neurodegeneration - multiple diseases	9697	155	17	7	1	0.56413	0.59099
Alzheimer disease	9697	155	17	8	1	0.61419	0.62848
Pathways in cancer	9697	155	17	9	1	0.65881	0.65881
Cell cycle	9768	155	24	14	11	3.2386e-08	1.2955e-06
Oocyte meiosis	9768	155	24	7	6	4.8365e-05	0.00096731
p53 signaling pathway	9768	155	24	4	4	0.0004594	0.0061254
Cellular senescence	9768	155	24	7	5	0.001022	0.0081761
Progesterone-mediated oocyte maturation	9768	155	24	7	5	0.001022	0.0081761
Human T-cell leukemia virus 1 infection	9768	155	24	7	4	0.011489	0.052989
Pyrimidine metabolism	9768	155	24	4	3	0.011923	0.052989
Nucleotide metabolism	9768	155	24	4	3	0.011923	0.052989
DNA replication	9768	155	24	4	3	0.011923	0.052989
Platinum drug resistance	9768	155	24	2	2	0.023125	0.092501
Drug metabolism - other enzymes	9768	155	24	3	2	0.062725	0.22809
Human immunodeficiency virus 1 infection	9768	155	24	7	3	0.075286	0.25095
FoxO signaling pathway	9768	155	24	4	2	0.11353	0.29493
Ubiquitin mediated proteolysis	9768	155	24	4	2	0.11353	0.29493
MicroRNAs in cancer	9768	155	24	4	2	0.11353	0.29493
Purine metabolism	9768	155	24	1	1	0.15484	0.29493
Base excision repair	9768	155	24	1	1	0.15484	0.29493
Non-homologous end-joining	9768	155	24	1	1	0.15484	0.29493
Fanconi anemia pathway	9768	155	24	1	1	0.15484	0.29493
Hippo signaling pathway	9768	155	24	1	1	0.15484	0.29493
Carbohydrate digestion and absorption	9768	155	24	1	1	0.15484	0.29493
Chemical carcinogenesis - receptor activation	9768	155	24	5	2	0.1714	0.31163
Glutathione metabolism	9768	155	24	2	1	0.28655	0.39524
One carbon pool by folate	9768	155	24	2	1	0.28655	0.39524
MAPK signaling pathway	9768	155	24	2	1	0.28655	0.39524
Apoptosis	9768	155	24	2	1	0.28655	0.39524
Apoptosis - multiple species	9768	155	24	2	1	0.28655	0.39524
ECM-receptor interaction	9768	155	24	2	1	0.28655	0.39524
Colorectal cancer	9768	155	24	2	1	0.28655	0.39524
Viral carcinogenesis	9768	155	24	13	3	0.32449	0.43266
Hepatitis B	9768	155	24	8	2	0.35896	0.45539
Antifolate resistance	9768	155	24	3	1	0.39847	0.45539
AMPK signaling pathway	9768	155	24	3	1	0.39847	0.45539
Gap junction	9768	155	24	3	1	0.39847	0.45539
Acute myeloid leukemia	9768	155	24	3	1	0.39847	0.45539
Pathways in cancer	9768	155	24	9	2	0.41991	0.46656
Transcriptional misregulation in cancer	9768	155	24	8	1	0.74845	0.80473
Metabolic pathways	9768	155	24	24	3	0.7645	0.80473
Human papillomavirus infection	9768	155	24	10	1	0.82412	0.84525
Epstein-Barr virus infection	9768	155	24	11	1	0.85323	0.85323
Cell cycle	9787	155	27	14	12	4.9715e-09	2.088e-07
Oocyte meiosis	9787	155	27	7	6	0.00010432	0.0021907
DNA replication	9787	155	27	4	4	0.00075875	0.0079669
p53 signaling pathway	9787	155	27	4	4	0.00075875	0.0079669
Cellular senescence	9787	155	27	7	5	0.0018696	0.013087
Progesterone-mediated oocyte maturation	9787	155	27	7	5	0.0018696	0.013087
Antifolate resistance	9787	155	27	3	3	0.0048054	0.028833
Human T-cell leukemia virus 1 infection	9787	155	27	7	4	0.017987	0.094432
Glutathione metabolism	9787	155	27	2	2	0.029409	0.10293
One carbon pool by folate	9787	155	27	2	2	0.029409	0.10293
Folate biosynthesis	9787	155	27	2	2	0.029409	0.10293
Platinum drug resistance	9787	155	27	2	2	0.029409	0.10293
Human immunodeficiency virus 1 infection	9787	155	27	7	3	0.10193	0.30484
Pyrimidine metabolism	9787	155	27	4	2	0.14029	0.30484
Nucleotide metabolism	9787	155	27	4	2	0.14029	0.30484
Biosynthesis of cofactors	9787	155	27	4	2	0.14029	0.30484
FoxO signaling pathway	9787	155	27	4	2	0.14029	0.30484
Ubiquitin mediated proteolysis	9787	155	27	4	2	0.14029	0.30484
MicroRNAs in cancer	9787	155	27	4	2	0.14029	0.30484
Purine metabolism	9787	155	27	1	1	0.17419	0.30484
Base excision repair	9787	155	27	1	1	0.17419	0.30484
Non-homologous end-joining	9787	155	27	1	1	0.17419	0.30484
Fanconi anemia pathway	9787	155	27	1	1	0.17419	0.30484
Hippo signaling pathway	9787	155	27	1	1	0.17419	0.30484
Chemical carcinogenesis - receptor activation	9787	155	27	5	2	0.2089	0.35096
MAPK signaling pathway	9787	155	27	2	1	0.31898	0.44657
Apoptosis	9787	155	27	2	1	0.31898	0.44657
Apoptosis - multiple species	9787	155	27	2	1	0.31898	0.44657
ECM-receptor interaction	9787	155	27	2	1	0.31898	0.44657
Colorectal cancer	9787	155	27	2	1	0.31898	0.44657
Viral carcinogenesis	9787	155	27	13	3	0.40196	0.51235
Hepatitis B	9787	155	27	8	2	0.42096	0.51235
Drug metabolism - other enzymes	9787	155	27	3	1	0.43916	0.51235
AMPK signaling pathway	9787	155	27	3	1	0.43916	0.51235
Gap junction	9787	155	27	3	1	0.43916	0.51235
Acute myeloid leukemia	9787	155	27	3	1	0.43916	0.51235
Pathways in cancer	9787	155	27	9	2	0.4866	0.55236
Metabolic pathways	9787	155	27	24	4	0.63965	0.70698
Protein processing in endoplasmic reticulum	9787	155	27	6	1	0.68943	0.74246
Transcriptional misregulation in cancer	9787	155	27	8	1	0.7921	0.8317
Human papillomavirus infection	9787	155	27	10	1	0.86167	0.88268
Epstein-Barr virus infection	9787	155	27	11	1	0.88743	0.88743
Cell cycle	983	155	26	14	12	2.8017e-09	1.1767e-07
Oocyte meiosis	983	155	26	7	6	8.1668e-05	0.001715
DNA replication	983	155	26	4	4	0.00064635	0.0067866
p53 signaling pathway	983	155	26	4	4	0.00064635	0.0067866
Cellular senescence	983	155	26	7	5	0.0015427	0.010799
Progesterone-mediated oocyte maturation	983	155	26	7	5	0.0015427	0.010799
Antifolate resistance	983	155	26	3	3	0.0042715	0.025629
Human T-cell leukemia virus 1 infection	983	155	26	7	4	0.015599	0.081896
One carbon pool by folate	983	155	26	2	2	0.027231	0.10397
Folate biosynthesis	983	155	26	2	2	0.027231	0.10397
Platinum drug resistance	983	155	26	2	2	0.027231	0.10397
Human immunodeficiency virus 1 infection	983	155	26	7	3	0.092605	0.29355
Pyrimidine metabolism	983	155	26	4	2	0.13115	0.29355
Nucleotide metabolism	983	155	26	4	2	0.13115	0.29355
Biosynthesis of cofactors	983	155	26	4	2	0.13115	0.29355
FoxO signaling pathway	983	155	26	4	2	0.13115	0.29355
Ubiquitin mediated proteolysis	983	155	26	4	2	0.13115	0.29355
MicroRNAs in cancer	983	155	26	4	2	0.13115	0.29355
Purine metabolism	983	155	26	1	1	0.16774	0.29355
Base excision repair	983	155	26	1	1	0.16774	0.29355
Non-homologous end-joining	983	155	26	1	1	0.16774	0.29355
Fanconi anemia pathway	983	155	26	1	1	0.16774	0.29355
Hippo signaling pathway	983	155	26	1	1	0.16774	0.29355
Carbohydrate digestion and absorption	983	155	26	1	1	0.16774	0.29355
Chemical carcinogenesis - receptor activation	983	155	26	5	2	0.1962	0.32961
Glutathione metabolism	983	155	26	2	1	0.30825	0.41763
MAPK signaling pathway	983	155	26	2	1	0.30825	0.41763
Apoptosis	983	155	26	2	1	0.30825	0.41763
Apoptosis - multiple species	983	155	26	2	1	0.30825	0.41763
ECM-receptor interaction	983	155	26	2	1	0.30825	0.41763
Colorectal cancer	983	155	26	2	1	0.30825	0.41763
Viral carcinogenesis	983	155	26	13	3	0.37612	0.48335
Hepatitis B	983	155	26	8	2	0.40046	0.48335
Drug metabolism - other enzymes	983	155	26	3	1	0.4258	0.48335
AMPK signaling pathway	983	155	26	3	1	0.4258	0.48335
Gap junction	983	155	26	3	1	0.4258	0.48335
Acute myeloid leukemia	983	155	26	3	1	0.4258	0.48335
Pathways in cancer	983	155	26	9	2	0.46472	0.51364
Transcriptional misregulation in cancer	983	155	26	8	1	0.77835	0.83822
Metabolic pathways	983	155	26	24	3	0.81525	0.85602
Human papillomavirus infection	983	155	26	10	1	0.85004	0.87078
Epstein-Barr virus infection	983	155	26	11	1	0.87693	0.87693
Cell cycle	990	155	38	14	12	6.5706e-07	4.5337e-05
Oocyte meiosis	990	155	38	7	6	0.00090289	0.03115
DNA replication	990	155	38	4	4	0.0031913	0.05505
p53 signaling pathway	990	155	38	4	4	0.0031913	0.05505
Cellular senescence	990	155	38	7	5	0.010066	0.11576
Progesterone-mediated oocyte maturation	990	155	38	7	5	0.010066	0.11576
Protein processing in endoplasmic reticulum	990	155	38	6	4	0.032205	0.31745
Glutathione metabolism	990	155	38	2	2	0.058902	0.38717
Platinum drug resistance	990	155	38	2	2	0.058902	0.38717
Intestinal immune network for IgA production	990	155	38	2	2	0.058902	0.38717
Human T-cell leukemia virus 1 infection	990	155	38	7	4	0.061723	0.38717
Chemical carcinogenesis - receptor activation	990	155	38	5	3	0.095036	0.49702
Antifolate resistance	990	155	38	3	2	0.14899	0.49702
Cytokine-cytokine receptor interaction	990	155	38	3	2	0.14899	0.49702
Human immunodeficiency virus 1 infection	990	155	38	7	3	0.22997	0.49702
Purine metabolism	990	155	38	1	1	0.24516	0.49702
Glycine, serine and threonine metabolism	990	155	38	1	1	0.24516	0.49702
Glyoxylate and dicarboxylate metabolism	990	155	38	1	1	0.24516	0.49702
Carbon metabolism	990	155	38	1	1	0.24516	0.49702
Biosynthesis of nucleotide sugars	990	155	38	1	1	0.24516	0.49702
Protein export	990	155	38	1	1	0.24516	0.49702
Base excision repair	990	155	38	1	1	0.24516	0.49702
Non-homologous end-joining	990	155	38	1	1	0.24516	0.49702
Fanconi anemia pathway	990	155	38	1	1	0.24516	0.49702
Hippo signaling pathway	990	155	38	1	1	0.24516	0.49702
Estrogen signaling pathway	990	155	38	1	1	0.24516	0.49702
Thyroid hormone synthesis	990	155	38	1	1	0.24516	0.49702
Oxytocin signaling pathway	990	155	38	1	1	0.24516	0.49702
Pancreatic secretion	990	155	38	1	1	0.24516	0.49702
Primary immunodeficiency	990	155	38	1	1	0.24516	0.49702
Pyrimidine metabolism	990	155	38	4	2	0.25211	0.49702
Nucleotide metabolism	990	155	38	4	2	0.25211	0.49702
FoxO signaling pathway	990	155	38	4	2	0.25211	0.49702
Ubiquitin mediated proteolysis	990	155	38	4	2	0.25211	0.49702
MicroRNAs in cancer	990	155	38	4	2	0.25211	0.49702
Pathways in cancer	990	155	38	9	3	0.38535	0.58369
Amino sugar and nucleotide sugar metabolism	990	155	38	2	1	0.43142	0.58369
One carbon pool by folate	990	155	38	2	1	0.43142	0.58369
Nicotinate and nicotinamide metabolism	990	155	38	2	1	0.43142	0.58369
Folate biosynthesis	990	155	38	2	1	0.43142	0.58369
MAPK signaling pathway	990	155	38	2	1	0.43142	0.58369
Calcium signaling pathway	990	155	38	2	1	0.43142	0.58369
Apoptosis	990	155	38	2	1	0.43142	0.58369
Apoptosis - multiple species	990	155	38	2	1	0.43142	0.58369
ECM-receptor interaction	990	155	38	2	1	0.43142	0.58369
IL-17 signaling pathway	990	155	38	2	1	0.43142	0.58369
Th17 cell differentiation	990	155	38	2	1	0.43142	0.58369
Salivary secretion	990	155	38	2	1	0.43142	0.58369
Salmonella infection	990	155	38	2	1	0.43142	0.58369
Colorectal cancer	990	155	38	2	1	0.43142	0.58369
Fluid shear stress and atherosclerosis	990	155	38	2	1	0.43142	0.58369
Metabolic pathways	990	155	38	24	6	0.56643	0.66969
Drug metabolism - other enzymes	990	155	38	3	1	0.57264	0.66969
PI3K-Akt signaling pathway	990	155	38	3	1	0.57264	0.66969
AMPK signaling pathway	990	155	38	3	1	0.57264	0.66969
Gap junction	990	155	38	3	1	0.57264	0.66969
Prostate cancer	990	155	38	3	1	0.57264	0.66969
Acute myeloid leukemia	990	155	38	3	1	0.57264	0.66969
Lipid and atherosclerosis	990	155	38	3	1	0.57264	0.66969
Hepatitis B	990	155	38	8	2	0.62678	0.7208
Viral carcinogenesis	990	155	38	13	3	0.66248	0.74936
Biosynthesis of cofactors	990	155	38	4	1	0.67948	0.75619
Viral life cycle - HIV-1	990	155	38	5	1	0.76014	0.81952
Hematopoietic cell lineage	990	155	38	5	1	0.76014	0.81952
Parkinson disease	990	155	38	6	1	0.8209	0.87142
Pathways of neurodegeneration - multiple diseases	990	155	38	7	1	0.86658	0.90597
Transcriptional misregulation in cancer	990	155	38	8	1	0.90084	0.92773
Human papillomavirus infection	990	155	38	10	1	0.94561	0.95951
Epstein-Barr virus infection	990	155	38	11	1	0.95986	0.95986
Cell cycle	991	155	23	14	11	1.7912e-08	7.165e-07
Oocyte meiosis	991	155	23	7	6	3.6507e-05	0.00073014
p53 signaling pathway	991	155	23	4	4	0.00038284	0.0051045
Cellular senescence	991	155	23	7	5	0.00081917	0.0065534
Progesterone-mediated oocyte maturation	991	155	23	7	5	0.00081917	0.0065534
Human T-cell leukemia virus 1 infection	991	155	23	7	4	0.0097443	0.046621
Pyrimidine metabolism	991	155	23	4	3	0.01049	0.046621
Nucleotide metabolism	991	155	23	4	3	0.01049	0.046621
DNA replication	991	155	23	4	3	0.01049	0.046621
Drug metabolism - other enzymes	991	155	23	3	2	0.057775	0.2311
Human immunodeficiency virus 1 infection	991	155	23	7	3	0.067311	0.24477
FoxO signaling pathway	991	155	23	4	2	0.10506	0.30017
Ubiquitin mediated proteolysis	991	155	23	4	2	0.10506	0.30017
MicroRNAs in cancer	991	155	23	4	2	0.10506	0.30017
Purine metabolism	991	155	23	1	1	0.14839	0.31239
Base excision repair	991	155	23	1	1	0.14839	0.31239
Non-homologous end-joining	991	155	23	1	1	0.14839	0.31239
Fanconi anemia pathway	991	155	23	1	1	0.14839	0.31239
Hippo signaling pathway	991	155	23	1	1	0.14839	0.31239
Chemical carcinogenesis - receptor activation	991	155	23	5	2	0.15934	0.31868
Glutathione metabolism	991	155	23	2	1	0.27558	0.39368
One carbon pool by folate	991	155	23	2	1	0.27558	0.39368
Platinum drug resistance	991	155	23	2	1	0.27558	0.39368
MAPK signaling pathway	991	155	23	2	1	0.27558	0.39368
Apoptosis	991	155	23	2	1	0.27558	0.39368
Apoptosis - multiple species	991	155	23	2	1	0.27558	0.39368
ECM-receptor interaction	991	155	23	2	1	0.27558	0.39368
Colorectal cancer	991	155	23	2	1	0.27558	0.39368
Viral carcinogenesis	991	155	23	13	3	0.29892	0.41231
Hepatitis B	991	155	23	8	2	0.33806	0.45075
Antifolate resistance	991	155	23	3	1	0.38448	0.45233
AMPK signaling pathway	991	155	23	3	1	0.38448	0.45233
Gap junction	991	155	23	3	1	0.38448	0.45233
Acute myeloid leukemia	991	155	23	3	1	0.38448	0.45233
Pathways in cancer	991	155	23	9	2	0.39705	0.45377
Protein processing in endoplasmic reticulum	991	155	23	6	1	0.62508	0.69454
Transcriptional misregulation in cancer	991	155	23	8	1	0.73223	0.77422
Metabolic pathways	991	155	23	24	3	0.73551	0.77422
Human papillomavirus infection	991	155	23	10	1	0.80971	0.83047
Epstein-Barr virus infection	991	155	23	11	1	0.83989	0.83989
